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Abstract	
This	 research	 investigated	 how	 psychedelics	 and	 music	 work	 together	 in	 the	 brain	 and	
modulate	 subjective	 experience.	 Chapter	 1	 highlighted	 the	 prominent	 role	 of	 music	 in	
psychedelic	therapy	in	the	1950s	and	1960s,	and	how	music	continues	to	be	used	in	modern	
psychotherapeutic	 trials	with	psychedelics.	Although	 ‘psychedelic	 therapy’	 shows	promising	
findings	for	mental	health	care,	little	is	known	empirically	about	the	therapeutic	functions	of	
music.	The	primary	objective	of	 this	 thesis	was	to	address	this	knowledge	gap,	via	studying	
the	effects	of	psychedelics	and	music	on	human	brain	function	in	healthy	volunteers,	and	via	
studying	 the	 subjective	 experience	 of	 music,	 both	 in	 healthy	 volunteers	 and	 in	 patients	
undergoing	psychedelic	therapy.	
Study	 1	 (Chapter	 3)	 demonstrated	 intensified	 music-evoked	 emotions	 under	 the	 classic	
psychedelic	 LSD,	 including	 emotions	 of	 ‘wonder’	 and	 ‘transcendence’.	 In	 subsequent	work	
(study	2,	Chapter	4),	 increased	activation	 in	the	 inferior	frontal	gyrus	and	the	precuneus	to	
the	 timbre	 features	 in	 the	music,	was	associated	with	 increased	music-evoked	emotions	of	
wonder.	 Study	 3	 (Chapter	 5)	 demonstrated	 that	 LSD	 and	 music	 interact	 to	 enhance	
information	 flow	 from	 the	 parahippocampus	 to	 the	 visual	 cortex,	 and	 that	 this	 effect	
correlated	with	increased	complex	mental	imagery	and	autobiographical	memories.	Study	4	
(Chapter	 6),	 showed	 that	music	 has	 a	 substantial	 influence	 on	 the	 therapeutic	 experience	
with	psilocybin	in	patients	with	depression,	and	the	quality	of	the	music-experience	predicted	
peak	 experiences	 and	 insightfulness	 during	 sessions,	 and	 reductions	 in	 depression	 after	
sessions.		
These	 findings	 support	 the	 hypothesis	 that	 the	 music-experience	 is	 intensified	 under	
psychedelics,	 and	 the	 widely-held	 view	 that	 this	 effect	 may	 be	 therapeutically	 significant.	
Possible	 brain	 mechanisms	 and	 therapeutic	 mechanisms	 are	 discussed	 in	 Chapter	 7,	 but	
further	 research	 is	 warranted	 to	 better	 understand	 these	 mechanisms,	 and	 to	 learn	 how	
music	can	be	best	used	in	psychedelic	therapy.	
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Glossary	
	
Psychedelics	 |	 The	 word	 psychedelic	 is	 derived	 from	 the	 Greek	 words	 psychḗ	 meaning	
“mind”	 or	 “soul”,	 and	 dêlos,	 meaning	 “to	 manifest”	 or	 “make	 visible”.	 Compounds	
considered	 “classic”	 psychedelics	 include	psilocybin	 (the	psychoactive	 constituent	 of	magic	
mushrooms),	 LSD,	mescaline	 (the	 psychoactive	 constituent	 of	 peyote	 and	 san	 pedro	 cacti)	
and	 DMT	 (a	 major	 psychoactive	 ingredient	 in	 the	 Amazonian	 brew	 ayahuasca).	 All	 these	
drugs	 share	 the	 property	 of	 being	 agonists	 at	 the	 serotonin	 2A	 receptor	 and	 have	
phenomenological	similarities.	The	use	of	the	term	‘psychedelics’	 in	this	paper	refers	to	the	
classic	psychedelics	such	as	those	listed	above.	
	
Peak	 experience	 |	 Peak-experiences	 are	 characterized	 by	 a	 “transcending”	 of	 one’s	 usual	
sense	 of	 selfhood,	 typically	 accompanied	 by	 emotions	 of	 wonder,	 blisfulnesss	 and	 awe	
(Maslow,	1970).	They	are	often	are	associated	with	a	sensation	of	union	or	completeness,	a	
sense	 of	 absence	 or	 resolution	 of	 inner	 conflict,	 and	 a	 sense	 of	 serenity,	 confidence	 and	
meaningful	purpose	in	one’s	personal	life	(Maslow,	1970,	Stace,	1970).	
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“Music	may	be	a	human	invention,	but	if	so,	it	resembles	the	ability	to	make	
and	control	fire:	it	is	something	we	invented	that	transforms	human	life.	
Indeed,	it	is	more	remarkable	than	fire	making	in	some	ways,	because	not	only	
is	it	a	product	of	our	brain’s	mental	capacities,	it	also	has	the	power	to	change	
the	brain.	It	is	thus	emblematic	of	our	species’	unique	ability	to	change	the	
nature	of	ourselves.”	
Aniruddh	D.	Patel	
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1		 Background	|	Why	study	psychedelics	
and	music?
Psychedelic	drugs	and	music	have	a	profound	capacity	to	alter	consciousness,	and	have	been	
used	 by	 humans	 for	 thousands	 of	 years	 and	 across	 various	 cultures.	 In	 recent	 years,	
increasing	numbers	of	studies	have	assessed	the	psychotherapeutic	potential	of	psychedelic	
drugs,	 commonly	 referred	 to	 as	 “psychedelic	 therapy”.	 Within	 this	 approach,	 music	 is	
considered	 to	 be	 an	 important	 therapeutic	 component.	 The	 results	 of	 these	 studies	 are	
promising,	yet	so	far,	the	function	of	music	 in	psychedelic	therapy	has	not	been	addressed.	
Increasing	numbers	of	studies	have	examined	how	psychedelic	drugs	and	music	work	in	the	
brain	separately,	yet	so	far,	no	study	has	investigated	how	they	work	together.	
The	 research	 presented	 here	 was	 founded	 on	 the	 primary	 motivation	 to	 increase	 our	
understanding	 of	 the	 therapeutic	 functions	 of	music	 in	 psychedelic	 therapy,	 by	 combining	
neuroscience	and	qualitative	research	methods.	Because	the	subjective	experiences	of	music	
that	 are	 often	 described	 under	 a	 psychedelic	 depict	 a	 remarkable	 profoundness,	 their	
combined	 study	 can	 prove	 fruitful	 as	 a	 new	 research	 paradigm	 in	 itself;	 one	 that	 may	
significantly	advance	our	understanding	of	how	the	human	brain	processes	music,	and	more	
broadly,	how	the	human	brain	produces	certain	subjective	states	that	are	otherwise	difficult	
to	access	under	experimental	conditions	(e.g.	peak	experiences	and	emotional	catharsis).	
This	introduction	chapter	serves	to	introduce	the	reader	to	the	rich	history	in	which	this	topic	
is	embedded,	and	to	provide	a	comprehensive	overview	of	the	relevant	academic	literature.	
In	 the	 first	 half,	 this	 chapter	 will	 describe	 the	 historic	 use	 of	 psychedelics	 and	music,	 the	
development	of	psychedelic	therapy	in	the	1950s	and	1960s,	and	the	major	perspectives	that	
emerged	 from	 this	 work,	 including	 the	 original	 motivations	 for	 the	 use	 of	 music.	 In	 the	
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second	 half,	 this	 chapter	 will	 review	 the	 recent	 clinical,	 psychopharmacological,	 and	
neuroscience	 literature	 on	 psychedelics	 and	music,	 and	 converge	 into	 an	 outlining	 of	 the	
primary	research	questions	this	study	aims	to	answer.	
	
1.1	What	are	psychedelics?	
The	 term	 psychedelic	 was	 first	 coined	 by	 the	 British	 psychiatrist	 Humphrey	 Osmond	 in	
conversation	with	the	author	Aldous	Huxley	in	1956.	Osmond	had	introduced	Huxley	to	the	
cacti-derived	psychoactive	drug	mescaline	in	1953,	after	which	Huxley	wrote	the	classic	book	
The	Doors	of	Perception	to	Heaven	and	Hell.	Their	research	and	their	personal	accounts	with	
mescaline,	 and	 later	 with	 lysergic	 acid	 diethylamide	 (LSD),	 contributed	 to	 the	 then	
revolutionary	 idea	 in	 the	 psychiatric	 community	 that	 changes	 in	 mental	 states	 are	 due	
changes	in	neurochemistry.	Humprhey	and	Huxley	engaged	in	a	quest	to	replace	terms	that	
were	 previously	 used	 for	 these	 compounds,	 such	 as	 psychoto-mimetic	 (i.e.	 psychosis-
mimicking	compounds)	or	hallucinogen	 (i.e.	hallucination-inducing	compounds),	with	a	new	
term	that	they	intended	to	be	“more	inclusive”:	a	term	that	would	not	solely	describe	their	
ability	 to	 elicit	 psychosis-like	 symptoms	 or	 hallucinations,	 but	 also	 their	 ability	 to	 evoke	
experiences	that	have	psychodynamic,	aesthetic	and	spiritual	significance.		
	
In	a	famous	letter	in	1956,	Huxley	sent	Osmond	the	following	rhyme:			
"To	make	this	trivial	world	sublime,	take	half	a	gram	of	phanerothyme."		
Osmond	responded	to	this	by	writing:		
"To	fathom	hell	or	soar	angelic,	just	take	a	pinch	of	psychedelic."	
	
The	word	psychedelic	was	derived	from	combining	the	Greek	words	psychḗ,	meaning	“mind”	
or	“soul”,	with	dêlos,	meaning	“to	manifest”	or	“to	make	visible”.	It	refers	to	the	notion	that	
these	 compounds	 can	 bring	 into	 the	 awareness	 a	 wide	 spectrum	 of	 latent	 psychological	
content,	 that	 can	both	strongly	positive	or	negative	 in	emotional	 valence	–	hence	 the	 idea	
that	they	let	the	individual	who	takes	them	“fathom	hell	or	soar	angelic”.	Osmond	presented	
the	term	“psychedelic”	for	the	first	time	at	a	scientific	conference	in	1957	(Osmond,	1957),	
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and	Huxley	illustrated	this	view	in	an	elaboration	on	his	personal	experience	with	mescaline,	
in	1954,	in	his	book	The	Doors	of	Perception:	
“But	what	 I	had	expected	did	not	happen.	 I	had	expected	 to	 lie	with	my	eyes	 shut,	
looking	 at	 visions	 of	many-colored	 geometries,	 of	 animated	 architectures,	 rich	with	
gems	 and	 fabulously	 lovely,	 of	 landscapes	 with	 heroic	 figures,	 of	 symbolic	 dramas	
trembling	perpetually	on	the	verge	of	the	ultimate	revelation.	But	I	had	not	reckoned,	
it	 was	 evident,	 with	 the	 idiosyncrasies	 of	 my	 mental	 make-up,	 the	 facts	 of	 my	
temperament,	training	and	habits.”	(Huxley,	1954)	
	
Drugs	 considered	 “classic”	 psychedelics	 include	 lysergic	 acid	 diethylamide	 (LSD),	 psilocybin	
(the	 major	 psychoactive	 constituent	 of	 magic	 mushrooms),	 mescaline	 (a	 psychoactive	
constituent	of	peyote	and	San	Pedro	cacti)	and	DMT	(a	major	psychoactive	ingredient	in	the	
Amazonian	 brew	 ayahuasca).	 As	 will	 be	 discussed	 in	 greater	 detail	 in	 later	 paragraphs,	 all	
these	compounds	share	the	property	of	stimulating	the	serotonin	2A	receptor	(Vollenweider	
et	 al.	 1998;	 Aghajanian	 and	 Marek,	 1999).	 The	 use	 of	 the	 term	 “psychedelics”	 in	 this	
manuscript	 refers	 to	 these	 compounds	or	 to	 the	plants,	mushrooms	or	 cacti	 that	naturally	
produce	them.		
	
1.2	Psychedelics	and	music	in	pre-historic	times	
Both	 psychedelics	 and	 music	 share	 an	 interesting	 history,	 and	 one	 that	 may	 be	 more	
intertwined	than	separated.	An	introduction	to	the	modern	study	of	psychedelics	and	music	
may	 therefore	 not	 be	 complete	 without	 connecting	 it	 to	 their	 rich	 historical	 and	 cultural	
origins.	The	challenge	with	discussions	of	ancient	history	lies	however	in	the	tendency	of	the	
earth	 to	 decompose	 virtually	 anything	 in	 time.	 This	 not	 only	 renders	 controlled	 scientific	
experimentation	impossible,	but	the	little	archaeological	findings	that	are	well-preserved	and	
successfully	uncovered	are	 therefore	precious,	and	also	need	to	be	viewed	 in	 that	 respect:	
They	 are	 likely	 to	 represent	 a	mere	minuscule	 fraction	 of	 everything	 that	 once	 has	 been.	
What	can	we	therefore	safely	infer,	without	too	much	speculation,	about	the	historical	use	of	
music	and	the	historical	consumption	of	psychedelics?	
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For	music,	this	task	may	be	relatively	simpler,	as	music-making	can	(but	not	necessarily)	imply	
the	crafting	of	musical	instruments.	Such	artefacts	are	more	likely	to	be	preserved	than,	let’s	
say,	 a	mushroom.	 Various	 uncovered	 stones	 show	modifications	 that	 indicate	 their	 use	 as	
rhythm	 instruments,	 such	 as	 rasping	 and	 drumming.	Mammoth	 bones	 showing	 such	 signs	
were	found	along	beaters	and	ivory	rattles	in	Mezin,	Ukraine,	and	dated	to	20,000	years	old	
(Lbova	et	al.,	2013;	Bibikov,	1978).	But	the	oldest	artefacts	that	have	been	identified	reliably	
as	musical	instruments	are	bone	and	ivory	flutes	found	in	Germany,	and	these	are	estimated	
to	be	more	than	35.000	years	old	(Conard	et	al.,	2009;	d’Errico	et	al.,	2003).	Not	only	is	this	
finding	striking	because	of	the	age	(i.e.	these	flutes	were	thus	played	in	a	period	long	before	
the	 onset	 of	 agricultural	 settlements,	 and	 in	 a	 time	 period	 where	 human	 cave-dwellers	
shared	 these	 untamed	 natural	 landscapes	 with	 other	 hominid	 species,	 such	 as	
Neanderthalers);	 but	 also,	 because	 these	 instruments	 are	 already	 evident	 of	 a	 remarkable	
sophistication.	 The	 separate	 holes	 allow	 the	 production	 of	 a	 broad	 repertoire	 of	 auditory	
pitches.	 This	 suggests	 that	 humans	 have	 likely	 engaged	 in	musical	 activities	 for	 periods	 of	
time	preceding	the	production	of	these	advanced	musical	instruments.		
Indeed,	instruments	are	not	necessary	to	make	music,	and	from	records	of	hunter-gatherer	
societies	 across	 the	 globe	 it	 is	 clear	 that,	 for	 example,	 vocalisation	 and	 clapping	 play	
important	roles	 in	a	variety	of	musical	activities.	 In	many	of	 these	aboriginal	societies	 (e.g.,	
Native	Americans,	Aka	and	Mbuti	African	pygmies,	Australian	aboriginals	and	Yupik	Eskimos	
of	Alaska),	music	has	strong	ceremonial	functions,	including	social,	celebratory,	medicinal	and	
–particularly	 frequent-	 shamanic	 (Nettl,	 1956).	 The	 pioneering	 ethnomusicologist	 Bruno	
Nettle	was	amongst	the	first	to	point	this	out	in	his	book	Music	in	Primitive	Culture,	where	he	
writes:	
“Among	 many	 American	 Indian	 and	 some	 Paleo-Siberian	 tribes,	 composition	 is	
ordinarily	relegated	to	shamans	(medicine-men)	or	other	 individuals	connected	with	
religion	 in	 a	 particular	 way.	 Indeed,	 musical	 and	 religious	 specialisation	 are	 often	
correlated,	and	are	probably	the	two	activities	of	primitive	life	in	which	specialisation	
most	commonly	occurs.”	(Nettl,	1956)	
	
Nettle	 also	 documented	 the	 central	 role	 of	 music	 during	 shamanic	 ceremonies	 of	 Native	
American	Indians	that	include	the	consumption	of	mescaline-containing	cacti.	This	was	soon	
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followed	by	the	documentation	the	ayahuasca-ceremonies	in	many	tribes	in	South-America,	
the	mushroom-ceremonies	in	Central	America,	Siberia	and	Papua	New	Guinea,	the	Ibogaine-
ceremonies	in	west	Africa,	the	Yopo	-ceremonies	in	the	Caribbean’s,	and	so	forth	(Schultes	et	
al.,	 2001)	 -	 all	 of	 which	 are	 characterised	 by	 the	 prominent	 use	 of	 music	 during	 the	
ceremonies.	 Typically,	 this	 music	 consists	 of	 lengthily	 repeated	 and	 simple	 melodic	
structures,	produced	via	chanting	or	whistling,	and	often	has	significant	rhythmic	properties,	
emphasised	by	 the	use	of	 rattles,	drums	or	 clapping.	 This	 simplicity	may	be,	 and	has	been	
argued	to	be	(Becker,	2004),	ideally	suited	to	support	the	strong	introspective	altered	states	
of	 consciousness	 facilitated	 by	 these	 ceremonies.	 In	 these	 contexts,	 the	 music	 is	 often	
considered	 sacred,	 only	 to	be	used	 for	 this	 purpose,	 and	 is	 associated	with	 the	evoking	of	
vivid	eyes-closed	 imagery	and	powerful	emotions.	A	good	example	for	this	 is	 the	singing	of	
the	 “spirit-songs”	 or	 icaro’s	 that	 are	 sung	 during	 ayahuasca-ceremonies,	 of	 which	 the	
anthropologist	Marlene	Dobkin	De-Rios	said	the	following:	
“We	could	only	marvel	at	the	pervasive	presence	of	music	in	a	variety	of	forms,	as	an	
integral	 part	 of	 the	 psychedelic	 experience	 [..]	 Shamans	 state	 that	 the	 music	 they	
create	provokes	special	types	of	visions.	Healers	told	me	that	the	particular	traditional	
melodies,	 icaros,	 that	 they	 choose	 to	 sing	 or	 whistle,	 would	 evoke	 visions	 they	
specifically	desired	their	clients	to	have,	to	permit	them	to	see	the	agent	responsible	
for	bewitchment,	to	resolve	anxiety	created	in	the	wake	of	psychedelics	use,	and	so	
on.”	(Dobkin	de	Rios,	2009)	
	
How	 far	do	 these	 traditions	 stretch	back	 into	human	history?	Evidence	 for	 the	pre-historic	
use	of	psychedelic	plants,	cacti	and	mushrooms	in	combination	with	music-making	is	elusive.	
However,	their	use	by	hunter-gatherer	societies	in	the	modern	era	is	suggestive	for	their	use	
by	earlier	communities.	Since	their	natural	resources	and	tool-use	are	often	similar,	and	thus	
likely	remained	static,	and	given	that	natural	resources	and	tool-use	define	cultural	lifestyles	
to	 a	 large	 degree,	 ceremonial	 constructs	 may	 be	 preserved	 for	 lengthy	 times	 too.	 This	
argument	has	been	made	for	the	archaeology	of	music	(Morley,	2013),	and	can	equally	apply	
to	 the	 archaeology	 of	 psychedelics	 and	 their	 combined	 use	 with	 music-making.	 The	
ceremonial	 use	 of	 psycho-active	 plants	 and	 music	 is	 shown	 amongst	 many	 aboriginal	
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societies	on	different	continents,	and	may	therefore	be	considered	to	be	as	central	to	human	
culture	as	is	commonly	argued	for	music	alone.	
More	direct	 archaeological	 evidence	 for	 the	 ceremonial	 consumption	of	psychedelic	plants	
comes	from	various	uncovered	artefacts.	Of	these,	the	rock	and	cave	art	of	the	Tassili	n	Ajjer	
desert	in	Algeria,	dated	to	be	7000	to	9000	years	old,	may	be	both	the	most	ancient	and	the	
most	 mysterious	 association	 with	 psychedelic	 mushrooms	 (Lajoux	 et	 al.,	 1964;	 Samorini,	
1992;	McKenna,	1993).	These	include,	and	are	not	limited	to,	a	feathered-headed	bee-faced	
figure	 with	 mushrooms	 sprouting	 out	 of	 his	 body,	 smiling	 figures	 with	 mushroom-shaped	
hats	 running	 around	 with	 mushrooms	 in	 their	 hands,	 and	 female	 figures	 with	 round	 and	
colourful	 mushroom-capped	 faces.	 Some	 authors	 have	 argued	 that	 the	 vast	 amounts	 of	
geometric	 drawings	 found	 on	 cave-walls	 alongside	 these	 and	 other	 regions,	 supplements	
evidence	for	the	authors	of	these	drawings	to	be	in	an	altered	state	(Rudgley,	1995,	2014).	In	
a	 cave	 in	 Spain,	 painted	 rows	 of	 mushrooms	 were	 found,	 resembling	 locally	 growing	
psychedelic	 mushrooms,	 and	 dated	 to	 be	 7000	 years	 old	 (Akers	 et	 al.,	 2011).	 In	 North	
America,	Texas,	specimen	of	peyote	found	in	caves	and	rock	shelters	were	dated	to	be	5600	
years	 old	 (Bruhn	 et	 al.,	 2002;	 El-Seedi	 et	 al.,	 2005).	 Pipes	 with	 residues	 of	 burned	 DMT-
containing	 seeds	 in	Argentinia	were	dated	 to	be	more	 than	4000	 years	old	 (Torres,	 1998).	
Many	mushroom-shaped	 stones	were	 uncovered	 in	 Guatemala,	 and	 dated	 to	 be	 between	
3000	 to	 2000	 years	 old,	 alongside	 multitudes	 of	 artistic	 depictions	 of	 mushrooms	 and	
mushroom-eating	figures	on	ceramics	from	the	same	regions	and	time-periods	(de	Borhegyi,	
1963;	Guerra-Doce,	2015).		
The	 Greek	 gods	 Persephone	 and	 Demeter	 are	 depicted	 sharing	 a	 mushroom,	 and	 are	
associated	 with	 the	 then	 highly	 popular	 mystery	 cult	 “Eleusis”,	 in	 which	 the	 participants	
gathered	to	share	a	psycho-active	drink	called	“Keykeon”	(Hoffman	and	Wasson,	2009).	The	
Eastern	 Vedic	 hymns	 are	 devotions	 to	 “Soma”,	 the	 “king	 of	 all	 plants”,	 which	 supposedly	
elevated	 the	 consumer	 to	 become	 godlike,	 and	 some	 Indian	 sects	 maintain	 the	 use	
psychedelic	drugs	as	part	of	 their	 rituals	 (Wasson,	1972).	Biblical	 traditions	tell	 the	story	of	
Moses	 who	 guides	 the	 Israelites	 to	 find	 “Manna”,	 “the	 bread	 of	 god”,	 which	 appears	 as	
circular	 disks	 in	 the	morning	 dew	 of	 the	 fields,	 and	 which	 would	make	 god	 visible	 to	 the	
human	eye	after	eating	(Merkur,	2000).		
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Reviewing	 the	 various	 references	 to	 the	historic	 consumption	of	 psychedelics	 in	 the	major	
spiritual	 traditions	 of	 today,	 is	 beyond	 the	objectives	 of	 this	 thesis,	 but	 this	 discussion	has	
sketched	 out	 a	 general	 message:	 The	 uncovering	 of	 the	 various	 artefacts	 and	 the	
conservation	of	psychedelic-	and	music-use	in	aboriginal	societies	today,	suggest	that	music-
making	and	the	consumption	of	psychedelics	are	both	ancient	and	universally	human.	
	
1.3.	Psychedelics	in	modern	times	
Although	 Europe	 is	 home	 to	 various	 psycho-active	 plants	 and	 psilocybin-containing	
mushrooms,	knowledge	about	psychedelics	 in	modern	 times	only	 started	 to	break	 through	
into	mainstream	science	 in	the	first	half	of	the	20th	century.	Some	argue	that	the	 infamous	
witch-hunts	 spanning	 the	 15th	 to	 the	 18th	 century	 in	 Europe	 played	 a	 role	 in	 eradicating	
ceremonial	psychedelic-plant	use	(Rudgley,	2014).	The	sudden	rise	in	interest	in	psychedelics	
in	 the	 20th	 century	 was	 catalysed	 by	 (1)	 the	 birth	 of	 ethnopharmacology,	 and	 (2)	 the	
discovery	of	LSD.	
One	of	the	most	significant	contributions	for	the	former,	may	be	the	work	of	Richard	Evans	
Schultes.	 Via	 more	 than	 450	 publications	 in	 the	 early-	 and	 mid	 20th	 century,	 Schultes	
increased	awareness	within	the	western	scientific	community	about	the	traditional	usages	of	
various	 psychedelic	 plants	 around	 the	 world	 (Schultes	 and	 Hofmann,	 1980;	 Schultes,	
Hofmann,	and	Rätsch,	2001).		
The	discovery	of	LSD	centres	around	Albert	Hofmann	and	his	work	in	Sandoz	laboratories	in	
Basel,	 Switzerland	 (Hofmann,	 1980).	 In	 search	 for	 a	 novel	 blood	 circulatory	 stimulant,	
Hofmann	synthesized	a	range	of	derivatives	from	ergot	alkaloids	in	1938,	one	of	which	being	
LSD-25.	 On	 16	 April	 1943	 Hofmann	 accidentally	 intoxicated	 himself	 while	 re-assessing	 his	
earlier	works	with	LSD.	He	felt	dizzy	and	went	home.	Three	days	later	Hofmann	intentionally	
ingested	 250	mcg	 of	 LSD,	 to	 test	 whether	 it	 was	 this	 drug	 that	 caused	 the	 symptoms	 he	
experienced	earlier.	What	he	believed	would	be	a	miniscule	dose,	turned	out	to	be	what	 is	
now	known	as	10	times	the	amount	of	a	threshold	psychoactive	dose.	Hofmann	described	his	
experience	as	both	frightening	and	fascinating.	After	reassurance	of	his	physiological	health	
by	 his	 doctor,	 he	 described	 how	 he	 experienced	 “an	 uninterrupted	 stream	 of	 fantastic	
pictures,	 extraordinary	 shapes	 with	 intense,	 kaleidoscope-like	 play	 of	 colours".	 But	 it	 was	
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what	 he	 experienced	 the	 day	 after,	 that	 provided	 an	 inspiration	 for	 the	many	 therapeutic	
investigations	that	would	soon	follow.	Hofmann	describes	in	his	autobiography	that	he	woke	
up	the	next	day	with	a	remarkable	mental	clarity,	and	wrote:	
“A	sensation	of	well-being	and	renewed	life	flowed	through	me.	The	world	was	as	if	
newly	created.	All	my	senses	vibrated	in	a	condition	of	highest	sensitivity.”		(Hofmann	
1980)	
	
Soon	LSD	was	actively	marketed	under	the	name	“delysid”	to	psychiatrists	and	researchers,	
as	an	adjunct	for	psychotherapy	and	as	a	tool	to	study	psychosis	(Stoll	and	Hofmann,	1944).	
The	 subsequent	 paragraphs	 will	 provide	 an	 overview	 of	 the	 early	 scientific	 efforts	 that	
followed	the	discovery	of	LSD,	and	the	perspectives	that	grew	out	of	this	on	its	therapeutic	
use	and	mechanisms.	
	
1.4	Development	of	psychedelic	therapy	in	the	1950s	and	1960s	
Claude	and	Ey	(1934),	and	Guttman	and	Maclay	(1936)	may	have	been	the	first	to	discuss	the	
potential	 therapeutic	 use	 of	 psychedelics	 in	 the	 academic	 literature	 (Claude	 and	 Ey,	 1934;	
Guttmann	 and	 Maclay,	 1936).	 The	 study	 by	 Guttmann	 and	 Maclay	 (1936)	 administered	
mescaline	 to	 patients	 with	 “depersonalisation”,	 and	 reported	 that	 the	 patients	 who	
demonstrated	 an	 improvement	 afterwards	 all	 shared	 a	 similar	 statement	 about	 their	
experience	with	mescaline:	
“I	have	seen	that	I	can	be	as	I	used	to	be	before.”		(Guttmann	and	Maclay,	1936)	
	
Regardless	of	 the	 infancy	of	 research	with	psychedelics	 at	 that	 time,	 this	 short	description	
already	 depicted	 succinctly	 what	 would	 soon	 be	 viewed	 as	 a	 principal	 effect	 via	 which	
psychedelics	 act	 therapeutically:	 their	 ability	 to	 quickly	 and	 radically	 change	 a	 person’s	
perspective,	leading	to	sustained	changes	in	outlook,	personality,	mood	and	behaviour	(Grof,	
1980;	 Grinspoon	 and	 Bakalar,	 1981).	 This	 section	will	 examine	 the	 perspectives	 that	were	
born	out	of	psychiatric	research	with	psychedelics	in	the	1950s	and	1960s,	and	how	this	led	
to	the	central	use	of	music	during	psychedelic	therapy	sessions.	
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1.4.1	The	function	of	therapeutic	experiences	
Despite	earlier	reports	on	mescaline,	it	was	the	discovery	of	the	psycho-active	effects	of	LSD	
in	 1943	 that	 sparked	 a	 great	 international	 interest	 in	 the	 therapeutic	 potentials	 of	
psychedelics.	Busch	and	 Johnson	 (1950)	were	 the	 first	 to	 report	on	 the	 therapeutic	use	of	
LSD,	 describing	 the	 effects	 of	 LSD	 as	 increasing	 the	 patient’s	 “expressiveness”	 and	 as	
“permitting	 re-examination	 of	 significant	 experiences	 of	 the	 past,	 which	 were	 sometimes	
relived	 with	 frightening	 realism”	 (Busch	 and	 Johnson,	 1950).	 This	 was	 the	 beginning	 of	
numerous	 experiments	 on	 the	 therapeutic	 usage	 of	 psychedelics,	 culminating	 into	 an	
estimated	40.000	patients	with	mood-	and	addiction	disorders	to	have	been	treated	with	LSD	
and	other	psychedelics	by	the	late	1960s	(Grinspoon	and	Bakalar,	1981).		
Psychiatrists	 who	 performed	 these	 experiments	 noticed	 that	 psychedelics	 can	 produce	
diverse	 types	 of	 experiences	 across	 patients	 and	 sessions.	 The	 characteristic	 perceptual	
effects	of	psychedelics	are	well	recognised,	but	it	was	other	effects,	in	particular	the	effects	
on	the	individual’s	emotionality,	that	ignited	the	strongest	motivation	amongst	psychiatrists	
to	 consider	 their	 therapeutic	 utility.	 These	 observations	 inspired	 the	 hypothesis	 that	
psychedelics	work	by	weakening	the	usual	psychological	defence-mechanisms	(also	referred	
to	as	“ego	dissolution”),	and	thereby	uncover	(usually	“repressed”)	emotions,	memories	and	
thoughts.	It	was	believed	this	effect	of	psychedelics	would	“speed	up”	psychotherapy.	
Eisner	and	Cohen	(1958)	reported	that	under	LSD	“frequently	whole	sequences	unroll	before	
the	patient's	eyes	as	though	they	had	been	stored	on	microfilm”	(Eisner	and	Cohen,	1958).	
Feld	et	al	(1958)	concluded	from	their	observations	that	"LSD-25	has	the	astonishing	quality	
of	bringing	into	focus	the	patient's	repressed	emotional	attitudes,	conflicts,	etc.,	and	permits	
their	 re-activation"	 (Feld	 et	 al.,	 1958).	 Abramson	 (1956)	 remarked	 that	 “emotions	hitherto	
camouflaged	 were	 brought	 out,	 without	 the	 intense	 guilty	 fears	 that	 had	 kept	 them	
submerged”	(Abramson,	1956).	And	Kurland	et	al	(1971)	wrote:	
“The	 major	 dimension	 of	 drug-altered	 reactivity	 with	 therapeutic	 relevance	 is	 the	
affective	 or	 emotional	 sphere:	 intense,	 labile,	 personally	meaningful	 emotionality	 is	
uniformly	produced,	with	periodic	episodes	of	overwhelming	feeling.”	(Kurland	et	al.,	
1971)	
	27	
	
Researchers	often	pointed	out	 the	apparent	unpredictability	and	diversity	of	 the	emotional	
effects	 engendered	by	 psychedelics,	 and	 the	 challenges	 this	 brought	 for	 therapeutic	work.	
LSD	 was	 found	 to	 be	 able	 to	 produce	 states	 of	 profound	 well-being,	 as	 well	 as	 states	 of	
immense	 anxiety;	 tranquil	 states	 of	 mind,	 as	 well	 as	 those	 riddled	 with	 confusion	 and	
paranoia;	moments	filled	with	intense	euphoria,	as	well	as	episodes	of	explosive	anger	(Terrill	
1962).	These	observations	fuelled	the	emerging	view	in	the	psychiatric	community	that	these	
compounds	can	produce	psychosis-like	symptoms.	Corresponding	to	this	view,	in	a	series	of	
initial	 clinical	 trials,	 LSD	 was	 administered	 to	 patients	 with	 severe	 alcoholism	 with	 the	
intention	to	experimentally	induce	a	“psychosis-like	state”.	It	was	thought	that	the	LSD-state	
would	to	a	large	extent	resemble	the	alcoholism-induced	psychosis,	Delerium	Tremens	(DT),	
and	 the	 hypothesis	 was	 that	 this	 experience	 would	 produce	 a	 “psychological	 shock”	 that	
would	frighten	patients	away	from	their	drinking	behaviour	(Osmond,	1957).		
The	 outcomes	 of	 these	 experiments	 did	 however	 not	 confirm	 this	 hypothesis.	 First,	
compared	 to	DT,	 LSD	was	 found	 to	 differ	markedly	 in	 its	 capacity	 to	 produce	 a	 “nebulous	
sense	of	wonderment”,	an	increased	“aesthetic	appreciation”	of	music	and	art,	an	increased	
perception	 of	 “new	 values”,	 and	 “a	 sense	 of	 quiet	 meditation”	 (Ditman	 and	 Whittlesey,	
1959).	Secondly,	out	of	the	variety	of	experiences	LSD	could	produce,	it	was	not	negative	or	
“frightening”	 experiences	 that	 were	 associated	 with	 clinical	 improvements,	 but	 rather	 the	
opposite.	 Patients	 who	 showed	 the	 strongest	 improvements,	 were	 described	 to	 have	 a	
certain	type	of	experience	that	was	characterised	by	such	enhanced	feelings	of	“wonder”	and	
a	sense	of	“transcending”	their	usual	sense	of	self.		Unger	(1963)	stated:	
“Nearly	 invariably,	whenever	dramatic	personality	 change	has	been	noted	 following	
the	use	of	these	drugs,	it	has	been	associated	with	this	kind	of	experience,	that	is	one	
called	transcendental	or	visionary”	(Unger,	1963)	
And	Terrill	(1962)	noted:	
“When	 therapeutic	 changes	 did	 occur,	 they	 were	 often	 of	 a	 qualitatively	 different	
order	 than	 those	which	 occur	 in	 traditional	 psychotherapy.	 Under	 the	 influence	 of	
LSD,	 the	 individual	goes	 through	highly	 intense	and	unusual	experiences	which	may	
very	well	change	the	way	in	which	he	views	life”	(Terrill,	1962)	
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Psychedelics	were	found	useful	by	psychiatrists	not	only	for	their	acute	psychological	effects,	
but	in	particular	for	their	capacity	to	facilitate	enduring	therapeutic	change	after	the	session,	
ranging	from	weeks,	months,	or	longer	(Terrill,	1962;	Unger,	1963;	Kurland	et	al.,	1971).	The	
type	 of	 experience	 under	 LSD	 that	was	 found	 to	 promote	 such	 therapeutic	 changes	most	
reliably,	were	argued	to	exhibit	this	“self-transcending”	quality	(Kurland	et	al.,	1971).	It	were	
these	 experiences	 that	 were	 thought	 to	 allow	 the	 individual	 to	 obtain	 a	 sudden	 shift	 in	
perspective	 on	 themselves,	 charged	 with	 emotionality,	 motivating	 a	 change	 in	 behaviour	
accordingly	 (Savage,	 1966).	 The	 general	 consensus	 arose	 that	 it	was	not	 the	 drug,	 but	 the	
experience	that	the	drug	can	facilitate,	which	is	therapeutic	(Hoffer,	1965).	By	the	mid	1960s,	
researchers	identified	the	types	of	experiences	that	were	considered	most	therapeutic,	and	
these	can	be	roughly	classified	into	two	main	categories	(Schmiege,	1963):	
1) Autobiographical	experiences:	characterised	by	an	emotional	“release”	or	“catharsis”,	
the	experience	of	vivid	and	emotionally	charged	personal	memories	and	insights	into	
one’s	 own	 personal	 life.	 These	 experiences	 were	 often	 interpreted	 within	 a	
psychodynamic	framework.	
2) Peak	experiences:	characterised	by	a	sense	of	dissolving	or	transcending	one’s	sense	
of	usual	self,	culminating	 into	a	sense	of	union,	and	feelings	of	bliss	and	spirituality.	
These	 experiences	 are	 sometimes	 also	 referred	 to	 as	 “spiritual-type	 experiences”,	
“mystical-type	 experiences”,	 or	 “psychedelic-peak	 experiences”,	 and	 were	 often	
interpreted	within	a	humanistic	framework.	
	
1.4.2	The	function	of	non-drug	variables	to	facilitate	therapeutic	experiences	
An	 increased	 awareness	 emerged	 of	 the	 influence	 that	 non-drug	 variables	 have	 on	
determining	 the	 types	 of	 experiences	 patients	 undergo	 (i.e.	 variables	 other	 than	 the	 drug,	
such	 as	 social	 atmosphere,	 the	 music,	 the	 physical	 environment,	 etc.)	 (Unger,	 1963;	 Fox,	
1967;	Kurland	et	al.,	1971;	Grof,	1980).	This	is	now	commonly	referred	to	as	the	importance	
of	 “set	 and	 setting”,	 where	 set	 refers	 to	 the	 mind-set	 of	 the	 individual,	 including	 its	
personality,	mood	and	expectations,	and	setting	refers	to	environment	 in	which	the	drug	 is	
taken,	including	its	interpersonal-	and	sensory-	qualities	(Johnson,	2008).		
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Psychiatrists	began	 to	experiment	with	a	 strategic	design	of	non-drug	variables	 in	order	 to	
promote	most	desirable	therapeutic	experiences	and	outcomes.	One	leading	example	for	this	
course	 in	 history	 was	 Humphrey	 Osmond,	 who	 arrived	 in	 1951	 at	 the	 Weyburn	 Mental	
Hospital	 in	 Canada,	 to	 be	 shocked	 by	 the	 “bleakness”	 of	 the	 institution.	Osmond	 engaged	
with	an	architect,	Kiyoshi	 Izumi,	who,	after	his	first	personal	experience	with	LSD,	set	off	to	
design	 a	 new	 psychiatric	 hospital,	 that	 eventually	 was	 recognized	 by	 the	 World	 Health	
Organisation	for	its	highly	innovative	quality	(Dyck,	2010).		
Chwelos	et	al	(1959)	summarised	the	growing	awareness	on	the	significance	of	the	setting	as	
follows:	
“We	 had	 noted	 before	 from	 our	 studies	 of	 the	 psychotomimetic	 properties	 of	 this	
drug	 that	 the	 environment	 and	 particularly	 the	 attitude	 of	 the	 people	 around	 the	
person	undergoing	the	LSD	experience	seemed	to	 influence	his	reaction	profoundly.	
[…]	The	environment	surrounding	the	patient	taking	LSD	was	changed	by	the	addition	
of	 auditory	 stimuli,	 visual	 stimuli,	 emotional	 stimuli	 and	a	 change	 in	 the	attitude	of	
the	people	in	contact	with	the	patient.”	(Chwelos	et	al.,	1959)	
	
A	particular	strong	example	of	this	attitude	towards	designing	setting-variables	in	service	of	
the	therapeutic	experience,	is	represented	by	the	psychiatrist	Van	Rhijn	(1960),	who	stated:	
“So	far,	as	Dr.	Abramson	clearly	outlined,	we	have	used	frames	of	reference	in	which	
LSD	is	used	as	an	aid	to	psychotherapy.	However,	within	our	frame	of	reference	[…],	
psychotherapy	is	used	as	an	aid	to	the	LSD	experience.	Our	objective	is	to	give	each	
patient	 a	 particular	 LSD	 experience.	 To	 this	 end,	 we	 use	 psychological	 and	
environmental	tricks:	sound	and	music;	visual	stimuli,	such	as	paintings	by	Van	Gogh;	
tactile	stimuli,	such	as	various	smooth	or	rough	objects	for	the	patients	to	handle.	We	
also	 take	 advantage	 of	 the	 heightened	 suggestibility	 of	 the	 subjects	 by	 using	
persuasion,	 suggestion,	 and	 reiterated	 demand,	 with	 the	 theme	 of	 hope	 and	
possibility	of	change.”	(Van	Rhijn,	1960)	
	
The	increased	emotional	responsiveness	under	the	drug,	was	not	seen	as	an	obstacle,	but	as	
an	 effect	 of	 the	 drug	 that	 can	 be	 utilised	 in	 service	 of	 therapeutic	 objectives.	 This	 was	
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attempted	 by	 tailoring	 the	 design	 of	 non-drug	 variables	 such	 as	 the	 environment	 and	 the	
music	 being	 played,	 in	 such	 way	 that	 these	 variables	 become	 an	 active	 part	 of	 the	
therapeutic	 sessions.	 By	 the	 late	 60s,	 the	 foundation	 of	 psychedelic	 therapy	 was	
characterised	 by	 a	 strong	 patient-centred	 approach,	 adapting	 setting-variables	 to	 patient’s	
therapeutic	 needs,	 to	maximise	 the	 occurrence	 of	 autobiographical-	 and	 peak	 experiences	
(Fox,	1967).	
	
1.4.3	Psycholytic	therapy	and	psychedelic	therapy	
At	 that	 moment	 in	 time,	 by	 the	 late	 1960s,	 broadly	 speaking	 two	 different	 therapeutic	
approaches	 had	 evolved	 via	which	 these	 views	manifested	 into	 practice:	 the	 “psycholytic”	
method,	mainly	practiced	in	Europe,	and	the	“psychedelic”	method,	mainly	practiced	in	the	
United	 States.	 These	 approaches	 differed	 in	 the	 dosages	 administered,	 the	 amount	 of	
sessions	conducted,	and	the	structure	of	the	sessions	themselves	(Grof,	1980):		
1. Psycholytic	 therapy	 was	 characterised	 by	 lower	 dosages,	 with	 the	 intention	 to	
preserve	sufficient	“ego-functioning”	for	the	patient	in	order	to	actively	engage	with	
the	 therapist	during	 the	 sessions.	Generally	 speaking,	 the	primary	goal	here	was	 to	
use	 the	 drug	 as	 an	 adjunct	 to	 psychotherapy,	 with	 the	 emphasis	 on	 facilitating	
“autobiographical	 experiences”.	 Typically,	 patients	 underwent	multiple	 psychedelic-
assisted	therapy	sessions	to	reach	the	therapeutic	objectives.	Music	was	often	used	in	
psycholytic	approaches,	but	more	frequently	intermitted	by	conversations	or	periods	
of	silence.		
2. Psychedelic	 therapy	 was	 characterised	 by	 higher	 dosages,	 with	 the	 intention	 to	
dissolve	“ego-functioning”,	and	for	the	individual	to	“immerse”	fully	in	the	unfolding	
experience.	The	primary	goal	here	was	 to	 facilitate	a	 “peak	experience”	 that	would	
result	 in	 enduring	 changes	 in	 personality,	 mood	 and	 behaviour.	 Typically,	 patients	
underwent	 one	 or	 a	 small	 number	 of	 sessions,	 and	 would	 listen	 to	 music	 for	 the	
majority	 of	 the	 time	 during	 these	 sessions	 -	 often	 with	 eyes	 closed	 to	 increase	
introspection.	
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In	 practice,	 autobiographical-	 and	 peak	 experiences	 often	 co-occurred	 within	 both	
psycholytic	and	psychedelic	methods,	and	within	one	session.	A	good	example	of	this	can	be	
found	in	an	excerpt	from	a	case	reported	by	Kurland	et	al	(1967),	describing	the	treatment	of	
a	patient	with	alcoholism	with	a	high	dose	of	LSD	(450	mcg).	This	excerpt	demonstrates	the	
use	of	various	therapeutic	elements	that	have	been	discussed	here,	such	as	the	significance	
of	 both	 autobiographical	 and	 peak	 experiences,	 and	 how	 the	 therapists	 utilises	 non-drug	
variables	to	provide	adequate	therapeutic	support:	
“I	was	now	very	conscious	of	the	fact	that	the	music	was	creating	variations	of	great	
beauty	 in	 my	 mind.	 It	 was	 such	 beauty	 that	 words	 can't	 describe	 it.	 The	 word	
"magnificent"	kept	running	through	my	mind.	I	felt	that	I	was	being	overwhelmed	by	
beauty.	I	stated	that	I	was	undergoing	the	most	magnificent	experience	of	my	life.	
By	 this	 point,	 I	 had	 lost	 all	 sense	 of	 time.	What	 seemed	 like	 an	 eternity	 later,	 but	
possibly	 only	 a	 minute	 or	 so	 in	 actual	 time,	 I	 became	 aware	 that	 my	 mood	 had	
changed.	I	suddenly	saw	myself	near	the	bottom	of	a	huge	filthy	pit.	It	seemed	to	be	
bottomless	and	was	crawling	with	horrible	things	such	as	octopi	and	enormous,	odd-
shaped	 frogs.	 I	 tried	 to	 crawl	 my	 way	 out	 of	 the	 pit	 and	 finally	 got	 near	 the	 top.	
Looking	down,	it	was	horrible	-	worse	than	I	have	ever	visualized	hell.	Huge	vats	and	
casks	containing	whiskey	were	being	poured	into	this	slimy	pit.	It	seemed	that	all	the	
whiskey	in	the	world	was	being	dumped	there.	I	began	to	cry.	A	feeling	of	deep	guilt	
and	remorse	had	come	over	me.	The	doctor	had	me	sit	up.	In	discussion	with	him,	I	
realized	the	significance	of	this	episode	for	my	own	experience	with	alcohol.	After	my	
crying	spell,	I	felt	relieved	and	cleaner	inside.		
Once	again	I	reclined	on	the	couch.	The	music	became	more	meaningful	to	me	than	
anything	I	had	ever	heard	before.	A	tremendous	feeling	of	exaltation	came	over	me.	It	
kept	 growing	 in	 intensity.	 I	 felt	 rapture	 and	 ecstasy.	 Each	moment	 I	 thought	 I	 had	
reached	the	zenith	of	rapture	and	joy;	then	the	intensity	and	ecstasy	would	increase.	
It	was	overwhelming!	There	are	no	words	to	describe	my	feelings.	
Then,	while	 I	was	 in	this	state,	all	became	still	and	quiet.	A	sense	of	cleanliness	and	
purity	swept	over	me.	I	was	alone	and	at	peace.	At	this	precise	moment,	I	felt	that	all	
was	holy	and	pure.	I	felt	humble	and	insignificant.	I	was	completely	awed!	It	was	the	
greatest,	most	magnificent	experience	of	my	 life.	 I	 knew	then	that	 life	has	meaning	
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and	riches	and	rewards.	I	felt	as	though	I	had	been	reborn.	Probably	never	again	will	I	
undergo	 such	an	experience.	But	 I	don’t	 care	–	once	 in	a	 lifetime	 is	more	 than	any	
mortal	can	hope	for.	 I	 then	began	to	think	about	mankind	 in	general.	 I	realised	that	
what	 I	had	experienced	was	potentially	 in	everyone,	and	I	 felt	compassion,	warmth,	
and	understanding	for	my	fellow	man.	 […]	 I	cried.	 I	 remember	wishing	that	my	wife	
could	be	at	my	side,	so	I	could	tell	her	and	show	her	how	I	now	felt.	I	knew	then	that	I	
had	been	 throwing	my	 life	away,	and	 that	 there	was	so	much	 I	 could	do	 to	change	
things	for	the	better.”	(Kurland	et	al.,	1967)		
	
1.5	The	use	of	music	in	psychedelic	therapy	in	the	1950s	and	1960s	
The	 realisation	 that	 non-drug	 variables	 (for	 example,	 the	 physical	 environment,	 the	 social	
environment,	the	mind-set	and	the	music)	assubstantially	influence	the	patient’s	experience	
under	a	psychedelic,	was	typically	explained	as	the	result	of	a	“weakening”	effect	of	the	drug	
on	 the	 patient’s	 psychological	 defence	 mechanisms.	 This	 would	 lead	 to	 an	 enhanced	
suggestibility	and	emotional	response	to	various	types	of	stimuli	from	the	environment.	From	
early	 on	 in	 the	 scientific	 literature,	 descriptions	 appeared	 that	 called	 attention	 to	 the	
particularly	 remarkable	 influence	 of	 music.	 Cutner	 et	 al	 (1959)	 describes	 the	 relationship	
between	 ego-boundary	 dissolving	 effects	 of	 LSD	 and	 the	 intensified	 response	 to	music	 as	
follows:	
“The	most	 impressive	 feature	 in	 the	experience	of	 the	non-rational	 system	was	 the	
disappearance	 of	 all	 boundaries	 between	 individual	 entities,	 or,	 indeed,	 the	
disappearance	 of	 individuality	 as	 such.	 […]	 In	 this	 way,	 the	 meanings	 of	 certain	
musical	phenomena	(rhythms,	intervals,	etc.)	were	felt	to	have	their	exact	equivalents	
in	certain	tensions	or	experiences	of	pressure,	movement	or	position	of	certain	parts	
of	the	body.”	(Cutner,	1959)	
	
In	 the	 efforts	 to	 provide	 optimal	 therapeutic	 support	 for	 patients	 via	 design	 of	 setting-
variables,	 a	 striking	 consistency	 appeared	 in	 the	 literature	 around	 the	 use	 of	 music.	
Therapists	frequently	emphasized	the	significance	of	playing	music.	In	general,	the	reasons	to	
incorporate	 music	 within	 psychedelic	 therapy	 were	 described	 as	 (1)	 music’s	 capacity	 to	
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modulate	emotion	and	mood,	(2)	music’s	capacity	to	evoke	autobiographical	memories	and	
to	stimulate	the	 imagination,	and	(3)	music’s	capacity	to	 facilitate	peak	experiences	 (Bonny	
and	Pahnke	1972;	Grof,	1980).	In	what	follows,	these	separate	points	will	be	discussed.		
	
1.5.1	The	use	of	music	to	facilitate	emotion	
The	 perceived	 value	 of	 the	 emotion-modulating	 effects	 of	 music	 are	 well	 described	 by	
Holzinger	 (1964),	 who	 stated	 that	 the	 patient’s	 ability	 “to	 regain	 fully	 his	 emotional	
expressive	abilities”	under	LSD,	“negatively,	and	especially,	positively”	to	be	one	of	the	most	
important	 therapeutic	mechanisms	within	LSD-assisted	psychotherapy.	Holzinger	continued	
to	describe	 the	main	 role	of	music	as	 “to	enhance	 this	ability	of	 the	patient	 to	express	his	
feelings”	(Holzinger,	1964).		
Eisner	and	Cohen	(1958)	wrote	that	music	was	used	“initially	to	aid	in	relaxation”,	but	that	it	
was	soon	realised	that	music	could	support	the	therapy	sessions	in	different	ways	too:	
“After	repeated	observations	that	music	seemed	to	potentiate	the	drug	action,	it	was	
used	when	 there	was	no	verbal	exchange.	Selections	of	 the	patient's	choice	or	of	a	
semi-classical	 nature	 were	 played	 during	 the	 early	 phase;	 certain	 piano	 concertos	
were	used	at	the	height	of	the	experience”.		(Eisner	and	Cohen,	1958)	
	
This	point	is	illustrated	especially	clearly	by	Butterworth	et	al	(1962),	who	reported	the	use	of	
music	to	intentionally	evoke	emotionally	intense	experiences:	
“After	 the	 initial	and	usually	apprehensive	episode,	an	attempt	 is	made	to	send	the	
patient	 into	 an	 intense	 episode.	 Factors	 encouraging	 such	 an	 episode	 are:	
reassurance,	 selection	 of	 meaningful	 music,	 absolute	 quiet	 and	 privacy,	 with	
discouragement	of	any	analysis	and	discussion	of	the	episode	while	it	is	in	progress.”	
(Butterworth,	1962)	
	
Hoffer	 (1965)	 noted	 that	music	 can	 “be	 very	 helpful”,	 but	 that	music	 and	 other	 non-drug	
variables	factors	“must	be	looked	upon	as	aids	and	not	as	objectives	of	the	experience”,	and	
that	the	music	should	always	be	tailored	to	every	patient’s	unique	needs:	
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“Some	subjects	find	music	intolerable	and	visual	aids	repulsive,	and	their	wishes	and	
feelings	 must	 be	 honoured.	 They	 find	 music	 extremely	 distracting	 and	 it	 prevents	
them	from	fully	experiencing	other	components	of	the	reaction.”	(Hoffer,	1965)	
	
Hoffer	continued	to	explain	that	the	effects	of	LSD	on	altering	the	perception	of	music	and	
the	emotional	 response	 to	music,	 can	however	be	utilised	 strategically	 to	 facilitate	 intense	
emotional	experiences	with	high	therapeutic	significance:	
“Very	often,	sounds	which	normally	have	no	particular	aesthetic	appeal,	were	heard	
in	a	most	unusual	manner.	Subjects	who	were	 indifferent	to	music,	were	enthralled	
by	it.	One	of	our	subjects,	a	physicist,	was	overwhelmed	by	the	beauty	of	music	being	
played	on	an	old	scratchy	record	player.	After	a	while	he	exclaimed	“I	wish	they	could	
play	 it	 as	beautifully	 as	 I	 now	hear	 it.”	 The	background	noise	of	 the	 record	did	not	
reduce	his	appreciation	of	the	music.	This	property	of	the	experience	is	very	useful	in	
bringing	out	the	psychedelic	reaction.	Carefully	selected	music	can	be	very	powerful	
in	 altering	 the	 subject’s	 mood	 and	 associations.	 One	 subject,	 an	 intellectual,	 cold	
physician,	who	was	an	alcoholic,	did	not	have	any	emotional	reaction	to	300	mcg	of	
LSD	for	about	2.5	hours.	When	Ave	Maria	was	played,	he	seemed	startled,	then	in	a	
few	 minutes,	 became	 transfixed	 with	 emotion	 and	 began	 to	 cry.	 The	 song	 had	
suddenly	taken	him	to	his	youth	when	he	had	been	very	happy.	The	music	triggered	
of	 an	 emotional	 catharsis	 which	 completely	 altered	 a	 psychotomimetic	 to	 a	
psychedelic	experience.”	(Hoffer,	1965)	
	
1.5.2	The	use	of	music	to	facilitate	autobiographical	experiences		
As	the	previous	section	showed,	the	evoked	emotionality	by	the	music	during	the	peak	of	the	
drug-effects	 were	 often	 found	 to	 be	 of	 autobiographical	 meaning.	 Psychiatrists	 typically	
reported	a	blending	of	vivid	memories	and	personal	thoughts	with	strong	feelings,	such	as	in	
the	following	statement	by	Sandison	(1963):	
“The	 immediate	 result	 of	 giving	 the	 LSD	 is	 to	produce	 a	deepening	of	 the	patient's	
emotional	 tone,	a	change	 in	 thinking,	 sometimes	 regression	 to	an	earlier	emotional	
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and	intellectual	period	and	the	reliving	of	emotionally	charged	memories.”	(Sandison,	
1963)	
	
The	first	clinical	observations	that	patients	under	LSD	remember	past	events	in	“frightening	
realism”	 (Busch	 and	 Johnson,	 1950),	 and	 that	 not	 infrequently	 “whole	 sequences	 unroll	
before	 the	 patient's	 eyes	 as	 though	 they	 had	 been	 stored	 on	 microfilm”,	 was	 a	 major	
incentive	to	explore	LSD’s	potential	therapeutic	use	further.	Subsequently,	music	was	found	
to	 be	 in	 particular	 helpful	 to	 exert	 a	 degree	 of	 guidance	 in	 this	 phenomenon.	 This	 is	well	
summarised	by	Chandler	and	Hartman	(1960),	who	said:	
“Music	 can	 be	 an	 effective	 stimulus	 in	 helping	 to	 bring	 out	 affectively	 charged	
memories	 and	 fantasies.	We	 have	 found	 classical	 music	 generally	 best,	 although	 a	
great	variety	of	different	kinds	of	music	can	be	effective,	especially	if	the	music	can	be	
selected	in	terms	of	specific	aspects	of	the	patient's	emotions	and	background.	Music	
was	 played	 throughout	 the	 sessions	 as	 "background"	 and	 sometimes	 with	 the	
instruction	 to	 "go	with	 the	music"	 and	 to	 have	 fantasies	 suggested	 by	 the	music.”	
(Chandler	and	Hartman,	1960)	
	
The	main	view	behind	the	significance	of	these	autobiographical	experiences,	was	that	they	
facilitate	a	state	of	personal	insightfulness,	characterised	by	new	perspectives	on	oneself	and	
on	one’s	life,	that	promote	changes	in	the	way	the	person	subsequently	lives	his	or	her	life.	
Smith	 et	 al	 1959	 described	 that	 “It	 is	 hoped	 by	 this	 method	 to	 make	 the	 experience	 a	
thought-provoking	one	 rather	 than	a	 frightening	one”	 (Smith,	 1959).	 The	authors	 illustrate	
their	appraised	therapeutic	benefits	from	the	effects	of	LSD	and	music	via	the	report	from	a	
39-old	alcoholic	patient,	describing	his	therapy	sessions	with	LSD	as	follows:	
“The	experience	 I	 have	had	 as	 a	 result	 of	 the	drug	was	unique	 and	most	 definitely	
constructive.	It	manifested	itself	in	many	ways,	the	most	important	being	my	ability	to	
recall	 certain	 events,	 some	 pleasant,	 some	 very	 unpleasant.	 It	 allowed	 me	 to	 see	
myself	 as	 I	 really	am,	as	a	person	who	 is	 first	 an	egotistical	deceitful	procrastinator	
and	 have	 many	 more	 defects	 which	 I	 am	 aware	 of	 but,	 because	 of	 my	 lack	 of	
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knowledge	 or	 something	 or	 other,	 have	 never	 been	 able	 to	 do	 anything	 about.”	
(Smith,	1959)	
	
1.5.3	The	use	of	music	to	facilitate	peak	experiences		
Music	played	a	particular	central	role	in	the	“high-dose”	psychedelic	therapy	approach.	After	
administration	of	 the	drug,	patients	were	 typically	 encouraged	 to	 fully	direct	 the	attention	
inwards	 and	 listen	 to	 a	 music	 playlist	 for	 the	 subsequent	 6	 to	 8	 hours	 (Grof,	 1980).	 This	
approach	was	heavily	influenced	by	Helen	Bonny,	a	music-therapist,	and	placed	a	significant	
emphasis	on	music’s	capacity	to	facilitate	peak	experiences:	
“The	 time	 of	 peak	 drug	 intensity	 when	 psychedelic	 peak	 experiences	 are	 most	
probable	comes	3	to	5	hours	after	ingestion.	The	greatest	effort	is	made	to	provide	an	
optimal	 setting	 for	 this	 type	 of	 experience.	 It	 is	 for	 this	 period	 that	 there	 is	 the	
greatest	agreement	among	therapists	regarding	the	type	of	music	to	employ.	[…]	As	
this	 is	 the	 most	 critical	 period	 of	 the	 session,	 a	 discussion	 of	 appropriate	 and	
inappropriate	 ways	 in	 which	 music	 can	 be	 used	 is	 especially	 important.	 In	 the	
repertoire	designated	as	‘peak	music’	are	certain	selections	which	have	been	shown	
by	 experience	 to	 evoke	 powerful	 emotions	 and	 to	 aid	 greatly	 in	 facilitating	 the	
occurrence	of	peak	experiences	 if	played	at	 the	proper	 time.	 If	 these	selections	are	
played	at	an	improper	time,	the	potential	effect	can	be	wasted	and	a	negative	musical	
imprint	for	that	particular	selection	may	result.”	(Bonny	and	Pahnke,	1972)	
	
The	 use	 of	 music	 to	 facilitate	 peak	 experiences	 derived	 significant	 inspiration	 from	
humanistic	 psychology,	 and	 in	 particular	 the	 views	 pioneered	 by	 Abraham	 Maslow,	 who	
argued	that	peak	experiences	are	 integral	to	the	lives	of	healthy	self-actualising	 individuals.	
Maslow	said	the	following	about	psychedelics:	
"In	 the	 last	 few	 years	 it	 has	 become	 quite	 clear	 that	 certain	 drugs	 called	
"psychedelic",	especially	LSD	and	psilocybin,	give	us	some	possibility	of	control	in	this	
realm	of	peak	experiences.	It	looks	as	if	these	drugs	often	produce	peak	experiences	
in	 the	 right	 people	 under	 the	 right	 circumstances,	 so	 perhaps	we	 needn't	 wait	 for	
them	to	occur	by	good	fortune.”	(Maslow,	1964)	
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At	 the	 time	 that	 the	 work	 by	 Bonny	 and	 Pahnke	 (1972)	 was	 published,	 new	 government	
regulations	were	already	put	in	place	(by	1966	in	the	US,	and	by	1967	in	Europe)	that	marked	
the	beginning	of	a	long	hiatus	in	research	with	psychedelics.	Although	the	intentions	behind	
these	 regulations	may	 have	 been	 to	 halt	 the	 growing	 uncontrolled	 use	 of	 psychedelics	 in	
society,	what	was	truly	halted	was	the	scientific	research	(Nutt	et	al.,	2014).	 It	took	several	
decades	 for	 academic	 human	 research	 with	 psychedelics	 to	 restart.	 The	 subsequent	
paragraphs	 serve	 to	provide	an	overview	of	 this	 recent	 renaissance	 of	modern	 research.	 It	
will	 show	 that	 the	 therapeutic	 approaches	 employed	 in	modern	 studies	with	 psychedelics,	
are	 heavily	 influenced,	 if	 not	 fully	 compatible,	with	 the	 views	 that	were	 developed	 by	 the	
1960s	as	outlined	above.	
	
1.6	Modern	psychological	and	psychotherapeutic	research	with	psychedelics	
The	level	of	interest	today,	in	studying	the	therapeutic	potential	and	the	human	neuroscience	
of	psychedelics,	stands	in	stark	contrast	to	the	almost	complete	absence	of	this	research	in	
the	 preceding	 decades.	 This	 revival	 is	 posing	 a	 number	 of	 important	 questions	 for	 the	
scientific	 and	 psychotherapeutic	 community.	 As	 was	 detailed	 in	 the	 previous	 section,	
psychedelic	 therapy	 differs	 from	 current	 treatment	 approaches	 on	 several	 major	 points.	
Compared	 with	 conventional	 pharmacotherapy	 (i.e.	 psychiatric	 medication),	 the	 strongest	
contrast	is	that	in	psychedelic	therapy	the	aim	is	not	to	administer	the	compound	repeatedly	
and	 continuously,	 but	 only	 on	 one	 or	 a	 few	 occasions,	 with	 the	 objective	 to	 facilitate	
sustained	 improvements	 (i.e.	 clinical	 remission	 that	extends	beyond	 the	acute	drug	effects	
during	 the	 therapy	 sessions).	 Compared	 to	 conventional	 psychotherapy,	 the	 strongest	
contrast	is,	first	of	all,	that	a	drug	is	administered,	and	secondly,	that	this	drug	has	powerful	
acute	 subjective	 effects:	 The	 lengthily	 periods	 of	 introspection	 and	 intense	 emotionality	
facilitated	by	psychedelics	do	not	merely	aid	the	usual	way	psychotherapy	is	performed,	but	
instead	 yield	 dramatic	 consequences	 on	 the	 way	 the	 therapeutic	 sessions	 are	 performed,	
including	their	structure,	duration	and	the	role	of	the	therapists.		
The	 views	 that	 led	 to	 the	 development	 of	 the	 procedures	 that	 characterize	 psychedelic	
therapy	 sessions	 in	 the	1950s	and	1960s,	are	 to	a	 large	extend	derived	 from	direct	 clinical	
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observations,	 case	 studies,	 or	 experiments	 that	 were	 not	 well-controlled.	 In	 addition,	 the	
practice	 was	 often	 informed	 by	 theoretical	 frameworks	 that	 are	 not	 always	 supported	 by	
sufficient	 scientific	 evidence.	 One	 example	 of	 this	 are	 psychodynamic	 hypotheses	 around	
ego-functioning,	 and	 the	 then-popular	 idea	 that	 psychedelics	 weaken	 “ego-defence	
mechanisms”,	 resulting	 in	 a	 regression	 to	 an	 earlier	 emotional	 and	 intellectual	 mode	 of	
cognition.	This	has	led	to	a	therapeutic	method	that	is	construed	from	various	concepts	and	
assumptions	that	await	empirically	validation.	
Addressing	 this	 is	 important,	 given	 psychedelic	 therapy	 receives	 an	 increasing	 amount	 of	
empirical	support	for	its	safety	and	efficacy,	and	is	being	implemented	at	increasingly	larger	
scales	 in	 the	 years	 ahead	 (i.e.	 larger	 numbers	 of	 therapists	 and	 patients	 will	 be	 working	
within	 this	 therapeutic	 framwork).	 Studies	 are	 therefore	warranted	 that	 not	 only	 establish	
safety	 and	 efficacy	 of	 the	 procedures,	 but	 also	 scrutinise	 the	 assumptions	 inherent	within	
these	 procedures	 and	 to	 further	 an	 empirically	 grounded	 development	 of	 the	 therapeutic	
working	model.		
These	 considerations	 were	 a	 central	 motivation	 for	 the	 research	 presented	 in	 this	 thesis.	
Given	the	primacy	of	music	during	psychedelic	therapy	sessions,	 the	focus	was	on	studying	
the	combined	effects	of	psychedelics	and	music.	In	order	to	formulate	the	primary	research	
questions	this	research	aims	to	address,	this	section	will	provide	an	overview	of	the	modern	
pre-clinical	and	clinical	human	research	with	psychedelics,	and	highlight	how	recent	research	
has	 addressed	 some	 of	 the	 observations	 and	 interpretations	 reported	 in	 the	 1950s	 and	
1960s.	 In	 summary,	 these	 are	 (1)	 the	 variety	 of	 subjective	 effects	 of	 psychedelics	 (hence,	
leading	to	a	need	to	structure	the	experience),	(2)	the	effects	of	psychedelics	on	emotion	and	
mood,	3)	the	effects	of	psychedelics	on	ego-functioning,	 (4)	the	capacity	of	psychedelics	to	
evoke	 autobiographical	 experiences,	 and	 (5),	 the	 capacity	 of	 psychedelics	 to	 evoke	 peak	
experiences.	 This	 section	 will	 conclude	 with	 a	 review	 of	 the	 recent	 clinical	 trials	 with	
psychedelics.	See	table	1.1,	for	methodological	details	regarding	these	referenced	studies.	
	
1.6.1	The	variety	of	subjective	effects	of	psychedelics	
Several	modern	studies	have	investigated	acute	subjective	effects	of	psychedelics	in	healthy	
volunteers	using	questionnaires	and	behavioural	experiments,	demonstrating	 that	 they	can	
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occasion	changes	 in	perception,	cognition	and	emotion	 (Vollenweider	et	al.,	1998;	Carhart-
Harris	et	al.,	2011;	Kometer	et	al.,	2012)	and	in	a	dose-dependent	manner	(Carhart-Harris	et	
al.,	 2011;	 Hasler	 et	 al.,	 2003;	 Griffiths	 et	 al.,	 2011).	 The	 acute	 subjective	 effects	 of	
psychedelics	are	often	assessed	via	 the	altered	state	of	 consciousness	questionnaire	 (ASC),	
that	measures	changes	in	distinct	factors	of	conscious	experience	(Dittrich,	1998;	Studerus	et	
al.,	2010).	One	major	 factor	of	effects	of	psychedelics	are	changes	 in	perception,	 including	
different	sensory	modalities	(i.e.	visual,	auditory,	tactile)	(Studerus	et	al.,	2011;	Schmid	et	al.,	
2015;	Carhart-Harris	et	al.,	2016),	but	also	changes	 in	the	perception	of	time	(Wittmann	et	
al.,	 2007;	Wackermann	 et	 al.,	 2008).	 Imagination	 is	 often	 reported	 to	 be	 highly	 vivid,	 and	
eyes-closed	imagery	of	an	“elementary”	nature	(i.e.	colours	and	patterns)	and	of	a	“complex”	
nature	(i.e.	concrete	objects,	landscapes	or	entities)	are	both	common	(Carhart-Harris	et	al.,	
2011;	Schmid	et	al.,	2015;	Studerus	et	al.,	2011).		
Cognitive-	and	behavioural	experiments	have	demonstrated	that	 impaired	attention	(Carter	
et	 al.,	 2005)	 and	 response	 inhibition	 (Quednow	 et	 al.,	 2012)	 after	 psilocybin,	 enhanced	
divergent	thinking	after	ayahuasca	 (Kuypers	et	al.,	2016),	and	 increased	spread	of	semantic	
activation	under	LSD	(Family	et	al.,	2016).	Several	studies	have	also	assessed	cognitive	effects	
of	 psychedelics	 via	 self-report	 questionnaires,	 showing	 increased	 cognitive	 disorganisation	
(Carhart-Harris	 et	 al.,	 2016),	 disordered	 thinking	 (Studerus	 et	 al.,	 2011),	muddled	 thinking	
(Carhart-Harris	et	 al.,	 2011),	 and	 insightfulness	 (Carhart-Harris	et	 al.,	 2016;	 Studerus	et	 al.,	
2011,	2012).		
In	an	effort	to	reconcile	the	“paradoxical”	capacity	of	psychedelics	to	induce	both	“positive”	
effects	 (positive	 mood,	 enhanced	 creative	 thinking,	 insightfulness,	 etc.)	 and	 “negative”	
effects	 (impaired	 cognition,	muddled	 thinking,	etc.),	 these	 cognitive	effects	of	psychedelics	
have	been	conceptualised	as	a	modulatory	effect	on	cognitive	flexibility	(Carhart-Harris	et	al.,	
2016;	 Carhart-Harris	 et	 al.,	 2014).	 Indirect	 support	 for	 the	 view	 that	 psychedelics	 enhance	
cognitive	flexibility	comes	from	a	study	that	demonstrates	psilocybin	increases	switching	rate	
when	 attending	 ambiguous	 stimuli	 (Carter	 et	 al.,	 2007),	 and	 a	 study	 that	 demonstrated	
increased	divergent	thinking	under	ayahuasca	(Kuypers	et	al.,	2016).	
The	 effects	 of	 psychedelics	 on	 emotion	 will	 be	 discussed	 separately	 in	 the	 following	
paragraph.	 Together,	 these	 studies	 illustrate	 the	 diverse	 spectrum	 of	 subjective	 effects	
psychedelics	can	occasion.	This	variety,	was	one	of	the	motivations	in	the	1950s	and	1960s,	
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to	 try	 to	 exert	 some	degree	of	 control	 over	 the	experience	 via,	 for	 example,	 utilizing	non-
drug	 variables.	 Some	 recent	 studies	 show	 support	 for	 this,	 demonstrating	 that	 acute	 drug	
effects	can	be	predicted	by	several	 factors	other	 than	drug	dose,	 including	the	mind-set	of	
the	individual,	and	the	individual’s	personality	traits	(Studerus	et	al.,	2012).	
	
1.6.2	The	effects	of	psychedelics	on	emotion	and	mood	
The	effect	of	psychedelics	on	emotionality	was	an	important	motivation	to	investigate	their	
therapeutic	 potential,	 and	 modern	 studies	 have	 demonstrated	 that	 psychedelics	 increase	
emotionality	via	different	research	paradigms.	Using	mood	rating	scales,	Hasler	et	al	(2003)	
showed	significant	increases	in	“emotional	excitability”	under	psilocybin	(Hasler	et	al.,	2003),	
and	Schmidt	 et	 al	 (2015)	demonstrated	 increases	 in	 “happiness”	under	 LSD	 (Schmid	et	 al.,	
2015).	 These	 findings	 were	 confirmed	 and	 corroborated	 by	 Dolder	 et	 al	 (2016)	 who	
compared	two	separate	dosing	regimens	(100	mcg	and	200	mcg	of	LSD)	and	reported	a	dose-
response	relationship	for	increases	in	emotional	excitability	(Dolder	et	al.,	2016),	confirming	
earlier	observations	of	dose-dependency	on	emotionality	(Studerus	et	al.,	2011).		
The	 study	 by	 Schmid	 et	 al	 (2015)	 also	 showed	 socio-emotional	 effects	 after	 LSD,	 such	 as	
increased	closeness,	trust	and	openness	(Schmid	et	al.,	2015).	Dolder	et	al	(2016)	performed	
behavioural	assessments	targeting	changes	in	socio-emotional	information	processing	under	
LSD,	 and	 reported	 impaired	 recognition	 of	 fearful	 and	 sad	 faces,	 but	 enhanced	 emotional	
empathy	 (Dolder	 et	 al.,	 2016).	 Kometer	 et	 al	 (2012)	 reported	 a	 comparable	 emotional-
information	bias	 in	a	 study	 showing	 that	psilocybin	produced	a	 significant	enhancement	 in	
positive	mood	and	decreases	accurate	recognition	of	negative	facial	expression	(Kometer	et	
al.,	2012).	A	study	by	Preller	et	al	(2016)	may	be	interpreted	along	similar	lines,	by	showing	
reduced	feelings	of	social	pain	under	psilocybin	within	in	a	behavioural	social	exclusion	task	
(Preller	et	al.,	2016).	
	
1.6.3	The	effects	of	psychedelics	on	ego-functioning	
As	was	detailed	 in	 the	 introduction	chapter,	one	major	 reported	effect	of	psychedelics	 is	a	
temporary	 dissolving	 of	 boundaries	 between	 self	 (i.e.	 the	 “me”)	 and	 object	 (i.e.	 the	 “not-
me”).	 This	 effect	 has	 been	 referred	 to	 as	 disturbed	 ego-functioning,	 ego-disintegration	 or	
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ego-dissolution,	and	was	emphasised	by	many	early	researchers	as	an	important	underlying	
mechanism	 via	 which	 psychedelics	 may	 work	 therapeutically.	 It	 has	 recently	 been	 argued	
that,	because	of	this	effect,	psychedelics	represent	an	opportunity	to	study	the	mechanisms	
via	 which	 the	 human	 brain	 produces	 a	 coherent	 sense	 of	 self	 or	 ego	 (Carhart-Harris	 and	
Friston	2010;	Lebedev	et	al.,	2015).		
Important	 for	 the	present	discussion	 is	 the	 study	by	Nour	et	 al	 (2016),	who	demonstrated	
construct	 validity	 for	 ego-dissolution,	 and	 specificity	 of	 ego-dissolution	 for	 the	 experiences	
with	psychedelics,	over	experiences	with	alcohol	or	cocaine	(which	were	associated	with	the	
opposite	 effect,	 i.e.	 “ego-inflation”)	 (Nour	 et	 al.,	 2016).	 Earlier	 questionnaire	 studies	 have	
also	 indicated	 prominent	 effects	 of	 psychedelics	 on	 ego-functioning,	 in	 particular	 via	 high	
ratings	 on	 the	 distinct	 ASC	 factor	 “oceanic	 boundlessness”,	 defined	 as	 “positively	
experienced	derealisation	and	depersonalisation”	(Dittrich,	1998;	Studerus	et	al.,	2010),	and	
via	increased	ratings	for	“impaired	control	and	cognition”	(Schmid	et	al.,	2015),	an	important	
marker	for	disturbed	ego-functioning.		Finally,	ego-dissolution	has	been	related	to	enhanced	
suggestibility	 under	 LSD	 (Carhart-Harris	 et	 al.,	 2014)	 –	 an	 effect	 that	 has	 also	 been	
prominently	hypothesised	in	early	research	as	a	potential	therapeutic	action	of	psychedelics.	
	
1.6.4	The	capacity	of	psychedelics	to	facilitate	autobiographical	experiences	
The	 capacity	 of	 psychedelics	 to	 facilitate	 autobiographical	 experiences	has	not	 given	much	
attention	 yet	 in	 modern	 research.	 Carhart-Harris	 et	 al	 (2011)	 demonstrated	 increased	
vividness	 for	 autobiographical	 memories	 (Carhart-Harris	 et	 al.,	 2012),	 and	 ratings	 in	
questionnaires	 that	 relate	 to	 autobiographical	 experiences,	 such	as	 “I	 saw	 scenes	 from	my	
past”	are	shown	to	be	enhanced	under	psilocybin	(Carhart-Harris	et	al.,	2011)	
	
1.6.5	The	capacity	of	psychedelics	to	facilitate	peak	experiences	
The	capacity	of	psychedelics	 to	 facilitate	peak	experiences	 requires	 special	attention,	given	
the	 significant	 emphasis	 that	 was	 placed	 on	 its	 therapeutic	 value	 by	 early	 researchers	 in	
previous	 literature.	 Overall,	 pronounced	 subjective	 effects	 that	 are	 consistently	 reported	
include	 experiences	 of	 “blissful”	 emotions,	 a	 “sense	 of	 unity”,	 and	 feelings	 of	 “spirituality”	
(Schmid	et	al.,	2015;	Studerus	et	al.,	2011;	Carhart-Harris	et	al.,	2016),	and	these	effects	have	
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been	 related	 to	 the	 ego-boundary	 dissolving	 effects	 of	 psychedelics	 (Nour	 et	 al.,	 2016).	
Although	these	studies	suggest	that	psychedelics	can	produce	subjective	effects,	that	can	be	
categorised	under	peak	experiences,	 important	work	has	been	done	by	Griffith	et	al	 (2006,	
2008,	2011),	who	explicitly	studied	the	occurrence	of	peak	experiences	under	psychedelics,	
and	tested	early	hypothesis	that	these	experiences	are	associated	with	sustained	changes	(up	
to	months/years)	 in	mood,	 behaviour	 and	 personality.	 The	 hallmark	 study	 of	 Griffith	 et	 al	
(2006)	 demonstrated	 that	 psilocybin	 is	 able	 to	 facilitate	 peak	 experiences	 (named	 by	 the	
authors	as	“mystical-type	experiences”)	with	sustained	personal	meaning,	in	individuals	who	
have	 never	 taken	 a	 psychedelic	 drug	 before	 (Griffiths	 et	 al.,	 2006).	 Subsequent	 studies	
replicated	these	findings	and	associated	these	experiences	with	enduring	positive	changes	in	
outlook,	personality	and	behaviour	(Griffiths	et	al.,	2008;	Griffiths	et	al.,	2011)	
72%	of	the	participants	who	received	psilocybin	for	their	first	time	reported	the	experience	
to	be	in	their	top	5	of	most	meaningful	experiences	in	their	lives,	and	65%	reported	improved	
well-being	14	months	 afterwards.	Maclean	et	 al	 (2011)	 showed	 that	only	 those	 individuals	
who	 experienced	 a	 strong,	 or	 “full”	 mystical-type	 experience,	 as	 defined	 by	 the	 Mystical	
Experience	 Questionnaire	 (MEQ),	 presented	 a	 significant	 increase	 in	 the	 personality	 trait	
“openness”,	14	months	after	the	experience	(MacLean	et	al.,	2011).	
These	 studies	 provide	 support	 for	 the	 hypothesis	 brought	 forth	 by	 earlier	 research	 that	
psychedelics	can	facilitate	peak	experiences,	and	support	the	view	that	peak	experiences	are	
associated	with	 sustained	 positive	 changes.	 In	 addition,	 the	 studies	 showed	 that	 enduring	
positive	 changes	 can	 be	 instantiated	 by	 administering	 psilocybin	 only	 once	 or	 on	 a	 few	
occasions,	and	that	these	changes	can	occur	in	constructs,	such	as	personality	traits,	that	are	
normally	considered	stable	in	adulthood.	
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1.6.6	Clinical	trials	with	psychedelics	
In	recent	years,	a	number	of	clinical	studies	have	focussed	on	the	treatment	of	addiction-	and	
mood	 disorders,	 and	 end-of-life	 care,	 using	 psychedelic	 therapy.	 Studies	 for	 psychedelic	
therapy	for	treating	addiction	have	been	implemented	for	tobacco-dependence	and	alcohol-
dependence	(Johnson	et	al.,	2014;	Bogenschutz	et	al.,	2015).	Johnson	et	al	(2014)	conducted	
an	 open-label	 pilot	 study	 to	 the	 efficacy	 of	 psilocybin-assisted	 psychotherapy	 for	 smoking	
cessation,	and	included	15	participants	that	had	an	average	of	six	previous	quitting	attempts,	
and	who	smoked	on	average	of	19	cigarettes	per	day	for	31	years.	The	study	showed	that	12	
of	15	participants	(80%)	completely	abstained	from	smoking	at	a	6-month	follow-up	(Johnson	
et	 al.,	 2014),	 and	 10	 of	 15	 participants	 maintained	 abstinence	 at	 12-month	 follow-up	
(Johnson	 et	 al.,	 2016).	 At	 the	 12-month	 follow-up,	 13	 participants	 (86.7%)	 rated	 their	
experience	with	psilocybin	to	be	“among	the	five	most	personally	meaningful	and	spiritually	
significant	 experiences	 of	 their	 lives”	 (Johnson	 et	 al.,	 2016).	 Furthermore,	 the	 participants	
who	 rated	high	on	measures	 for	mystical-type	experiences,	personal	meaning	and	 spiritual	
significance,	 also	 showed	 the	 strongest	 sustained	 reductions	 in	 craving	 (Garcia-Romeu,	
Griffiths,	and	Johnson	2014),	supporting	the	hypothesis	that	positive	therapy	outcomes	are	
mediated	by	peak	experience.	
Bogenschutz	et	al	(2015)	performed	the	first	open-label	pilot	study	to	test	safety	and	efficacy	
of	treating	ten	patients	with	alcohol-dependence	with	psilocybin	(Bogenschutz	et	al.,	2015).	
Patients	showed	a	significant	increase	in	drinking-abstinence	following	psilocybin,	and	these	
reductions	 were	maintained	 at	 a	 36-week	 follow-up.	 The	 general	 intensity	 of	 drug-effects	
during	the	psilocybin	experience	significantly	predicted	reductions	in	drinking	and	in	craving	
5	weeks	later.	Finally,	Krebs	and	Johanson	(2012)	performed	a	meta-analysis	on	studies	using	
LSD	to	treat	alcoholism	in	the	1950s	and	1960s,	including	six	studies	describing	the	treatment	
of	536	patients,	and	showed	improvements	up	to	6	months	after	one	dose	of	LSD	(Krebs	and	
Johansen	2012).	
There	are	 two	open-label	pilot	 studies	 that	have	assessed	safety	and	efficacy	of	 the	use	of	
psychedelics	to	treat	major	depression,	one	using	the	DMT-containing	Amazonian	plant-brew	
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ayahuasca	(Osório	et	al.,	2015)	and	one	using	psilocybin	(Carhart-Harris	et	al.,	2016).	Osorio	
et	 al	 (2015)	 administered	 ayahuasca	 to	 six	 patients	 with	 mild	 to	 severe	 depression	 and	
showed	significant	reductions	in	measures	for	depression	up	to	21	days	after	administration.	
Carhart-Harris	 et	 al	 (2016)	 administered	 psilocybin	 to	 patients	 with	 treatment	 resistant	
depression,	who	were	in	treatment	on	average	of	18	years,	and	showed	a	67%	response	rate	
(n=8)	 at	 1	 week	 after	 treatment	 with	 psilocybin,	 of	 which	 seven	 patients	 met	 the	 formal	
criteria	 for	 remission.	 Seven	 patients	 (58%)	maintained	 their	 response	 for	 up	 to	 3	months	
after	the	experience	and	five	patients	(42%)	remained	in	full	remission	(Carhart-Harris	et	al.,	
2016).		
Another	 application	of	 psychedelic	 therapy	 concerns	 its	 use	 in	 end-of-life	 care,	 to	 improve	
quality	of	life	in	patients	diagnosed	with	a	terminal	illness,	by	treating	co-morbid	diagnosis	of	
anxiety-disorders	and	distress.	Grob	et	al	 (2011)	administered	psilocybin	to	twelve	subjects	
with	advanced-stage	cancer	who	had	a	diagnosis	of	acute	stress	or	anxiety	disorder	due	their	
illness	(Grob	et	al.,	2011).	The	study	showed	significant	improvements	in	mood	at	6	months’	
prior	 the	 experience,	 but	 the	 effect-size	 was	 small,	 nor	 did	 the	 outcomes	 correlate	 with	
measures	for	peak	experiences	(Grob	et	al.,	2011).	The	authors	argue	that	the	findings	may	
reflect	 the	 relative	 low	 dose	 that	 was	 used	 (0.2	 mg/kg),	 compared	 with	 dosages	 used	 by	
Griffith	et	al	(2006,	2008,	2011)	(approx.	0.5mg/kg).		Gasser	et	al	(2014,	2015),	provided	two	
psychedelic	 therapy	 sessions	 with	 LSD	 to	 patients	 with	 end-of-life	 anxiety,	 and	 showed	
significant	 reductions	 in	 trait	 and	 state	 anxiety	 at	 the	 2month	 and	 12-month	 follow-up	
(Gasser	et	al.,	2014;	Gasser,	Kirchner,	and	Passie	2015).	The	authors	note,	however	that	only	
3	out	of	8	patients	in	the	experimental	group,	reduced	anxiety-measures	to	a	level	below	the	
diagnostic	cut-off	(Gasser	et	al.,	2014).	In	a	separate	12-month	follow-up	study,	Gasser	et	al	
(2015)	 reported	 that	 66.7%	 reported	 that	 LSD	 facilitated	 access	 to	 emotions,	 deepened	
introspection	 and	 insights,	 and	 changed	personality	 and	 values.	 The	 authors	 note	 that	 the	
observed	 therapeutic	 changes	 were	 “mainly	 dependent	 on	 a	 related	 encompassing	 of	
emotional	experiences”	 (Gasser	et	al.,	2015).	The	most	comprehensive	studies	towards	the	
efficacy	 of	 psychedelic	 therapy	 in	 end-of-life	 care,	 are	 two	 recent	 double-blind	 placebo-
controlled	clinical	trials	(Griffiths	et	al.,	2016;	Ross	et	al.,	2016).		Griffiths	et	al	(2016)	showed	
acute	improvements	after	high-dose	sessions	(30	mg/70	kg),	with	80%	of	the	51	participants	
showing	 clinically	 significant	 decreases	 in	 depressed	 mood	 and	 anxiety	 at	 the	 6-month	
	45	
follow-up	 (Griffiths	 et	 al.,	 2016).	 Ross	 et	 al	 (2016)	 demonstrated	 clinically	 significant	
reductions	in	depression	or	anxiety	after	one	dose	of	psilocybin	(0.3	mg/kg)	that	sustained	in	
60–80%	of	participants	at	the	6.5	month	follow-up	(Ross	et	al.,	2016).		
Finally,	in	a	small	open-label	pilot-study,	Moreno	et	al	(2006)	administered	psilocybin	to	nine	
patients	 with	 obsessive	 compulsive	 disorder	 (OCD).	 Symptom	 severity	 was	 measured	 at	
baseline	 and	 at	 4,	 8	 and	 24	 hours	 post-administration.	 All	 subjects	 demonstrated	 acute	
reductions	in	symptoms,	ranging	from	23%	to	100%	reduction.	Compared	to	baseline,	at	24-
hours	post-administration	88.9%	maintained	a	 reduction	 in	 symptoms	equal	or	 larger	 than	
25%,	and	66.7%	maintained	a	reduction	 in	symptoms	equal	or	 larger	than	50%	(Moreno	et	
al.,	2006).	See	appendix	for	study-details	of	these	clinical	trials.	
	
1.6.7	Safety	and	efficacy	of	psychedelics	
The	results	of	these	clinical	studies	show	a	promising	prospect.	Although	the	sample-sizes	are	
small,	 the	 fact	 that	 remission	and	abstinence	has	been	maintained	 for	 long	periods	after	a	
single	 or	 a	 few	 sessions,	 is	 “unheard	 of”	 in	 psychiatry	 (Bogenschutz	 and	 Johnson,	 2016).	
Particular	 notice	 must	 be	 given	 to	 the	 severity	 of	 the	 conditions	 of	 the	 patients	 in	 these	
studies,	 such	as	 long-term	drug-dependency	 (Johnson	et	al.,	2015;	 Johnson	et	al.,	2014)	or	
treatment-resistance	(Carhart-Harris	et	al.,	2016).	
Another	important	contribution	of	these	pilot-studies	is	their	demonstration	of	safety	within	
patient	 populations.	 So	 far	 there	 are	 no	 adverse	 events	 reported,	 apart	 from	 temporary	
anxiety	 and	 thought	 confusion	 in	 some	 volunteers	 during	 the	 sessions.	 Needless	 to	 say,	
although	the	current	data	is	suggesting	a	good	safety-profile,	the	strict	selection	criteria	and	
small	 study	 population	 sizes	 may	 have	 influenced	 these	 findings,	 and	 studies	 in	 larger	
populations	are	warranted.	But	the	emerging	picture	suggests	that	psychedelics	can	be	safely	
administered	 when	 appropriate	 guidelines	 are	 adhered.	 Indirect	 support	 for	 the	 safety-
profile	of	psychedelics	comes	from	meta-analyses	that	showed	mental	health	complications	
following	 psychedelic	 drug	 use	 amongst	 users	 to	 be	 rare	 (i.e.	 <0.1%)	 (Cohen	 and	 Ditman,	
1962).	 In	 addition,	 decreased	 rates	 of	 suicidality	 and	 psychological	 distress	 were	 reported	
among	individuals	with	a	history	of	psychedelic	drug	use	(Hendricks	et	al.,	2015)	and	there	is	
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no	 evidence	 for	 increased	 rates	 of	 mental	 health	 problems	 in	 populations	 who	 use	
psychedelics	(Krebs	and	Johansen,	2013;	Johansen	and	Krebs,	2015).		
1.7	Neuroscience	of	psychedelics	
To	inform	hypotheses	and	study-designs	for	the	investigation	of	how	psychedelics	and	music	
work	 in	 the	 brain	 in	 combination,	 an	 understanding	 of	 how	 they	 work	 separately	 is	 an	
important	 starting	 point.	 This	 section	 will	 provide	 an	 overview	 of	 early	 and	 modern	
neuroscience	 research	 of	 psychedelics.	 It	 will	 start	 with	 outlining	 the	 findings	 from	
neuroscience	 research	 with	 psychedelics	 at	 the	 microscopic	 level,	 i.e.	 the	 study	 of	 the	
interactions	of	 psychedelics	with	neurotransmitter-systems	 in	 the	brain,	 and	 then	describe	
how	 this	 influences	 behaviour	 of	 neurons	 and	 their	 communication.	 This	 will	 serve	 as	 an	
introduction	to	the	subsequent	sections,	which	will	review	our	current	understanding	on	the	
effects	of	psychedelics	on	the	macroscopic	level,	i.e.	the	changes	produced	by	psychedelics	in	
the	 behaviour	 of	 large	 populations	 or	 networks	 of	 neurons	 as	measured	 by	 neuroimaging	
studies,	 and	 how	 these	 changes	 in	 brain	 function	 have	 been	 associated	with	 some	 of	 the	
major	psychological	effects	occasioned	by	psychedelics	described	previously.		
	
1.7.1	Psychedelics	act	as	serotonin	2A	receptor	agonists	
Almost	a	decade	after	the	discovery	of	LSD,	the	presence	of	the	neurotransmitter	serotonin	
was	discovered	in	the	human	brain	(Twarog	and	Page,	1953).	It	was	the	structural	similarity	
between	 LSD	 and	 serotonin	 that	made	 researchers	 speculate	 about	 a	 role	 of	 serotonin	 in	
producing	 the	 behavioural	 and	 subjective	 effects	 of	 LSD.	 First,	 experiments	 proposed	
contradicting	mechanistic	models,	of	LSD	being	either	an	antagonist	(Gaddum	and	Hameed,	
1954)	or	an	agonist	(Andén	et	al.,	1968)	on	the	serotonin	receptor	system.	What	aided	the	
research	 significantly,	 was	 the	 increased	 knowledge	 on	 the	 different	 serotonin	 receptor	
subtypes	 (Peroutka	 and	 Snyder,	 1979),	 and	 the	 development	 of	 selective	 serotonin	
antagonists.	A	series	of	studies	using	drug	discrimination	models	in	rats	(Glennon	et	al.,	1984)	
and	 primates	 (Li	 et	 al.,	 2008),	 showed	 that	 serotonin	 2A	 antagonists,	 but	 not	 serotonin2C	
antagonists	 (Fiorella	 et	 al.,	 1995;	 Schreiber	 et	 al.,	 1994),	 blocked	 discriminative	 cues	 of	
psychedelics.		Behavioural	effects	of	psychedelics	in	mice,	such	as	head	twitching,	have	been	
successfully	 blocked	 by	 selective	 serotonin	 2A	 antagonists	 and	 by	 knocking	 out	 genes	
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encoding	serotonin	2A	receptors	 in	mice	(Halberstadt	and	Geyer,	2011;	Halberstadt,	2015).	
Radioligand	binding	studies	show	a	10	to	100-fold	higher	affinity	of	LSD	for	the	serotonin	2	
receptor	family,	compared	to	other	serotonin	receptor	sub-types	(Titeler	et	al.,	1988b),	and	
serotonin	2A	receptor	affinity	across	different	types	of	psychedelic	drugs	correlates	with	their	
potency	 (Glennon	 et	 al.,	 1984).	 However,	 ergotamide	 and	 lisuride	 do	 not	 produce	
behavioural	or	subjective	effects	like	“classic”	psychedelics	such	as	LSD,	yet	they	exhibit	high	
serotonin	2A	receptor	affinity	and	agonist	properties	(Halberstadt	and	Geyer,	2010).	This	led	
to	the	identification	of	down-stream,	intra-cellular	signalling	pathways	that	are	recruited	by	
psycho-active,	 but	 not	 by	 non-psychoactive	 serotonin2A	 agonists	 (González-Maeso	 et	 al.,	
2007).		
Important	evidence	for	the	role	of	the	serotonin	2A	receptor	in	producing	subjective	effects	
of	psychedelics	was	derived	from	human	studies	with	serotonin	2A	antagonists.	Vollenweider	
et	al	(1998)	showed	that	the	effects	of	psilocybin	are	abolished	when	co-administered	with	
the	serotonin	2A	receptor	antagonists	ketanserin	and	risperidone	(Vollenweider	et	al.,	1998).	
Subsequently,	 serotonin2A	 antagonists	 are	 shown	 to	 block	 effects	 of	 psilocybin	 within	
various	 cognitive-	 and	 behavioural	 measures,	 including	 tasks	 for	 automatic	 response	
inhibition	 (prepulse	 /	 sensorimotor	 gating)	 and	 controlled	 response	 inhibition	 (semantic	 /	
stroop	interference)	(Quednow	et	al.,	2012),	and	experiments	that	assessed	emotional	biases	
and	positive	mood	(Kometer	et	al.,	2012).	More	recently,	the	effects	of	ayahuasca	(Valle	et	
al.,	 2016)	 and	 of	 LSD	 (Preller	 et	 al,	 2017)	 were	 successfully	 blocked	 by	 ketanserin	 too.	
Together,	these	studies	provide	a	body	of	evidence	that	indicates	that	psychedelics	produce	
their	subjective	effects	via	activation	of	the	serotonin	2A	receptor.	
	
1.7.2	Expression	and	activation	of	the	serotonin	2A	receptor	
The	 serotonin	 2A	 receptor	 is	 expressed	 throughout	 the	 neocortex,	 but	 is	 especially	 highly	
expressed	 in	 high-level	 association	 areas	 (defined	 in	 subsequent	 paragraph),	 including	 the	
posterior	cingulate	cortex,	the	anterior	cingulate	cortex,	the	medial	temporal	 lobes	and	the	
insula	 (Erritzoe	 et	 al.,	 2010).	 What	 are	 the	 effects	 of	 activating	 these	 receptors?	 Upon	
activation	 of	 the	 serotonin	 2A	 receptor,	 the	 neuron’s	 cell	 membrane	 depolarizes	 and	
becomes	more	 excitable,	 i.e.	more	 likely	 to	 fire	 in	 response	 to	 incoming	 action	 potentials	
(Andrade,	 2011;	 Andrade	 and	 Weber,	 2010).	 The	 outcome	 of	 this	 increased	 excitability	
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depends	on	 the	 type	of	neuron	that	 is	 stimulated.	The	human	neo-cortex	 is	organised	 into	
distinct	 layers	 (six	 in	 total),	 and	 each	 layer	 is	 characterised	 by	 distinct	 cell	 types	 that	 are	
connected	 in	 a	 canonical	 fashion:	 distinct	 cell-types	 are	 forming	 a	 specific	 wiring-pattern,	
which	is	repeated,	like	the	patterning	of	a	tapestry,	throughout	the	neo-cortex	(Douglas	and	
Martin,	 2007).	 The	 majority	 of	 serotonin	 2A	 receptors	 are	 expressed	 on	 excitatory	
glutamatergic	pyramidal	neurons	within	the	deep	layer	V	of	the	cortex,	and	to	a	lesser	extent	
on	 GABA-ergic	 inhibitory	 interneurons	 (Celada	 et	 al.,	 2013).	 The	 deep	 layer	 V	 pyramidal	
neurons	 form	 an	 “output”,	 projecting	 to	 hierarchically	 subordinate	 regions,	 whereas	 deep	
layer	5	inhibitory	interneurons	provide	local	inhibition	of	pyramidal	neuronal	activity	(Bastos	
et	al.,	2012).	The	net-effect	of	increasing	the	excitability	of	both	neuron-types	may	therefore	
be	 difficult	 to	 predict.	 Because	 interneuron-to-pyramidal-neuron	 communication	
orchestrates	a	meticulously	balanced	activation/deactivation	of	neuronal	populations	under	
normal	conditions	(Celada	et	al.,	2013),	one	prediction	is	that	increasing	their	excitability	will	
have	a	desynchronizing	or	disordering	effect	on	neuronal	oscillations.	The	following	sections	
will	discuss	the	effects	of	serotonin	2A	receptor	activation	on	brain	activity	in	more	detail.	
	
1.7.3	Human	neuroimaging	with	psychedelics:	Introduction	
The	micro-level	organisation	outlined	above	provides	the	elementary	building-blocks	for	the	
macro-level	 organisation	of	 the	human	brain	 -	 a	highly	 complex	network	encompassing	 an	
approximate	100	billion	neurons,	that	are	organised	into	functionally	segregated	regions	and	
networks	 of	 regions.	 Brains	 construct	 internal	 working	 models	 of	 their	 environment	 that	
motivate	 behaviours	 accordingly.	 Because	 this	 environment	 is	 ever-changing,	 and	 a	 critical	
source	for	survival	as	well	as	it	is	a	continuous	source	of	challenges	and	threads,	much	of	the	
human	brain	 evolved	 into	highly	 specialized	 functions	 that	 account	 for	 the	 complexity	 and	
flexibility	 needed	 to	 thrive.	Understanding	how	 the	 brain	 does	 this,	 is	 the	 ultimate	 goal	 of	
human	neuroscience.	Neuroimaging,	 in	turn,	 is	one	of	human	neuroscience’s	most	valuable	
tools	to	do	so.		
Neuroimaging	refers	to	the	various	techniques	that	allow	the	imaging	of	either	the	structural	
(anatomical)	or	functional	(activity)	characteristics	of	the	nervous	system.	There	are	various	
modalities	 that	 allow	 the	 imaging	 of	 the	 living	 human	 brain,	 including	
electroencephalography	 (EEG),	 magnetoencephalography	 (MEG),	 direct	 recordings	 via	
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implanted	 electrodes,	 positron	 emission	 tomography	 (PET),	 single	 photon	 emission	
tomography	 (SPECT),	 and	magnetic	 resonance	 imaging	 (MRI).	 Each	modality	 poses	 unique	
advantages	and	 limitations,	 and	 in	addition,	 the	different	experimental	paradigms	 (e.g.	 the	
experimental	scanning	conditions)	and	the	data-analyses	techniques	(i.e.	the	processing	and	
drawing	 statistically-informed	 inferences	 from	 these	 measurements)	 add	 to	 the	 vast	
possibilities	of	how	the	human	brain	can	be	studied.	An	 introduction	 into	these	paradigms,	
techniques	and	terminologies,	and	in	particular	those	used	in	the	research	presented	in	this	
thesis,	will	be	provided	in	the	next	chapter	2	(methodology).	This	section	will	focus	primarily	
on	providing	an	overview	of	human	neuroimaging	with	psychedelics	performed	under	resting	
state	 (task-free)	 conditions.	 These	 studies	 have	 produced	 important	 insights	 into	 how	
psychedelics	change	brain	function,	unconstrained	by	experimental	conditions.	Furthermore,	
these	 studies	 provide	 an	 important	 foundation	 from	 which	 to	 formulate	 the	 primary	
hypotheses	in	this	study,	that	aim	to	understand	how	the	way	music	is	processed	in	the	brain	
is	changed	under	psychedelics.	
	
1.7.4	Human	neuroimaging	with	psychedelics:	Early	research	
Reviewing	early	neuroimaging	studies	with	LSD	in	the	1950s	and	1960s	presents	a	challenge,	
since	both	 the	 technologies	used	and	 the	methodological	 standards	 to	 statistically	 process	
and	analyse	complex	time-series,	have	undergone	significant	advances	over	the	last	decades.	
Nevertheless,	early	studies	that	used	direct	depth	EEG	and	scalp	EEG	to	record	spontaneous	
brain	 activity,	 have	 given	 important	 insights	 into	 possible	 brain	 mechanisms	 by	 which	
psychedelics	may	produce	their	subjective	effects	–	of	which	some	have	been	confirmed	or	
indirectly	supported	by	modern	neuroimaging	research.	
One	of	the	most	consistent	observations	of	the	early	work	may	be	a	lowering	of	the	power	or	
amplitude	of	 spontaneous	brain	activity	 after	psychedelics	 (Evarts,	 1957).	Decreases	 in	 the	
amplitude	 of	 spontaneous	 cortical	 activity	 are	 demonstrated	 after	 LSD	 and	 mescaline	 in	
rabbits	 (Delay	 et	 al.,	 1951;	 Rinaldi	 and	 Himwich,	 1955),	 in	 cats	 (Bradley	 and	 Elkes,	 1953;	
Bradley	and	Elkes,	1957),	in	rats	(Macadar	et	al.,	1970),	and	in	humans	(Bradley	et	al.,	1953;	
Rinkel	et	al.,	1952).	Often	these	reductions	in	oscillatory	power	occurred	in	the	alpha	range	
and	were	 accompanied	 by	 a	 simultaneous	 increase	 in	 the	 alpha	 frequency	 (Bradley	 et	 al.,	
1953;	Rinkel	et	 al.,	 1952).	 Schwarz	et	 al	 (1956)	performed	a	 series	of	experiments	utilising	
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intracerebral	 recordings	 using	 depth	 EEG	 in	 patients	 with	 schizophrenia	 and	 convulsive	
disorders,	and	reported	a	“pronounced	quieting	effects”	on	brain	activity,	with	simultaneous	
increases	 in	 infrequent	 recurrences	 of	 short	 bursts	 of	 “alpha-like	 discharges”	 in	 the	 visual	
cortex	and	deep	in	the	temporal	lobes	(Schwarz	et	al.,	1956).	The	authors	reported	that	these	
sudden	bursts	of	activity	corresponded	with	the	presence	of	eyes-closed	visual	hallucinations	
and	the	presence	of	music	(Schwarz	et	al.,	1956):	
“One	patient	had	waxing	and	waning	of	the	alpha-like	spindles	from	the	depths	of	the	
occipital	 region	 that	corresponded	with	 the	 rhythms	of	music.	This	appeared	at	 the	
height	 of	 the	mescaline	 effect	 but	 never	 appeared	without	music	 or	 in	 the	 control	
period	with	music”		
	
The	neuroimaging	studies	in	this	period	led	researchers	to	hypothesise	an	important	role	for	
the	temporal	 lobe	system	in	producing	the	subjective	effects	of	psychedelics.	 	Animal	work	
described	 disorganised	 activity	 within	 the	 hippocampus	 (Macadar	 et	 al.,	 1970),	 and	 the	
disappearance	of	behavioural	effects	of	LSD	in	chimpanzees	whose	temporal	lobes	have	been	
removed	 (Baldwin	 et	 al.,	 1959).	 Monroe	 et	 al	 (1957)	 used	 depth	 electrodes	 to	 study	 the	
effects	of	LSD	and	mescaline	on	brain	activity	in	humans,	and	associated	disorganized	activity	
within	 the	 hippocampus	 with	 the	 occurrences	 of	 visual	 hallucinations	 and	 emotionally	
charged	 memories	 (Monroe	 et	 al.,	 1957).	 Serafetinides	 et	 al	 (1965)	 corroborated	 these	
findings	 by	 demonstrating	 that	 after	 surgical	 removal	 of	 temporal	 lobes	 in	 humans	 with	
epilepsy,	LSD	lost	its	effectiveness	in	producing	changes	in	amplitude	or	frequency	of	cortical	
activity	(Serafetinides,	1965).		
	
1.7.5	Human	neuroimaging	with	psychedelics:	Brain	activity	
Modern	neuroimaging	in	animals	is	largely	consistent	with	earlier	work,	showing	pronounced	
reductions	 in	 oscillatory	 power	 across	 different	 frequency	 bands	 after	 administration	 of	
serotonin	2A	agonists	 (Wood	et	 al.,	 2012;	Puig	et	 al.,	 2010).	 In	what	 follows,	 the	aim	 is	 to	
provide	a	brief	but	 comprehensive	overview	of	 the	modern	human	neuroimaging	 research	
that	has	been	done	with	psychedelics,	with	a	focus	on	resting	state	neuroimaging	paradigms.		
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The	earliest	modern	EEG	study	with	a	psychedelic	may	be	the	report	by	Don	et	al	(1998),	who	
managed	to	perform	field	EEG	recordings	in	participants	of	an	ayahuasca	ritual	in	Brazil.	The	
study	reported	trend	decreases	in	oscillatory	power	in	the	alpha	and	theta	frequency	bands,	
and	trend	increases	in	oscillatory	power	in	the	beta	frequency	bands	(Don	et	al.,	1998).	Riba	
et	 al	 (2002,	2004)	 assessed	 the	effects	of	 ayahuasca	on	 cortical	 activity	using	EGG	 in	well-
controlled	experimental	conditions,	and	confirmed	earlier	observations,	showing	broad-band	
power	 decreases	 in	 spontaneous	 brain	 activity	 after	 ayahuasca	 (Riba	 et	 al.,	 2002,	 2004).	
Muthukumarawamy	 et	 al	 (2014)	 assessed	 the	 effects	 of	 psilocybin	 on	 resting	 state	 brain	
activity	using	MEG,	and	showed	significant	decreases	 in	oscillatory	power	across	 frequency	
bands,	 with	 particularly	 pronounced	 decreases	 in	 the	 alpha	 frequency	 range.	 These	
decreases	 appeared	 localised	 in	 the	 posterior	 cingulate	 cortex,	 and	 the	magnitude	 of	 the	
decreases	 in	 alpha	 activity	 correlated	 positively	 with	 ratings	 for	 ego-dissolution	
(Muthukumaraswamy	 et	 al.,	 2014).	 The	 finding	 that	 psychedelics	 decrease	 low-frequency	
oscillatory	power	in	the	human	brain	has	since	then	been	replicated	with	psilocybin	(Kometer	
et	 al.,	 2015),	 LSD	 (Carhart-Harris	 et	 al.,	 2016)	 and	 ayahuasca	 (Schenberg	 et	 al.,	 2015).	
Carhart-Harris	et	al	(2016)	replicated	previous	findings	with	psilocybin,	showing	reductions	in	
alpha	oscillatory	power	within	the	PCC	under	LSD	to	correlate	with	ratings	of	ego-dissolution	
(Carhart-Harris	 et	 al.,	 2016).	 Kometer	 et	 al	 (2015)	 furthermore	 showed	 that	 decreases	 in	
oscillatory	power	under	psilocybin	extended	into	parahippocampal	regions,	which	form	part	
of	the	medial	temporal	lobe	system	(Kometer	et	al.,	2015).		
Previous	studies	measured	effects	of	psychedelics	on	brain	dynamics	over	one	time-window	
during	 strongest	 drug	 effects.	 In	 contrast,	 Schenberg	 et	 al	 (2015)	 recorded	 resting-state	
cortical	 activity	 with	 EEG	 for	 over	 2	 hours	 in	 25	 minute	 intervals,	 and	 indicated	 that	
ayahuasca	 reduced	 alpha	power	 50	minutes	 post-administration,	 but	 that	 alpha	oscillatory	
power	was	restored	back	to	normal	levels	in	subsequent	measures	at	later	time-points,	and	
then	accompanied	by	significant	increases	in	gamma	power	(Schenberg	et	al.,	2015).	
Vollenweider	et	al	(1997)	reported	increases	in	glucose	metabolism	in	cortical	and	subcortical	
regions	after	psilocybin,	 including	 increases	 in	 the	anterior	 cingulate	cortex,	 the	 insula,	 the	
thalamus	and	the	(medial	and	lateral)	temporal	lobes.	These	changes	correlated	with	some	of	
the	subjective	effects	of	psilocybin,	such	as	visual	hallucinations	and	ego	dissolution,	and	in	
particular	with	 increases	 in	 the	 cingulate	 cortex,	medial	 temporal	 lobes	 and	medial	 frontal	
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lobes	 (Vollenweider	 et	 al.,	 1997).	 Similarly,	 Riba	 et	 al	 (2006)	 showed	 increased	 blood	
perfusion	after	ayahuasca	in	the	anterior	insula,	the	anterior	cingulate,	the	left	amygdala	and	
parahippocampal	 gyrus	 (Riba	et	 al.,	 2006).	 In	 contrast,	 the	 first	 fMRI	 study	assessing	acute	
effects	of	psilocybin	by	Carhart-Harris	et	al	(2012),	showed	decreases	in	the	BOLD	signal	and	
in	cerebral	blood	flow	(ASL)	in	cortical	and	subcortical	regions,	and	these	decreases	appeared	
in	high-level	association	regions	such	as	the	medial	prefrontal	cortex	and	the	precuneus	(part	
of	 the	 default	mode	 network	 (DMN)),	 and	 correlated	 with	 subjective	 effects	 of	 psilocybin	
(Carhart-Harris	 et	 al.,	 2012).	 	 These	 findings	 have	 been	 replicated	 by	 Palhano	 Fontes	 et	 al	
(2015),	 who	 showed	 decreases	 in	 the	 BOLD	 signal	 after	 ayahuasca	 in	 DMN	 regions	 under	
resting	state	conditions	(Palhano-Fontes	et	al.,	2015).	These	findings	have	been	interpreted	
as	a	disorganising	or	disintegrating	effect	of	psychedelics	on	the	integrity	of	high-level	brain	
regions	(Carhart-Harris	et	al.,	2014).	Accordingly,	Tagliazucchi	et	al	(2014)	showed	increased	
BOLD	 signal	 variability	 after	 psilocybin,	 with	 particularly	 pronounced	 changes	 within	 the	
hippocampi	and	the	anterior	cingulate	cortex	(Tagliazucchi	et	al.,	2014).	In	accord	with	these	
findings,	 Lebedev	 et	 al	 (2015,	 2016)	 showed	 that	 psilocybin	 and	 LSD	 produce	 significant	
increases	 in	 entropic	 brain	 activity,	 suggesting	 that	 brain	 activity	 becomes	 more	 dis-
organised,	unpredictable	or	uncertain	(Lebedev	et	al.,	2016;	Lebedev	et	al.,	2015).	
	
1.7.6	Human	neuroimaging	with	psychedelics:	Brain	connectivity		
An	 important	 advancement	 in	 neuroimaging	 is	 the	 study	 of	 functional	 integration,	 i.e.	 the	
communication	between	anatomically	and	functionally	segregated	brain	regions,	and	recent	
studies	 have	 provided	 insights	 into	 how	 psychedelics	 affect	 functional	 connectivity	 using	
fMRI.	 Carhart-Harris	 et	 al	 (2012)	 demonstrated	 significant	 decoupling	 between	 the	medial	
prefrontal	cortex	and	the	posterior	cingulate	cortex	(Carhart-Harris	et	al.,	2012).	This	finding	
has	 since	 then	 been	 replicated	with	 ayahuasca	 (Palhano-Fontes	 et	 al.,	 2015)	 and	with	 LSD	
(Carhart-Harris	 et	 al.,	 2016).	 In	 addition,	 Lebedev	 et	 al	 (2015)	 showed	 a	 decoupling	of	 the	
medial	 temporal	 lobe	areas	 from	parietal	 lobes	after	psilocybin	 (Lebedev	et	al.,	2015),	 and	
Carhart-Harris	et	al	 (2016)	showed	decoupling	of	 the	parahippocampus	 (part	of	 the	medial	
temporal	lobes)	from	the	DMN	after	LSD	(Carhart-Harris	et	al.,	2016).	The	medial	prefrontal	
cortex,	 the	 posterior	 cingulate	 cortex	 and	 the	medial	 temporal	 lobes	 are	 structurally	well-
connected	 and	 show	 strong	 functional	 coupling	 under	 normal	 resting	 state	 conditions	
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(Raichle	et	al.,	2001;	Greicius	et	al.,	2003).	These	regions	are	important	high-level	association	
regions	 that	 function	 like	 “communication	hubs”	 -	 central	 nodes	 in	 a	network	 that	 receive	
and	 integrate	 information	 from	many	 disperse	 and	 different	 functionally	 specialised	 brain	
regions	(Hagmann	et	al.,	2008;	Van	den	Heuvel	et	al.,	2012).	The	pronounced	reductions	in	
functional	connectivity	between	these	regions	facilitated	by	psychedelics	suggests	that	a	key	
mechanism	 via	which	psychedelics	work	 in	 the	brain	 is	 to	 dis-organise	 or	 dis-integrate	 the	
functional	 integrity	 of	 these	 high-level	 brain	 networks.	 This	 is	 in	 line	 with	 the	 body	 of	
evidence	 discussed	 previously	 indicating	 that	 psychedelics	 work	 by	 desynchronizing	 brain	
activity	 within	 high-level	 association	 cortices	 (Muthukumaraswamy	 et	 al.,	 2013;	 Carhart-
Harris	et	al.,	2016;	Wood	et	al.,	2012;	Riba	et	al.,	2002,	2004;	Kometer	et	al.,	2015).	
In	addition	to	studying	changes	of	functional	connectivity	between	different	regions,	valuable	
insights	have	emerged	from	studying	changes	in	coupling	between	different	brain	networks.	
Two	resting	state	brain	networks	 that	usually	display	anti-correlated	or	orthogonal	activity,	
the	DMN	and	the	Task	Positive	Network	(TPN),	are	shown	to	become	positively	coupled	after	
psilocybin	 (Carhart-Harris	 et	 al.,	 2013)	 and	 after	 ayahuasca	 (Palhano-Fontes	 et	 al.,	 2015).	
Expanding	 on	 these	 findings,	 Roseman	 et	 al	 (2015)	 investigated	 thirteen	 separate	 resting	
state	brain	networks	and	reported	marked	increases	after	psilocybin	between	brain	networks	
that	are	usually	more	strictly	functionally	segregated,	in	particularly	for	high-level	association	
networks	in	which	the	serotonin	2A	receptors	are	in	highly	expressed	(Roseman	et	al.,	2014),	
i.e.	the	posterior	cingulate	cortex	and	the	anterior	cingulate	cortex	within	the	DMN	(Erritzoe	
et	al.,	2009).	Similar	findings	were	reported	for	LSD,	including	significant	increased	coupling	
between	normally	segregated	brain	networks,	with	simultaneous	disintegrated	activity	within	
the	networks	themselves	(Carhart-Harris	et	al.,	2016).	Tagliazucchi	et	al	(2016)	assessed	the	
effects	of	LSD	on	whole-brain	functional	connectivity	density	(FCD),	which	corresponds	to	the	
strength	of	correlated	activity	for	each	region	with	all	other	parts	of	the	brain,	i.e.	high	FCD	
values	 indicate	 high	 global	 connectivity	 (Tagliazucchi	 et	 al.,	 2016).	 Key	 findings	 from	 this	
study	are	 that	FCD	was	 increased	within	high-level	association	networks,	 such	as	 the	DMN	
and	 the	 salience	 network,	 and	 that	 FCD	 increases	within	 the	 insula	 and	 the	 angular	 gyrus	
correlated	with	ego-dissolution	(Tagliazucchi	et	al.,	2016).			
	
1.7.7	Neuroscience	research	with	psychedelics:	Summary	
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Taking	 these	 findings	 together,	 a	 picture	 emerges	 of	 psychedelics	 desynchronizing	 and	
disorganising	neuronal	activity	via	serotonin	2A	receptor	activation,	and	 in	particular	within	
important	 hub-regions	 that	 form	 hierarchically	 high-level	 brain	 networks.	 Simultaneously,	
psychedelics	 facilitate	 an	 increased	 coupling	 between	 brain	 regions	 and	 networks	 that	 are	
normally	more	strictly	functionally	segregated.	This	“collapse”	of	the	usual	hierarchy	of	brain	
function,	 and	 the	 resulting	 decrease	 in	 the	 brain’s	 modularity,	 may	 be	 a	 fundamental	
mechanism	via	which	psychedelics	produce	their	interesting	subjective	effects.	
	
1.8	Neuroscience	of	music	
One	 key	 question	 that	 this	 research	 aims	 to	 address	 is	 how	 psychedelics	 change	 the	 way	
music	 is	processed	 in	 the	brain.	 To	 the	author’s	 knowledge,	 there	 is	only	one	 reference	 in	
previous	literature	on	the	effects	of	psychedelics	and	music	on	brain	function,	and	that	is	the	
study	by	Schwartz	et	al	 (1956)	who	reported	that	 the	effect	of	music	under	mescaline	was	
associated	with	“alpha-like	spindles”,	which	“never	appeared	without	music	or	in	the	control	
period	with	music”	 (Schwarz	et	 al.,	 1956).	A	 complete	 review	of	all	 neuroimaging	 research	
with	music	is	beyond	the	present	scope,	but	to	formalise	a	working	hypothesis,	this	section	
will	 provide	an	overview	of	 the	 relevant	 studies	 that	 informed	 the	present	 study’s	primary	
objectives:	 a	 discussion	 on	 the	 brain	 mechanisms	 of	 music-perception,	 music-evoked	
emotion,	and	music-evoked	mental	imagery.		
	
1.8.1	Human	neuroimaging	of	music-perception	
Music	 is	 a	 highly	 dynamic	 and	 multi-dimensional	 stimulus,	 consisting	 of	 distinct	 acoustic	
features,	 such	 as	 pitch,	 loudness,	 tempo,	 rhythm	 and	 timbre.	 Accordingly,	 the	
neurobiological	 and	 cognitive	 processes	 involved	 in	 music-listening	 display	 a	 complex	
functional	specialisation	and	a	strong	hierarchical	organisation	(Alluri	et	al.,	2013;	Toiviainen	
et	 al.,	 2014;	Griffiths	and	Warren	2004;	Koelsch	and	Siebel,	 2005).	 This	process	 serves	 the	
analysis	 of	 the	 spectral	 and	 temporal	 structures	 of	 the	 sound,	 and	 the	 linking	 of	 these	
patterns	with	high-level	mental	representations.	Hereby,	music	attains	its	profound	capacity	
to	elicit	thoughts,	sensations	and	emotions	(Koelsch	2010).	One	of	the	central	insights	of	the	
neuroimaging	of	music-listening,	is	that	music	recruits	large-scale	brain	networks	involved	in	
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attention,	 working	 memory,	 episodic	 memory,	 motor	 function	 and	 emotion	 (Alluri	 et	 al.,	
2012).	 This	 has	 turned	music	 into	 a	 valuable	 tool	 for	 cognitive	 neuroscience	 to	 study	 the	
functional	organization	of	the	human	brain.		
This	processing	of	music	starts	at	 the	 lowest	 levels	of	 the	brain’s	hierarchy,	at	 the	cochlea,	
where	 incoming	 auditory	 information	 is	 filtered,	 before	 being	 forwarded	 to	 the	 brainstem	
and	the	medial	geniculate	nucleus	(MGN)	–	a	region	within	the	thalamus	that	 is	specialised	
into	relaying	auditory	information	to	the	auditory	cortex	(Pannese	et	al.,	2015;	Pickles	2015).	
Within	the	auditory	cortex,	the	processing	of	music	starts	by	analysing	music’s	“elementary”	
acoustic	 properties,	 such	 as	 the	 loudness,	 tempo,	 pitch	 and	 timbre.	 This	 process	 involves	
Heschl’s	 gyrus,	 the	 superior	 temporal	 gyrus	 (STG)	 and	 the	 planum	 temporale,	 and	 these	
processes	occur	 in	parallel	and	are	 integrated	progressively	within	the	processing	hierarchy	
(Kumar	 et	 al.,	 2007;	 Alluri	 et	 al.,	 2012;	Griffiths	 and	Warren	 2004).	 The	 linking	 of	 acoustic	
information	with	complex	“high-level”	mental	representations,	is	associated	with	information	
exchange	between	these	auditory	cortices	and	the	inferior	frontal	gyrus	(IFG).	The	IFG,	also	
termed	 Broca’s	 area,	 plays	 an	 important	 role	 in	 auditory	 working-memory,	 and	 has	 been	
implicated	 as	 a	 critical	 area	 for	 the	 syntactical	 processing	 of	 sound,	 that	 both	 music	 and	
spoken	language	have	in	common	(Maess	et	al.,	2001;	Friederici	et	al.,	2000;	Koelsch	2006;	
Koelsch	et	al.,	2002;	Patel,	2003).	
	
1.8.2	Human	neuroimaging	of	music-evoked	emotion	
Music-evoked	emotions	are	often	described	 in	the	 literature	as	“complex”,	since	music	not	
only	 evokes	 basic,	 “simple”	 emotions	 such	 as	 pleasure	 and	 fear,	 but	 often	 a	 mixture	 of	
emotions.	Feelings	of	“nostalgia”	or	feelings	of	“wonder”	are	good	example	of	such	complex	
music-evoked	 emotion	 (Zentner	 et	 al.,	 2008;	 Juslin,	 2013).	 The	 emotion-evoking	 effects	 of	
music	are	found	to	rely	on	the	engagements	of	both	limbic	brain	areas,	such	as	the	amygdala	
and	the	striatal	system	(Blood	and	Zatorre	2001;	Blood	et	al.,	1999;	Salimpoor	et	al.,	2011),	
and	high-level	association	cortices,	such	as	the	insula	the	hippocampus	and	the	orbitofrontal	
cortex	(Petrini	et	al.,	2011;	Koelsch	2014;	Trost	et	al.,	2012).	
The	 ventral	 striatum	 is	 consistently	 activated	 to	 music,	 and	 several	 neuroimaging	 studies	
have	associated	the	ventral	striatum	with	music-evoked	pleasure	and	the	encoding	of	music-
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evoked	reward	(Salimpoor	et	al.,	2009,	2011).	Of	particular	significance	for	the	present	study	
may	 be	 the	 notably	 high	 numbers	 of	 studies	 that	 implicate	 an	 important	 function	 of	 the	
medial	temporal	 lobe	system	(including	hippocampus	and	parahippocampus)	and	the	insula	
in	music-evoked	emotion	 (Koelsch	2014;	 Frühholz	et	 al.,	 2014).	 The	medial	 temporal	 lobes	
are	 high-level	 unimodal	 association	 cortices,	 specialised	 in	 memory-formation,	 memory-
activation	and	context-dependent	cognition	(Lavenex	and	Amaral,	2000),	and	are	considered	
to	 be	 important	 for	 top-down	 regulation	 of	 emotion	 (Pessoa,	 2017).	 In	 turn,	 the	 insula	 is	
often	 activated	 to	 music-evoked	 emotion,	 and	 has	 been	 more	 described	 as	 a	 high-level	
association	region	 involved	 in	self-awareness	and	emotional	–awareness	(Craig	2009;	Gu	et	
al.,	2013;	Singer	et	al.,	2009).	
	
1.8.3	Human	neuroimaging	of	music-evoked	mental	imagery	
Mental	 imagery	 is	defined	as	a	perceptual	experience,	without	 the	presence	of	an	external	
perceptual	 stimuli	 (Arbuthnott	et	al.,	 2001;	Abraham,	2016).	Neuroimaging	 studies	 suggest	
that	 mental	 imagery	 has	 overlapping,	 if	 not	 identical,	 neural	 mechanisms	 to	 the	 neural	
mechanisms	 underlying	 perception	 (Kosslyn	 et	 al.,	 2001).	 With	 regard	 to	 the	 relationship	
between	music	and	mental	imagery,	musical	mental	imagery	has	been	studied	in	the	context	
of	music	performance	(Aleman	et	al.,	2000;	Keller,	2012),	but	there	exists	a	significant	lack	of	
knowledge	 into	 how	music	 can	 evoke	 visual	mental	 imagery.	 This	 is	 striking,	 since	music’s	
effect	 on	 mental	 imagery,	 and	 more	 broadly	 on	 spontaneous	 imagination,	 is	 popularly	
considered	 to	 be	 amongst	music’s	major	 effects,	 and	 plays	 a	 central	 role	 in	 several	music	
therapy	modalities	(Schulberg,	1999;	Summer,	2011;	Finch	and	Moscovitch,	2016).	
	
1.9	Primary	research	objectives	of	this	thesis	
This	 introduction	 chapter	 provided	 an	 overview	 of	 the	 historical	 and	 modern	 scientific	
knowledge	 and	 psychotherapeutic	 perspectives	 on	 psychedelics	 and	 music.	 It	 highlighted	
how	music	plays	a	central	role	in	the	increasing	numbers	of	clinical	trials	that	implement	and	
study	 psychedelic	 therapy,	 yet	 it	 demonstrated	 how	 little	 is	 known	 empirically	 on	 the	
function	 of	 music	 in	 this	 context.	 The	 reportedly	 profound	 effects	 of	 psychedelics	 on	 the	
subjective	 experience	 of	 music	 suggests	 that	 music	 may	 play	 an	 important	 therapeutic	
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function,	that	demands	empirical	studies	in	order	to	advance	the	rapidly	expanding	scientific	
and	psychotherapeutic	community	 that	works	with	psychedelics	and	music	 in	combination.	
Furthermore,	 by	 studying	 the	 brain	 mechanisms	 underlying	 their	 combined	 effects	 on	
subjective	 experience,	 our	 understanding	 of	 how	 the	 brain	 processes	 music	 and	 complex	
subjective	 states	may	be	 significantly	 furthered.	 Example	of	 this	 are	 the	brain	mechanisms	
underlying	 complex	 emotions	 associated	 with	 peak	 experiences,	 autobiographical	
experiences	and	visual	mental	imagery	evoked	by	music.	
The	 primary	 research	 objectives	 of	 this	 thesis	 are	 (1)	 to	 study	 the	 acute	 effects	 of	
psychedelics	and	music	in	combination	on	brain	function	under	LSD	(2)	to	associate	changes	
in	music-evoked	emotion	and	music-evoked	mental	 imagery	with	changes	 in	brain	 function	
under	LSD,	(3)	to	study	the	music-experience	in	psychedelic	therapy	with	psilocybin	and	the	
relationship	 between	 music-experience	 and	 therapy	 outcomes.	 These	 objectives	 will	 be	
addressed	via	four	separate	studies,	of	which	the	hypothesis	and	methods	will	be	discussed	
separately	in	more	detail	in	each	corresponding	chapter:		
	
Study	1:	Effects	of	LSD	on	music-evoked	emotion	
Objective:	To	study	changes	in	music-evoked	emotions	under	LSD	in	healthy	volunteers.	
Study	2:	Effects	of	LSD	and	music	on	brain	activity	and	emotion		
Objective:	To	 investigate	changes	 in	music-evoked	brain	activity	and	music-evoked	emotion	
under	LSD,	using	fMRI	in	healthy	volunteers.	
Study	3:	Effects	of	LSD	and	music	on	parahippocampus	connectivity	and	mental	imagery	
Objective:	To	investigate	the	neural	correlates	of	music-induced	mental	 imagery	under	LSD,	
using	fMRI	in	healthy	volunteers.	
Study	4:	Music-experience	in	psychedelic	therapy		
Objective:	To	assess	the	phenomenology	of	the	music-experience	in	patients	with	depression	
undergoing	psychedelic	therapy	with	psilocybin,	and	the	relation	between	music-experience	
and	therapy	outcomes.	
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“The	conclusion	from	all	these	considerations	is	that	the	most	important	step	in	
the	art	of	being,	is	everything	that	leads	to	and	enhances	our	capacity	for	
heightened	awareness	and,	as	far	as	the	mind	is	concerned,	for	critical,	
questioning	thinking”	
Erich	Fromm	
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2		
	
Methodology
This	chapter	serves	to	provide	an	introduction	into	the	methods	used	in	this	research.	It	will	
briefly	 explain	 the	 background	 of	 functional	 magnetic	 resonance	 imaging	 (fMRI),	 and	
introduce	 the	 different	 fMRI	 data	 analysis	 methods	 used	 to	 measure	 changes	 in	 brain	
function	 (BOLD	 activity,	 functional	 connectivity	 and	 effective	 connectivity).	 Finally,	 it	 will	
introduce	 the	 selection	 of	 the	 psychological	 metrics	 used	 to	 study	 changes	 in	 musical	
experiences	 under	 LSD,	 including	 the	 Geneva	 Emotional	 Music	 Scale	 (GEMS)	 and	
Interpretative	 Phenomenological	 Analysis	 (IPA).	 The	 chapter	 will	 outline	 the	 study-designs	
that	were	used	 in	 the	experiments	 in	 this	 thesis,	but	details	will	be	provided	seperatey	 for	
each	separate	experiment	in	the	corresponding	chapters.	
	
2.1	A	brief	introduction	to	fMRI	research	
	
The	emergence	of	fMRI	in	neuroscience	research	in	the	1990s	had	a	revolutionary	impact	in	
the	field.	It	was	the	first	time	that	neuroscientists	were	able	to	measure	human	brain	activity	
non-invasively	 and	 in	 vivo	 in	 a	 relative	high	 spatial	 resolution.	MRI	works	by	 exploiting	 the	
behaviour	 of	 hydrogen	 (H)	 atoms	 in	 a	 strong	 magnetic	 field.	 The	 MRI	 machine	 applies	 a	
strong	 magnetic	 field,	 that	 aligns	 the	 hydrogen	 protons	 with	 the	 magnetic	 field.	
Subsequently,	radio	frequency	energy	is	applied	to	the	hydrogen	protons	in	the	brain	using	a	
gradient	coil	around	the	head,	“exciting”	the	protons	into	a	high-energy	state	and	“flipping”	
the	protons	90°	from	the	magnetic	field	axis.	After	excitation,	the	hydrogen	protons	release	
radio	frequency	energy	while	returning	to	their	“relaxed”	baseline	state.	This	release	of	radio	
frequency	energy	is	measured	by	the	MRI	scanner,	and	underlies	the	generation	of	an	image.	
The	full	3D	brain	images	are	usually	acquired	one	slice	at	a	time,	with	each	slice	being	a	2D	
image.	 To	 overcome	 this	 relatively	 slow	 process,	 gradient	 echo	 planar	 imaging	 (EPI)	
techniques	 were	 developed	 that	 allow	 a	 faster	 acquisition	 of	 sequences	 of	 images,	 by	
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collecting	multiple	“echoes”	from	each	radio	frequency	pulse,	providing	one	full	brain	image	
each	few	seconds	-	depending	on	the	MRI	scanner	&	selected	parameters.	
fMRI	measures	the	blood	oxygenation	level-dependent	(BOLD)	signal,	which	is	a	surrogate	or	
indirect	 signal	 for	 brain-activity.	 The	 BOLD	 signal	 reflects	 the	 oxygenation	 of	 blood	 in	 the	
brain,	 estimated	 via	 magnetization	 difference	 between	 oxyhaemoglobin	 and	
deoxyhaemoglobin.	 When	 brain	 areas	 have	 increased	 synaptic	 brain	 activity,	 these	 areas	
undergo	an	increased	metabolic	demand,	which	results	in	the	proportion	of	oxyheamoglobin	
and	deoxyhaemoglobin	to	be	relatively	reduced.	Thus,	the	BOLD-signal	correlates	with	brain	
activity,	and	hence,	BOLD-increases	are	typically	inferred	as	increases.	
There	 are	 several	 limitations	 using	 fMRI	 to	 study	 changes	 in	 brain	 function.	 One	 major	
limitation	of	measuring	the	BOLD	signal,	 is	 that	the	signal	changes	occur	much	slower	than	
real	brain	activity	(up	to	80Hz).	Changes	in	blood	flow	show	a	slow	peak	(5	second	from	the	
beginning	 of	 the	 increase),	 a	 signal	 referred	 to	 as	 the	 haemodynamic	 response	 function	
(HRF),	and	thereby	significantly	limit	the	temporal	resolution	of	the	BOLD	measure.	Secondly,	
the	BOLD-signal	changes	are	non-absolute,	making	only	 relative	 fluctuations	 in	BOLD	signal	
within	one	scanning	session	utilisable.	Thirdly,	the	analyses	of	the	BOLD-signal	need	to	take	
into	account	a	significant	amount	of	noise	in	the	data	(e.g.	non-specific	background	noise	or	
head-movement	 artefacts	 in	 the	 measured	 fMRI	 signal).	 And	 finally,	 one	 needs	 to	 be	
reminded,	 that	 despite	 the	 superior	 spatial	 resolution	 of	 fMRI	when	 compared	with	 other	
neuroimaging	modalities,	the	BOLD-signal	that	is	measured	per	3-dimensional	unit	or	voxel,	
still	 represents	 the	 mixed	 activity	 of	 approximately	 one	 million	 neurons	 (Arthurs	 and	
Boniface,	2002;	Logothetis,	2008;	Logothetis	and	Wandell,	2004).	
Nevertheless,	 advances	 in	methodology	have	made	 fMRI	a	dominant	paradigm	 for	 relating	
brain	 function	 to	 behaviour	 and	 cognition,	 and	 over	 the	 previous	 decennia,	 fMRI	 has	
provided	 important	 insights	 into	 the	 brain’s	 functional	 organisation.	 For	 example,	 fMRI	
research	has	highlighted	 the	 functional	 specialisation	of	 functionally	 segregated	 “modules”	
that	 are	 localised	 in	 distinct	 regions	 and	 networks	 of	 the	 brain,	 such	 as	 for	 example	 the	
auditory	cortex	being	specialised	into	the	processing	of	auditory	information	(Morosan	et	al.,	
2001;	 Hackett,	 2011).	 Furthermore,	 fMRI	 research	 furthered	 our	 understanding	 of	 the	
functional	 organisation	 of	 the	 brain,	 and	 highlighted	 processing	 hierarchies.	 For	 example,	
auditory	information	received	by	the	cochlea,	is	forwarded	to	areas	in	the	brain	stem	and	the	
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thalamus	that	are	specialised	into	the	processing	of	sound,	which	then	relays	this	information	
to	 the	 primary	 auditory	 cortex	 in	 ascending	 levels	 of	 specialisation,	 abstraction,	 and	
association	(Hackett	2011;	Kumar	et	al.,	2007;	Romanski	et	al.,	1999;	Wessinger	et	al.,	2001).	
The	 auditory	 cortices,	 in	 turn,	 represent	 different	 regions	 specialised	 into	 processing	
different	properties	of	the	sound,	 including	its	pitch,	 loudness	and	timbre.	This	will	then	be	
forwarded,	 in	 parallel,	 to	 other	 areas	 that	 process	 the	what	 (object	 recognition)	 and	 the	
where	 (localisation)	of	 the	sound,	and	 link	 the	sound	with	complex	mental	 representations	
and	emotional	responses	(Wang	et	al.,	2008;	Bizley	and	Cohen,	2013;	Romanski	et	al.,	1999;	
Hackett	2011).	The	further	in	the	processing	hierarchy,	the	more	abstracted	and	multi-modal	
the	signal	is	processed.	This	is	one	example	of	how	fMRI	research	has	advanced	the	field,	by	
moving	 the	 focus	 away	 from	 localising	 specialised	 brain	 functions,	 to	 studying	 how	 brain	
areas	 communicate	with	 each	other	 as	 part	 of	 a	 highly	 interconnected	 complex	 system	of	
processing	units	 -	 also	 known	as	 functional	 integration	 (Friston,	 2011).	Understanding	how	
the	brain	coordinates	and	integrates	activity	from	separate	specialised	regions	as	a	dynamic	
network,	 is	one	of	the	central	challenges	 in	neuroscience	research	today.	The	experimental	
methods	 representing	 these	advances	 that	were	used	 in	 this	 research,	will	be	 the	 focus	of	
the	following	sections.	
	
2.2	Methods	for	fMRI	research	
2.2.1	Designing	fMRI	experiments	
The	hypotheses	that	fMRI	allows	to	address	are	determined	by	the	design	of	the	experiment.	
A	general	distinction	can	be	made	between	stimulus-	or	 task-based	paradigms	and	resting-
state	or	task-free	paradigms.	In	a	task-based	paradigm,	the	aim	to	is	to	present	a	stimulus	or	
a	cognitive/behavioural	task	for	a	certain	duration	(a	block	or	epoch)	(e.g.	an	auditory	tone	
for	 5	 seconds),	 and	 to	 contrast	 this	 with	 a	 control	 condition	 (e.g.	 silence	 for	 5	 seconds).	
Contrasting	these	two	conditions	will	then	allow	to	identify	the	brain	regions	that	are	more	
activated	(sound	>	silence)	or	less	activated	(silence	>	sound)	during	the	auditory	tone.	Task-
based	 paradigms,	 allow	 to	 investigate	 specific	 modes	 of	 perception	 and	 cognition	 (e.g.	
auditory	processing	and	working	memory).	 In	contrast,	 task-free	or	 resting-state	paradigms	
are	characterised	by	the	absence	of	stimuli	or	tasks,	and	allow	to	investigate	“resting-state”	
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brain	functioning,	and	the	“spontaneous”	cognition	associated	with	this	(e.g.	self-referential	
thinking	 or	 day-dreaming).	 A	 baseline	 or	 “default	 mode”	 of	 resting	 brain	 function	 was	
discovered	 via	 observing	 consistent	 de-activations	 in	 a	 set	 of	 brain	 regions	 during	 tasks	
(Raichle	 et	 al.,	 2001).	 This	 led	 to	 identification	 of	 resting	 state	 brain	 networks,	 and	 to	
important	 insights	 into	 the	 intrinsic	 functional	 organisation	of	 the	human	brain	 (Fox	 et	 al.,	
2005;	Greicius	et	al.,	2003;	Yeo	et	al.,	2011).	
With	 regard	 to	 the	 fMRI	 experiments	 (study	 2	 and	 3),	 the	 stimuli	 consisted	 of	 full	 music	
tracks,	that	were	contrasted	with	a	stimulus-free	condition	(resting-state)	to	study	an	effect	
of	music.	In	addition,	given	the	objective	to	assess	how	psychedelics	alter	the	effects	of	music	
on	 the	 brain,	 the	 experiments	 consisted	 of	 two	 separate	 study	 days,	 where	 on	 one	 day	
placebo	(saline)	was	administered,	and	on	the	other	day	the	drug	(LSD)	resulting	in	a	factorial	
design	(i.e.	two	conditions	(music	vs	no	music),	present	within	2	conditons	(LSD	vs	placebo).	
The	 order	 of	 the	 conditions	 was	 randomised,	 to	 control	 for	 possible	 order-effects.	 These	
criteria	did	not	apply	to	study	1,	which	was	placebo-controlled,	but	in	fixed	order,	and	study	
2,	wich	was	an	open-label	clinical	trial	(i.e.	with	no	placebo	condition).	Detailed	motivations	
behind	 these	 study	 designs,	 including	 the	 motivations	 behind	 the	 music	 selection,	 are	
provided	in	the	respective	chapters.	
	
2.2.2	fMRI	scanning	and	data	pre-processing	of	fMRI	data	
Neuroimaging	was	performed	on	a	3T	GE	HDx	system.	An	 initial	3D	FSPGR	anatomical	scan	
was	obtained	in	an	axial	orientation,	with	field	of	view	=	256×	256×	192	and	matrix	=	256	×	
256×	192	to	yield	1-mm	isotropic	voxel	resolution	(TR/TE	=	7.9/3.0	ms;	inversion	time	=	450	
ms;	 flip	angle	=	20°).	This	was	used	for	registration	and	segmentation	of	 functional	 images.	
Functional	 images	were	 acquired	 using	 a	 gradient	 echo	 planer	 imaging	 sequence,	 TR/TE	 =	
2000/35ms,	field-of-view	=	220mm,	64	×	64	acquisition	matrix,	parallel	acceleration	factor	=	
2,	90°	flip	angle.	35	oblique	axial	slices	were	acquired	in	an	interleaved	fashion,	each	3.4mm	
thick	with	 zero	 slice	 gap	 (3.4mm	 isotropic	 voxels).	 The	precise	 length	of	 each	of	 the	BOLD	
scans	was	7	minutes	and	20	seconds.	
fMRI	scanning	sessions	usually	acquire	a	high-resolution	anatomical/structural	(T1-weighted)	
image	and	a	number	of	functional	(T2-weighted)	 images.	Both	the	structural	and	functional	
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images	undergo	a	sequence	of	pre-processing	procedures.	This	is	critical,	in	order	to	correct	
for	motion-	or	scanner-	related	noise	 in	the	data	and	to	be	able	to	compare	the	functional	
scans	 across	 subjects.	 The	 methods	 used	 in	 this	 thesis	 aimed	 to	 reflect	 the	 most	 recent	
advances	in	pre-processing	methods	(such	as	for	example	methods	for	correcting	for	motion-
artefacts),	 in	 accord	 with	 the	 significant	 changes	 these	 guidelines	 underwent	 over	 recent	
years.	
The	 fMRI	pre-processing	programme	was	assembled	 from	several	different	complementary	
imaging	 software	 packages:	 FMRIB	 Software	 Library	 (FSL)	 (Smith	 et	 al.,	 2004),	 AFNI	 (Cox,	
1996),	Freesurfer	(Dale	et	al.,	1999)	and	Advanced	Normalization	Tools	(ANTS)	(Avants	et	al.,	
2011)	 were	 used.	 More	 details	 of	 the	 utilised	 pre-processing	 procedures	 and	 the	 chosen	
parameters	are	provided	in	the	methods	section	of	each	separate	neuroimaging	study	(study	
2	and	3),	but	in	general,	the	following	pre-processing	procedures	were	included:		
1)	De-spiking	(3dDespike,	AFNI):	removal	of	“spikes”	in	the	time	series,	to	correct	for	motion	
artefacts.	
2)	 Re-allignment	 (3dvolreg,	 AFNI):	 registration	 (mapping)	 of	 each	 functional	 image	 to	 the	
functional	 image	 that	 is	most	 similar	 to	 all	 other	 images	within	 the	 same	 scanning	 session	
(per	subject),	to	correct	for	motion	artefacts.	
3)	Brain	extraction	(BET,	FSL):	removing	of	all	non-brain	tissue	from	the	structural	images,	to	
aid	subsequent	image	registration	of	functional	images	onto	anatomical	images.	
4)	Anatomical	registration	(rigid	body	registration	using	FSL’s	BBR,	or	Freesurfer’s	bbregister	
when	done	manually):	registration	of	all	functional	images	to	anatomical	image	per	subject.	
5)	 Template	 registration	 (aka	 normalisation)	 (SyN),	 ANTS):	 Non-linear	 registration	 to	 2mm	
MNI	 template	brain	 to	 align	 all	 subject-level	 images	 to	 the	 same	 template	 image,	 allowing	
subsequent	group	level	analyses.	
6)	Scrubbing	(Power	et	al.,	2012):	substituting	TR’s	with	high	framewise	displacement	(FD),	to	
correct	for	motion	correction.	
7)	 Spatial	 smoothing	 (FWHM)	 (3dBlurInMask,	AFNI):	 convolution	of	 the	BOLD	 signal	with	 a	
5mm	full-width	gaussian	kernel,	to	control	for	spatial	inhomogeneity	and	for	radio	frequency	
noise	within	the	scanner	.	
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8)	Temporal	filtering:	using	a	high-pass	filtering	at	a	cut-off	frequency	of	0.01	Hz	to	remove	
baseline	signal	drifts	in	the	BOLD	signal,	to	correct	for	scanner	noise	(drift)	correction.	
9)	Nuisance	regressors	(9	in	total)	were	added	into	subsequent	data-analysis	(General	Linear	
Model,	explained	below)	to	correct	for	motion	correction.	These	were	six	motion-related	(3	
translations,	3	rotations)	and	three	anatomically-related	(not	smoothed).	
	
2.2.3	The	General	Linear	Model	
The	 general	 linear	 model	 (GLM)	 is	 a	 statistical	 linear	 model,	 consisting	 of	 explanatory	
variables	that	predict	the	response	variable.	In	fMRI	data	analysis,	the	GLM	typically	implies	a	
multiple	linear	regression,	where	the	BOLD	signal	is	the	response	variable	(Y),	described	by	a	
linear	combination	of	multiple	explanatory	variables	(X),	which	can	be	the	time	courses	that	
describe	the	experimental	design	(e.g.	presence	or	absence	of	auditory	tone)	and	nuisance-	
or	noise-variables	(e.g.	time	courses	for	head-movement).		This	is	written	as:	𝑌	 =	𝛽0	+	𝑋1𝛽1	+	𝑋2𝛽2	+	…	+ 	𝜀	
For	 each	 voxel,	 the	 GLM	 finds	 the	 weights	 (𝛽i)	 that	 minimize	 the	 residual	 variance	 (𝜀)	
between	 the	 predicted	 and	 observed	 BOLD	 signal.	 This	 informs	 a	 statistical	 map	 for	
explanatory	variables	of	interest,	that	can	be	examined	in	isolation	or	can	be	contrasted	with	
other	variables	 (e.g.	auditory	 tone	A	versus	auditory	 tone	B).	This	 statistical	map	 illustrates	
BOLD-activations	 or	 BOLD-deactivations	 on	 a	 subject	 level,	 but	 most	 fMRI	 studies	 aim	 to	
make	 inferences	 on	 group	 level	 (e.g.	 condition	 A	 compared	 to	 condition	 B).	 To	 do	 so,	 the	
estimates	of	the	subject-level	GLMs	enter	a	group-level	(high-level)	analysis,	which	typically	
involves	a	t-test	or	ANOVA.	This	results	in	a	group	average,	which	can	be	contrasted	between	
different	conditions	(e.g.	LSD	vs	placebo).	
	
2.2.4	Measuring	changes	in	BOLD	activation	
The	 analysis	 employed	 in	 study	 2	 (chapter	 4),	will	 assess	 BOLD	 activity	 changes	 related	 to	
different	 aspects	 (acoustic	 features)	 of	 the	music.	 This	 study	 follows	 a	 classical	 task-based	
design	as	described	above,	where	multiple	time	courses,	each	describing	a	distinct	feature	in	
the	music,	will	be	added	as	regressors	 into	one	GLM	(e.g.	 loudness,	pitch,	brightness,	etc.).	
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This	 allows	 the	 generation	 of	 a	 statistical	 map	 for	 each	 different	 acoustic	 feature,	 and	
thereby	allows	to	assess	what	regions	are	involved	in	the	processing	each	separate	feature,	
and	 subsequently,	 to	 investigate	 the	 differences	 between	 drug	 and	 non-drug	 condition	 in	
processing	these	features.		
	
2.2.5	Measuring	functional	integration:	Functional	connectivity	
As	was	said	in	the	beginning	of	this	chapter,	the	field	has	witnessed	a	significant	shift	in	focus	
from	 studying	 functional	 localisation	 to	 studying	 functional	 integration.	 Various	 ways	 of	
assessing	 functional	 integration	 in	 the	 human	 brain	 have	 been	 developed	 for	 analyses	 of	
fMRI	data	(Friston,	2011;	O’Reilly	et	al.,	2012).	The	most	commonly	employed	are	measures	
of	 “functional	 connectivity”,	 which	 refers	 to	 the	 statistical	 dependencies,	 or	 correlations,	
between	time	courses	representing	BOLD-signal	variations	 from	different	voxels	or	 regions.	
In	 the	 present	 study,	 functional	 connectivity	 has	 been	 measured	 by	 using	 “seed-based	
paradigms”,	where	the	BOLD	signal	time-course	of	one	region	of	interest	(ROI,	the	“seed”)	is	
extracted	 to	 correlate	 against	 each	 other	 voxel	 in	 the	 brain.	 The	 research	 presented	 here	
used	two	different	seed-based	methods	of	measuring	functional	connectivity:	
Standard	seed-based	functional	connectivity:	 In	seed-based	functional	connectivity	analyses,	
the	BOLD-signal	timecourse	from	one	region	of	interest	(ROI),	i.e.	the	“seed”,	is	extracted	and	
correlated	against	each	other	voxel	in	the	brain.	This	allows	the	identification	of	other	regions	
that	 show	 co-variation	 in	 activity	with	 the	 seed	 region,	 and	permits	 to	 assess	 the	 changes	
regions	 or	 networks	 of	 regions	 show	 in	 correlated	 activity,	 across	 different	 experimental	
conditions	 (e.g.	 comparing	 functional	 connectivity	 between	 LSD	 and	 placebo	 conditions)	
(Friston,	2011).		
Psycho-physiological	 interaction	analysis:	 In	psychophysiological	 interactions	(PPIs)	analyses,	
a	time	course	from	one	seed	ROI	is	extracted,	and	then	multiplied,	element-by-element,	with	
the	 task-regressor.	 This	 generates	 a	 “PPI	 regressor”,	 that	 will	 correlate	 with	 the	 seed	 ROI	
time	 course	 during	 tasks,	 but	 anti-correlated	 with	 the	 seed	 ROI	 time-course	 during	 rest	
blocks.	Therefore,	when	the	PPI	regressor	is	correlated	against	each	voxel	in	the	brain,	task-
specific	changes	in	functional	connectivity	can	be	revealed	(O’Reilly	et	al.,	2012).		
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2.2.6	Measuring	functional	integration:	Effective	connectivity	
Correlations	can	however	arise	in	various	ways.	For	example,	activity	in	two	separate	regions	
can	correlate	because	they	share	a	common	input	of	the	stimulus,	or	their	activity	correlates	
because	activity	in	one	region	causes	activity	in	another	via	excitatory	forward	connections.	
Measures	 for	 the	 latter	 are	 called	 “effective	 connectivity”,	 i.e.	 the	 causal	 or	 directed	
information	 flow	 between	 separate	 brain	 regions	 (Friston,	 2011).	 Measures	 for	 effective	
connectivity	 take	 into	 account	 the	 hierarchical	 organisation	 of	 the	 brain	 via	 differentiating	
between	 forward	and	backward	connections,	and	hence	give	a	more	accurate	depiction	of	
the	involved	brain	mechanisms.	Effective	connectivity	can	be	assessed	by	different	methods,	
including	 Granger	 Causality,	 Structural	 Equation	 Modelling	 and	 Dynamic	 Causal	 Modelling	
(DCM).	 In	 the	 present	 study,	 effective	 connectivity	 was	 assessed	 using	 DCM.	 Informed	 by	
standard	DCM	procedures,	this	was	preceded	by	functional	connectivity	analyses	to	identify	
the	network	 to	 interrogate	with	 further	hypothesis	 testing	using	DCM	(Friston	et	al.,	2003;	
Karl	J.	Friston	et	al.,	2011;	B.	Li	et	al.,	2011;	Stephan	et	al.,	2010).	
Dynamic	 causal	 modelling:	 DCM	 is	 a	 biologically-informed	 modelling	 procedure	 that	
estimates	the	causal	 interactions	(i.e.	effective	connectivity)	between	different	pre-selected	
nodes	of	a	network,	and	the	changes	in	coupling	strength	between	and	within	those	nodes	
(extrinsic	 and	 intrinsic	 connections	 respectively)	 due	 to	 experimental	 manipulations.	 The	
basic	 architecture	of	 a	model	 is	 defined	by	 structurally	plausible	 and	 functionally-informed	
brain	 regions,	 whose	 connections	 are	 defined	 as	 either	 bilinear	 (i.e.	 information	 flow	
between	 regions)	 or	 non-linear	 (i.e.	 activity	 in	 one	 region	 modulating	 information	 flow	
between	 regions).	 Typically,	 experimental	manipulations	 can	 directly	 affect	 activity	 in	 each	
node	 (as	 ‘driving	 inputs’)	 or	 alter	 the	 strength	 of	 coupling	 within	 or	 between	 nodes	 (as	
‘modulatory	inputs’)	(Friston	et	al.,	2003).	
In	DCM,	a	series	of	plausible	models,	representing	competing	hypotheses,	are	specified.	Each	
model	corresponds	to	a	hypothesis	about	how	observed	changes	in	BOLD	signal	were	caused	
by	changes	in	neural	activity	in	each	network	node.	The	different	models	can	vary	in	terms	of	
the	 position	 of	 driving	 and	 modulatory	 inputs.	 DCM	 uses	 a	 biophysical	 model	 of	 the	
hemodynamic	 response	 to	 predict	 the	 underling	 neuronal	 activity	 –	 and	 the	 underlying	
(changes	 in)	connectivity	–	 from	the	observed	BOLD	signal.	Model	estimation,	or	 inversion,	
returns	conditional	estimates	for	the	changes	in	connectivity	and	scores	the	model	in	terms	
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of	its	accuracy	and	complexity	(Kahan	and	Foltynie,	2013;	Friston	and	Penny,	2011;	Stephan	
et	al.,	2010).		
Following	model	 estimation,	 Bayesian	Model	 Selection	 (BMS)	 is	 used	 to	 compare	 different	
models	to	identify	the	model	with	the	greatest	evidence	–	i.e.	the	model	that	offers	the	best	
explanation	of	the	data.	This	model	can	be	selected	to	assess	coupling	parameters	post-hoc,	
to	characterize	 the	size	and	direction	of	 the	changes	 in	connection	strength	caused	by	 the	
experimental	manipulations.	 Coupling	 parameters	 quantify	 the	 strength	 of	 the	 coupling	 in	
terms	of	the	rate	(in	Hz)	at	which	a	response	is	caused	in	a	given	region,	and	modulation	is	
expressed	as	either	an	increase	or	decrease	in	this	coupling	measure	(Friston,	2003;	Friston	
and	Penny,	2011;	Kahan	and	Foltynie,	2013).		
	
2.3	Methods	for	qualitative	research		
This	 thesis	 also	 aims	 to	 investigate	 changes	 in	 the	 subjective	 experience	 of	music	 under	 a	
psychedelic.	 In	 particular,	 the	 objective	 is	 to	 assess	 changes	 in	music-evoked	 emotion	 and	
music-induced	imagery,	to	associate	these	effects	with	measured	changes	in	brain	function	in	
the	neuroimaging	studies,	and	to	study	the	music-experience	during	psychedelic	therapy.	The	
methods	 employed	 to	 do	 so,	 include	 questionnaires,	 visual	 analogue	 scales	 (VAS)	 and	
qualitative	analysis	of	interview	data.	
Visual	 Analogue	 Scales	 and	 questionnaires:	Visual	 analogue	 scales	 (VAS)	 for	 questions	 that	
assess	the	subjective	experience	of	music	were	implemented.	Examples	of	such	questions	are	
“how	emotionally	affected	were	you	by	the	music?”	(study	1),	or	“did	you	experience	simple	
eyes-closed	imagery?”	(study	2),	and	responses	to	these	questions	are	scored	on	a	VAS	scale	
ranging	 from	 0	 to	 100,	with	 respective	 anchors	 to	 indicate	 the	 qualitative	meaning	 of	 the	
value.	 Comparing	 average	 ratings	 between	 conditions,	 allows	 to	 assess	 difference	 in	
subjective	experience	between	drug	and	non-drug	states,	and	the	change-scores	(drug>non-
drug)	 allows	 correlation-analyses	 that	 associate	 changes	 in	 subjective	 experience	 with	
changes	 in	 brain	 function	 (e.g.	 correlating	 increases	 in	 ratings	 for	 mental	 imagery	 versus	
changes	in	effective	connectivity	(study	3)).	
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There	have	been	several	psychological	metrics	developed	to	assess	music-evoked	emotion.	A	
classic	 approach	 utilises	 a	 2-dimensional	 model	 that	 differentiates	 between	 arousal	
(activating	 versus	 relaxing),	 and	 valence	 (positive	 emotions	 versus	negative	 emotions).	 The	
critique	 on	 this	 metric	 is	 that	 it	 does	 not	 acknowledge	 the	 complexity	 inherent	 in	 music-
evoked	emotion:	music-evoked	emotions	are	argued	to	often	be	a	mixture	of	basic	emotions.	
For	 example,	 feelings	 of	 nostalgia	 include	 feelings	 of	 sadness	 (negative	 valence)	 and	 joy	
(positive	 valence)	 (Juslin,	 2013;	 Zentner	 et	 al.,	 2008).	 Some	 argued	 that	 those	 complex	 or	
aesthetic	 emotions	 are	 what	 makes	 the	 scientific	 study	 of	 music-evoked	 emotions	 in	
particular	significant,	and	questionnaires	have	been	developed	that	address	this,	such	as	the	
Geneva	Emotional	Music	Scale	 (GEMS).	This	 study	uses	 the	GEMS,	which	has	been	derived	
from	 a	 sequence	 of	 studies,	 starting	 with	 qualitative	 studies,	 towards	 large-sample	 rating	
studies,	that	used	factor-analyses	to	validate	distinct	dimensions	or	factors	of	music-evoked	
emotion	(Zentner	et	al.,	2008).	
Phenomenological	analysis.		The	objective	of	study	4	was	to	deepen	our	understanding	of	the	
subjective	 experience	 and	 therapeutic	 function	 of	 music	 in	 psychedelic-assisted	
psychotherapy.	Understanding	patient-experiences	in	a	naturalistic	setting	was	an	important	
motivation	 for	 this	 objective,	 given	 other	 expriments	 in	 this	 thesis	 concerned	 effects	 of	
psychedelics	and	music	on	healthy	voltuneers,	and	within	a	context	that	is	strikingly	different	
from	the	therapeutic	application	(i.e.	fMRI	scanner	vs	quiet	room	with	supportive	therapists	
and	music	listening).		
To	accomplish	this	objective,	 like	in	any	other	experiment,	the	study	design	determines	the	
the	conclusions	that	can	be	drawn.	Science,	 in	simplest	terms,	 is	a	practice	of	advancing	an	
emperical	understanding	of	reality	by	finding	meaningful	patterns	in	data,	in	order	to,	in	the	
words	 of	 physicist	 David	 Deutsch,	 “test	 new	 theories	 that	 seem	 to	 show	 promise	 of	
explaining	things	better	than	the	prevailing	ones	do”	(Deutsch,	1997).		
To	 find	 meaningful	 patterns,	 many	 research	 designs	 are	 hypotesis-driven,	 in	 which	 the	
experiments	are	designed	as	such	so	that	inferences	can	be	made	regarding	specific,	isolated	
variables	of	interest.	A	caveat	with	hypothesis-driven	approaches	is	that	hypohteses	are	per	
definition	 bounded	 by	 the	 limitations	 of	 current	 knowledge	 (Helden,	 2013).	 Designing	
experiments	with	prior	expectations,	therefore,	runs	the	risk	of	biasing	and	thereby	excluding	
alternative,	 better	 explanations.	 This	 is	 especially	 problematic,	 when	 chartering	 unknown	
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terrorities,	 such	 as	 the	 case	 in	 this	 thesis.	 Data-driven	 research	 approaches,	 on	 the	 other	
hand,	allowing	inferences	to	be	told	by	the	“data	itself”	(Shih,	2016),	on	the	assumption	that	
when	 prior	 beliefs	 are	 absent	 there	 is	 a	 greater	 possibility	 of	 insight	 into	 a	 phenomenon	
“where	nobody	had	looked	before”	(Helden,	2013).	
For	 study	 4,	 we	 haven	 implemented	 a	 qualitative	 (semi)	 data-driven	 approach,	 called	
interpretative	phenomenological	analysis	(IPA)	(Smith	et	al.,	1997).	This	approach	was	chosen	
to	analyse	interviews	with	patients	about	their	experience	with	the	music	during	psychedelic	
therapy	psilocybin,	 after	 their	 therapy	 session.	 The	 interviews	 consisted	of	 open	questions	
(for	example:	“Did	the	music	influence	your	experience?	And	if	so:	in	what	ways?”,	to	allow	
patients	 to	 share,	using	 their	own	words	and	 interpretations,	unbiased	by	 the	 researcher’s	
hypotheses,	whether	or	not,	and	how	the	music	influenced	their	subjective	experience.	IPA	is	
an	 approach	 increasingly	 used	 in	 healthcare	 research	 (Biggerstaff	 and	 Thompson,	 2008;	
Smith,	2011),	and	is	considered	in	particular	appropriate	when	ascertaining	and	unveiling	the	
complexity	 behind	 patients’	 subjective	 experiences	 (Smith,	 2011).	 Details	 on	 the	methods	
and	 implementation	of	this	analysis	will	be	provided	 in	the	corresponding	chapter	(Chapter	
6).	
	
2.4	Overview	of	software	used	for	data-analyses	
FSL	 FEAT	 GLM	 was	 used	 in	 experiment	 2	 to	 assess	 effects	 of	 LSD	 and	 music	 on	 BOLD	
activation.	Statistical	Parametric	Mapping	(SPM12b)	was	used	for	GLM	and	DCM	analyses	in	
experiment	 3.	 The	Music	 Information	 Retrieval	 (MIR)	 toolbox	 (version	 1.6.1)	 (Lartillot	 and	
Toiviainen,	 2007),	 implemented	 in	MATLAB,	was	used	 to	extract	 acoustic	 properties	 in	 the	
music	 in	experiment	2.	MATLAB	was	used	 to	extract	 timecourses	 from	ROI’s.	And	all	other	
statistical	 tests	 (t-tests,	 Anova’s	 and	 correlation	 analyses)	 were	 performed	 in	 Statistical	
Package	for	the	Social	Sciences	(SPSS)	for	Windows.	(For	overview	of	software	used	for	pre-
processing	of	fMRI	sata	see	2.2.2)	
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2.5	Study	approvals	
All	 studies	 were	 approved	 by	 the	 National	 Research	 Ethics	 Service	 (NRES)	 London	 and	 by	
Imperial	 College	 London’s	 Joint	 Research	 and	 Compliance	 Office	 (JRCO)	West	 London	 and	
was	 conducted	 in	 accordance	 with	 the	 revised	 declaration	 of	 Helsinki	 (2000),	 the	
International	 Committee	 on	 Harmonisation	 Good	 Clinical	 Practice	 guidelines	 and	 NHS	
Research	 Governance	 Framework.	 Imperial	 College	 London	 sponsored	 the	 research	 which	
were	 conducted	 under	 a	 Home	 Office	 license	 for	 research	 with	 schedule	 1	 drugs.	 The	
National	 Institute	 for	 Health	 Research/Wellcome	 Trust	 Imperial	 Clinical	 Research	 Facility	
provided	approval	for	the	study-site	for	study	4.	
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“For	me,	the	climax	of	the	service	came	during	a	solo	that	was	sung	by	a	
soprano	whose	voice	(as	it	came	to	me	through	the	prism	of	psilocybin)	I	can	
only	describe	as	angelic.	What	she	sang	was	no	more	than	a	simple	hymn,	but	it	
entered	my	soul	so	deeply	that	its	opening	and	closing	verses	have	stayed	with	
me	ever	since	…	“My	times	are	in	Thy	hands	my	God”	…	the	gestalt	transformed	
a	routine	musical	progression	into	the	most	powerful	cosmic	homecoming	I	
have	ever	experienced”	
Huston	Smith	
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3		 Study	1	|	Effects	of	LSD	on	music-
evoked	emotion	
	
3.1	Background	
The	rather	profound	effects	of	classic	psychedelics	on	emotion	that	early	researchers	in	the	
1950s	and	1960s	observed,	was	one	of	the	primary	motivations	for	their	therapeutic	use.	It	
was	believed	that	by	dismantling	usual	control-mechanisms,	or	“ego	defences”,	psychedelics	
enhance	emotional	 therapeutic	processes	 (Busch	and	 Johnson,	1950;	Kurland	et	al.,	1971).	
Like	was	detailed	in	the	introduction	chapter,	psychedelics	were	found	to	produce	a	diverse	
spectrum	of	 subjective	 experience,	 and	music	was	 introduced	 as	 a	means	 to	 promote	 the	
occurrence	 of	 those	 types	 of	 experiences	 that	 were	 believed	 to	 have	 most	 therapeutic	
significance.	These	included	peak	experiences	as	well	as	autobiographical	experiences	(Bonny	
and	 Pahnke	 1972;	 Grof,	 1980).	 Music	 became	 a	 key	 component	 in	 psychedelic	 therapy	
sessions,	and	is	still	used	in	modern	psychedelic	therapy	studies	(Griffiths	et	al.,	2016;	Ross	et	
al.,	2016;	Grob	et	al.,	2011;	Gasser	et	al.,	2014;	Carhart-Harris	et	al.,	2016;	Bogenschutz	et	al.,	
2015;	Johnson	et	al.,	2014).		
Psychedelics	 under	 music-listening	 conditions	 are	 shown	 to	 reliably	 facilitate	 peak	
experiences	 (Griffiths	 et	 al.,	 2006),	 and	 those	 experiences	 are	 correlated	 with	 sustained	
positive	changes	in	behaviour	(Griffiths	et	al.,	2008),	personality	(MacLean	et	al.,	2011),	and	
clinical	outcomes	(Griffiths	et	al.,	2016;	Ross	et	al.,	2016;	Johnson	et	al.,	2014).	To	study	the	
contribution	of	music	in	facilitating	these	types	of	experiences,	a	basic	question	must	first	be	
addressed:	is	music-evoked	emotion	intensified	under	psychedelics?		
This	first	study	sought	to	test	the	hypothesis	that	music-evoked	emotion	is	enhanced	under	
the	 classic	 psychedelic	 drug	 LSD.	 Secondly,	 to	 probe	more	 specific	 aspects	 of	 participants’	
emotional	experiences	during	music	 listening,	 the	Geneva	Emotional	Music	Scale	 (GEMS-9)	
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was	 implemented	 (Zentner	 et	 al.,	 2008).	 The	GEMS	was	 developed	 to	measure	 a	 range	of	
emotional	experiences	during	music	listening	and	has	been	considered	in	particular	useful	to	
assess	complex	or	“aesthetic”	emotions,	such	as	feelings	of	“transcendence”,	“wonder”	and	
“nostalgia”.	The	study	predicted	that	the	emotional	response	to	music	 is	higher	under	LSD,	
and	 that	 specifically	emotions	 related	 to	peak	experiences	 (“transcendence”	and	“wonder”	
(Maslow	1964,	1971))	would	be	enhanced.		
	
3.2	Methods	
3.2.2	Recruitment	and	screening	of	participants	
All	study	participants	were	recruited	via	word	of	mouth	and	gave	written	informed	consent	
before	participating	in	the	study.	Prior	to	study	enrolment,	all	participants	were	screened	in	a	
clinical	research	centre	at	the	Hammersmith	hospital	campus	of	Imperial	College	London	(the	
Wellcome	Trust	Clinical	Research	Facility,	WTCRF).	This	 screening	consisted	of	 recording	of	
demographic	 information	 and	 medical	 history,	 as	 well	 as	 a	 physical	 examination	
(electrocardiogram	 (ECG),	 routine	 blood	 tests	 and	 blood	 pressure	 measurement),	 and	 a	
psychiatric	 assessment.	 All	 participants	 gave	 full	 disclosure	 of	 their	 drug	 taking	 histories.	
Participants	and	were	properly	briefed	on	the	study	and	the	potential	drug	effects.	
Key	exclusion	criteria	were:	<21	years	of	age,	personal	history	of	diagnosed	psychiatric	illness,	
immediate	family	history	of	a	psychotic	disorder,	an	absence	of	previous	experience	with	a	
classic	 psychedelic	 (E.g.	 LSD,	 mescaline,	 psilocybin/magic	 mushrooms	 or	 DMT/ayahuasca),	
having	 experienced	 a	 persistent	 adverse	 reaction	 after	 psychedelic	 drug	 use,	 pregnancy,	
problematic	 alcohol	 use	 (i.e.	 >	 40	 units	 consumed	 per	 week),	 or	 a	 medically	 significant	
condition	rendering	the	volunteer	unsuitable	for	the	study.				
	
3.2.3	Drug	dosing	and	setting	
One	thousand	µg	of	LSD	freebase	(certified	99.4%	purity)	was	reconstituted	with	10ml	saline	
and	sterile	 filtered,	yielding	a	100µg:1ml	sterile	 solution.	Since	a	primary	motivation	of	 the	
study	was	to	determine	a	safe	and	appropriate	dose	of	LSD	for	a	subsequent	neuroimaging	
study,	 the	 dosage	 of	 LSD	 varied	 among	 participants,	 i.e.	 one	 received	 40µg,	 two	 50µg,	 six	
70µg	and	one	80µg.	For	each	administration,	 the	appropriate	amount	of	 LSD	solution	 (E.g.	
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0.7ml	=	70µg)	was	transferred	to	a	10ml	syringe	and	made	up	to	10ml	with	saline.	The	10ml	
solution	was	then	infused	intravenously	over	a	three-minute	period,	followed	by	a	60	second	
infusion	(“flush”)	with	10ml	saline.		
The	 experiments	 were	 performed	 at	 the	 WTCRF	 at	 the	 Hammersmith	 Hospital.	 All	
experiments	 took	 place	 in	 a	 clinical	 room,	 consisting	 of	 a	 hospital	 bed,	 physiological	
monitoring	equipment	and	en	suite	bathroom	facilities.	Since	psychedelics	have	the	potential	
to	induce	psychological	distress,	the	clinical	conditions	of	the	room	were	adapted	to	promote	
feelings	 of	 comfort	 and	 safety,	 i.e.	 the	 lighting	was	 dimmed	 and	 the	 room	was	 decorated	
with	soft	furnishings	(Johnson	et	al.,	2008).	The	setting	was	identical	for	all	study	days.	
	
3.2.4	Experiment	overview	and	procedures	
Participants	were	carefully	prepared	for	the	drug	experience	at	screening	and	the	study	was	
conducted	 in	 accordance	 with	 guidelines	 for	 the	 safe	 management	 of	 psychedelic	 drug	
sessions	 (Johnson	et	 al.,	 2008).	 This	 included	psychoeducation	on	 the	 subjective	 effects	 of	
LSD,	 introductions	 to	 the	 research-team	 that	 will	 be	 present,	 and	 an	 outline	 on	 how	 the	
experiment	 days	 are	 structured.	 After	 screening,	 eligible	 participants	 attended	 two	 study	
days,	with	at	least	five	days	in	between.	Participants	were	told	they	would	receive	LSD	on	one	
of	these	two	occasions	but	were	not	told	in	which	order.	Thus,	participants	were	blind	to	the	
condition	(i.e.	drug	or	placebo),	however	the	researchers	were	not.	Placebo	(10ml	saline)	was	
always	 administered	 on	 the	 first	 day.	 This	 single-lind	 fixed	 order	 design	 was	 chosen	 to	 1)	
avoid	 potential	 carry-over	 effects	 (E.g.	 residual	 psychological	 effects)	 of	 LSD	 into	 the	 next	
session,	given	evidence	psychedelics	can	occasion	changes	in	berhaviour	and	persionality	up	
to	months	 after	 the	 experience	 (Maclean	 et	 al.,	 2011),	 and	 also	 2)	 given	 experiences	with	
psychedelics	 can	 be	 profound,	 having	 the	 placebo	 session	 first	 was	 argued	 to	 build	 inter-
personal	 rapport,	prior	 the	drug	 session.	Aware	of	 the	 trade-offs	of	 this	design	choice,	 the	
limitations	are	acknowledged	and	discussed	in	the	discussion	section.	
Volunteers	 arrived	at	 the	 research	 centre	between	10:00am	and	11:00am	on	 testing	days,	
were	briefed	about	the	study	procedure,	gave	a	urine	test	for	drugs	of	abuse	and	pregnancy	
(where	 relevant)	 and	carried	out	a	breathalyser	 test	 for	 recent	alcohol	use.	A	 cannula	was	
inserted	into	a	vein	in	the	antecubital	fossa	by	a	medical	doctor	and	secured.	Subsequently,	
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volunteers	were	encouraged	to	close	their	eyes	and	relax	in	a	reclined	position	before	a	10ml	
solution	of	saline	alone	(placebo)	or	containing	LSD	was	intravenously	infused	over	a	period	
of	 3	 minutes.	 Blood	 pressure	 was	 measured	 prior	 to	 dosing	 (baseline),	 45	 minutes	 after	
dosing	 and	 at	 the	 end	 of	 the	 study	 day	 (prior	 to	 discharge).	 Heart-rate	 was	 recorded	 at	
regular	intervals,	together	with	self-ratings	of	the	subjective	intensity	of	the	drug	effects	on	a	
scale	of	zero	(“no	effects”)	 to	ten	(“extremely	 intense	effects”).	These	measurements	were	
taken	 every	 1-5	minutes	 during	 the	 first	 45	minutes	 post-infusion,	 and	 then	 continued	 in	
intervals	of	approximately	30-45	minutes	until	the	end	of	the	experiment.	During	the	 initial	
45	minutes	post-infusion,	participants	were	encouraged	to	relax	with	their	eyes	closed	and	
maintain	a	supine	position	while	listening	to	music	by	the	ambient	music	artists	“Stars	of	The	
Lid”.	This	music	was	only	played	during	the	initial	45	minutes,	and	not	during	the	subsequent	
psychological	testing.		
Participants	 reported	 first	 noticing	 subjective	 drug	 effects	 between	 5	 to	 15	minutes	 post-
dosing,	 and	 these	 approached	 peak	 intensity	 between	 45	 to	 90	minutes	 post-dosing.	 The	
duration	of	a	subsequent	plateau	of	drug	effects	varied	among	individuals	but	was	generally	
maintained	 for	approximately	 three	hours	post-dosing.	Psychological	 tests	were	performed	
within	this	time-frame.	Five	music	tracks	were	played	to	each	participant	during	each	session	
at	 the	 following	 time	points	 post-dosing	 (minutes:	mean,	 SD):	 44	 ±	 17	 (Track	 1),	 101	 ±	 25	
(Track	2),	139	±	33	(Track	3	and	4)	and	250	±	53	(Track	5).	The	time	in	between	the	tracks,	
participants	either	spent	relaxing	or	performing	tasks	that	were	part	of	separate	experiments	
and	therefore	not	reported	here.	Once	the	subjective	effects	of	LSD	had	sufficiently	subsided	
participants	completed	a	29-item	questionnaire	enquiring	about	the	drug’s	subjective	effects	
(Carhart-Harris	 et	 al.,	 2012,	 2011).	 Following	 this,	 the	 study	 psychiatrist	 assessed	 the	
participant’s	 suitability	 for	 discharge.	 Participants	 remained	 in	 the	 research	 centre	 for	 an	
average	of	six	hours	post-infusion.	
		
3.2.5	Stimulus	selection	and	task	design	
Two	 playlists	 were	 compiled	 (A	 and	 B),	 each	 containing	 five	 different	 music	 tracks.	 One	
version	was	heard	on	the	first	study	day	and	the	other	on	the	second,	with	the	order	of	the	
playlists	 counterbalanced	 across	 participants.	 The	 emotional	 potency	 of	 the	 two	 lists	 was	
balanced	 based	 on	 pre-study	 ratings	 from	 a	 separate	 sample	 (n=10).	 Pre-ratings	 were	
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provided	 for	16	 instrumental	music	 tracks	of	 the	 classical,	 neo-classical,	 ambient	and	new-
age	genres	using	the	GEMS-9.	 In	addition,	 the	tracks	were	also	rated	 for	general	 liking	and	
familiarity.	 It	was	 from	 the	 subsequent	 ratings	 that	 10	 tracks	were	 selected	 for	 the	 study.	
Specifically,	 tracks	 were	 chosen	 that	 produced	 highest	 liking	 and	 lowest	 familiarity,	 and	 a	
two-tailed	paired	t-test	confirmed	no	significant	differences	between	the	playlists	on	 liking,	
familiarity	and	GEMS-9	scores.	The	final	five	tracks	selected	for	each	playlist	consisted	of	neo-
classical	and	ambient	music	composed	by	the	following	four	contemporary	musicians:	Greg	
Haines,	Ólafur	Arnalds,	Arve	Henriksen	and	Brian	McBride	 (see	table	3.1).	Each	music	 track	
and	all	rating	scales	were	presented	via	Psychopy	presentation	software	(Peirce,	2009).		
Before	 listening	to	a	music	track,	participants	were	 instructed	to	close	their	eyes	and	relax.	
Music	 was	 played	 via	 high-quality	 stereo	 headphones	 (Beyerdynamic	 DT990	 Pro)	 and	
participants	were	allowed	to	adjust	the	volume	via	remote	volume	control.	When	the	music	
ended,	a	pre-recorded	voice	instructed	them	to	open	their	eyes.	They	were	then	presented	
with	 the	 question	 “how	 emotionally	 affected	 were	 you	 by	 the	 music?”	 Participants	 gave	
ratings	 via	 a	 continuous	 visual	 analogue	 scale	 from	 0	 (“not	 at	 all”)	 to	 100	 (“very	much”).	
Following	 this,	 a	 digitalized	 and	 shortened	 version	 of	 the	 full	 GEMS,	 the	 GEMS-9,	 was	
presented	 (Zentner	 et	 al.,	 2008).	 A	 particularly	 important	 instruction	 given	 prior	 to	
completing	the	questionnaire	was	that	participants	should	rate	how	he	or	she	personally	felt	
in	 response	 to	 the	 music,	 and	 not	 what	 he	 or	 she	 thought	 the	 music	 was	 trying	 to	
communicate	 to	 them	or	how	he	or	she	 felt	 in	general.	The	GEMS-9	consists	of	9	 items	or	
categories	 of	 emotion,	 with	 sub-items	 presented	 in	 brackets:	 wonder	 (filled	 with	 wonder,	
dazzled,	 moved),	 transcendence	 (fascinated,	 overwhelmed,	 feelings	 of	 transcendence	 and	
spirituality),	power	(strong,	triumphant,	energetic),	tenderness	(tender,	affectionate,	in	love),	
nostalgia	 (nostalgic,	 dreamy,	 melancholic),	 peacefulness	 (serene,	 calm,	 soothed),	 joyful	
activation	 (joyful,	 amused,	 bouncy),	 sadness	 (sad,	 sorrowful),	 tension	 (tense,	 agitated,	
nervous).	 	 Each	 item	 was	 scored	 from	 0	 to	 4:	 0	 =	 “not	 at	 all”,	 1	 =	 “somewhat”,	 2	 =	
“moderately”,	3	=	“quite	a	lot”,	and	4	=	“very	much”.	
	
3.2.6	Data	analysis	
All	 statistical	 tests	were	 performed	 in	 Statistical	 Package	 for	 the	 Social	 Sciences	 (SPSS)	 for	
Windows,	Version	21.0.	Scores	for	the	question	“how	emotionally	affected	were	you	by	the	
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music?”	for	each	stimulus	were	averaged	for	each	subject	per	condition.	A	paired	two-tailed	
t-test	 was	 performed	 to	 test	 for	 significant	 difference	 between	 conditions.	 Since	 the	 5	
possible	 ratings	 for	 the	GEMS-9	were	ascribed	a	 relevant	number	 (e.g.	0	=	“not	at	all”,	1	=	
“somewhat”)	and	the	resultant	data	was	normally	distributed,	two-tailed	paired	t-tests	were	
used	to	analyse	between-condition	differences.	Subsequent	false	discovery	rate	(FDR)	control	
was	used	to	correct	for	multiple	comparisons	(Benjamini	&	Hochberg,	1995).				
Finally,	 a	 Pearson’s	 correlational	 analysis	 was	 performed	 to	 evaluate	 a	 hypothesised	
relationship	 between	 the	 peak	 intensity	 of	 LSD’s	 subjective	 effects	 and	 the	 intensity	 of	
emotional	arousal	in	response	to	music	under	LSD	(i.e.	the	average	score	for	all	music	stimuli	
to	 the	 question	 “how	 emotionally	 affected	 were	 you	 by	 the	 music?”)	 as	 well	 as	 the	
relationship	between	peak	drug	intensity	and	increases	in	the	GEMS-9	item	“transcendence”.	
	
Table	3.1	|	The	two	music		playlists.		
	 Playlist	A	 Playlist	B	
Stimulus	 Artist	name	 Track	title	 Duration	 Track	title	 Duration	
1	 Greg	Haines	 183	Times	 09:08	 Azure	 14:14	
2	 Brian	McBride	 Toil	theme	part	2	&	part	3	 05:11	 Supposed	Essay	on	the	
Piano		
04:10	
3	 Ólafur	Arnalds	 The	Wait	 03:35	 Autumn	Day	 03:26	
4	 Brian	McBride	 Mélodrames	Télégraphiés	
Part	2	
04:12	 Mélodrames	Télégraphiés	
Part	1	
05:25	
5	 Arve	Henriksen	 In	the	Light	 05:29	 Leaf	and	Rock	 02:17	
	
	
3.3	Results	
3.3.1	Participants	
Ten	healthy	volunteers	participated	 in	the	study	(1	female;	mean	age	=	34.2	±	7.4,	range	=	
26-47	years).	All	had	at	least	one	previous	experience	with	a	classic	psychedelic	drug	(mean	
estimated	LSD	uses	=	65	±	90,	range	=	0	-	250)	but	not	within	21	days	of	the	study	(mean	last	
	78	
use	of	LSD	=	1829	±	2348,	range	=	30-5000	days).	Self-estimates	of	other	drug	use	were	as	
follows	(mean,	SD,	range):	weekly	alcohol	units	=	9.2	±	9.1,	0-26;	daily	cigarettes	=	3.5	±	6.6,	
0-20;	 lifetime	cannabis	uses	=	822	±	377,	20-1000;	 lifetime	MDMA	uses	=	79	±	117,	3-400;	
lifetime	psilocybin/magic	mushroom	uses	=	19.5	±	14,	6-40;	lifetime	ketamine	uses	=	51	±	84,	
0-200;	lifetime	cocaine	uses	=	23.1	±	31,	0-100.	Beck	Depression	Inventory	scores	at	baseline	
were:	1.9	±	1.6,	0-4;	NEO-FFI	scores	were:	neuroticism	=	13.2	±	6.5,	5-26;	extraversion	=	32	±	
8,	20-44;	openness	=	31	±	3.8,	26-35;	agreeableness	=	35.7	±	4.1,	32-45;	conscientiousness	=	
34.2	±	6.5,	25-42.	
	
3.3.2	Physiological	effects	of	LSD	
Measurements	 of	 blood	 pressure	 and	 heart	 rate	 under	 placebo	 and	 LSD	 are	 displayed	 in	
table	 3.2.	 Systolic	 blood	 pressure	was	 slightly	 elevated	 under	 LSD	 relative	 to	 baseline	 and	
placebo	 but	 these	 changes	 were	 not	 statistically	 significant	 after	 correcting	 for	 multiple	
comparisons.		
	
Table	3.2	|	Physiological	measurements	for	placebo	and	LSD.	Values	(millimeters	of	mercury	(mmHg)	for	blood	
pressure,	and	beats	per	minute	(bpm)	for	heart	rate)	are	displayed	in	rounded	mean	values	+	standard	error	of	
the	mean.		
	 Systolic	blood	pressure	 Diastolic	blood	pressure	 Heart	rate	
	 Placebo	 LSD	 Placebo	 LSD	 Placebo	 LSD	
Baseline	 125±	5	 123	±	4	 72	±	4	 78	±	4	 78	±	5	 77	±	5	
45th	minute	 120	±	3	 132	±	6	 69	±	3	 76	±	4	 75	±	4	 77	±	4	
180th	minute	 n.a.	 n.a.	 n.a.	 n.a.	 65	±	3	 79	±	5		
End	 118	±		3	 134	±	5	 68	±	3	 74	±	4	 68	±	3	 74	±	4	
	
	
3.3.3	Subjective	effects	of	LSD	
Subjective	drug	effects	were	first	noticed	between	5	to	15	minutes	post-LSD	and	approached	
peak	intensity	between	45	to	90	minutes	post-dosing.	Drug	effects	maintained	a	subsequent	
plateau	for	approximately	three	hours,	and	showed	a	gradual	decline	in	the	following	hours.	
These	 results	 suggest	 that	 compared	with	 oral	 administration	 of	 LSD	 (Schmid	 et	 al.,	 2015;	
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Passie	et	al.,	2008;	Nichols	2016),	intravenous	administration	produces	a	quicker	onset,	and	
(slightly)	shorter	lasting	experience.	LSD	produced	diverse	subjective	effects	(see	Figure	3.1).	
The	five	VAS	items	that	were	scored	highest	under	LSD	were	(in	descending	order)	were	“my	
thoughts	wandered	 freely”,	 “my	 imagination	was	extremely	vivid”,	 “I	 felt	amazing”,	 “things	
looked	strange”	and	“I	felt	an	inner	warmth”.		
	
3.3.4	Effects	of	LSD	on	music-evoked	emotion		
The	average	scores	for	all	music	stimuli	to	the	question	“how	emotionally	affected	were	you	
by	the	music?”	were	significantly	higher	for	the	LSD	condition	(0.71	±	0.14)	than	for	placebo	
(0.51	±	0.18),	t	=	3.559,	df	=	9,	p	=	0.006	(see	Figure	3.2).	Significant	increases	were	observed	
in	 the	 GEMS	 for	 the	 items	 “wonder”	 (p=0.027),	 “transcendence”	 (p=0.027),	 “power”	
(p=0.027)	and	“tenderness”	(p=0.027)	(reported	p-values	are	FDR	adjusted,	see	Figure	3.3).	
	
3.3.5	Effects	of	LSD	on	music	liking		
The	average	scores	for	“liking”	the	music	showed	a	trend-level	significant	increase	under	LSD	
(0.80	±	0.14)	compared	to	placebo	(0.71	±	0.06),	df	=	9,	p	=	0.06.		A	Pearson	correlation	test	
revealed	a	significant	positive	correlation	between	“liking”	of	 the	music	and	VAS	ratings	on	
the	question	 “how	emotionally	 affected	were	 you	by	 the	music?”	 (R	=	0.68,	 p	 <0.001,	 n	 =	
100)	 (see	 Figure	 3.4).	 A	 significant	 positive	 relationship	was	 found	 between	 ratings	 of	 the	
intensity	of	LSD’s	effects	and	emotional	arousal	to	music	(r	=	0.79,	n	=	10,	p	=	0.01),	as	well	as	
between	the	former	and	increases	in	the	GEMS-9	factor	“transcendence”	(r	=	0.79,	n	=	10,	p	
=	0.01).	
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Figure	3.1	|	Subjective	effects	of	LSD.	Group	averages	plus	standard	error	values	for	all	VAS	scored	subjective	
effect	after	placebo	(blue)	and	after	LSD	(red).	All	ratings	were	given	with	reference	to	peak	drug	effects.	
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Figure	 3.2	 |	 Effect	 of	 LSD	 on	 music-evoked	 emotion.	 Each	 data	 point	 represents	 one	 participant’s	 average	
response	 (average	 rating	 from	 the	 five	 songs)	 to	 the	 question	 “How	 emotionally	 affected	 were	 you	 by	 the	
music?”	The	dotted	horizontal	 line	represents	the	group	average	for	each	condition.	The	 lines	connecting	the	
data	 points	 demonstrate	 the	 individual	 increases	 in	 emotional	 arousal	 to	 music	 from	 placebo	 to	 LSD.	
Participants	gave	significantly	higher	ratings	under	LSD	than	placebo,	t	=	3.559,	df	=	9,	p	=	0.006.	
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Figure	3.3		Geneva	Emotional	Music	Scale	(GEMS).	Mean	plus	standard	error	values	for	the	GEMS-9	scores	for	
the	complete	playlist	per	condition.	Scores	were	significantly	higher	for	the	LSD	condition	than	placebo	for	the	
items	 “wonder”	 (p=0.027),	 “transcendence”	 (p=0.027),	 “power”	 (p=0.027)	 and	 “tenderness”	 (p=0.027).	
Reported	P-values	are	FDR	adjusted.	*	=	p	<	0.05	after	FDR	correction	for	multiple	comparisons.	
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Figure	3.4	|	Correlation	between	“liking”	and	the	emotional	response	to	music.	Each	data	point	represents	one	
rating	 for	one	 song	per	participant	 and	per	 condition	 (Blue	=	placebo,	 red	=	 LSD).	A	Pearson	 correlation	 test	
demonstrated	a	significant	positive	correlation	between	ratings	 for	“liking”	of	 the	music	and	ratings	 for	“how	
emotionally	affected	were	you	by	the	music?”	(R	=	0.68,	p<0.001).		
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3.4	Discussion	
This	 study	 assessed	 changes	 in	music-evoked	 emotion	 under	 LSD.	 The	 primary	 hypothesis	
that	 music-evoked	 emotions	 are	 intensified	 under	 LSD	 was	 supported,	 as	 was	 the	 more	
specific	 hypothesis	 that	 music-evoked	 emotions	 related	 to	 peak	 experiences	 showed	 an	
increase	under	LSD.	Ratings	for	the	Geneva	Emotional	Music	Scale	(GEMS)	were	significantly	
higher	 under	 LSD	 for	 the	 emotions	 “wonder”	 (i.e.	 filled	 with	 wonder,	 dazzled,	 moved),	
“transcendence”	 (i.e.	 fascinated,	 overwhelmed,	 feelings	 of	 transcendence	 and	 spirituality),	
“tenderness”	 (i.e.	 tender,	 affectionate,	 in	 love)	 and	 “power”	 (i.e.	 strong,	 triumphant,	
energetic).	Ratings	for	drug	intensity	correlated	positively	with	ratings	for	emotional	arousal	
to	music,	 as	well	 as	with	music-evoked	 feelings	 of	 “transcendence”.	 In	 addition,	 the	 study	
also	showed	a	trend	increase	for	ratings	of	music-liking	under	LSD,	and	a	positive	correlation	
between	music-liking	and	the	emotional-response	to	music.	
	
3.4.1	Implications	for	psychedelic	therapy	
These	findings	reinforce	the	assumption	that	normal	musical	influences	are	intensified	under	
psychedelic	drugs,	and	that	this	effect	may	be	harnessed	for	therapeutic	objectives.	Typically,	
the	 conditions	 in	 which	 psychedelic	 therapy	 sessions	 are	 performed,	 are	 intended	 to	
promote	 a	 state	 of	 enhanced	 “introspection”,	 where	 music	 constitutes	 the	 only	 external	
stimulus:	Individuals	lie	supine	in	a	relaxed	position,	close	their	eyes	or	wear	eye-shades,	and	
listen	 to	 a	music	 for	 the	 duration	 of	 the	 drug-effects	 (5-8	 hours).	 Under	 these	 conditions,	
peak	experiences	can	be	reliably	facilitated	(Pahnke	and	Richards,	1966;	Griffiths	et	al.,	2008;	
Griffiths	 et	 al.,	 2011),	 and	 the	 occurance	 of	 these	 experiences	 has	 been	 correlated	 with	
sustained	 improvements	 in	 well-being	 (Johnson	 et	 al.,	 2008;	 RolandGriffiths	 et	 al.,	 2011),	
increases	openness	(MacLean	et	al.,	2011),	and	improved	therapy	outcomes	(Griffiths	et	al.,	
2016;	Ross	et	al.,	2016;	Garcia-Romeu	et	al.,	2014).	
Emotions	 of	 transcendence	 and	 wonder	 are	 considered	 core	 constituents	 of	 peak-	 and	
spiritual	 experiences	 (Maslow,	 1971,	 1964).	 Thus,	 the	 ability	 of	 music	 to	 evoke	 these	
emotions,	and	of	LSD	to	facilitate	an	enhancement	of	these	music-evoked	emotions,	suggests	
that	 their	 combination	 may	 contribute	 to	 the	 occurrence	 of	 peak	 experiences.	 If	 peak	
experiences	are	associated	with	the	sustained	therapeutic	effects	of	psychedelic	therapy,	and	
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if	the	likelihood	of	their	occurrence	can	be	increased	by	music,	then	this	would	support	the	
view	that	music	is	a	valuable	component	within	psychedelic	therapy.		
	
3.4.2	Study	limitations	and	future	directions	
This	experiment	had	several	 important	limitations	that	need	to	be	addressed.	First,	LSD	has	
been	 found	 to	 enhance	 suggestibility	 (Carhart-Harris	 et	 al.,	 2014),	 and	 such	 an	 effect	may	
have	influenced	the	present	findings.	Participants	were	not	informed	of	our	hypotheses,	but	
it	 would	 not	 have	 been	 difficult	 for	 them	 to	 have	 inferred	 them	 from	 the	 experimental	
procedures.	Participants’	ratings	for	the	question	“how	emotionally	affected	were	you	by	the	
music”,	 may	 have	 been	 higher	 to	 reinforce	 their	 own	 expectations	 or	 to	 confirm	 (their	
perception	of)	the	researchers’.	In	addition,	the	discernible	subjective	effects	of	LSD	make	it	
difficult,	 if	not	 impossible,	 to	maintain	study	blind,	and	may	have	compounded	any	of	such	
biases.		
Therefore,	measures	to	reduce	expectation	or	 increase	uncertainty	about	the	experimental	
aims	could	be	introduced	in	future	studies.	For	example,	variable	doses	of	LSD	and	a	 larger	
sample	 size	 would	 allow	 to	 examine	 dose-dependent	 effects	 of	 the	 present	 findings.	 In	
addition,	physiological	measures	for	emotional	arousal	could	also	be	introduced,	such	as	the	
measure	of	“chills”	via	changes	in	galvanic	skin	response,	which	have	previously	been	related	
to	emotional	arousal	to	music	(Juslin	and	Sloboda,	2010).	Secondly,	an	active	control	would	
strengthen	the	blinding	of	the	conditions	in	individuals	who	are	naïve	to	subjective	effects	of	
psychedelics.	For	example,	Griffith	et	al	(2008)	utilised	methyl-phenidate	as	an	active	placebo	
condition,	and	found	some	participants	to	be	“fooled”	by	the	condition	(Griffiths	et	al.,	2008).	
In	 addition,	 alternative	 pharmacological	 conditions	 could	 serve	 to	 probe	 into	 mechanistic	
hypotheses.	 For	 example,	 if	 the	 effects	 of	 psychedelics	 are	 instantiated	 via	 serotonin	 2A	
receptor	 activation,	 co-administration	 with	 a	 selective	 serotonin	 2A	 receptor	 antagonist	
would	be	predicted	to	significantly	diminish	the	effects	of	the	psychedelic	on	music-evoked	
emotion.	This	hypothesis	is	supported	by	a	body	of	animal	research	suggesting	an	important	
role	 for	 serotonin	 2A	 receptor	 activation	 in	 emotion	 regulation	 and	 emotion-guided	
behaviour	(Aznar	and	Klein,	2013).		
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Another	 limitation	 of	 the	 experiment	 is	 that	 it	 did	 not	 have	 a	 balanced	 order,	 i.e.	 all	
participants	received	placebo	on	the	first	visit,	and	LSD	on	the	second	visit.	Randomising	or	at	
least	balancing	 the	order	of	 the	 LSD	and	placebo	 sessions	be	worth	 incorporating	 into	 the	
design	of	future	studies	to	control	for	potential	effects	of	order.		However,	it	is	unlikely	that	
order	contributed	significantly	to	the	present	outcomes,	given	that	the	music	playlists	were	
balanced	across	participants	and	days,	and	order	effects	are	 typically	 sensitive	 to	elements	
like	 learning	 and	 habituation.	 However,	 it	 may	 be	 argued	 that	 by	 the	 second	 visit	 in	 this	
experiment,	participants	may	have	been	more	 familiar	with	 the	study	procedure	and	study	
environment,	 and	 that	 this	 could	 have	 positively	 influenced	 their	 ability	 to	 be	 emotionally	
affected,	thereby	introducing	a	bias	towards	a	positive	finding.	
One	 other	 major	 limitation	 of	 this	 experiment	 concerns	 its	 ability	 (or	 lack	 thereof)	 to	
differentiate	 between	 the	 effect	 of	 drug	 and	 the	 effect	 of	music.	 The	 experiment	 did	 not	
assess	emotion	pre-	and	post-music,	but	assessed	the	magnitude	of	being	emotional	affected	
by	 the	music	 after	 listening.	 	Without	 pre-	 and	 post-	music	 ratings	 implemented	within	 a	
factorial	design,	this	experiment	cannot	exclude	the	possibility	that	the	findings	are	driven	by	
a	 general	 drug	 effect	 rather	 than	 a	 specific	 effect	 of	music	 in	 combination	with	 drug.	 The	
positive	correlation	between	drug	effects	intensity	and	increased	feelings	of	“transcendence”	
to	music	 could	 be	 construed	 as	 supportive	 of	 this	 alternative	 interpretation.	 Alternatively,	
however,	stronger	drug	effects	may	have	simply	enhanced	a	true	music	x	LSD	interaction.			
In	defence	of	the	present	findings,	both	the	ratings	for	“How	emotionally	affected	were	you	
by	the	music?”,	as	the	ratings	for	GEMS-9,	explicitly	requested	that	the	participant	rate	how	
the	music	made	them	feel	and	not	how	they	felt	in	general	or	what	they	thought	the	music	
was	 intending	 to	 convey.	While	 no	 formal	 statistical	 tests	 for	 an	 interaction	between	drug	
and	 music	 on	 emotion	 was	 performed,	 the	 questions	 were	 intentionally	 constructed	 to	
enquire	 about	 the	 effect	 of	music	 on	 emotion.	 This	 does	 allow	 to	 interpret	 the	 findings	 as	
differences	 in	 music-evoked	 emotion	 between	 the	 two	 conditions.	 Nevertheless,	 to	
investigate	an	interaction	between	drug	and	music	on	emotion,	a	factorial	design	will	need	to	
be	 performed,	 since	 the	 absence	 of	 such	 a	 design	 in	 the	 present	 study	 prevents	 a	 formal	
rejecting	of	the	hypothesis	that	the	results	were	driven	by	a	general	drug	effect.		
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Other	 limitations	 of	 the	 study	 design	 that	 future	 studies	 can	 address	 include	 studying	 the	
route	of	drug-administration,	and	identifying	advantages	of	 IV	over	oral	administration.	The	
assumption	 that	 a	 fixed-order	 design	 (with	 drug	 on	 the	 first),	 prevents	 possible	 “residual”	
psychological	 effects	 on	 the	 second	 study	 day,	 must	 be	 tested.	 Also,	 it	 is	 important	 to	
emphasise	 that	 this	was	 a	 pilot	 study	with	 a	 small	 sample	 size.	 Future	 studies	with	 larger	
sample	 sizes,	 could	 address	 the	 dose-response	 relationship	 of	 LSD	 by	 including	 sufficient	
numbers	 of	 participant	 within	 different	 dose-groups.	 Moreover,	 only	 one	 female	 was	
recruited,	all	participants	were	psychedelic-experienced	and	only	a	selection	of	music	styles	
were	 included.	 Inferences	on	 the	present	 results	 can	 therefore	not	be	 generalised	beyond	
the	music	styles	used	in	the	present	study	and	neither	can	they	be	easily	generalised	to	larger	
populations.	Future	studies	could	assess	the	importance	of	specific	genres	or	styles	of	music	
and	the	effect	of	individual	music	taste	in	determining	outcomes	in	response	to	psychedelics.		
	
3.4.3	Conclusions		
The	results	of	this	experiment	provide	tentative	support	for	the	hypothesis	that	psychedelics	
enhance	 music-evoked	 emotion,	 yet	 more	 extensive	 studies	 are	 required	 to	 confirm	 and	
extend	 the	 inferences	 that	 have	 been	 discussed	 here.	 Specifically,	 more	 studies	 are	
warranted	 to	 probe	 into	 the	 relation	 between	 drug-effect	 and	 music-effect	 on	 subjective	
experience,	 as	 well	 as	 studies	 that	 test	 the	 importance	 of	 music	 as	 a	 component	 in	
psychedelic	 therapy,	 and	 studies	 that	 investigate	how	 psychedelics	 enhance	 the	 emotional	
response	 to	 music	 via	 their	 effect	 on	 brain	 activity.	 	 These	 will	 be	 the	 objectives	 of	 the	
subsequent	experiments.	
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“My	flesh	is	charged	with	emotional	responsiveness	to	the	Mozart	E-flat	
symphony.	My	skin	seems	microscopically	thick	and	porous	as	to	admit	the	
music	more	easily.	The	inner	lines	of	counterpoints	are	suddenly	so	clear.	The	
dissonances	are	so	penetrating	and	the	bass-line	is	positively	alive.	It	jumps	and	
strides	with	a	kind	of	cosmic	purpose.	[…]	I	felt	that	I	saw	directly	into	its	heart,	
and	was	interested	only	in	what	the	music	was	really	saying.”	
LSD-experience	by	anonymous	
	
	
	
	89	
4	
	
Study	2	|	Effects	of	
LSD	and	music	on	
brain	activity	and	
emotion
	
4.1	Background		
The	quote	 that	 opens	 this	 chapter	 is	 provides	 a	 glimpse	 into	how	profound	 the	 subjective	
experience	of	music	can	be	under	a	psychedelic.	Similar	reports	are	not	difficult	to	find,	and	
the	widespread	historical	use	of	psychedelics	and	music	by	humans	(Nettl,	1956;	Bruhn	et	al.,	
2002),	 may	 very	 well	 be	 related	 to	 their	 capacity	 to	 evoke	 such	 deeply	 idiosyncratic	
experiences.	The	potential	of	music	on	its	own	to	evoke	“complex”	emotions,	such	as	feelings	
of	wonder	and	self-transcendence,	as	opposed	to	merely	“simple”	or	“basic”	emotions	such	
as	 fear	 and	 pleasure,	 has	 been	 argued	 to	 yield	 an	 important	 tool	 for	 studying	 the	 neural	
correlates	of	human	emotions	(Trost	et	al.,	2012).	Music	allows	a	relatively	reliable	activation	
of	 complex	 emotions	 under	 experimental	 conditions,	 such	 as	 feelings	 of	 nostalgia	 (Barrett	
and	 Janata,	 2016;	 Janata	 2009)	 or	 intense	 emotional	 experiences	 (Gabrielsson	 and	 Wik,	
2003).	 Psychedelic	 drugs	 are	 shown	 to	 reliably	 facilitate	 emotionally	 intense	 peak	
experiences	under	music-listening	conditions	(Griffiths	et	al.,	2006;	Griffiths	et	al.,	2011),	and	
the	 findings	 reported	 in	 the	 previous	 chapter	 (study	 1)	 indicated	 that	 music	 may	 play	 an	
important	function	in	facilitating	these	experiences.	Studying	the	brain	mechanisms	of	music-
listening	 under	 psychedelics	 will	 help	 to	 understand	 how	 they	 interact	 on	 subjective	
experience,	 what	 their	 therapeutic	 potential	 may	 be	 when	 used	 in	 combination,	 and	 to	
provide	 empirical	 insights	 on	 how	music	may	be	 best	 implemented	 in	 psychedelic	 therapy	
sessions.	
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Studying	music	brings	unique	experimental	challenges	and	opportunities,	because	music	is	a	
highly	dynamic	and	multi-dimensional	stimulus.	Music	consists	of	distinct	acoustic	 features,	
such	 as	 pitch,	 loudness,	 tempo,	 rhythm	 and	 timbre,	 and	 neuroimaging	 studies	with	music	
have	highlighted	a	hierarchy	of	processes	(Stewart	et	al.,	2008;	Kumar	et	al.,	2007);	ascending	
from	the	cochlear,	the	auditory	system	processes	increasingly	complex	acoustic	features	that	
are	 subsequently	 integrated	 via	multi-modal	 and	 higher-order	 cortical	 regions	 that	 furnish	
the	experience	with	mnemonic	and	affective	properties	(Wang	et	al.,	2008;	Bizley	and	Cohen,	
2013;	 Griffiths	 and	 Warren,	 2004).	 Several	 neuroimaging	 studies	 have	 used	 controlled	
auditory	 experiments	 to	 study	 acoustic	 features	 in	 isolation,	 however,	 recent	 studies	
advocate	the	use	of	more	naturalistic	paradigms	in	which	participants	listen	to	real,	extended	
pieces	 of	music.	 These	naturalistic	 conditions,	 increase	 the	 ecological	 validity	 and	obtain	 a	
more	 comprehensive	 description	 of	 the	 brain	 mechanisms	 involved	 in	 processing	 the	
complexity	 inherent	 in	 real	 musical	 stimuli	 and	 the	 complex	 emotionality	 they	 can	 evoke	
(Alluri	 et	 al.,	 2012;	 Burunat	 et	 al.,	 2016),	 such	 as	 those	 emotions	 that	 are	 associated	with	
peak	experiences.	
	
Psychedelics	activate	 the	serotonin	2A	receptor	 (Glennon	et	al.,	1984;	Titeler	et	al.,	1988a;	
Vollenweider	 et	 al.,	 1998),	 and	 produce	 an	 altered	 state	 of	 consciousness	 that	 is	
characterised	by	marked	 reductions	 in	 functional	 coupling	within	high-level	brain	networks	
(Carhart-Harris	et	al.,	2016,	2012;	Palhano-Fontes	et	al.,	2015),	and	simultaneous	 increased	
cross-talk	 between	 low-level	 areas	 (Tagliazucchi	 et	 al.,	 2016,	 2014).	 This	 “collapse”	 of	 the	
usual	 processing	 hierarchy,	 is	 thought	 to	 be	 a	 core	mechanism	underlying	 their	 subjective	
effects	(Carhart-Harris	et	al.,	2014;	Lebedev	et	al.,	2015).	This	study	intends	to	investigate	the	
changes	in	brain	processing	of	distinct	acoustic	features	in	under	naturalistic	music-listening	
conditions	under	LSD.	The	primary	aim	of	this	study	was	to	identify	what	specific	features	of	
music	are	most	sensitive	to	modulation	by	LSD,	and	how	this	relates	to	the	changes	in	music-
evoked	emotions	under	LSD.		More	broadly,	this	experiment	can	offer	insight	into	the	brain’s	
processing	 of	 complex	 naturalistic	 stimuli	 accompanying	 this	 network	 collapse	 under	
psychedelics.	
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4.2	Methods		
4.2.2	Participants	
Twenty	participants	 (16	males	and	4	 females)	were	 recruited	 for	 the	study	after	 successful	
screening	and	written	 informed	consent.	Screening	consisted	of	physical	and	mental	health	
assessments.	 Physical	 health	 assessments	 included	 electrocardiogram	 (ECG),	 routine	 blood	
tests,	 disclosure	 of	 full	medical	 history	 and	 urine	 test	 for	 recent	 drug	 use	 and	 pregnancy.	
Mental	 health	 assessment	 consisted	 of	 psychiatrics	 interview.	 All	 participants	 provided	 full	
disclosure	of	their	drug	use	history.	Exclusion	criteria	included:	being	younger	than	21	years	
of	age,	having	a	personal	history	of	diagnosed	psychiatric	illness,	having	an	immediate	family	
history	of	a	psychotic	disorder,	having	used	illicit	drugs	within	6	weeks	of	the	first	scanning	
day,	 having	 experienced	 a	 persistent	 adverse	 reaction	 to	 a	 psychedelic	 drug,	 pregnancy,	
problematic	alcohol-use	(i.e.	>	40	units	consumed	per	week),	and	having	a	medical	condition	
rendering	them	unsuitable	for	the	study.	All	participants	were	required	to	have	at	least	one	
previous	 experience	 with	 a	 classic	 psychedelic	 drug	 (E.g.	 LSD,	 mescaline,	 psilocybin	 or	
dimethyltryptamine	(DMT)).	One	participant	did	not	complete	the	MRI	scans	due	anxiety	and	
three	 participants	were	 excluded	 from	analyses	 due	 to	 technical	 problems	with	 the	 sound	
delivery.	 This	 resulted	 in	 including	 the	 data	 of	 16	 participants	 (13	males,	 3	 female)	 in	 the	
data-analysis;	with	preserved	counterbalanced	experimental	design.	
	
4.2.3	Stimuli	
Two	 excerpts	 (A	 and	 B)	 from	 two	 songs	 by	 musician’s	 Robert	 Rich	 &	 Lisa	 Moskow	 were	
selected	 for	 the	study	 (form	the	album	yearning).	The	stimuli	were	both	7	minutes	and	20	
seconds	 long	and	were	balanced	 in	 their	acoustic	properties,	and	rich	 in	 timbre,	but	not	 in	
rhythm	 (see	 table	 4.1).	 Pre-study	 assessments	 using	 GEMS	 in	 a	 separate	 group	 confirmed	
balance	 for	 their	emotional	potency	 (n=10).	To	 reduce	 interference	of	 fMRI	 scanning	noise	
with	 the	music	 experience,	 volume-maximization	 and	 broadband	 compression	was	 carried	
out	 using	 Ableton	 live	 9	 software.	 Each	 participant	 listened	 to	 both	 stimuli,	 in	 a	 balanced	
order	 across	 conditions.	 The	 selective	 choice	 for	 calm	 ambient	 music	 for	 this	 study,	 was	
motivated	 by	 a	 study	 from	 Studerus	 et	 al	 (2012),	who	 performed	 a	 regression	 analysis	 on	
pooled	 data	 from	 261	 healthy	 volunteers,	 showing	 that	 under	 the	 influence	 of	 psilocybin,	
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neuroimaging,	together	with	trait	“emotional	excitability”,	are	strong	predictors	for	anxiety.	
That	ambient	music	can	compensate	for	this,	however,	is	an	assumption.	Trade-offs	of	genre-
selection	for	this	study,	and	implications	for	future	studies,	will	be	provided	in	more	detail	in	
the	discussion	section.	
	
4.2.4	Experiment	overview	and	procedures	
All	participants	attended	 two	 study	days	 that	were	 separated	by	at	 least	14	days.	 LSD	was	
received	on	one	of	 the	 study	days,	 and	placebo	 (saline)	 on	 the	other.	 The	 condition-order	
was	balanced	across	participants,	and	the	participants,	but	not	the	researchers,	were	blind	to	
the	condition-order	 (i.e.	 the	study	was	a	single-blind	within-subject	design).	All	participants	
received	75	µg	of	LSD	intravenously,	via	a	10ml	solution	infused	over	a	two-minute	period	via	
an	 inserted	 cannula.	 Administration	 was	 always	 followed	 by	 an	 acclimatization	 period	 of	
approximately	 60	min,	 in	 which	 participants	 were	 encouraged	 to	 relax.	 Drug	 effects	 were	
noticed	between	5	to	15	min	post-dosing,	approached	peak	intensity	between	60	to	90	min	
post-dosing,	and	maintained	peak	 intensity	for	approximately	four	hours	post-dosing.	BOLD	
fMRI	scanning	was	performed	during	peak	drug	intensity,	starting	approximately	120	minutes	
post-dosing,	and	lasted	for	approximately	60	minutes.	Once	the	subjective	effects	of	LSD	had	
sufficiently	subsided,	the	study	psychiatrist	assessed	the	participant’s	suitability	for	discharge.		
Each	fMRI	scanning	session	involved	three	eyes-closed	resting	state	scans,	each	lasting	seven	
minutes	 and	 twenty	 seconds.	 The	music-listening	 scan	 (220	 TRs,	 7.3	min)	 always	 occurred	
after	the	first	resting	state	(no	music)	scan	and	before	a	final	resting-state	scan	(no	music).	
Prior	to	each	scan,	participants	were	 instructed	via	a	display	screen	to	close	their	eyes	and	
relax.	 The	 music	 itself	 was	 triggered	 by	 the	 first	 TR,	 and	 listened	 to	 via	 MR	 compatible	
headphones	(MR	Confon).	Music	volume	was	adjusted	to	a	personal	level	that	was	“loud,	but	
not	unpleasant”	and	maintained	for	both	condition.			
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Table	4.1	|	Average	values	for	all	acoustic	features.		Displayed	values	are	the	calculated	average	and	standard	
deviation	for	acoustic	features	extracted	from	stimulus	A	and	B.	
	 STIMULUS	A	 	 STIMULUS	B	 	
ACOUSTIC	FEATURE	 Mean	 SDev	 Mean	 SDev	
LOUDNESS	 0.17	 0.04	 0.20	 0.04	
BRIGHTNESS	 0.13	 0.03	 0.14	 0.04	
ROUGHNESS	 51.41	 25.42	 92.27	 36.44	
FLATNESS	 0.04	 0.01	 0.04	 0.00	
SPECTRAL	ROLL-OFF	 1317.61	 250.70	 1437.68	 243.82	
CPEXTRAL	CENTROID	 907.33	 99.68	 966.11	 117.57	
SPREAD	 1932.38	 114.73	 1901.17	 95.45	
ENTROPY	 0.61	 0.03	 0.62	 0.03	
SPECTRAL	FLUX	 54.75	 11.42	 50.51	 10.31	
ZERO-CROSS	 416.79	 99.44	 490.04	 138.06	
SPECTRAL	FLUX	SUBBAND	1	 11.71	 5.21	 4.21	 3.93	
SPECTRAL	FLUX	SUBBAND	2	 15.00	 6.02	 11.16	 4.66	
SPECTRAL	FLUX	SUBBAND	3	 9.71	 4.40	 13.78	 4.24	
SPECTRAL	FLUX	SUBBAND	4	 5.86	 2.52	 8.47	 3.22	
SPECTRAL	FLUX	SUBBAND	5	 2.97	 0.98	 5.86	 2.74	
SPECTRAL	FLUX	SUBBAND	6	 1.50	 0.55	 1.91	 0.82	
SPECTRAL	FLUX	SUBBAND	7	 0.62	 0.26	 1.22	 0.67	
SPECTRAL	FLUX	SUBBAND	8	 0.15	 0.08	 0.26	 0.14	
SPECTRAL	FLUX	SUBBAND	9	 0.13	 0.08	 0.13	 0.07	
SPECTRAL	FLUX	SUBBAND	10	 0.06	 0.03	 0.06	 0.03	
PULSE	CLARITY	 0.23	 0.09	 0.22	 0.08	
KEY	CLARITY	 0.69	 0.10	 0.74	 0.07	
MODE	STRENGTH	 0.01	 0.11	 -0.06	 0.09	
	
4.2.5	Qualitative	measurements	
The	 intensity	 of	 different	 types	 of	 music-evoked	 emotion	 was	 assessed	 via	 the	 25-item	
Geneva	 emotional	music	 scale	 (GEMS)	 (Zentner	 et	 al.,	 2008),	 and	was	 administered	 under	
placebo	and	under	LSD	immediately	after	fMRI	scanning	was	completed.	The	GEMS	assesses	
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music-evoked	or	“personally	felt”	emotion,	and	not	the	perception	of	musical	emotion	in	the	
music.	 	 The	 25	 items	 were	 averaged	 into	 nine	 distinct	 factors	 of	 emotions:	 wonder,	
transcendence,	 power,	 tenderness,	 nostalgia,	 peacefulness,	 joyful	 activation,	 sadness,	 and	
tension.	A	paired	t-test	was	performed	to	compare	ratings	between	conditions	 (LSD	versus	
placebo)	for	each	emotion.	Non-parametric	permutation	testing	(10,000	permutations,	two-
tailed)	was	carried	out	to	correct	for	multiple	comparisons.	
4.2.6	Acoustic	feature	extraction		
Acoustic	 features	 from	 excerpt	 A	 and	 B	 were	 extracted	 separately	 using	 the	 Music	
Information	 Retrieval	 (MIR)	 toolbox	 (version	 1.6.1)	 (Lartillot	 and	 Toiviainen,	 2007),	
implemented	 in	MATLAB.	Selection	of	acoustic	 features	was	 informed	by	Alluri	et	al	 (2012,	
2013),	who	identified	25	features	that	broadly	capture	the	dynamics	of	the	timbral,	tonal	and	
rhythmic	properties	present	in	the	music	stimuli.	From	the	original	25	features	we	excluded	
fluctuation	 entropy	 and	 fluctuation	 centroid	 because	 they	 have	 not	 been	 studied	 in	 the	
literature	 and	 did	 not	 carry	 any	 valid	 perceptual	 meaning	 (Alluri	 et	 al.,	 2012,	 Alluri	 2016	
personal	communication).	The	23	acoustic	features	used	in	our	analyses	were	categorized	in	
short-term	features	and	long-term	features	(for	an	overview	see	Table	4.2).	The	short-term	
features	were	 extracted	with	 a	 sliding	window	 of	 25	ms,	with	 50%	 overlap	 between	 each	
segment	while	for	the	computation	of	the	long-term	features	a	longer	sliding	window	of	3	s	
was	employed,	with	33%	overlap	between	each	segment	(following	the	approach	in	Alluri	et	
al.,	2012,	2013).	Subsequently,	principle	component	analysis	(PCA)	on	the	acoustic	features	
(combined	 for	 excerpt	A	 and	B)	was	performed	 to	 (1)	 identify	 acoustic	properties	 that	 are	
present	in	both	excerpts	and	(2)	to	reduce	the	number	of	regressors	that	entered	the	general	
linear	model	(GLM)	for	fMRI	analyses.	To	prepare	the	acoustic	features	for	the	PCA,	we	first	
resampled	short	and	long-term	features	to	the	same	sampling	rate	of	1	s.	We	then	rescaled	
(between	0	and	1)	those	acoustic	features	separately	that	were	computed	by	different	MIR	
toolbox	 functions	 (i.e.,	 measured	 on	 different	 scales)	 whilst	 rescaling	 acoustic	 features	
combined	 that	 were	 computed	 by	 the	 same	MIR	 toolbox	 function	 (i.e.,	 measured	 on	 the	
same	 scale	 as	 the	 case	 for	 the	 10	 sub-band	 flux	 features)	 in	 order	 to	 preserve	 their	
covariance	structure.	The	resulting	time	courses	for	excerpt	A	and	B	were	then	concatenated,	
to	undergo	the	PCA.	We	performed	varimax	rotation	on	the	first	eight	principal	components	
	95	
(PCs)	 that	 explained	 over	 90%	 of	 the	 variance	 (see	 Figure	 4.2	 for	 rotated	 PCs	 and	 their	
respective	loadings).	
In	order	to	validate	that	the	first	eight	PCs	explained	the	two	excerpts	equally	well	(i.e.,	that	
PCs	were	not	driven	by	either	one	excerpt	or	the	other),	we	correlated	(Pearson	r)	each	of	
the	23	predicted	timeseries	(by	multiplying	the	eight	rotated	PC	loadings	with	the	23	PC	time	
courses)	with	the	corresponding	acoustic	features	for	the	two	excerpts	separately.	Across	all	
23	acoustic	features,	we	found	a	mean	±	SD	r	of	0.9098	±	0.0919	for	excerpt	A	and	0.8835	±	
0.1037	 for	 excerpt	 B	 (for	 correlation	 values	 per	 acoustic	 feature,	 see	 Figure	 4.1).	 As	 the	
difference	in	variance	explained	between	the	two	excerpts	was	negligible,	we	used	the	time	
courses	of	the	first	eight	rotated	components	for	our	subsequent	analyses.		
Next,	 we	 split	 the	 time	 courses	 of	 the	 rotated	 PCs	 to	 obtain	 timeseries	 corresponding	 to	
excerpt	 A	 and	 B,	 respectively.	 Those	 were	 then	 convolved	 with	 a	 double-gamma	
hemodynamic	 response	 function	 (HRF)	 to	 account	 for	 the	 hemodynamic	 delay,	 down-
sampled	to	2	s,	to	match	the	sampling	rate	of	the	fMRI	data	and	high-pass	filtered	at	the	cut-
off	frequency	of	0.01	Hz	(same	as	fMRI	data).	The	first	10	seconds	(5	TRs)	of	each	excerpt’s	
timeseries	were	excluded	for	subsequent	analysis	 in	order	to	avoid	any	artefacts	caused	by	
the	convolution	operation.	Those	timeseries	were	then	entered	as	regressors	of	interest	into	
subject-level	GLMs	of	the	fMRI	analysis.		
	
Table	4.2	|	Acoustic	features	used	in	the	analysis.	Derived	from	the	Music	Information	Retrieval	toolbox.	
Short-term	features	
Zero	crossing	rate,	spectral	centroid,	high	energy–low	energy	ratio,	spectral	spread,	spectral	roll-off,	spectral	
entropy,	spectral	flatness	(Wiener	entropy),	roughness,	RMS	energy,	spectral	flux,	and	Sub-Band	Flux	(10	
coefficients).	
Long-term	features	
Pulse	clarity,	fluctuation	centroid,	fluctuation	entropy,	mode	and	key	clarity.	
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Figure	 4.1	 |	 Correlations	 of	 acoustic	 features.	 Significant	 correlations	 between	 the	 predicted	 timeseries	 and	
corresponding	acoustic	 feature	 for	both	excerpts,	 indicate	 that	 the	 first	eight	PCs	explained	 the	 two	excerpts	
equally	well.	
	
4.2.7	fMRI	scanning	and	data	pre-processing	
Neuroimaging	was	performed	on	a	3T	GE	HDx	system.	An	 initial	3D	FSPGR	anatomical	scan	
was	obtained	in	an	axial	orientation,	with	field	of	view	=	256×	256×	192	and	matrix	=	256	×	
256×	192	to	yield	1-mm	isotropic	voxel	resolution	(TR/TE	=	7.9/3.0	ms;	inversion	time	=	450	
ms;	 flip	angle	=	20°).	This	was	used	for	registration	and	segmentation	of	 functional	 images.	
Functional	 images	were	 acquired	 using	 a	 gradient	 echo	 planer	 imaging	 sequence,	 TR/TE	 =	
2000/35ms,	field-of-view	=	220mm,	64	×	64	acquisition	matrix,	parallel	acceleration	factor	=	
2,	90°	flip	angle.	35	oblique	axial	slices	were	acquired	in	an	interleaved	fashion,	each	3.4mm	
thick	with	 zero	 slice	 gap	 (3.4mm	 isotropic	 voxels).	 The	precise	 length	of	 each	of	 the	BOLD	
scans	was	7	minutes	and	20	seconds.	
The	fMRI	pre-processing	pipeline	was	assembled	from	four	complementary	imaging	software	
packages	 .	 Specifically,	 FMRIB	Software	Library	 (FSL)	 (Smith	et	al.,	 2004),	AFNI	 (Cox,	1996),	
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Freesurfer	(Dale	et	al.,	1999)	and	Advanced	Normalization	Tools	(ANTS)	(Avants	et	al.,	2009)	
were	used.	 The	 following	pre-processing	 stages	were	performed:	1)	de-spiking	 (3dDespike,	
AFNI);	2)	motion	correction	(3dvolreg,	AFNI)	by	registering	each	volume	to	the	volume	most	
similar,	in	the	least	squares	sense,	to	all	others	(in-house	code);	3)	brain	extraction	(BET,	FSL);	
4)	 rigid	 body	 registration	 to	 anatomical	 scans	 (eleven	 subjects	with	 FSL’s	 BBR,	 one	 subject	
with	Freesurfer’s	bbregister	and	four	subjects	manually.	Different	software	was	required	due	
variance	 in	 degrees	 in	 head-movement	between	participants);	 5)	 non-linear	 registration	 to	
2mm	MNI	brain	(Symmetric	Normalization	(SyN),	ANTS);	6)	scrubbing	(Power	et	al.,	2012)	-	
using	a	framewise	displacement	(FD)	threshold	of	1.0	mm;	7)	spatial	smoothing	(FWHM)	of	
5mm	(3dBlurInMask,	AFNI)	and	high-pass	filtering	at	a	cut-off	frequency	of	0.01	Hz	to	remove	
baseline	signal	drifts.	 In	addition,	nine	nuisance	regressors	were	obtained:	six	were	motion-
related	 (3	 translations,	 3	 rotations)	 and	 three	 were	 anatomically-related	 (not	 smoothed).	
Specifically,	 the	 anatomical	 nuisance	 regressors	 were:	 I)	 ventricles	 (Freesurfer,	 eroded	 in	
2mm	space),	II)	draining	veins	(DV)	(FSL’s	CSF	minus	Freesurfer’s	Ventricles,	eroded	in	1mm	
space)	 and	 III)	 white	 matter	 (WM)	 (FSL’s	 WM	minus	 Freesurfer’s	 subcortical	 grey	 matter	
(GM)	 structures,	 eroded	 in	 2mm	 space).	 In	 order	 to	 cut	 the	 fMRI	 data	 and	 nuisance	
regressors	to	the	same	length	as	the	PC	time	courses,	we	removed	the	first	5	TRs.		
	
4.2.8	fMRI	data	analysis	
We	 applied	 standard	 FSL	 FEAT	 GLM	 to	 determine	 the	 effect	 of	 PC	 time	 courses	 on	 BOLD	
activation.	All	eight	PC	time	courses	were	entered	as	regressors	of	interest	into	subject-level	
GLMs	in	addition	to	their	temporal	derivatives	and	all	nine	nuisance	regressors	(resulting	in	
27	regressors	in	total).	We	then	analysed	the	fMRI	data	with	respect	to	eight	contrasts	(one	
contrast	for	each	PC).	The	resulting	individual	subject-level	contrasts	were	then	entered	into	
a	high-level	(mixed-effects)	cluster-corrected	FEAT	analysis	(FLAME	1+2)	to	obtain	the	paired	
t-test	 contrasts	 of	 LSD	 >	 Placebo	 and	 Placebo	 <	 LSD.	 In	 order	 to	model	 out	 any	 potential	
effect	 of	 the	 order	 in	 which	 subjects	 listened	 to	 the	 different	 music	 excerpts	 under	 the	
different	conditions,	respectively,	we	included	an	interaction	term	in	the	higher-level	FEAT	as	
a	regressor	of	no	interest.	We	repeated	the	high-level	analysis	without	the	interaction	term	
and	 obtained	 nearly	 identical	 results	 (not	 reported).	 All	 final	 group-level	 images	 were	
thresholded	 using	 a	 cluster	 correction	 threshold	 of	 Z	 >	 2.3	 and	 a	 cluster	 significance	
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threshold	of	p	=	0.05.	Group-level	images	were	visualized	on	an	average	surface	brain	using	
MRIcron	(Rorden	et	al.,	2007).	
	
4.2.9	ROI	selection	and	extraction	for	correlation	analyses	
Regions	of	 interest	 (ROI)	 analysis	was	 constrained	 to	 the	 group-level	 contrast	 LSD>Placebo	
for	timbral	complexity	(i.e.,	PC3,	see	Results).	ROI	selection	was	based	on	previous	literature	
and	encompassed	structures	that	have	been	commonly	identified	for	music-evoked	emotion	
(striatum,	 precuneus	 and	 insula)	 (Trost	 et	 al.,	 2012;	 Koelsch	 2014),	 auditory	 perception	
(planum	 temporale	 and	 right	 IFG)	 (Griffiths	 and	Warren,	 2002b;	 Alluri	 et	 al.,	 2013,	 2012;	
Zatorre	 and	 Salimpoor,	 2013)	 and	 the	 subjective	 effects	 of	 psychedelics	 (precuneus	 and	
insula)	 (Muthukumaraswamy	 et	 al.,	 2013;	 Tagliazucchi	 et	 al.,	 2016;	 Carhart-Harris	 et	 al.,	
2016).	ROIs	were	created	by	first	selecting	corresponding	binarized	structural	areas	from	the	
Harvard-Oxford	atlas	(using	a	probability	threshold	of	10%)	and	then	multiplying	these	with	
the	group-level	 results	 to	guarantee	anatomical	and	functional	specificity	of	 the	ROIs.	Note	
that	 only	 the	 largest	 consecutive	 cluster	 of	 voxels	 were	 considered	 within	 each	 ROI.	 This	
procedure	led	to	nine	ROIs:	right	planum	temporale,	left	planum	temporale,	right	precuneus,	
right	putamen,	left	putamen,	right	caudate,	left	caudate,	right	inferior	frontal	gyrus	and	right	
anterior	 insula	 (see	 table	 4.3).	 The	 mean	 parameter	 estimates	 within	 each	 ROI	 were	
extracted	for	each	participant,	and	Spearman’s	rank	correlation	tests	were	used	to	relate	the	
changes	 in	 parameter	 estimates	 (LSD	 >	 Placebo)	 with	 changes	 in	 GEMS-ratings	 for	music-
evoked	emotions	for	the	factors	wonder	and	transcendence	(LSD	>	Placebo).	Non-parametric	
permutation	testing	(10,000	permutations,	one-tailed)	was	carried	out	to	correct	for	multiple	
comparisons	(9	ROIs	x	2	GEMS	scales).		
	
4.2.10	Psychophysiological	interaction	analysis	
In	 order	 to	 assess	 timbral-specific	 changes	 in	 functional	 connectivity	 for	 the	 brain	 regions	
that	showed	a	significant	relationship	with	music-evoked	feelings	of	wonder	(i.e.,	precuneus	
and	right	inferior	frontal	gyrus,	see	Results),	we	conducted	two	separate	psychophysiological	
interaction	(PPI)	analyses.	For	this,	we	first	extracted	subject-specific	time	courses	from	those	
ROIs	and	then	applied	standard	FSL	FEAT	GLM.	In	addition	to	regressors	that	were	included	in	
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the	initial	fMRI	analysis	(eight	PC	time	courses,	their	temporal	derivatives	and	nine	nuisance	
regressors),	we	 included	the	ROI	timecourse	(physiological	regressor)	and	the	PPI	regressor	
that	 consisted	 of	 the	 element-wise	 multiplication	 of	 the	 physiological	 regressor	 with	 the	
timecourse	 encoding	 timbral	 complexity	 (psychological	 regressor,	 i.e.	 PC	 3).	 The	 resulting	
individual	subject-level	contrasts	were	then	entered	into	the	same	higher-level	(mixed-effect)	
cluster-corrected	FEAT	analysis	 as	described	above	 (with	an	 interaction	 term	 to	model	out	
the	effect	of	“group”).		
	
4.3	Results		
4.3.1	Acoustic	feature	extraction		
For	acoustic	feature	selection	and	extraction,	an	approach	similar	to	that	described	in	Alluri	
et	al.	(2012,	2013)	was	used	(Alluri	et	al.,	2012,	2013).	From	the	two	musical	excerpts	used	in	
the	present	study	we	extracted	23	acoustic	features	capturing	tonal,	rhythmical,	and	timbral	
properties	that	subsequently	underwent	a	principle	component	analysis	(PCA)	to	reduce	the	
dimensionality	of	the	data.	The	first	eight	principal	components	that	together	explained	more	
than	90%	of	the	variance	were	selected,	and	qualitatively	were	similar	with	the	components	
identified	in	previous,	independent	studies	(Alluri	et	al.,	2013,	2012).	The	consistency	of	the	
identified	 components	 across	 musical	 genres	 (tango	 (Alluri	 et	 al.,	 2012),	 classic	 and	 pop	
(Alluri	et	al.,	2013),	as	well	as	ambient	music	here)	supports	their	reliability	for	representing	
fundamental	acoustic	properties	in	music.	Importantly,	perceptual	validation	and	labelling	for	
similar	 components	 has	 been	 demonstrated	 (Alluri	 et	 al.,	 2012).	 In	 the	 present	 study,	 a	
similar/comparable	 labelling	 for	 the	 principle	 components	 was	 therefore	 adopted	 (PCs)	
(Figure	4.1).	 In	 fact,	when	quantitatively	comparing	our	PC’s	with	the	PC’s	 from	Alluri	et	al.	
(2012),	medium	to	very	high	correlations	 (Pearson	 r)	were	 found	 for	 fullness	 (r	=	0.37,	p	=	
0.08,	df	=	22),	brightness	(r	=.96,	p<0.001,	df	=	22),	timbral	complexity	(r	=	.91,	p<0.001,	df	=	
22),	key	clarity	(r	=	.96,	p<0.001,	df	=	22)	and	pulse	clarity	(r	=	.96,	p<0.001,	df	=	22).	
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Figure	4.2	|	Principle	Component	Analysis	(PCA)	of	acoustic	features.	Loadings	of	the	acoustic	features	on	the	
first	8	PCs	obtained	from	PCA	followed	by	varimax	rotation	explained	more	than	90%	of	the	variance.	The	x-axis	
shows	the	ordering	of	principal	components,	with	the	components	ordered	by	explained	variance.	The	colour	
bar	 corresponds	 to	 the	 strength	of	 the	 loading	 for	each	acoustic	 feature	 for	 that	 components:	warm	colours	
indicates	a	positive	loading,	and	cold	colours	a	negative	loading.	
	
4.3.2	Effects	of	LSD	on	music-evoked	brain	activity	
The	 time	 courses	 of	 the	 first	 eight	 PCs	 were	 entered	 into	 subject-level	 fMRI	 analyses	 as	
regressors	of	 interests.	 	 Resulting	 individual	 subject-level	 contrasts	were	 then	entered	 into	
high-level	 analyses	 to	 obtain	 paired	 t-test	 contrasts	 of	 LSD	 >	 Placebo	 and	 Placebo	 <	 LSD.	
These	analyses	revealed	altered	blood-oxygen-level	dependent	(BOLD)	responses	under	LSD	
for	different	acoustic	components	and	within	distinct	cortical	and	sub-cortical	areas.	For	the	
component	brightness,	decreases	under	LSD	were	observed	in	the	left	lateral	occipital	cortex	
(Figure	4.3A).	For	fullness,	LSD	increased	activation	in	the	bilateral	thalamus,	and	decreased	
activation	 in	 the	 occipital	 cortex	 and	 right	 middle	 and	 inferior	 frontal	 gyrus	 (IFG)	 (Figure	
4.3B).	 For	 timbral	 complexity	 increases	 under	 LSD	 were	 found	 in	 widespread	 cortical	 and	
subcortical	 networks,	 including	 auditory	 and	 auditory	 association	 cortices	 such	 as	 Heschl’s	
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Gyrus,	 superior	 temporal	 gyrus	 (STG),	 and	 planum	 temporale	 as	 well	 as	 higher-level	
heteromodal	 cortices	 such	 as	 the	 precuneus,	 the	 right	 insula	 and	 the	 right	 IFG,	 bilateral	
striatum,	 the	 occipital	 cortex	 and	 the	 supplementary	 motor	 cortex.	 Increased	 BOLD	
activations	 to	 timbral	 complexity	 were	 more	 evident	 for	 left	 auditory	 cortices	 and	 more	
extensive	in	the	right	IFG	and	right	anterior	insula	(Figure	4.3C).	For	the	component	Subband	
3	LSD	significantly	increased	activation	in	occipital	cortices	while	decreased	activation	in	the	
cerebellum	(Figure	3D).		For	key	clarity,	significant	increases	under	LSD	were	observed	in	the	
right	lateral	occipital	cortex,	and	decreases	were	found	in	the	left	striatum	(Figure	4.3E).	For	
the	component	Subband	2,	LSD-related	increases	could	be	shown	in	the	right	lateral	occipital	
cortex	(Figure	4.3F).	
BOLD	changes	under	LSD	appeared	particularly	pronounced	to	timbral	complexity,	and	within	
brain	networks	commonly	identified	for	music	perception	and	emotion	(Koelsch	2014;	Alluri	
et	al.,	2012).	ROI	selection	for	connectivity	analyses	described	below	(paragraph	4.3.4)	where	
therefore	constrained	to	this	contrast	(see	table	4.3	for	ROI’s).	For	insight	into	the	effects	of	
LSD	and	on	timbral-complexity	induced	BOLD	changes,	parameter	estimates	from	these	ROI’s	
for	timbral	complexity	were	plotted	for	placebo	and	LSD	separately	(see	figure	4.4)	
	
4.3.3	Effects	of	LSD	on	music-evoked	emotion	
Alongside	investigating	changes	in	music-evoked	brain	activity	under	LSD,	our	study	aimed	to	
assess	 the	 effects	 of	 LSD	 on	music-evoked	 emotions.	We	measured	 nine	 different	 music-
evoked	 emotions	 using	 the	Geneva	 Emotional	Music	 Scale	 (GEMS)	 that	was	 completed	 by	
each	participant	after	listening	to	music	in	each	condition	(Zentner	et	al.,	2008).	Paired	t-tests	
on	 the	 GEMS	 scales	 revealed	 that,	 compared	 to	 placebo,	 music-evoked	 emotions	 were	
significantly	 higher	 under	 LSD	 for	 wonder	 (t(18)=4.47,	 p=.002),	 transcendence	 (t(18)=4.17,	
p=.004),	 power	 (t(18)=3.82,	 p=.008),	 tenderness	 (t(18)=3.78,	 p=.008),	 nostalgia	 (t(18)=3.94,	
p=.006),	peacefulness	(t(18)=4.45,	p=.003),	and	joyful	activation	(t(18)=4.86,	p=.001),	but	not	for	
sadness	 (t(18)=1.93,	p=.25)	or	tension	 (t(18)=1.42,	p=.63)	(Figure	4.5).	 	P-values	reported	here	
are	corrected	for	multiple	comparisons	using	two-sided	permutation	testing	with	α	set	to	.05.	
These	 results	 replicate	 the	 findings	 from	 study	 1,	 demonstrating	 intensified	music-evoked	
emotion	under	LSD.	
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Figure	 4.3	 |	 Brain	 regions	 showing	 altered	 BOLD	 response	 to	 acoustic	 features	 under	 LSD.	 Increases	
(LSD>placebo)	 are	 displayed	 in	 yellow,	 and	 decreases	 (placebo>LSD)	 are	 displayed	 in	 blue.	 Cluster-correction	
was	applied	to	all	 images	with	a	threshold	of	Z	>	2.3.	Significant	effects	were	observed	 in:	A)	brightness,	with	
decreases	in	the	occipital	cortex,	in	B)	fullness,	with	decreases	in	occipital	cortex	and	right	inferior	frontal	gyrus	
(IFG)	and	increases	in	bilateral	thalamus,	in	C)	timbral	complexity,	with	increases	in	bilateral	striatum,	occipital	
cortex,	 supplementary	 motor	 cortex,	 auditory	 cortices,	 right	 insula	 and	 right	 IFG,	 in	 D)	 subband	 3,	 with	
decreases	 in	 the	cerebellum,	and	 increases	 in	 the	occipital	cortice,	 in	E)	key	clarity,	with	decreases	 in	 the	 left	
striatum	and	the	right	 lateral	occipital	cortex,	and	finally,	 in	F)	subband	2,	with	 increases	 in	the	right	occipital	
cortex.	
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Figure	 4.4	 |	 BOLD	 activation	 to	 timbral	 complexity	 under	 placebo	 and	 LSD.	 The	 group	 average	 parameter	
estimates	+	 standard	error	of	 the	mean	 (Z-scores,	 displayed	on	 the	 y-axis)	 for	nine	 regions	of	 interest	 (ROIs)	
(displayed	on	the	x-axis),	for	placebo	(blue)	and	LSD	(red).		
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Figure	4.5	|	Effects	of	LSD	on	music-evoked	emotion.	The	average	scores	+	standard	error	of	the	mean	for	each	
condition	(placebo	and	LSD)	for	the	nine	music-evoked	emotions	assessed	with	the	25-item	Geneva	Emotional	
Music	 Scale	 (GEMS).	 Asterisks	 indicate	 a	 statistically	 significant	 finding	 (p<0.05)	 after	 multiple	 comparison	
correction.	
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4.3.4	Correlation	analyses	between	music-evoked	brain	activity	and	emotion	
Having	 established	 that	 psychedelics	 intensify	 the	 emotional	 experience	 with	 music,	 we	
subsequently	 focused	 exploring	 the	 interactions	 between	 peak	 experience	 emotions	 (as	
captured	by	the	GEMS	scales	wonder	and	transcendence	(Maslow,	1964,	1971;	Zentner	et	al.,	
2008)	 and	 associated	 increases	 in	 music-evoked	 brain	 activity.	 We	 therefore	 conducted	
correlation	 analyses	 (Spearman’s	 rank)	 between	 changes	 in	 music-evoked	 peak	 emotions	
(LSD	>	Placebo)	and	music-evoked	BOLD	activity	(LSD	>	Placebo)	for	nine	regions	of	interest	
(ROIs).	This	correlation	analysis	was	constrained	to	the	contrast	for	timbral	complexity	(i.e.,	
PC3)	 as	 related	 BOLD	 changes	 were	 most	 pronounced	 and	 occurred	 in	 brain	 networks	
commonly	identified	for	music	perception	and	emotion	(Koelsch	2014;	Alluri	et	al.,	2012).	ROI	
selection	 was	 based	 on	 previous	 literature	 and	 encompassed	 structures	 that	 have	 been	
commonly	identified	for	music-evoked	emotion	(striatum,	precuneus	and	insula)	(Trost	et	al.,	
2012;	 Koelsch	 2014),	 auditory	 perception	 (planum	 temporale	 and	 right	 IFG)	 (Griffiths	 and	
Warren	 2002b;	 Alluri	 et	 al.,	 2013,	 2012;	 Zatorre	 and	 Salimpoor,	 2013)	 and	 the	 subjective	
effects	of	psychedelics	(precuneus	and	insula)	(Muthukumaraswamy	et	al.,	2013;	Tagliazucchi	
et	al.,	2016;	Carhart-Harris	et	al.,	2016).	See	 table	4.3	 for	 the	coordinates	and	size	of	each	
ROI.	We	found	significant	positive	correlations	between	changes	in	music-evoked	feelings	of	
wonder	 and	music-evoked	BOLD	activation	 to	 timbral	 complexity	within	 the	precuneus	 (r	=	
0.67,	p	=	.034)	as	well	as	within	the	right	inferior	frontal	gyrus	(r	=	0.65,	p	=	.045)	(see	Figure	
4.6).	 In	addition,	we	 found	 trend-level	positive	 correlations	between	changes	 in	 feelings	of	
transcendence	and	the	right	inferior	frontal	gyrus	(r	=	0.61,	p	=	.066).	P-values	reported	were	
corrected	for	multiple	comparisons	using	one-sided	permutation	testing	with	α	set	to	.05.	
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Figure	4.6	|	Results	from	correlation	analysis.	A)	Correlation	matrix	of	parameter	estimates	with	music-evoked	
peak	emotions:	wonder	and	transcendence.	Asteriks	indicate	a	statistically	significant	correlation	(p	≤	0.05)	after	
multiple	 comparison	 correction.	 B)	 Location	 of	masks	 for	 the	 right	 precuneus	 and	 right	 inferior	 frontal	 gyrus	
(IFG).	 C)	 Correlation	 plot	 showing	 a	 positive	 correlation	 between	 changes	 in	 parameter	 estimates	 in	 right	
precuneus	and	increases	in	music-evoked	emotions	of	wonder	under	LSD	(r	=	0.67,	p	=	.034).	D)	Correlation	plot	
showing	a	positive	correlation	between	changes	 in	parameter	estimates	 in	the	right	 inferior	 frontal	gyrus	and	
increases	(difference	between	scores	for	LSD	and	scores	for	placebo,	calculated	as	LSD	minus	placebo)	in	music-
evoked	emotions	of	wonder	under	LSD	(r	=	0.65,	p	=	.045).		
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Table	4.3	|	MNI	coordinates	for	the	centres	of	gravity	of	the	ROIs	(L	=	left,	R	=	right).	
Region	 Coordinates	(X,Y	Z)	 #	voxels	
R	Planum	Temporale	 54.8	 -22.6	 11	 290	
L	Planum	Temporale	 -48.8	 -33	 15.2	 658	
Precuneus	 14.6	 -62.6	 19	 414	
R	Putamen	 22.8	 10.2	 -0.4	 308	
L	Putamen	 -25.6	 1.4	 3.8	 364	
R	Caudate	 15.2	 14	 8	 158	
L	Caudate	 -14.2	 17.8	 3.4	 76	
R	IFG	(Broca	area)	 58.8	 9.8	 14.6	 60	
R	Anterior	Insula	 31.2	 13.8	 9	 48	
	
	
4.3.5	Effects	of	LSD	and	music	on	functional	connectivity	
The	 relationship	 between	 feelings	 of	 wonder	 and	 music-evoked	 activation	 to	 timbral	
complexity	in	the	precuneus	and	the	right	IFG	informed	subsequent	PPI	analyses	with	the	aim	
to	gain	 insights	 into	underlying	music-specific	changes	 in	functional	connectivity	under	LSD.	
Two	separate	PPI	analyses	were	conducted,	using	either	precuneus	or	right	IFG	as	seed	ROI,	
in	order	to	identify	brain	areas	for	which	the	activation	time	course	during	the	LSD	condition	
were	more	(increased)	or	 less	(decreased)	coupled	with	the	seed	regions	depending	on	the	
level	of	timbral	complexity	in	the	music.	Under	LSD,	we	found	significantly	increased	coupling	
of	 the	 precuneus	with	 the	 right	 superior	 frontal	 gyrus	 (SFG)	 for	 passages	when	 the	music	
exhibited	high	timbral	complexity.	 In	addition,	we	found	significantly	decreased	coupling	of	
the	precuneus	with	the	right	IFG	as	well	as	the	right	auditory	cortex	under	LSD	when	timbral	
complexity	 in	 the	 music	 increased.	 No	 significant	 timbral-specific	 changes	 in	 functional	
connectivity	were	found	for	the	right	IFG	as	seed	(Figure	4.7).	
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Figure	 4.7	 |	 Brain	 regions	 showing	 altered	 timbral-specific	 functional	 connectivity	 under	 LSD.	A).	Group	 level	
results	from	the	PPI	analysis	using	the	right	precuneus	ROI	(displayed	in	red).	Increased	coupling	was	observed	
in	the	right	superior	frontal	gyrus,	and	decreases	were	observed	in	the	right	auditory	cortex	and	right	 inferior	
frontal	 gyrus.	 Increases	 (LSD>placebo)	 are	 displayed	 in	 yellow,	 and	 decreases	 (placebo>LSD)	 are	 displayed	 in	
blue.	Z	<	2.3.	B)	Connectivity	values	of	each	individual	participant	and	for	each	condition	for	the	precuneus	with	
the	right	superior	frontal	gyrus,	and	C)	for	the	precuneus	with	the	right	inferior	frontal	gyrus	and	auditory	cortex	
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4.3.6	Effects	of	head	motion	
In	order	to	investigate	the	effect	of	motion	on	our	results,	frame-wise	displacement	(FD)	was	
investigated	 between	 the	 drug	 and	 placebo	 condition	 as	 well	 as	 conducted	 correlation	
analyses	between	changes	in	FD	(LSD>placebo)	and	extracted	parameter	estimates	from	the	
nine	 ROIs.	 The	 mean	 ±	 SD	 FD	 for	 placebo	 and	 LSD	 were	 0.091	 ±	 0.037	 and	 0.174	 ±0.1,	
respectively,	which	was	found	to	be	statistically	significant	using	a	paired	t-test	(t(15)	=	-3.28,	
p=0.005).	 However,	 no	 significant	 correlations	 (Spearman’s	 rank)	 was	 found	 between	
changes	 in	 FD	 (LSD>Placebo)	 and	 changes	 in	 music-evoked	 BOLD	 activity	 for	 the	 contrast	
timbral	complexity	(LSD	>	Placebo)	in	any	of	the	nine	ROIs:	right	planum	temporale	(r=0.04,	
p=0.88),	left	planum	temporale	(r=-0.01,	p=0.97),	precuneus	(r=0.02,	p=0.93),	right	putamen	
(r=-0.29,	p=0.27),	left	putamen	(r=-0.21,	p=0.42),	right	caudate	(r=-0.2,	p=0.45),	left	caudate	
(r=-0.28,	p=0.3),	right	IFG	(r=0.29,	p=0.27)	and	right	insula	(r=0.28,	p=0.28).	It	can	therefore	
be	 concluded	 that	 the	 effect	 of	motion	 for	 our	 results	 seem	negligible.	 	 P-values	 reported	
here	are	uncorrected	for	multiple	comparisons.	In	addition,	to	control	for	an	effect	of	FD	on	
timbral	 complecity-evoked	 brain-activity,	 average	 FD	 for	 stimulus	 A	 and	 stimulus	 B	 were	
correlated	 with	 respective	 time-courses	 for	 timbral	 complexity,	 and	 no	 significant	
correlations	 were	 detected	 (r=0.11,	 p=0.09,	 df=25	 (stimulus	 A);	 r=0.12,	 p=0.07,	 df=215	
(stimulus	B)).	
	
	4.4	Discussion		
This	 study	 investigated	 the	 effects	 of	 LSD	 on	 the	 brain’s	 processing	 of	 distinct	 acoustic	
features	in	music,	and	the	relationship	of	these	effects	to	changes	in	music-evoked	emotion	
under	 LSD.	 Widespread	 BOLD	 activity	 changes	 were	 observed	 under	 LSD	 in	 cortical	 and	
subcortical	 areas	 to	 different	 acoustic	 features	 in	 the	 music.	 	 The	 BOLD	 signal	 increases	
observed	 under	 LSD	 to	 the	 component	 timbral	 complexity	 were	 found	 to	 be	 particularly	
meaningful,	 as	 the	 regions	 appear	 to	 lie	 within	 brain	 networks	 commonly	 identified	 for	
music-perception	and	music-evoked	emotion.	These	include	bilateral	auditory	cortices,	right	
inferior	 frontal	 gyrus	 (IFG),	 right	 insula,	 precuneus,	 bilateral	 striatum	 and	 supplementary	
motor	 area	 (SMA).	 Music-evoked	 emotions	 were	 rated	 higher	 under	 LSD,	 and	 increased	
feelings	 of	wonder	 correlated	with	 increased	 BOLD	 activation	 to	 timbral	 complexity	 in	 the	
right	precuneus	and	in	the	right	IFG.	Reduced	functional	connectivity	under	LSD	in	relation	to	
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timbral	 complexity	was	 found	 between	 the	 right	 precuneus	 and	 auditory	 regions,	 and	 the	
right	 IFG.	 Increased	functional	connectivity	under	LSD	 in	relation	to	timbral	complexity	was	
found	between	the	right	precuneus	and	the	superior	frontal	gyrus	(SFG).	These	findings	invite	
us	 to	 discuss	 some	 of	 the	 following	 key	 questions:	Why	 does	 LSD	 produced	 such	marked	
changes	in	the	way	the	brain	processes	timbre,	also	known	as	tone	colour?	And	what	are	the	
possible	brain	mechanisms	at	stake?	In	the	subsequent	paragraphs,	this	will	be	discussed	in	
light	of	previous	neuroscience	research,	and	of	 the	significance	of	 timbre	 for	music-evoked	
emotion.	
Timbre,	or	tone	colour,	 refers	to	the	properties	of	 the	sound	distinct	 for	pitch	or	 loudness.	
Timbral	 complexity,	 in	 turn,	 corresponds	 to	 the	complexity	 in	 the	 shape	and	 the	 spread	of	
music’s	 spectral	 distribution.	 Thus,	 timbral	 complexity,	 can	 be	 treated	 as	 an	 index	 for	 the	
complexity	in	the	shape	of	power	spectrum	of	the	sound	signal.	Spectral	properties	of	sound	
are	 initially	 processed	 by	 the	 planum	 temporale	 (Kumar	 et	 al.,	 2007),	 a	 central	
“computational	 hub”	 within	 the	 auditory	 cortex	 that	 segregates	 incoming	 spectral	 signals	
into	 distinct	 spectrotemporal	 patterns	 (Griffiths	 and	 Warren,	 2002b).	 Subsequent	
information	exchange	with	higher	cortical	regions	such	as	the	IFG,	is	thought	to	facilitate	the	
linking	 of	 the	 perceived	 spectrotemporal	 patterns	 with	 learned	 representations	 and	
associations	 (Zatorre	and	Salimpoor,	2013;	Hackett,	2011).	The	auditory	cortex	and	 IFG	are	
anatomically	(Plakke	and	Romanski,	2014)	and	functionally	(Tomasi	and	Volkow,	2012)	well-
connected,	 and	 considered	 an	 important	 pathway	 for	 the	 perception	 of	 auditory	 objects	
(Griffiths	 and	Warren	 2004;	 Zatorre	 and	 Salimpoor,	 2013),	musical	melody	 (Zatorre	 et	 al.,	
1994),	 musical	 harmony	 (Schönwiesner	 et	 al.,	 2007;	 Opitz	 et	 al.,	 2002),	 musical	 syntax	
(Koelsch	et	al.,	2002),	and	the	encoding	of	musical	expectation	(Osnes	et	al.,	2012;	Zatorre,	
2015)	 as	 well	 as	 musical	 imagination	 (Herholz	 et	 al.,	 2012).	 Damage	 and	 abnormal	
functioning	in	the	auditory-IFG	network	has	been	linked	to	impaired	music	perception	(Hyde	
et	al.,	2007;	Hyde	et	al.,	2011;	Leveque	et	al.,	2016)	and	auditory	hallucinations	(Looijestijn	et	
al.,	2013).	The	findings	of	the	present	study	indicate	that	LSD	has	major	effects	on	the	way’s	
the	brain	processes	music’s	timbre	properties,	and	it	seems	plausible	that	this	effect	relates	
to	changes	in	auditory	perception	under	psychedelics	that	are	often	reported	(such	as	in	the	
opening	quote	of	this	chapter),	but	this	remains	yet	to	be	determined	experimentally.	
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This	experiment	focussed	on	relating	changes	 in	brain	function	to	changes	 in	music-evoked	
emotion	 under	 LSD.	 Apart	 from	 a	 key	 role	 in	 music	 perception,	 converging	 evidence	
describes	 the	 IFG’s	 involvement	 in	 the	 evaluation	 of	 emotional	 valence	 in	 acoustic	
information	more	 generally.	 Happy	 emotional	 vocalisations	 produce	 increased	 IFG	 activity	
compared	to	angry	vocalisations	(Schirmer	and	Kotz,	2006;	Wiethoff	et	al.,	2008;	Frühholz	et	
al.,	 2016)	 -	 an	 effect	 that	 has	 been	 observed	 as	 early	 as	 7-months	 in	 human	 infants	
(Grossmann	et	 al.,	 2010).	 Brain	 damage	 and	 experimentally	 disrupting	 brain	 activity	 in	 the	
IFG	using	 transcranial	magentic	 stimulation	 (TMS),	 is	 linked	with	 impairments	 in	 identifying	
vocal	emotion	(Hoekert	et	al.,	2010).	The	IFG	processes	emotionally	salient	information	from	
different	 sensory	 modalities	 (Lee	 and	 Siegle,	 2012),	 and	 has	 been	 more	 generally	
conceptualised	 as	 being	part	 of	 a	 cognitive	 control	 network	 (Marklund	 and	Persson,	 2012;	
Irlbacher	 et	 al.,	 2014)	 that	 redistributes	 attentional	 resources	 for	 emotionally	 salient	
information	(Vuilleumier,	2005).	Paying	attention	to	the	emotional	valence	of	visual	(Critchley	
et	al.,	2000;	Schindler	and	Kissler,	2016)	and	auditory	(Bach	et	al.,	2008)	stimuli	is	associated	
with	 increases	 in	 IFG	 activity,	 and	 emotionally	 salient	 information	 can	 produce	 marked	
attentional	 biases	 (Vuilleumier,	 2005).	 Increased	 right	 IFG	 activation	 to	 music’s	 timbral	
complexity	 under	 LSD,	 and	 the	 positive	 corelation	with	music-evoked	 ‘peak’	 emotion,	may	
therefore	 indicate	 increased	 allocation	 of	 attentional	 resources	 for	 emotional	 information	
processed	within	the	auditory-IFG	circuitry.		
This	 view,	 that	 the	 auditory-IFG	 network	 may	 play	 an	 important	 role	 in	 LSD’s	 effects	 on	
musical	 information	 processing,	was	 further	 supported	 from	 the	 findings	 of	 the	 functional	
connectivity	 analyses.	 The	 PPI	 analysis	 revealed	 a	 significant	 decoupling	 between	 the	 right	
precuneus	and	the	right	auditory	cortex	and	right	IFG	under	LSD,	in	interaction	with	timbral	
complexity.	The	precuneus	 is	a	highly	connected	hub	region	that	plays	an	 important	role	 in	
self-referential	 cognition	 (Buckner	 et	 al.,	 2008;	 Cavanna	 and	 Trimble,	 2006)	 and	 emotion-
regulation	 (Schilbach	 et	 al.,	 2012;	 Cavanna	 and	 Trimble,	 2006),	 and	 shows	 desynchronized	
activity	 under	 psychedelics	 (Carhart-Harris	 et	 al.,	 2016;	 Muthukumaraswamy	 et	 al.,	 2013;	
Riba	 et	 al.,	 2002).	 This	 disorganising	 effect	 of	 psychedelics	 on	 precuneus	 activity	 has	 been	
associated	 with	 “ego-dissolution”,	 characterised	 by	 increased	 emotional	 liability	 (Carhart-
Harris	 et	 al.,	 2016;	 Tagliazucchi	 et	 al.,	 2014,	 2016;	 Lebedev	 et	 al.,	 2015).	 Although	 the	
precuneus	 is	 activated	 to	 music-evoked	 emotion	 (Trost	 et	 al.,	 2012;	 Koelsch	 2014;	
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Baumgartner	et	al.,	 2006),	 the	 region	 shows	poor	anatomical	 (Cavanna	and	Trimble,	2006)	
and	 resting	 state	 functional	 connectivity	 (Tomasi	 and	Volkow,	2012)	with	 auditory	 regions.	
The	precuneus	is	however	anatomically	and	functionally	well-connected	with	frontal	regions	
such	as	the	IFG	and	SFG	(Zhang	and	Li,	2012),	and	is	thought	to	provide	top-down	control	to	
these	 (hierarchically	 subordinate)	 brain	 regions	 (Cavanna	 and	 Trimble,	 2006).	 As	 such,	
decreased	 precuneus-auditory/IFG	 coupling	 under	 LSD	 may	 reflect	 a	 reduced	 regulatory	
influence	 of	 the	 precuneus	 over	 emotion	 processing	 in	 the	 auditory/IFG	network,	 and	 this	
may	facilitate	an	intensified	(or	disinhibited)	emotional	response	to	music.		
Finally,	LSD	also	produced	marked	increases	in	BOLD	activation	to	timbral	complexity	in	the	
striatum	and	in	the	insula;	regions	that	have	been	consistently	associated	with	music-evoked	
emotion.	 The	 striatum	 has	 been	 implicated	 in	 brain	mechanisms	 underlying	music-evoked	
pleasure	(Blood	and	Zatorre	2001;	Salimpoor	et	al.,	2011),	likely	via	the	encoding	of	auditory	
expectation	and	reward	 in	 interaction	with	auditory	cortices	 (Salimpoor	et	al.,	2015,	2013).	
The	insula	is	a	high-level	hub	region	that	is	thought	to	facilitate	emotional	awareness	(Craig	
2009),	the	attribution	of	emotional	meaning	to	music,	sound	and	human	voice	(McGettigan	
et	al.,	2013;	Frühholz	et	al.,	2016;	Petrini	et	al.,	2011;	Trost	et	al.,	2012;	Koelsch	2014),	and	
the	subjective	effects	of	classic	psychedelics	 (Carhart-Harris	et	al.,	2016;	Tagliazucchi	et	al.,	
2014,	2016;	Lebedev	et	al.,	2015).	Interestingly,	the	present	study	did	not	find	a	relationship	
between	 music-evoked	 feelings	 of	 wonder	 and	 transcendence,	 and	 the	 striatum.	 An	
implication	of	this	could	be	that	the	striatum	is	predominantly	concerned	with	the	processing	
of	 “simple”	 affective	 states	 characterised	 by	 pleasure,	 whereas	 more	 complex	 emotional	
states,	such	as	feelings	of	wonder	and	transcendence,	may	require	more	complex	cognition,	
and	 thus	 more	 complex	 cortical	 mechanisms	 to	 facilitate	 them.	 The	 selective	 positive	
correlation	 between	 increased	 feelings	 of	wonder	 and	BOLD	 signal	 changes	 in	 higher-level	
brain	regions	such	the	IFG	and	precuneus	support	this	idea.		
Taken	 together,	 these	observations	 suggest	 that	 LSD	alters	 the	dynamic	 interplay	between	
the	analysis	of	“low-level”	spectral	properties	in	the	music,	and	the	subsequent	“high-level”	
regulation	 and	 processing	 of	 the	 emotional	 associations.	 The	 precuneus,	 the	 IFG	 and	 the	
insula	may	play	a	particular	 important	role	 in	facilitating	music-evoked	peak	emotion,	given	
previous	 literature	 implicating	 their	 involvement	 in	 the	processing	of	 emotional	 awareness	
(Craig,	2009)	and	“complex”	music-evoked	emotion	(McGettigan	et	al.,	2013;	Frühholz	et	al.,	
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2016;	Petrini	et	al.,	2011;	Trost	et	al.,	2012;	Koelsch	2014).	A	disintegration	or	weakening	of	
the	mechanisms	 that	 normally	 regulate	 emotion	 (Tagliazucchi	 et	 al.,	 2016;	 Lebedev	 et	 al.,	
2015),	may	be	a	fundamental	mechanism	via	which	strong	emotional	experiences	with	music	
can	be	 facilitated	under	psychedelics.	Discussing	 the	possible	brain	mechanisms	will	be	 the	
focus	of	the	subsequent	paragraph.	
4.4.1	Possible	brain	mechanisms	
Classic	psychedelics	such	as	LSD	stimulate	serotonin	2A	receptors	(Kometer	et	al.,	2013;	Riga	
et	al.,	2016;	Titeler	et	al.,	1988a),	which	are	primarily	expressed	on	deep	 layer	V	pyramidal	
cells	 (Celada	 et	 al.,	 2013).	 Upon	 activation	 of	 these	 receptors,	 the	 cells’	 membranes	
depolarize,	reducing	the	neuron’s	threshold	for	firing	(Andrade	2011).	Hyper-activation	of	the	
serotonin	 2A	 receptor	 underlies	 desynchronised	 activity	 within	 high-level	 brain	 networks	
(Muthukumaraswamy	et	al.,	2013),	 leading	 to	 impaired	 top-down	control	and	an	 increased	
information	 exchange	 between	 brain	 modules	 that	 are	 usually	 more	 strictly	 functionally	
segregated	(Tagliazucchi	et	al.,	2016;	Carhart-Harris	et	al.,	2016).	Deep	layer	V	pyramidal	cells	
encode	 learned	 mental	 representations	 or	 “predictions”	 that	 are	 matched	 with	 incoming	
sensory	 stimuli	 in	 a	 top-down	 fashion	 (Bastos	 et	 al.,	 2012),	 and	 over-activation	 of	 the	
serotonin	 2A	 receptor	 system	 by	 psychedelics	 is	 reasoned	 to	 produce	 a	 disorganised	 or	
“entropic”	quality	of	brain	activity,	manifesting	as	a	more	variegated	quality	of	consciousness	
(Carhart-Harris	et	al.,	2014).		
The	 high	 density	 of	 serotonin	 2A	 receptors	 within	 the	 precuneus,	 insula	 and	 the	 planum	
temporale	(Ettrup	et	al.,	2014;	Erritzoe	et	al.,	2009)	suggests	that	psychedelics	alter	auditory	
information	 processing	 at	 different	 stages	 of	 the	 processing	 hierarchy.	 Since	 the	 planum	
temporale	is	functionally	specialised	in	classifying	distinct	spectrotemporal	patterns	(Griffiths	
and	 Warren,	 2002b),	 the	 particularly	 pronounced	 BOLD	 increases	 under	 LSD	 to	 “timbral	
complexity”	 in	 this	 region	 may	 reflect	 an	 increased	 activation	 of	 intrinsic	 deep-pyramidal	
neurons	that	encode	(predictions	for)	music’s	spectral	properties.	Such	an	effect	may	result	
in	dramatic	alterations	in	the	processing	and	perception	of	auditory	spectral	information	(i.e.	
timbral	 complexity)	 in	 music,	 and	 thereby	 indirectly	 lead	 to	 an	 intensification	 of	 the	
emotional	meanings	that	are	conveyed	through	timbre.		
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Alternative	 to	 this	 hypothesis	 that	 holds	 LSD	 changes	 timbre-perception,	 is	 the	 view	 that	
increased	activity	in	planum	temporale	may	be	consequential	of	an	increased	input	from	top-
down	 projecting	 deep	 layer	 V	 pyramidal	 cells,	 originating	 from	 the	 IFG	 and	 insula	 and	
encoding	emotional	valence	of	timbre	(McGettigan	et	al.,	2013;	Frühholz	et	al.,	2016;	Petrini	
et	 al.,	 2011;	 Trost	 et	 al.,	 2012;	 Koelsch	 2014),	 i.e.	 an	 increased	 IFG/insula	 to	 planum	
temporale	effective	connectivity.	Effective	connectivity	has	not	been	assessed	 in	this	study,	
but	 doing	 so	 would	 aid	 testing	 such	 mechanistic	 hypotheses	 of	 LSD’s	 effects	 on	 timbre-
processing.	Finally,	one	other	possible	brain	mechanism	at	play	could	be	that	the	decoupling	
of	 the	 auditory/IFG	 circuitry	 from	 the	 precuneus	 propagates	 an	 unregulated	 activation	 of	
timbre-emotion	associations.	The	absence	of	this	top-down	control,	would	hence	produce	an	
intensified	(disinhibited)	emotional	response	to	the	emotions	conveyed	through	music.	
	
4.4.2	The	significance	of	timbre		
An	 important	question	 is	why	did	 LSD	have	 such	a	marked	effect	 specifically	on	 the	brain’s	
processing	of	music’s	timbral	complexity?	One	explanation	may	be	found	in	the	significance	
of	 timbre	 in	 acoustic	 communication	 across	 species.	 Timbre	 is	 used	 across	 species	 to	
communicate	 salient	 information	 such	 as	 the	 presence	 of	 predators	 or	 the	 fitness	 of	
potential	mates	(Fitch,	1997;	Bregman	et	al.,	2016),	and	the	perception	of	timbre	is	argued	to	
have	underwent	high	evolutionary	selection	pressure.	Timbre’s	capacity	to	convey	emotion	is	
shown	cross-culturally	 (Egermann	et	al.,	2015),	 to	do	so	 independently	 from	other	acoustic	
features	(Hailstone	et	al.,	2009),	and	timbre-perception	is	present	in	very	early	infancy	before	
the	 perception	 of	 other	 acoustic	 features	 develop,	 such	 as	 tempo	 and	musical	mode,	 and	
long	before	the	acquisition	of	verbal	language	(Dalla	Bella	et	al.,	2001).	The	infants’	ability	to	
memorise	 and	 recognize	 their	 mother’s	 voice	 as	 early	 as	 at	 2	 days	 after	 birth	 has	 been	
argued	 to	 be	 due	 the	 infant’s	 innate	 tuning	 to	 timbral	 properties	 common	 to	 speech	 and	
music	 (Tsang	 and	 Trainor,	 2002).	 Timbre	 has	 been	 conceptualised	 to	 function	 like	 an	
interface,	that	connects	distinctive	spectral	features	within	sound	with	meaningful	emotional	
associations	(Hailstone	et	al.,	2009).	The	findings	of	 this	study	suggest	that	LSD	targets	this	
interface,	“tuning”	the	brain	to	non-verbal,	or	even	pre-verbal,	acoustic	properties	that	carry	
important	emotional	information.		
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4.4.3	Effects	of	LSD	on	the	brain’s	processing	of	other	acoustic	features	
The	 previous	 discussion	 centred	 around	 the	 changes	 observed	 for	 timbral-complexity,	
because	 these	 changes	 were	most	 pronounced	 and	 appeared	 to	 be	 localised	 in	 networks	
commonly	 associated	 with	 music-perception	 and	 music-evoked	 emotion.	 However,	 there	
were	 other	 findings	 that	 must	 be	 mentioned.	 Increased	 thalamus	 and	 decreased	 IFG	
activation	was	observed	under	LSD	in	response	to	“fullness”,	 i.e.	simply	the	loudness	of	the	
sound.	Loudness	reflects	a	less	complex	acoustic	property	(occupying	a	single	dimension,	i.e.	
amplitude	of	the	signal),	and	has	previously	been	associated	with	a	preferential	activation	of	
lower	 auditory	 regions	 (Reiterer	 et	 al.,	 2007).	 Significant	 BOLD	 signal	 changes	 were	 also	
observed	 in	 occipital	 cortices	 for	 various	 acoustic	 features,	 an	 area	 rich	 in	 serotonin	 2A	
receptors	and	significantly	functionally	altered	under	LSD	alone	(Roseman	et	al.,	2016).	
	
4.4.4	Implications	for	psychedelic	therapy	
The	present	study	supports	the	usefulness	of	music	in	facilitating	peak	experience,	which	are	
associated	with	positive	therapy	outcomes	(Garcia-Romeu	et	al.,	2014;	Griffiths	et	al.,	2016;	
Ross	et	al.,	2016).	The	findings	also	suggest	that	knowledge	on	how	timbre	conveys	emotion,	
may	be	a	particular	fruitful	avenue	to	inform	music-selection	for	psychedelic	therapy.		
	
4.4.5	Study	limitations	and	future	directions	
The	 study	 focussed	 on	 LSD’s	 effects	 on	 the	 neurophysiological	 processing	 of	 acoustic	
properties	 in	 music,	 but	 did	 not	 included	 perceptual	 measures	 for	 these	 features.	 Future	
studies	may	 address	 questions	 such	 as	 “is	 timbre	 perceived	 differently?”,	 and	 “are	 certain	
acoustic	features	experienced	more	differently	than	other	features?”.	Studies	assessing	these	
questions	will	be	in	particular	important	for	our	understanding	of	how	psychedelics	alter	the	
perception	 of	 music,	 how	 this	 relates	 to	 changes	 in	 music-evoked	 emotion,	 and	 more	
broadly,	in	how	understand	and	use	music	in	psychedelic	herapy.			
Another	study	limitation	was	that	only	a	single	musical	genre	was	used.	The	music	used	was	
rich	in	timbre,	but	low	in	tempo.	The	music	choice	may	therefore	have	resulted	in	a	selective	
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reflection	of	LSD’s	effect	on	timbral	features	in	music,	since	it	can	be	hypothesised	that	other	
brain	networks	will	be	engaged	when,	for	example,	more	rhythmic	music	is	used.	However,	
the	 component	 for	 which	 LSD	 showed	 most	 pronounced	 neurophysiological	 changes	 (i.e.	
“timbral	complexity”),	was	not	the	component	that	explained	most	of	the	variance	within	the	
music	 (i.e.	being	the	third	component),	supporting	the	validity	of	 the	method	 in	 identifying	
brain	 changes	 to	 distinct	 and	 diverse	 musical	 features	 within	 a	 naturalist	 music	 listening	
experience.		
	
4.4.6	Conclusions	
The	 present	 study	 revealed	 altered	 brain	 activity	 and	 connectivity	 to	 acoustic	 features	 in	
music	 under	 LSD.	 Most	 pronounced	 changes	 were	 observed	 for	 the	 component	 timbral	
complexity,	 representing	 the	 complexity	 of	 the	 music’s	 spectral	 distribution,	 and	 these	
occurred	 in	 brain	 networks	 previously	 identified	 for	 music-perception	 and	 music-evoked	
emotion.	 These	 changes	 showed	 a	 correlation	 with	 enhanced	 music-evoked	 feelings	 of	
wonder	 under	 LSD.	 The	 findings	 suggest	 music	 can	 be	 utilised	 in	 psychedelic	 therapy	 to	
facilitate	peak	experiences,	and	provided	insights	 into	the	brain	processes	underlying	music	
perception	and	peak	emotion	under	naturalistic	listening	conditions.		
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“The	reactions	music	evokes	are	not	feelings,	but	they	are	the	images,	
memories	of	feelings.	Dreams,	memories,	musical	reactions	-	all	three	are	made	
of	the	same	stuff”	
Paul	Hindemith	
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5	
	
	
Study	3	|	Effects	of	
LSD	and	music	on	
parahippocampus	
connectivity	and	
mental	imagery
	
	
5.1	Background		
Albert	Hofmann	described	his	first	experience	with	LSD,	in	his	memoir	LSD,	my	problem	child.	
He	wrote:	
“It	was	particularly	remarkable	how	every	acoustic	perception,	such	as	the	sound	of	a	
door	handle	or	a	passing	automobile,	became	transformed	 into	optical	perceptions.	
Every	 sound	 generated	 a	 vividly	 changing	 image,	with	 its	 own	 consistent	 form	 and	
colour.”	(Hofmann,	1980)	
This	 experience	 was	 also	 the	 first	 experience	 with	 LSD	 in	 modern	 history,	 and	 it	 already	
captured	 a	 feature	 of	 psychedelics’	 subjective	 effects	 that	 became	 a	 great	 fascination	 for	
scientists,	 artists	 and	 therapists:	 the	 combined	 effects	 of	music	 and	 psychedelics	 on	 visual	
mental	 imagery.	 Since	 the	 inception	 of	 psychedelic	 therapy,	 it	 is	 thought	 that	 music	 acts	
synergistically	with	the	drug	to	stimulate	the	imagination	in	idiosyncratic	and	powerful	ways:	
to	 evoke	mental	 images,	memories	 and	 thoughts	 that	 are	 highly	 vivid	 and	have	 significant	
personal	meaning	 (Bonny	 and	Pahnke	1972;	Grof,	 1980).	 The	 focus	 of	 study	 2	was	 on	 the	
effects	of	LSD	on	music-evoked	emotion,	yet	it	was	striking	to	us	how	frequently	participants	
elaborated	on	the	ways	music	influenced	their	“extremely	vivid”	eyes-closed	mental	imagery,	
such	as	in	this	remark	on	the	music-experience:	
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“The	 imagery	 was	 quite	 strong.	 And	 I	 felt	 quite	 present	 in	 the	 imagery.	 In	 the	
beginning,	I	felt	like	I	was	in	a	ditch,	a	muddy	ditch,	then,	like	a	sort	of	faded	vision	or	
photograph,	 I	 felt	 like	 I	 was	 on	 a	 rock,	 a	 version	 of	 a	 planet,	 and	 I	 was	 revolving	
around	it	and	I	then	flew	into	space.	And	then	I	had	clear	images	of	my	daughter,	and	
this	was	very	moving.	There	was	a	sense	of	mortality,	and	the	music	kind	of	forced	me	
to	have	a	larger	perspective.	I	saw	specific	images,	and	with	strong	emotions.”	
	
And	another	participant	recalled:	
“There	were	 lots	 of	memories	 of	 home,	 and	 lots	 of	memories	 and	 thoughts	 of	my	
own	family.	[…]	It	was	like	the	soundtrack	of	a	film,	a	little	trailer	of	a	film.”	
	
The	main	aim	of	this	study	was	to	investigate	this	phenomenon	empirically,	by	studying	brain	
mechanisms	 underlying	 the	 effects	 of	 LSD	 and	 music	 on	 mental	 imagery.	 Of	 particular	
interest	to	the	neuro-scientific	study	of	mental	imagery	is	the	parahippocampal	cortex	(PHC).	
The	PHC	is	an	 important	hub	within	the	medial	temporal	 lobe	(MTL)	system	(Burwell	2000;	
Eichenbaum	and	Lipton	2008),	and	plays	a	role	in	constructing	mental	imagery	(Spreng	et	al.,	
2009;	Zeidman	et	al.,	2014)	and	autobiographical	memory	recall	(Fink	et	al.,	1996).	Damage	
to	the	PHC	can	result	in	visual	deficits	(Harding,	Broe,	and	Halliday	2002;	Hensley-Judge	et	al.,	
2013),	 whereas	 direct	 stimulation	 of	 the	 PHC	 can	 produce	 visual	 hallucinations	 of	 scenes	
(Mégevand	et	al.,	2014),	vivid	autobiographical	memories	(Vignal	et	al.,	2007)	and	dream-like	
states	 (Bancaud	 et	 al.,	 1994;	 Bartolomei	 et	 al.,	 2004),	 accompanied	 by	 enhanced	 coupling	
between	the	PHC	and	the	visual	cortex	(VC)	(Barbeau	et	al.,	2005).	
Importantly,	 PHC	 activity	 is	 modulated	 by	 music	 and	 psychedelics	 separately.	 The	 PHC	
receives	 direct	 projections	 from	 the	 auditory	 cortex	 (Amaral	 et	 al.,	 1983),	 and	 shows	
increased	 activity	 during	 music-evoked	 emotion	 (Gosselin	 et	 al.,	 2006;	 Koelsch	 2014)	 and	
music-evoked	personal	memories	 (Janata	2009).	The	PHC	expresses	serotonin	2A	receptors	
(Pazos,	Probst,	and	Palacios	1987),	and	altered	PHC	functioning	under	psychedelics	has	been	
observed	 using	 fMR	 (Tagliazucchi	 et	 al.,	 2014),	 depth	 EEG	 (Monroe	 et	 al.,	 1957;	 Schwarz,	
Sem-Jacobsen,	 	 CW,	 and	 Petersen,	 MC	 1956)	 and	 PET	 (Vollenweider	 et	 al.,	 1997).	
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Furthermore,	 attenuation	 of	 the	 subjective	 and	 behavioural	 effects	 of	 LSD	were	 observed	
after	 resection	 of	 the	MTLs	 in	 humans	 (Serafetinides	 1965)	 and	 chimpanzees	 (Ramey	 and	
O'Doherty,	 1960),	 suggesting	 a	 role	 for	 the	 MTL	 in	 facilitating	 subjective	 effects	 of	
psychedelics.	
These	insights	motivated	the	hypothesis	that	LSD	in	combination	with	music	modulates	PHC	
functional	 connectivity	 to	 enhance	 mental	 imagery.	 This	 hypothesis	 was	 tested	 using	
functional	 magnetic	 resonance	 imaging	 (fMRI)	 and	 a	 balanced-order,	 placebo-controlled	
design,	 with	 healthy	 participants.	 Measures	 for	 changes	 in	 PHC	 functional	 connectivity	
informed	 a	 subsequent	 Dynamic	 Causal	 modelling	 (DCM)	 analysis	 that	 assessed	 how	 an	
interaction	 effect	 between	 music	 and	 LSD	 modulates	 the	 direction	 of	 information	 flow	
between	 the	PHC	and	 the	VC	 (i.e.	effective	connectivity).	Participants	 completed	 ratings	of	
eye-closed	 visual	 imagery	 and	 spontaneous	 recall	 autobiographical	 memories	 to	 assess	
subjective	effects,	which	were	correlated	with	changes	in	effective	connectivity.		
	
5.2	Methods	
5.2.1	Approvals		
This	study	was	approved	by	the	National	Research	Ethics	Service	(NRES)	committee	London	–	
West	 London	 and	 was	 conducted	 in	 accordance	 with	 the	 revised	 declaration	 of	 Helsinki	
(2000),	the	International	Committee	on	Harmonisation	Good	Clinical	Practice	guidelines	and	
National	 Health	 Service	 (NHS)	 Research	 Governance	 Framework.	 Imperial	 College	 London	
sponsored	the	research	which	was	conducted	under	a	Home	Office	license	for	research	with	
schedule	I	drugs.		
	
5.2.2	Participants		
Twenty	participants	(16	males	and	4	females)	were	recruited,	carefully	screened	for	physical	
and	 mental	 health	 and	 provided	 written	 informed	 consent	 before	 participation.	 The	
screening	 for	 physical	 health	 included	 electrocardiogram	 (ECG),	 routine	 blood	 tests,	 and	
urine	test	 for	recent	drug	use	and	pregnancy.	A	psychiatric	assessment	was	conducted	and	
participants	provided	full	disclosure	of	their	drug	use	history.	Key	exclusion	criteria	included:	
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being	younger	than	21	years	of	age,	having	a	personal	history	of	diagnosed	psychiatric	illness,	
an	immediate	family	history	of	a	psychotic	disorder,	an	absence	of	previous	experience	with	
a	classic	psychedelic	drug	(E.g.	LSD,	mescaline,	psilocybin	or	dimethyltryptamine	(DMT),	drug	
use	within	6	weeks	of	the	first	scanning	day,	a	persistent	adverse	reaction	to	a	psychedelic	
drug,	 pregnancy,	 problematic	 alcohol-use	 (i.e.	 >	 40	 units	 consumed	 per	 week),	 and/or	 a	
medically	significant	condition	rendering	them	unsuitable	for	the	study.		
	
5.2.3	Experiment	overview	and	procedures	
Screening	 took	 place	 at	 Imperial’s	 clinical	 research	 facility	 at	 the	 Hammersmith	 hospital	
campus.	All	study	days	were	performed	at	Cardiff	University	Brain	Research	Imaging	Centre	
(CUBRIC).	 Eligible	participants	 attended	 two	 study	days	 that	were	 separated	by	at	 least	14	
days.	 LSD	was	 received	on	one	of	 the	 study	days,	 and	placebo	on	 the	other.	 The	order	 of	
receipt	of	LSD	was	balanced	across	participants,	and	they	were	kept	blind	to	this	order	but	
the	researchers	were	not.		
On	scanning	days,	volunteers	arrived	at	the	study	centre	at	8:00	am,	were	given	a	detailed	
brief	about	the	study	day	schedule,	gave	a	urine	test	for	recent	drug-use	and	pregnancy,	and	
carried	out	a	breathalyser	test	for	recent	alcohol-use.	A	cannula	was	 inserted	into	a	vein	 in	
the	antecubital	fossa	by	a	medical	doctor	and	secured.	Participants	were	encouraged	to	close	
their	eyes	and	relax	 in	a	reclined	position	while	the	drug	was	administered.	All	participants	
received	75	µg	of	 LSD,	 administered	 intravenously	 via	 a	10	ml	 solution	 infused	over	 a	 two	
minute	period,	followed	by	an	 infusion	of	saline.	Dosing	was	followed	by	an	acclimatization	
period	 of	 approximately	 60	minutes,	 in	 which	 (for	 at	 least	 some	 of	 the	 time)	 participants	
were	 encouraged	 to	 relax	 and	 lie	 with	 their	 eyes	 closed	 inside	 a	mock	MRI	 scanner.	 This	
functioned	to	prepare	the	participants	for	the	subsequent	(potentially	anxiogenic	(Studerus	
et	al.,	2012))	MRI	scanning	experience.	
Participants	reported	noticing	subjective	drug	effects	between	5	to	15	minutes	post-dosing,	
and	these	approached	peak	intensity	between	60	to	90	minutes	post-dosing.	The	duration	of	
a	subsequent	plateau	of	drug	effects	varied	among	individuals	but	was	generally	maintained	
for	 approximately	 four	 hours	 post-dosing.	 BOLD	 MRI	 scanning	 started	 approximately	 120	
minutes	 post-dosing,	 and	 lasted	 for	 approximately	 60	 minutes.	 This	 included	 a	 structural	
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scan,	 arterial	 spin	 labelling	 (ASL)	 fMRI,	 and	 BOLD	 fMRI.	 After	 the	 MRI	 scanning,	
magnetoencephalography	(MEG)	scanning	was	performed	but	these	findings	will	be	reported	
elsewhere.	Once	the	subjective	effects	of	LSD	had	sufficiently	subsided,	the	study	psychiatrist	
assessed	the	participant’s	suitability	for	discharge.		
	
5.2.4	fMRI	study	design	
Each	fMRI	scanning	session	involved	three	eyes-closed	resting	state	scans,	each	lasting	seven	
minutes.	 After	 each	 scan	 (7	minutes	 and	 20	 seconds),	 visual	 analogue	 scale	 (VAS)	 ratings	
were	 performed	 in	 the	 scanner	 via	 a	 response-box	 after	 each	 scanning	 block	 (no	 music,	
music,	 no	music).	 The	music-listening	 scan	always	occurred	after	 the	 first	 resting	 state	 (no	
music)	scan	and	before	a	final	resting-state	scan	(no	music).	The	music	itself	was	triggered	by	
the	first	TR,	and	listened	to	via	MRI	compatible	headphones	(MR	Confon).	Two	long	excerpts	
(A	 and	 B,	 each	 7	 minutes	 and	 20	 seconds	 in	 duration)	 were	 selected	 from	 the	 album	
Yearning,	by	musicians	Robert	Rich	and	Lisa	Moskow.	Pre-study	assessments	confirmed	the	
two	excerpts	 to	be	balanced	 for	 their	emotional	potency.	Each	participant	 listened	to	both	
stimuli,	 in	 a	 balanced	 order	 across	 conditions.	 Volume-maximization	 and	 broadband	
compression	was	carried	out	using	Ableton	live	9	software.	
Prior	to	each	scan,	participants	were	 instructed	via	a	display	screen	to	close	their	eyes	and	
relax.	Prior	to	the	music	scan,	the	music	volume	was	adjusted	to	a	level	that	was	“as	loud	as	
possible,	 without	 being	 unpleasant”	 and	 then	 maintained	 for	 each	 condition.	 When	 the	
music	ended,	participants	were	instructed	to	open	their	eyes	and	rate	the	degree	of	simple	
mental	visual	 imagery	 (i.e.	 “with	my	eyes	closed	 I	 saw	colours	or	geometric	patterns”)	and	
complex	mental	visual	imagery	(i.e.	“with	my	eyes	closed	I	saw	complex	hallucinations”)	they	
experienced.	 Complex	 imagery	 was	 defined	 for	 the	 participants	 prior	 the	 scanning	 as	 the	
seeing	of	concrete	objects,	 landscapes	or	entities	(E.g.	plants,	buildings,	people	or	animals).	
Items	 were	 completed	 on	 a	 continuous	 visual	 analogue	 scale	 from	 0	 (“not	 at	 all”)	 to	 20	
(“extremely	intense”).	Soon	after	the	MRI	scanning	session	was	complete,	participants	rated	
some	further	VAS	 items	that	assessed	their	subjective	experience	during	scanning.	The	VAS	
item	“I	saw	scenes	from	my	past”	was	selected	for	special	consideration	because	of	personal	
memory	 recollection	 being	 consistently	 associated	with	 PHC	 functioning	 (Fink	 et	 al.,	 1996;	
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Spreng	et	al.,	2009),	as	well	as	a	prior	hypothesis	inspired	by	previous	findings	(Carhart-Harris	
et	al.,	2012b)	that	this	would	be	modulated	by	the	experimental	conditions.	
	
5.2.5	fMRI	scanning	and	data	pre-processing	
All	 imaging	 was	 performed	 on	 a	 3T	 GE	 HDx	 system.	 For	 registration	 and	 segmentation	 of	
functional	images,	an	initial	3D	FSPGR	anatomical	scan	was	obtained	in	an	axial	orientation,	
with	field	of	view	=	256×	256×	192	and	matrix	=	256	×	256×	192	to	yield	1-mm	isotropic	voxel	
resolution	(TR/TE	=	7.9/3.0	ms;	inversion	time	=	450	ms;	flip	angle	=	20°).	Functional	images	
were	acquired	using	a	gradient	echo	planer	imaging	sequence,	TR/TE	=	2000/35ms,	field-of-
view	 =	 220mm,	 64	 ×	 64	 acquisition	matrix,	 parallel	 acceleration	 factor	 =	 2,	 90°	 flip	 angle.	
Thirty	five	oblique	axial	slices	were	acquired	in	an	interleaved	fashion,	each	3.4mm	thick	with	
zero	 slice	gap	 (3.4mm	 isotropic	 voxels).	 The	precise	 length	of	 each	of	 the	BOLD	 scans	was	
7:20	minutes.	
Pre-processing	 utilised	 a	 combination	 of	 AFNI	 (Cox,	 1996),	 FSL	 (Smith	 et	 al.,	 2004b),	
Freesurfer	 (Dale	 et	 al.,	 1999)	 and	 ANTS	 (Avants	 et	 al.,	 2011).	 After	 brain	 extraction	
(Freesurfer),	 anatomical	 images	 were	 segmented	 into	 their	 three	 underlying	 tissue	 types:	
cerebrospinal	fluid	(CSF),	grey	matter	(GM)	and	white	matter	(WM)	(fast,	FSL)	and	registered	
to	a	2mm	MNI152	template	using	affine	(ANTS),	followed	by	non-linear	transformation	(SyN,	
ANTS).	 Anatomical	 images	 also	 underwent	 segmentation	 to	 define	 subcortical	 structures	
(Freesurfer).	
Participants	in	this	study	were	from	the	same	experiment	as	study	2,	but	due	differences	in	
the	measures	 used	 in	 the	 separate	 studies,	 different	 inclusion	 criteria	were	used	 for	 data-
analyses	(connectivity	measures	here	versus	BOLD	activition	in	study	2).	One	participant	was	
excluded	 from	analyses	because	of	early	 termination	of	 the	 scanning	due	 to	him	 reporting	
significant	 anxiety	 during	 the	 LSD	 session.	 Three	 participants	were	 excluded	 from	 analyses	
due	 to	 technical	problems	with	 the	 sound	delivery	and	 four	more	 subjects	were	discarded	
from	 the	 group	 analyses	 due	 to	 excessive	 head	 movement.	 This	 leaves	 a	 total	 of	 twelve	
participants	that	entered	the	group	analyses.	Principally,	motion	was	measured	using	frame-
wise	displacement	 (FD)	 (Power	et	al.,	2014).	 	The	criterion	 for	exclusion	 for	excessive	head	
movement	was	subjects	displaying	higher	 than	15%	scrubbed	volumes	when	 the	scrubbing	
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threshold	is	FD	=	0.5.		After	discarding	these	subjects,	we	reduced	the	threshold	to	FD	=	0.4.	
The	 between-condition	 difference	 in	mean	 FD	 for	 the	 4	 subjects	 that	were	 discarded	was	
0.286±0.185	and	for	the	12	subjects	that	were	used	in	the	analysis	the	difference	in	mean	FD	
was	0.049	±0.029	(mean	FD	for	placebo	was	0.085	±0.028	and	mean	FD	for	LSD	was	0.134	
±0.037,	p	=	0.0001).		
Functional	 images	were	pre-processed	according	 to	 the	 following	 sequence:	1)	Removal	of	
first	three	volumes	2)	de-spiking	(3dDespike,	AFNI),3)	slice	time	correction	(3dTshift,	AFNI),	4)	
motion	correction	(3dvolreg,	AFNI),	5)	brain	extraction	(bet,	FSL),	6)	rigid	body	registration	to	
anatomical	scans	(nine	subjects	with	FSL’s	BBR,	one	subject	with	Freesurfer’s	bbregister	and	
two	subjects	manually)	,	7)	transformation	of	functional	to	MNI	2mm	space,	using	previously	
calculated	transformation	matrix	from	the	anatomical	scans,	8)	motion	scrubbing	using	an	FD	
threshold	of	0.4,	and	replacement	with	the	mean	of	neighbouring	volumes	(mean	percentage	
of	 volumes	 scrubbed	 for	 placebo	 and	 for	 LSD	 was	 0.5%	 ±1	 and	 1.9%	 ±2.2,	 respectively.	
Maximum	volumes	scrubbed	for	scan	was	7.8%),	9)	spatial	smoothing	with	a	Gaussian	kernel	
of	 6mm	 (FWHM)	 (3dBlurInMask,	 AFNI),	 10)	 band-pass	 filtering	 between	 0.01	 to	 0.08	 Hz	
(3dFourier,	 AFNI)	 11)	 linear	 and	 quadratic	 de-trending	 and	 regression	 of	 9	 nuisance	
parameters:	6	motion-related	(3	translations,	3	rotations)	and	3	anatomically-defined.	
The	anatomically	defined	regressors	consisted	of	Ventricles	(Freesurfer),	Cerebrospinal	fluid	
(CSF)	(FSL's	FAST	with	Freesurfer’s	Ventricles	subtracted)	and	White	matter	(WM)	(FSL’s	FAST	
with	Freesurfer’s	subcortical	grey-matter	subtracted).	All	three	masks	were	eroded	to	reduce	
partial	 volume	 effects	 and	were	 used	 to	 extract	 nuisance	 timeseries	 from	 an	 unsmoothed	
version	of	 the	pre-processed	functional	data.	The	CSF	and	Venticles	were	used	to	extract	a	
single	mean	 time-course	 for	each	mask,	while	WM	mask	was	used	 to	produce	a	voxelwise	
regressor	 (3dLocalStat,	 AFNI).	 Voxelwise	 WM	 regression	 has	 been	 found	 to	 outperform	
approaches	using	whole-brain	averaged	WM	signal	(Jo	et	al.,	2010,	2013).			
	
5.2.6	Subjective	effects	
A	two-way	repeated	measures	ANOVA	with	two	factors	(drug	condition	and	music	condition)	
was	 performed	 to	 test	 for	 an	 interaction	 between	 LSD	 and	music	 on	 in-scanner	 ratings	 of	
simple	 and	 complex	 visual	 imagery.	 A	 paired	 one-tailed	 t-test	 was	 performed	 to	 examine	
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between-condition	differences	in	the	post-scanner	questionnaire	item	“I	saw	scenes	from	my	
past”.		
5.2.7	Seed-based	functional	connectivity	analysis	
A	bilateral	PHC	region	of	interest	(ROI)	was	acquired	from	the	Harvard	anatomical	atlas	tool	
and	used	to	extract	PHC	time	series	for	each	subject.	To	begin	with,	a	general	 linear	model	
(GLM)	was	used	(FEAT,	FSL)	to	model	whole	brain	resting	state	functional	connectivity	with	
the	PHC	seed,	with	correction	for	autocorrelations	(FILM,	FSL)	for	each	run	separately.	Next,	
a	fixed-effects	model	was	used	to	compare	music	versus	non-music	runs	for	each	subject,	for	
LSD	and	placebo	separately.	Finally,	these	drug	effects	(LSD	versus	placebo)	were	fed	into	a	
higher-level	mixed	effects	model	(FLAME1,	FSL)	to	calculate	the	modulation	of	the	effects	of	
music	by	LSD	on	PHC	functional	connectivity	across	the	brain	(cluster	correction	threshold	z	>	
2.3,	p	<	0.05).	
	
5.2.8	Dynamic	Causal	Modelling:	Background	and	implementation	
Dynamic	Causal	Modelling	(DCM,	as	implemented	in	SPM12b)	was	used	to	estimate	changes	
in	effective	connectivity.	DCM	is	a	biologically-informed	modelling	procedure	that	estimates	
the	causal	interactions	(i.e.	effective	connectivity)	between	different	pre-selected	nodes	of	a	
network,	 and	 the	 changes	 in	 coupling	 strength	 between	 and	within	 those	 nodes	 (extrinsic	
and	 intrinsic	 connections	 respectively)	 due	 to	 experimental	 manipulations	 (Friston	 et	 al.,	
2003).	The	basic	architecture	of	a	model	is	defined	by	structurally	plausible	and	functionally-
informed	 brain	 regions,	 whose	 connections	 are	 defined	 as	 either	 bilinear	 (i.e.	 information	
flow	between	regions)	or	non-linear	(i.e.	activity	 in	one	region	modulating	 information	flow	
between	 regions).	 Typically,	 experimental	manipulations	 can	 directly	 affect	 activity	 in	 each	
node	 (as	 ‘driving	 inputs’)	 or	 alter	 the	 strength	 of	 coupling	 within	 or	 between	 nodes	 (as	
‘modulatory	inputs’).	
In	 the	 present	 study,	 all	 six	 scans	 were	 concatenated	 in	 the	 following	 order:	 placebo	 no-
music	(NM),	placebo	music	(M),	placebo	NM,	LSD	NM,	LSD	M,	LSD	NM.	The	measured	BOLD	
time-series	for	the	DCM	were	extracted	as	the	first	principal	eigenvalue	from	a	bilateral	PHC	
and	 VC	mask	 (The	 PHC	mask	 was	 defined	 by	 Harvard-Oxford	 atlas,	 and	 the	 VC	mask	 was	
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defined	by	results	of	the	PHC	functional	connectivity	analysis,	 i.e.	the	occipital	cluster),	and	
adjusted	 for	 the	 effects	 of	 interest	 (i.e.	main	 effect	 of	music,	main	 effect	 of	 drug,	 and	 an	
interaction	 effect	 -	 described	 below).	 Between-node	 connections	 were	 defined	 as	 bilinear	
meaning	 that	 information	 flow	could	be	modulated	 in	either	direction.	Three	experimental	
inputs	entered	the	model	as	modulatory	inputs:	a	main	drug	effect,	a	main	music	effect,	and	
an	 interaction	 effect	 of	 music	 and	 drug	 (0.5	 -1	 0.5	 -0.5	 1	 -0.5).	 Due	 to	 the	 resting-state	
conditions	of	the	scanning,	activity	 in	the	nodes	was	driven	by	stochastic	(i.e.	spontaneous)	
fluctuations	(Li	et	al.,	2011).		
	
5.2.9	Dynamic	Causal	Modelling:	Bayesian	Model	Selection	
In	DCM,	a	series	of	plausible	models,	representing	competing	hypotheses,	are	specified.	Each	
model	corresponds	to	a	hypothesis	about	how	observed	changes	in	BOLD	signal	were	caused	
by	changes	in	neural	activity	in	each	network	node.	The	different	models	can	vary	in	terms	of	
the	 position	 of	 driving	 and	 modulatory	 inputs.	 DCM	 uses	 a	 biophysical	 model	 of	 the	
hemodynamic	 response	 to	 predict	 the	 underling	 neuronal	 activity	 –	 and	 the	 underlying	
(changes	 in)	connectivity	–	 from	the	observed	BOLD	signal.	Model	estimation,	or	 inversion,	
returns	conditional	estimates	for	the	changes	in	connectivity	and	scores	the	model	in	terms	
of	its	accuracy	and	complexity	(using	a	Free	Energy	bound	on	log	model	evidence).	Bayesian	
Model	Selection	 (BMS)	 is	used	to	compare	different	models	 to	 identify	 the	model	with	 the	
greatest	evidence	–	i.e.	the	model	that	offers	the	best	explanation	of	the	data.	In	the	present	
study,	 one	 “full	 model”	 was	 specified,	 with	 all	 three	 experimental	 inputs	 modulating	 all	
extrinsic	and	intrinsic	connections.	Following	inversion	of	this	full	model,	a	post	hoc	Bayesian	
model	optimisation	scheme	was	used	to	identify	the	model	structure	with	the	greatest	model	
evidence	 (i.e.	 lowest	 free	 energy).	 This	 approach	 provides	 an	 efficient	 scheme	 for	 scoring	
large	numbers	of	 competing	models	 (Friston	and	Penny,	2011).	Optimal	model	 structure	 is	
usually	determined	by	computing	Bayes	factors,	as	an	approximation	of	the	model	evidence.	
A	 Bayes	 factor	 of	 20	 corresponds	 to	 a	 belief	 of	 95%	 in	 the	 statement	 that	 a	 particular	
hypothesis	(i.e.	the	proposed	model)	is	true,	and	therefore	a	p	value	of	0.05.	A	Bayes	factor	
higher	 than	 150	 corresponds	 to	 a	 belief	 of	 99%	 in	 the	 hypothesis,	 and	 equates	 a	 p-value	
smaller	than	0.01.	A	Bayes	factor	higher	than	95	is	therefore	considered	as	strong	evidence	
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for	the	proposed	model.	After	model	selection,	coupling	parameters	are	analysed	post-hoc	to	
characterize	 the	 size	 and	 direction	 of	 the	 changes	 in	 connection	 strength	 caused	 by	 the	
experimental	manipulations.	 Coupling	 parameters	 quantify	 the	 strength	 of	 the	 coupling	 in	
terms	of	the	rate	(in	Hz)	at	which	a	response	is	caused	in	a	given	region,	and	modulation	is	
expressed	as	either	an	increase	or	decrease	in	this	coupling	measure.		
	
5.2.10	Correlation	analyses	between	changes	in	effective	connectivity	and	subjective	effects	
Following	model	selection,	the	hypothesis	was	tested	that	the	magnitude	of	the	modulation	
in	effective	connectivity	by	the	music	x	drug	interaction	would	explain	the	observed	variance	
in	 participants’	 subjective	 responses	 to	 the	 music	 under	 LSD.	 More	 specifically,	 we	 asked	
whether	 the	 size	 of	 the	 interaction	 effect	 as	 estimated	 by	 the	 DCM,	 correlated	 with	 the	
magnitude	of	the	enhancement	of:	1)	eyes-closed	imagery	and	2)	visions	of	one’s	past	(“I	saw	
scenes	from	my	past”).	A	spearman’s	correlation	was	used	due	the	non-parametric	nature	of	
the	data.	
	
5.3	Results	
5.3.1	Participants	
The	data	from	twelve	participants	were	found	suitable	for	data-analysis	(2	female,	mean	age	
=	 33±9	 years,	 range	 22-47	 years).	 All	 had	 at	 least	 one	 previous	 experience	 with	 a	 classic	
psychedelic	 drug.	 Mean	 estimated	 lifetime	 LSD-use	 was	 12	 ±	 15	 (range	 =	 0	 -	 40).	 Self-
estimates	of	other	drug-use	were	as	follows	(mean	±	SD,	range):	weekly	alcohol	units	=	8	±	8,	
0-28;	daily	cigarettes	=	0;	lifetime	cannabis	uses	=	686	±	625,	30-2000;	lifetime	MDMA	uses	=	
20±	 18,	 2-50;	 lifetime	 psilocybin/magic	 mushroom	 uses	 =	 10	 ±	 9,	 1-35;	 lifetime	
ayahuasca/DMT	uses	=	14	±	21,	0-50;		lifetime	ketamine	uses	=	3	±	6,	0-20;		lifetime	cocaine	
uses	=	6	±	8,	0-20;		lifetime	amphetamine	uses	=	6	±	11,	0-35;		lifetime	heroin	uses	=	1	±	3,	0-
10.	
	
5.3.2	Subjective	effects	as	measured	by	in-scanner	ratings	
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A	paired	t-test	revealed	a	significant	increase	in	personal	memory	recollection	under	LSD	(t	=	
1.9,	 df	 =	19,	p	=	0.04).	 For	 simple	 visual	 imagery,	 a	 two-way	ANOVA	 revealed	a	 significant	
drug	effect	(F	=	42.2,	df	=	18,	p	<	0.001)	but	no	significant	effects	were	found	for	music	(F	=	
1.7,	df	=	18,	p	=	0.2)	or	the	interaction	between	music	and	LSD	(F	=	1.1,	df	=	18,	p	=	0.3).	For	
complex	visual	 imagery,	a	two-way	ANOVA	revealed	a	significant	drug	effect	 (F	=	24.7,	df	=	
18,	 p	 <	 0.001),	 a	 trend	 level	 effect	 of	 music	 (F	 =	 10.0,	 df	 =	 18,	 p	 =	 0.09),	 but	 again,	 no	
significant	 interaction	effect	 for	music	x	LSD	(F	=	1.8,	df	=	18,	p	=	0.5).	Positive	 (enhanced)	
drug	 effects	 on	 simple	 and	 complex	 visual	 imagery	 survived	 multiple	 comparisons,	 using	
Bonferroni	adjusted	alpha	levels	of	.025	per	test	(0.05/2)	(see	Figure	5.1).	
	
5.3.4	Functional	connectivity	
Seed-based	functional	connectivity	analysis	of	the	bilateral	PHC	showed	a	positive	interaction	
between	music	and	LSD	for	the	contrast	LSD	(music	versus	no	music)	versus	placebo	(music	
versus	 no	 music),	 with	 increased	 coupling	 between	 the	 PHC	 and	 two	 main	 clusters:	 One	
being	the	bilateral	visual	cortex	and	the	other	being	the	left	inferior	frontal	gyrus	and	insula.	
No	 decreases	 in	 PHC	 functional	 connectivity	 were	 observed	 for	 this	 contrast.	 All	 effect	
reported	are	cluster-corrected,	Z>2.3.	(see	Figure	5.2,	for	the	reader’s	insight,	other	contrasts	
are	displayed	too).	
		
5.3.5	Effective	connectivity		
Post-hoc	model	 optimisation	 determined	 the	 optimal	model	 structure.	 The	 optimal	model	
had	 a	 Bayes	 factor	 344	 higher	 than	 the	 2nd	 best	 model.	 	 This	 equates,	 in	 a	 frequentist	
statistical	approach,	to	a	p-value	much	smaller	than	0.01,	and	is	therefore	considered	as	very	
strong	evidence	for	the	model.	The	optimal	model	features	a	main	effect	of	drug	and	music	
modulating	the	intrinsic	connections	of	both	nodes,	and	an	interaction	effect	modulating	the	
connection	 from	 the	 PHC	 to	 the	 VC.	 Group	 averages	 for	 the	 posterior	 estimates	 are	 -
0.41±0.05	Hz	for	drug	effect	on	PHC,	-0.42±0.06	Hz	for	music	effect	on	PHC,	-0.38±0.06	Hz	
for	drug	effect	on	VC,	and	-0.40±0.06	Hz	 for	music	effect	on	VC.	The	group	average	of	 the	
posterior	estimate	for	the	interaction	effect	is	0.02±0.04	Hz	(see	Figure	5.3)	
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5.3.6	Correlations	between	changes	in	effective	connectivity	and	subjective	effects	
A	significant	positive	correlation	was	found	between	the	interaction	effect	of	LSD	and	music	
on	PHC	to	VC	effective	connectivity,	and	increases	in	the	in-scanner	ratings	for	complex	visual	
imagery	(Spearman’s	ρ	=0.71,	with	p=0.01,	and	Pearson	r	=	0.65,	with	p	=	0.03).	A	trend-level	
positive	correlation	was	found	between	the	interaction	effect	of	LSD	and	music	on	PHC	to	VC,	
and	 the	post-scanner	questionnaire	 item	“I	 saw	 scenes	 from	my	past”	 (Spearman	ρ	=0.67,	
with	 p=0.02,	 and	 Pearson	 r	 =	 0.69,	 with	 p	 =0.01).	 These	 tests	 were	 conducted	 using	
Bonferroni	adjusted	alpha	levels	of	.0167	per	test	(0.05/3)	(see	Figure	5.4).		
	
	
	
	
	
	
	
	
	
	
	
Figure	 5.1	 |	 Scanner-ratings	 for	 mental	 imagery.	 For	 simple	 visual	 imagery,	 a	 two-way	 ANOVA	 revealed	 a	
significant	drug	effect	(F	=	42.2,	df	=	18,	p	<	0.001)	but	no	significant	effects	were	found	for	music	(F	=	1.7,	df	=	
18,	p	=	0.2)	or	the	interaction	between	music	and	LSD	(F	=	1.1,	df	=	18,	p	=	0.3).	For	complex	visual	imagery,	a	
two-way	ANOVA	revealed	a	significant	drug	effect	(F	=	24.7,	df	=	18,	p	<	0.001),	a	trend	level	effect	of	music	(F	=	
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10.0,	df	=	18,	p	=	0.09),	but	no	significant	interaction	effect	between	music	and	LSD	(F	=	1.8,	df	=	18,	p	=	0.5).	
Drug	effects	 on	 simple	 and	 complex	 imagery	 survived	multiple	 comparisons,	 using	Bonferroni	 adjusted	 alpha	
levels	of	.025	per	test	(0.05/2).	
	
	
Figure	 5.2	 |	 Seed-based	 functional	 connectivity	 analysis	 of	 the	 bilateral	 parahippocampus.	 Brain	 regions	
showing	increased	coupling	with	the	bilateral	parahippocampus	(PHC,	displayed	in	red)	are	displayed	in	yellow,	
and		brain	regions	showing	decreased	coupling	with	the	bilateral	PHC	are	displayed	in	blue	(Cluster-corrected,	
Z>2.3).	A)	The	contrast	LSD	(music	>	no	music)	>	placebo	(music	>	no	music).	No	decreases	were	found.	B)	The	
effect	of	music	under	LSD	(music	>	no	music).	No	decreases	were	found.	C)	The	effect	of	music	under	placebo	
PCB	 (no	music	 >	music).	No	 increases	were	 found.	D)	 The	effect	 LSD	under	 resting	 state	 conditions	 (LSD	 (no	
music)	>	placebo	(no	music))	and	(placebo	(no	music)	>	LSD	(no	music))	
	131	
	
Figure	5.3	|	Dynamic	Causal	Modelling.	A)	All	scans	are	concatenated,	and	three	effects	of	interest	are	modelled	
accordingly.	D	 (red)	=	drug	effect,	M	 (blue)	=	music	effect,	 I	 (purple)	=	 interaction	effect.	B)	 Time	 series	 that	
enter	the	DCM	are	extracted	as	first	principal	eigenvalues	from	the	PHC	mask	and	the	VC	mask.	C)	The	full	DCM	
model	has	two	nodes	(PHC	and	VC)	that	are	connected	via	extrinsic	bilinear	connections,	and	each	node	has	one	
intrinsic	connection.	Every	connection	has	all	modulatory	effects.	D)	Post-hoc	model	optimisation	determined	
the	optimal	model	structure.	Dashed	lines	indicate	a	negative	connection	or	modulation,	whereas	normal	lines	
indicate	 a	positive	 connection	or	modulation.	 This	model	has	 the	main	effect	of	drug	and	 the	main	effect	of	
music	modulating	the	intrinsic-connections	of	both	nodes.	The	interaction	effect	only	has	a	modulatory	effect	
on	the	connection	from	PHC	to	VC.	
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Figure	 5.4	 |	 Correlations	 between	 changes	 in	 effective	 connectivity	 and	 subjective	 effects.	 The	 correlation	
analyses	 revealed	 that	 the	 estimated	 modulation	 of	 PHC-to-VC	 effective	 connectivity	 (by	 Dynamic	 Causal	
Modelling),	by	the	interaction	between	LSD	and	music,	correlates	positively	with	A)	increased	complex	imagery	
(Spearman’s	 ρ	 =0.71,	with	p=0.01,	 and	Pearson	 r	 =	 0.65,	with	p	=	0.03).,	 and	B)	 increases	 in	 visions	of	 one’s	
personal	 past	 (Spearman	 ρ	 =0.67,	 with	 p=0.02,	 and	 Pearson	 r	 =	 0.69,	 with	 p	 =0.01).	 Changes	 in	 coupling	
parameters	are	displayed	on	the	x-axis,	and	changes	in	subjective	ratings	are	displayed	on	the	y-axis.	
	
5.4	Discussion		
This	 study	 assessed	 neurophysiological	 changes	 associated	 with	 music-induced	 mental	
imagery	 under	 LSD.	 The	 results	 demonstrated	 increased	 functional	 connectivity	 of	 the	
parahippocampus	(PHC)	with	the	left	inferior	frontal	gyrus	(IFG),	the	left	insula	and	the	visual	
cortex	 (VC)	 during	music	 listening	 under	 LSD.	 By	 using	 dynamic	 causal	modelling	 (DCM),	 a	
positive	 modulation	 of	 effective	 connectivity	 (i.e.	 the	 direction	 of	 information	 flow)	 was	
found	from	the	PHC	to	VC,	by	an	interaction	between	the	LSD	and	music.	Furthermore,	we	
found	 that	 the	 magnitude	 of	 this	 modulation	 correlated	 with	 increased	 ratings	 for	 eyes-
closed	complex	visual	imagery	and	personal	memory	recall.	
These	results	are	consistent	with	the	converging	view	that	the	PHC-VC	pathway	serves	as	an	
important	 network	 for	 the	 (re)construction	 of	 mental	 images.	 The	 PHC	 is	 implicated	 in	
imagining	 scenes	 (Brewer	 et	 al.,	 1998;	 Spreng	 et	 al.,	 2009),	 episodic	 personal	 memory	
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recollection	 (Fink	 et	 al.,	 1996;	 Spreng	 et	 al.,	 2009)	 and	 music-evoked	 personal	 memories	
(Janata	2009).	The	PHC	and	VC	are	structurally	(Catani	et	al.,	2002)	and	functionally	(Libby	et	
al.,	2012;	Powell	et	al.,	2004)	connected,	and	increased	effective	connectivity	from	the	PHC	
to	 the	 VC	 has	 previously	 been	 associated	with	 the	 construction	 of	 imagined	 visual	 scenes	
(Chadwick	et	al.,	2013).		
Of	particular	significance	for	the	present	findings,	are	studies	in	which	the	PHC	was	directly	
stimulated	 or	 damaged.	 Direct	 stimulation	 of	 the	 PHC	 has	 been	 found	 to	 produce	
hallucinations	 of	 complex	 visual	 scenes	 (Mégevand	 et	 al.,	 2014)	 and	 recall	 of	
autobiographical	 memories	 (Bancaud	 et	 al.,	 1994;	 Bartolomei	 et	 al.,	 2004).	 Furthermore,	
Barbeau	et	al	(2005)	demonstrated	that	upon	direct	stimulation	of	the	PHC,	a	strengthening	
of	PHC-VC	coupling	occurred	only	when	such	visual	experiences	were	reported	(Barbeau	et	
al.,	2005).	Damage	to	the	PHC	can	result	in	visual	impairments	(Hensley-Judge	et	al.,	2013),	
visual	hallucinations	(Harding	et	al.,	2002),	and	hippocampal	damage	has	been	associated	to	
an	impaired	ability	to	imagine	autobiographical	past	and	future	(Cooper	et	al.,	2011)		
Altogether,	these	studies	provide	a	body	of	evidence	that	 implicate	the	PHC-VC	network	as	
an	important	mechanistic	pathway	for	the	construction	of	mental	visual	images,	whether	this	
imagery	is	real	(i.e.	personal	memories)	or	 imaginary	(Chadwick	et	al.,	2013;	Zeidman	et	al.,	
2014).	 And	 consistent	 with	 this	 view,	 the	 present	 findings	 suggest	 that	 psychedelics	 and	
music	influence	mental	imagery	by	modulation	of	PHC-to-VC	effective	connectivity.	Possible	
underlying	 mechanisms	 via	 which	 psychedelics	 and	 music	 may	 cause	 this	 modulatory	
influence	will	be	proposed	in	the	following	section.	
	
5.4.1	Possible	brain	mechanisms	
The	 PHC	 can	 be	 subdivided	 into	 the	 perirhinal	 cortex,	 the	 postrhinal	 cortex	 and	 the	
entorhinal	cortex	(Burwell,	2000;	Eichenbaum	and	Lipton,	2008;	van	Strien	et	al.,	2009).	The	
entorhinal	cortex	shows	prominent	bidirectional	connectivity	with	the	visual	cortex	(Morris	et	
al.,	1999),	and	receives	direct	input	from	the	auditory	cortex	(Amaral	et	al.,	1983).	The	PHC	
can	 be	 conceptualised	 as	 a	 central	 “hub”,	 an	 important	 relay	 station,	 that	 receives	 and	
integrates	input	from	dispersed	functionally	specialised	brain	areas	(Eichenbaum	and	Lipton,	
2008).		
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The	majority	of	axonal	projection	that	the	entorhinal	cortex	receives	from	the	auditory	cortex	
terminate	 on	 deep	 layer	 V	 pyramidal	 neurons	 (Mohedano-Moriano	 et	 al.,	 2007).	 These	
neurons	 express	 serotonin	 2A	 receptors	 (Pazos,	 Probst,	 and	 Palacios	 1987;	 Celada	 et	 al.,	
2013),	and	provide	intra-hippocampal	forward	projections	as	well	as	backward	projections	to	
the	 visual	 cortex	 (Sewards	 and	 Sewards	 2003).	 Because	 LSD	 increases	 excitability	 of	 deep	
layer	V	pyramidal	neurons	via	serotonin	2A	receptor	activation	(Aghajanian	and	Marek	1999),	
this	 leads	 to	 the	 prediction	 that	 under	 LSD	 the	 backward	 PHC-to-VC	 projections	 are	more	
likely	to	fire	in	response	to	input	from	the	auditory	cortex.	
In	 light	 of	 these	 studies,	 the	 findings	 of	 this	 study	may	 indicate	 that	 under	 LSD,	 backward	
PHC-to-VC	projecting	pyramidal	neurons	in	the	PHC	become	abnormally	engaged	in	response	
to	music.	An	interesting	analogy	can	be	found	in	epileptic	seizures,	where	abnormal	activity	
of	backward	projecting	pyramidal	neurons	within	the	MTL	are	hypothesised	to	be	responsible	
for	the	seizures,	and	the	entorhinal	cortex	is	found	to	be	in	particular	susceptible	for	epileptic	
seizures	(Spencer	and	Spencer,	1994;	Stringer	and	Lothman,	1992)	via	recurrent	signalling	of	
layer	V	pyramidal	neurons	(Dhillon	and	Jones,	2000).	MTL	epilepsy	shares	phenomenological	
characteristics	 with	 the	 psychedelic-induced	 states	 (e.g.,	 spontaneous	 personal	 memory	
recollection).	 Most	 importantly,	 these	 experiences	 can	 be	 experimentally	 induced	 by	
increasing	coupling	between	the	PHC	and	the	visual	cortex	(Barbeau	et	al.,	2005).		
A	complementary	brain	mechanism	can	be	formulated	in	light	of	the	psychedelics’	effects	on	
brain	networks	that	control	PHC	activity.	The	PHC	possesses	high	baseline	connectivity	with	
high-level	cortical	regions	that	make-up	the	so-called	default-mode	network	(DMN)	(Raichle	
and	Snyder	2007;	Ward	et	al.,	2014).	Under	normal	conditions,	top-down	inhibitory	control	
over	 PHC	 activity	 is	 provided	 by	 projections	 from	 the	 precuneus,	 the	 posterior	 cingulate	
cortex	 (PCC),	 the	 retrosplenial	 cortex	 (RSC)	 and	 the	medial	 prefrontal	 cortex	 (mPFC),	 that	
terminate	on	inhibitory	interneurons	within	the	PHC	(Mohedano-Moriano	et	al.,	2007;	Morris	
et	 al.,	 1999;	Vann,	Aggleton,	 and	Maguire	2009).	Human	PET	 studies	have	 shown	 that	 the	
RSC,	 PCC	 and	mPFC	 express	 notably	 high	 levels	 of	 serotonin	 2A	 receptors	 (Erritzoe	 et	 al.,	
2009),	 and	 psychedelics	 are	 found	 to	 have	 a	 dysregulating	 effect	 on	 activity	 within	 these	
regions	 as	 shown	 with	 fMRI	 (Carhart-Harris	 et	 al.,	 2012;	 Tagliazucchi	 et	 al.,	 2014,	 2016;	
Carhart-Harris	et	al.,	2016;	Palhano-Fontes	et	al.,	2015),	MEG	and	(Carhart-Harris	et	al.,	2016;	
Muthukumaraswamy	 et	 al.,	 2013)	 and	 EEG	 (Riba	 et	 al.,	 2002;	 Kometer	 et	 al.,	 2015).	 This	
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dysregulation	 effect	 likely	 compromises	 the	 ability	 of	 these	 regions	 to	maintain	 top-down	
control	over	the	PHC,	and	subsequently,	may	increase	responsiveness	of	the	PHC	to	stimuli	
that	normally	engage	it,	such	as	music	(Mitterschiffthaler	et	al.,	2007;	Koelsch	2014;	Trost	et	
al.,	 2012).	 In	 support	 of	 this	 view	 is	 the	 finding	 that	 reductions	 in	 functional	 connectivity	
between	the	PHC	and	the	RSC	are	observed	after	both	psilocybin	and	LSD	(Carhart-Harris	et	
al.,	2014;	Carhart-harris	et	al	2016).		
This	naturally	 leads	 to	 the	question	how	 this	 could	explain	 the	vivid	mental	 images	people	
experience	 under	 LSD	 and	music.	What	 is	 it	 that	 the	 PHC-to-VC	 pathway	 does	 to	 produce	
such	subjective	experiences	when	modulated	by	the	LSDxMusic	interaction?	Information	flow	
from	the	PHC	to	the	VC	has	been	associated	with	to	the	encoding	of	learned	representations,	
or	top-down	(prior)	“predictions”,	for	complex	mental	scenes	(Aguirre	and	D’Esposito,	1999;	
Libby	et	al.,	2012;	Summerfield	et	al.,	2006).	The	experience	of	perceiving	complex	scenes	in	
the	absence	of	visual	input	may	therefore	be	the	result	of	an	enhanced	gain	on	circuits	that	
normally	confer	complex,	top-down	information	about	(a	potential)	visual	scene.	The	present	
experiment	 showed	 that	 the	 modulation	 of	 PHC-to-VC	 effective	 connectivity	 by	 the	
combination	 of	 LSD	 and	music,	was	 associated	with	 an	 enhancement	 in	 eyes-closed	 visual	
imagery.	 This	 association	was	 however	 only	 present	 for	 the	 item	 assessing	 complex	 visual	
imagery	item	(i.e.	concrete	visual	features,	such	as	objects,	entities	and	scenes),	and	not	for	
the	item	that	assessed	simple	visual	imagery	(i.e.	low-level	visual	features	such	as	colours	and	
patterns).	 This	 lends	 indirect	 support	 for	 the	 view	 that	 LSD	 and	 music	 facilitate	 complex	
mental	 imagery	via	an	abnormal	engagement	of	backward	projecting	pyramidal	neurons	 in	
the	PHC	that	encode	learned	representations	or	“predictions”	of	complex	visual	imagery.	
	
5.4.2	Implications	for	psychedelic	therapy	
Music	 alone	 is	 an	 effective	 medium	 for	 stimulating	 the	 imagination,	 and	 these	 effects	 of	
music	are	typically	exploited	in	the	context	of	conventional	forms	of	music	therapy	(Castillo-
Pérez	et	al.,	2010;	Erkkilä	et	al.,	2011).	The	present	experiment	supports	the	hypothesis	that	
under	psychedelics,	music-induced	imagery	is	intensified.	This	suggests	that	psychedelics	can	
be	 utilised	 to	 allow	 an	 enhanced	 engagement	 with	 mental	 images	 music	 on	 subjective	
experience.	 The	 findings	 of	 the	 present	 study	 help	 to	 elucidate	 the	mechanisms	 by	which	
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music	and	psychedelics	can	do	this	in	healthy	volunteers.	Further	research	is	required	to	test	
the	therapeutic	value	of	enhanced	mental	imagery	in	the	context	of	psychedelic	therapy.	
	
5.4.3	Study	limitations	and	future	directions	
This	 experiment	 represented	 several	 limitations.	 First,	 no	 significant	 interaction	 effect	was	
found	between	LSD	and	music	on	 in-scanner	subjective	 ratings	 for	visual	 imagery,	whereas	
connectivity	 analyses	 did	 show	 a	 significant	 interaction	 effect	 on	 PHC-VC	 coupling.	 Since	
enhanced	 PHC-VC	 coupling	 via	 the	 interaction	 between	 LSD	 and	 music	 correlated	 with	
complex	 visual	 imagery,	 this	may	be	explained	by	 small	 sample	 size	 and	 variance	between	
individuals	in	their	subjective	responses	to	LSD	and	music.	In	addition,	appraisal	of	the	music	
may	have	played	a	role	too:	some	participants	may	have	disliked	the	genre	of	music	or	may	
not	 have	 been	 engaged	 with	 it	 for	 other	 reasons,	 such	 as	 being	 distracted	 by	 the	
considerable	noise	emitted	by	the	MRI	machinery.		
Only	one	style	of	music	was	used	 in	 this	experiment,	and	therefore	the	results	may	not	be	
generalised	to	the	experience	of	other	music’s.	For	example,	the	music	used	in	this	study	did	
not	contain	clear	rhythmicity,	whereas	some	studies	indicate	effects	of	repetitive	drumming	
on	mental	 imagery	 (Hove	 et	 al.,	 2016).	 A	 study	 could	 be	 designed	 that	 incorporates	more	
than	one	genre	of	music	 (E.g.	emotionally	 relaxing	music	versus	emotionally	 intensifying	or	
arousing	music).		
Finally,	the	study	group	represented	psychedelic-experienced	users	with	no	history	of	mental	
health	issues.	The	present	results	can	therefore	not	be	extrapolated	to	a	patient	population,	
in	which	the	combination	of	music	and	psychedelics	is	thought	to	be	especially	important	for	
psychedelic	 therapy	 (Bonny	 and	Pahnke,	 1972).	 Subsequent	work	 is	 needed	 to	 further	our	
understanding	 of	 how	 music	 and	 psychedelics	 interact	 and	 how	 this	 may	 be	 useful	 for	
psychedelic-assisted	therapy.	
	
	
	
	137	
5.4.4	Conclusions	
The	present	study	revealed	a	positive	interaction	between	LSD	and	music	on	PHC	functional	
and	PHC-VC	effective	 connectivity.	 	More	 specifically,	 a	modulation	of	 PHC	 to	VC	effective	
connectivity	 was	 observed	 that	 correlated	 positively	 with	 eyes-closed	 visual	 imagery,	 and	
particularly	 imagery	 of	 a	 complex	 and	 autobiographical	 nature.	 These	 results	 extend	 our	
understanding	 of	 circuitry	 involved	 in	 mental	 visual	 imagery	 and	 suggest	 candidate	 brain	
mechanisms	 for	 how	 LSD	 and	music	 can	work	 in	 concert	 to	 facilitate	mental	 imagery.	 The	
study	 supports	 the	 view	 that	 psychedelics	 influence	 the	 experience	 of	 music,	 however,	 a	
large	amount	of	work	is	required	to	further	our	understanding	of	psychedelic	therapy	and	the	
roles	of	music.	
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“The	listener	does	not	find	a	simple	reflection	of	his	or	her	own	expectancies.	
The	music	forms	the	listener’s	experience,	and	in	its	unique	negotiation	of	the	
tension	between	striving	and	grief,	it	creates	knowledge	of	something	that	has	
been	formerly	unknown,	something	that	asks	to	be	integrated	in	the	mind	of	
the	hearer”	
Naomi	Cumming	
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6		
	
Study	4	|	Music-
experience	in	
psychedelic	
therapy
	
6.1	Background	
The	 capacity	 of	 psychedelics	 to	 facilitate	 intense	 emotionality	 and	 autobiographical	 salient	
experiences	 was	 a	 primary	 motivation	 for	 their	 therapeutic	 use	 in	 the	 1950s	 and	 1960s	
(Busch	and	Johnson,	1950).	Music	was	soon	introduced	within	the	therapeutic	framework	as	
a	way	to	non-verbally	guide	patient’s	experiences	into	therapeutically	meaningful	directions	
(Hoffer,	1965;	Bonny	and	Pahnke,	1972;	Grof,	1980).	Although	modern	psychedelic	therapy	
sessions	 typically	 involve	 a	 ‘hands-off’	 approach	 on	 behalf	 of	 the	 therapists,	 music	 is	 still	
widely	 used,	 and	 considered	 to	 be	 a	 valuable	 therapeutic	 tool.	 During	 the	 drug	 sessions,	
patients	 are	 typically	 encouraged	 to	 focus	 their	 attention	 inwards,	 while	 lying	 down	 in	 a	
relaxing	 position	 and	 listening	 to	music.	 It	 is	 believed	 that	 in	 this	way,	music	 can	 facilitate	
experiences	 that	 have	 most	 therapeutic	 value,	 such	 as	 psychedelic	 peak	 experiences	 or	
autobiographical	experiences.		
The	 views	 behind	 this	 procedure	 were	 described	 in	 detail	 in	 the	 introduction	 chapter	
(chapter	1),	and	in	subsequent	chapters,	data	was	presented	that	demonstrated	that	music-
evoked	 emotion	 and	 music-evoked	 mental	 imagery	 are	 significantly	 modulated	 by	 LSD	
(chapters	 3,	 4	 and	 5).	 Although	 these	 studies	 support	 the	 hypothesis	 that	 the	 subjective	
response	 to	 music	 is	 intensified	 under	 psychedelics,	 these	 studies	 were	 performed	 in	 a	
population	 of	 healthy	 volunteers,	 and	 only	 used	 a	 short	 duration	 of	 music-listening	 and	
limited	music	 styles.	 At	 present,	 there	 is	 no	 empirical	 data	 available	 on	 the	 experience	 of	
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music	under	therapeutic	conditions,	and	on	the	therapeutic	functions	that	music	may	serve	
in	this	context.	
This	present	 study	aimed	 to	 address	 this	matter,	 by	 investigating	 the	different	ways	music	
influences	 the	 subjective	 experience	 of	 patients	 undergoing	 psychedelic	 therapy	 with	
psilocybin	 for	 depression.	 This	 study	 used	 psilocybin,	 and	 not	 LSD,	 given	 most	 clinical	
evidence	 for	 safety	 and	 efficacy	 is	 for	 psilocybin,	 and	 psilocybin	 has	 a	 favourable	 half-life	
compared	to	LSD	(which	last	longer).	In	addition,	the	study	aimed	to	assess	how	the	music-
experience	 relates	 to	 the	 different	 aspects	 of	 the	 psilocybin-experience	 and	 to	 therapy	
outcomes.	 Nineteen	 patients	with	moderate	 to	 severe	 depression	 received	 psilocybin	 in	 a	
controlled	therapeutic	environment,	and	listened	to	a	six-hour	music	playlist	designed	for	this	
study.	 Clinical	measures	 for	 depression	were	 taken	 before	 and	 after	 the	 intervention,	 and	
patient’s	 psilocybin-experiences	 were	 assessed	 via	 the	 11-factor	 Altered	 States	 of	
Consciousness	 (ASC)	 questionnaire.	Music-experiences	were	 assessed	 by	 a	 semi-structured	
interview	 and	 Interpretative	 phenomenological	 analysis	 (IPA).	 Ratings	 of	 the	 interview-
transcripts	 by	 researchers	 were	 subsequently	 correlated	 with	 measures	 for	 psilocybin-
experience	and	reductions	in	depression.	
Because	music-evoked	emotion	(study	1	and	2)	and	music-induced	mental	imagery	(study	3)	
are	 significantly	modulated	 under	 psychedelics,	 and	 because	 both	music	 (Gabrielsson	 and	
Wik,	 2003)	 and	 psychedelics	 (Griffiths	 et	 al.,	 2006)	 can	 facilitate	 peak	 experiences,	 the	
influence	of	music	on	patient’s	experiences	and	on	 therapy	outcomes	was	predicted	 to	be	
substantial.	These	findings	will	be	discussed	in	light	of	previous	work,	 including	a	discussion	
on	 possible	 therapeutic	 mechanisms	 of	 music	 in	 psychedelic	 therapy,	 and	 on	 how	 the	
findings	inform	strategies	for	the	use	of	music	in	psychedelic	therapy	sessions.		
	
6.2	Methods	
6.2.1	Approvals	
The	National	Research	Ethics	Service	London	 (West	London)	provided	a	 favourable	opinion	
for	 this	 study.	 The	 study	was	 sponsored	 and	 approved	 by	 Imperial	 College	 London’s	 Joint	
Research	 and	 Compliance	 Office	 (JRCO),	 and	 the	 National	 Institute	 for	 Health	 Research	
Clinical	 Research	 Network	 adopted	 the	 study.	 The	 National	 Institute	 for	 Health	
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Research/Wellcome	Trust	Imperial	Clinical	Research	Facility	provided	approval	for	the	study-
site.	A	Home	Office	Licence	for	storing	and	dispensing	Schedule	One	drugs	was	obtained.	
	
	
6.2.2	Participants	
Inclusion	criteria	for	the	study	were	moderate	to	severe	major	depression,	as	determined	by	
the	 21-item	 Hamilton	 Depression	 Rating	 scale	 (HAM-D),	 with	 absence	 of	 improvements	
despite	at	least	two	different	pharmaceutical	antidepressant	treatments	for	a	minimum	of	6	
weeks	within	the	current	depressive	episode.	Exclusion	criteria	included	current	or	previously	
diagnosed	 psychotic	 disorder,	 diagnoses	 of	 psychotic	 disorders	 in	 immediate	 family	
members,	a	medically	significant	condition	rendering	the	patient	unsuitability	for	the	study,	
history	of	suicide	attempts	that	required	hospitalisation,	history	of	mania,	having	a	blood	or	
needle	phobia,	pregnancy,	and	current	drug	or	alcohol	dependence.	
	
6.2.3	Experiment	overview	and	procedures	
Psilocybin	 was	 synthesised	 and	 obtained	 from	 THC-Pharm	 (Frankfurt,	 Germany),	 and	
formulated	 into	 5mg	 capsules	 of	 psilocybin,	 by	 Guy’s	 and	 St	 Thomas’	 Hospital’s	 Pharmacy	
Manufacturing	Unit	(London,	UK).	Screening	consisted	of	evaluating	the	patient’s	current	and	
past	physical	and	mental	health.	Patient-rated	scales	for	the	severity	of	depressive	symptoms	
were	completed	during	the	screening	visit	and	served	as	baseline	measures.	These	included	
the	16-item	Quick	Inventory	of	Depressive	Symptoms	(QIDS)	and	Beck	Depression	Inventory	
(BDI).	Written	informed	consent	was	given,	and	by	the	end	of	the	screening,	eligible	patients	
met	with	the	two	therapists	that	would	support	them	through	the	remainder	of	the	trials.	
A	 subsequent	 visit	 functioned	 as	 preparation	 for	 the	 session.	 This	 included	 conversations	
with	 the	 therapists	 about	 the	 patient’s	 personal	 history,	 expectations	 for	 the	 sessions	 and	
education	 about	 the	 effects	 of	 psilocybin.	 The	patient	 also	had	 an	opportunity	 to	 listen	 to	
samples	 of	 session	 music	 while	 wearing	 eye-shades,	 as	 a	 simulation-experience	 in	
preparation	for	their	first	session.	The	preparation	visit	lasted	approximately	4	hours	in	total.	
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Following	 the	preparation	session,	patients	 received	two	different	dosages	of	psilocybin	on	
two	 separate	 subsequent	 occasions,	 each	 separated	 by	 one	 week.	 In	 the	 first	 session,	 all	
patients	received	an	oral	dose	of	10	mg	psilocybin.	This	lower	dose	was	intended	to	function	
like	a	“taster”,	a	preparation	for	the	higher	dose	administered	one	week	later.	In	the	second	
session,	 all	 patients	 received	 25	 mg.	 Each	 session	 included	 only	 one	 patient	 and	 two	
therapists,	 and	 took	 place	 in	 a	 specially	 designed	 therapeutic	 environment.	 Each	 session	
started	with	arrival	at	the	research	facility	at	9am,	and	with	psilocybin	being	administered	at	
10.30am.	 The	majority	 of	 patients	 were	 ready	 to	 leave	 the	 facility	 approximately	 7	 hours	
after	 administration.	 Transport	 from	 the	 research	 facility	 to	 home	was	organised	 ahead	of	
the	sessions	and	consisted	of	being	accompanied	by	a	close	friend	or	relative.	Patients	also	
had	the	option	of	staying	overnight	 in	accommodation	adjacent	to	the	research	facility,	the	
night	before	and	the	night	after	the	session.	
Clinical	improvement	was	defined	as	reductions	in	depression	severity,	and	measured	via	the	
QIDS,	 completed	 by	 all	 patients	 at	 baseline,	 and	 1	 week	 and	 6	 months	 after	 the	 final	
psilocybin	 session.	 The	 different	 aspects	 of	 the	 subjective	 experience	 of	 psilocybin	 were	
measured	with	the	11-dimensional	Altered	States	of	Consciousness	Scale	(11D-ASC)	(Dittrich,	
1998)	at	the	end	the	session.	The	structured	interview	assessing	the	patient’s	experience	of	
the	music	was	always	conducted	1	week	after	the	high	dose	(25	mg)	session.	For	a	report	on	
the	clinical	outcomes,	see	Carhart-Harris	et	al	(2016)	(Carhart-Harris	et	al.,	2016).	
	
6.2.4	Therapeutic	setting		
Considering	 the	 importance	of	 the	 therapy	 setting	 (Johnson	 et	 al.,	 2008),	 all	 sessions	 took	
place	 in	 a	 specially	 designed	 therapy	 room	within	 the	 Clinical	 Research	 Facility	 at	 Imperial	
College	 London.	 All	 unnecessary	 medical	 equipment	 was	 either	 removed	 or	 hidden,	 light	
quality	 was	 adjusted	 using	 Philips	 hue	 lamps.	 Drapes,	 cushions,	 plants,	 art	 paintings	 and	
artefacts	were	introduced	to	engender	a	cosy	and	comfortable	climate.	
After	receiving	psilocybin,	patients	were	encouraged	to	relax	in	a	reclined	position	on	the	bed	
and	wear	eye-shades.	Two	therapists	were	present	on	either	side	of	the	bed,	and	checked-in	
with	 the	 patient	 every	 30-60	 minutes,	 to	 obtain	 insight	 into	 how	 the	 patient’s	 subjective	
experience	 was	 unfolding,	 and	 to	 determine	 whether	 psychological	 support	 might	 be	
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needed.	 Calming	 ambient	 music	 was	 played	 on	 entrance,	 but	 the	 session	 playlist	 (see	
appendix,	chapter	8.3)	was	started	upon	 ingestion	of	psilocybin.	Patients	had	the	option	to	
listen	to	the	music	via	high	quality	in-ear	headphones	(Sennheiser	IE	800)	or	via	a	high	fidelity	
standing	 stereo-speaker	 (Meridian	 DSP3200).	 Both	 headphones	 and	 speakers	 received	 the	
same	audio	signal,	which	allowed	the	music	be	played	in	synchrony	and	continuously	through	
both	channels.	This	set-up	was	considered	helpful	for:		
1)	providing	a	sense	of	continuation	of	the	experience	 in	case	the	headphones	were	pulled	
off	or	muted	while	the	music	was	still	playing.	
2)	helping	the	therapists	have	insight	into	the	patient’s	experience,	as	well	as	how	the	patient	
responds	to	particular	parts	of	the	music.	
3)	allowing	the	music	to	be	perceived	not	only	via	the	ears,	but	also	bodily	and	more	spatially.	
	
6.2.5	Music	selection	
The	central	purpose	of	the	use	of	music	in	the	present	therapeutic	study	was	consistent	with	
that	of	early	psychedelic-therapy	studies,	i.e.	to	facilitate	personally	meaningful	experiences.	
In	order	to	achieve	this,	researchers	often	emphasised	the	importance	of	adapting	the	music	
to	 individual	 patient’s	 changing	 therapeutic	 needs,	 as	 their	 therapeutic	 experience	 unfolds	
dynamically	 (Hoffer	 1965;	 Bonny	 and	 Pahnke	 1972;	 Grof,	 1980).	 For	 the	 present	 study,	
however,	 a	 standardized	playlist	was	 used	 to	 control	 for	music	 as	 a	 potential	 confounding	
variable.	Therefore,	all	patients	were	intended	to	 listen	to	the	same	music	playlist.	 In	(rare)	
cases	where	the	music	selection	was	strongly	disliked	by	the	patient	in	the	first	session,	or	a	
strong	preference	was	expressed	to	only	listen	to	classical	music,	the	music	playlist	used	by	
John	Hopkins	was	used	(Richards	2015),	which	includes	music	originally	suggested	by	Bonny	
and	Pahnke	(Bonny	and	Pahnke	1972).		
Several	of	the	musical	works	originally	included	in	playlists	for	psychedelic-therapy	(Richards	
2015;	Bonny	and	Pahnke	1972)	are	very	familiar	today.	Examples	 include:	“Samuel	Barber	-	
Adagio	for	strings”	and	“Beethoven	–	Piano	Concerto	5”.	Such	high	familiarity	may	reduce	the	
opportunity	 for	 patients	 to	 have	 a	 new	 experience	 with	 the	 music,	 unfettered	 by	 prior	
associations.	In	addition,	a	strong	emphasis	on	music	with	“Christian	religious”	content	may	
not	be	appropriate	for	individuals	that	are	either	non-religious	or	practice	a	different	religion.	
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Therefore,	 a	 music	 playlist	 was	 designed	 for	 the	 present	 study,	 containing	 predominantly	
contemporary	music	such	as	the	ambient-,	neo-classical-,	modern	classical-,	jazz-	and	diverse	
ethnic-	 music	 styles.	 The	 intention	 with	 this	 music	 selection	 was	 to	 transcend	 religious	
boundaries,	 and	 to	 support	 spiritual	 peak	 experiences	 within	 a	 secular	 framework.	 In	
addition,	a	part	of	the	music-selection	was	tailored	to	the	condition	treated	(i.e.	depression),	
via	a	selection	of	music	that	reflected	sentiments	of	sadness	and	grief,	yet	simultaneously,	in	
the	 song’s	 dynamical	 narrative,	 reflected	 themes	 of	 hope,	 change,	 beauty	 and	 personal	
empowerment.	 Music	 with	 such	 emotional	 sentiments	 was	 only	 played	 during	 peak	 drug	
intensity,	 on	 the	 assumption	 that	 this	 music	 would	 then	 reflect	 autobiographical	 and	
therapeutically	 significant	 content,	 and	 thereby	 increase	 the	 person’s	 therapeutic	
engagement	in	the	experience.	
	
6.2.6	Playlist	design	
The	 design	 of	 the	 music-playlist	 was	 informed	 by	 Bonny	 and	 Pahnke	 (1972)	 (Bonny	 and	
Pahnke	 1972)	 and	 the	 LSD	 psychotherapist	 and	 author	 Stanislav	 Grof	 (Grof,	 1980),	 who	
defined	 different	 phases	 in	 psychedelic	 therapy	 sessions,	 where	 each	 phase	 is	 associated	
with	a	distinguishable	set	of	psychological	needs	 the	music	can	serve.	These	phases	are,	 in	
chronological	 order:	 “pre-onset”,	 “onset”,	 “building	 towards	 peak”,	 “peak”,	 “re-entry”	 and	
“return”.	 In	 the	 present	 study,	 the	 durations	 of	 the	 phases	 were	 adjusted	 to	 the	 shorter	
duration	 of	 psilocybin’s	 effects,	 compared	 with	 LSD.	 Furthermore,	 “onset”	 and	 “building	
towards	peak”,	were	grouped	together	as	“ascent”,	and	“re-entry”	was	named	“descent”.		
	
6.2.7	The	structured	interview	
The	structured	interview	was	always	conducted	one	week	after	the	final	session,	by	the	same	
researcher,	apart	from	on	one	occasion.	The	interview	consisted	of	four	open	questions:	1)	
“Did	the	music	influence	your	experience?	And	if	so:	in	what	ways?”,	2)	“Can	you	comment	
on	how	the	different	styles	of	music	 influenced	your	experience?	And	which	music	did	you	
prefer?”,	 3)	 “Were	 there	 any	 aspects	 in	 the	 music	 that	 in	 particular	 influenced	 your	
experience	 positively?”,	 and	 4)	 “Were	 there	 any	 aspects	 in	 the	 music	 that	 in	 particular	
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influenced	 your	 experience	 negatively?”.	 Additional	 questions	 were	 sometimes	 asked	 to	
clarify	patient’s	responses	if	the	interviewer	felt	the	need	to	do	so.		
	
6.2.8	Theoretical	approach	of	interview	data-analysis	
Interpretative	phenomenological	analysis	 (IPA)	was	chosen	to	analyse	the	 interviews	(Smith	
et	 al.,	 1997).	 IPA	 is	 an	 approach	 increasingly	 used	 in	 healthcare	 research	 (Biggerstaff	 and	
Thompson,	 2008;	 Smith,	 2011)	 that	 examines	 the	meanings	 particular	 experiences	 hold	 to	
people.	 It	 is	 particularly	 appropriate	 for	 ascertaining	 the	 complexity	 (i.e.	 the	 quality	 and	
phenomenology	 of	 experience)	 behind	 patients’	 subjective	 experience	 of	music	 during	 the	
therapeutic	 sessions,	 and	 has	 previously	 been	 used	 to	 investigate	 the	 benefits	 of	 music	
therapy	interventions	in	cancer	care	settings	(Pothoulaki	et	al.,	2012)	
	
6.2.9	Interview	data	analysis:	Coding	
Interviews	were	 transcribed	verbatim	and	checked	 for	accuracy.	All	 coding	was	done	by	at	
least	 two	 researchers,	 to	 increase	 inter-rater	 reliability.	A	 step-by-step	analysis	 of	 the	data	
was	followed	(Smith,	2011).	All	transcripts	were	read	through	twice	before	carrying	out	the	
analysis.	During	the	third	reading,	any	phrases	considered	as	especially	pertinent	in	terms	of	
how	 the	music	 influenced	 the	patient’s	 subjective	experience,	were	highlighted	and	 coded	
into	 initial	 interpretations.	 	 At	 this	 stage,	 some	 text	 was	 assigned	 to	more	 than	 one	 code	
when	more	than	one	interpretation	could	be	made,	and	queries	about	the	meaning	of	what	
was	 being	 said	 were	 recorded	 in	 a	 separate	 column.	 This	 process	 was	 repeated	 for	 four	
further	transcripts.	
Key	words,	phrases	and	initial	interpretations	from	the	first	four	completed	transcripts	were	
then	 comprehensively	 explored,	 leading	 to	 the	 creation	 of	 themes	 in	 a	 separate	 column.	
These	 themes	 were	 then	 used	 as	 guidelines	 for	 subsequent	 transcripts.	 As	 new	 themes	
emerged	from	these	subsequent	transcripts,	all	data	were	iteratively	scrutinised	and	the	list	
of	themes	refined.	Throughout	the	process	of	analysis,	codes	were	examined	and	discussed	
among	 the	 authors	 to	 decide	 which	 themes	 were	 the	 most	 accurate	 reflections	 of	
participants’	experiences.	
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Following	 further	 discussion	 between	 authors,	 a	 final	master	 list	 of	 themes	 emerged.	 The	
final	stage	of	analysis	involved	the	organisation	of	the	list	of	themes	into	a	more	concise	list	
of	overarching,	superordinate	“clusters”	or	domains	representing	the	patient	experience	of	
music,	each	of	which	contained	a	number	of	subsidiary	themes.		
After	all	transcripts	were	coded	into	themes	and	clusters,	the	presence	of	each	unique	theme	
and	 cluster	 across	 all	 patients’	 responses	 was	 calculated.	 This	 lead	 to	 a	 percentage	 index	
describing	 the	 frequency	 to	 which	 the	 themes	 and	 clusters	 were	 present	 within	 the	 total	
study	population.		
	
6.2.11	Ratings	for	music-experience	
Three	predictors	for	therapy-response	were	hypothesized:	1)	“liking”,	referring	to	the	degree	
to	which	the	music	styles	and	the	music	quality	were	liked,	2)	“resonance”,	referring	to	the	
degree	to	which	the	music	matched	with	or	was	“harmonious”	with	the	 intrinsic	emotional	
state	 of	 the	 patient,	 and	 3)	 “openness”,	 referring	 to	 the	 degree	 in	which	 the	 patient	was	
open	to,	or	accepting	of	the	music-evoked	experience.	
Four	 researchers	 that	 were	 blinded	 to	 patient	 identifiers	 and	 treatment	 outcomes	 rated	
these	variables	for	all	19	patients	based	on	their	interview	transcripts.	Ratings	were	done	via	
a	 visual	 analogue	 scale,	 with	 five	 anchors	 presented.	 For	 the	 “liking”,	 the	 question	 was	
formulated	as	“To	what	extent	did	the	patient	like	or	dislike	the	music?”,	with	the	following	
anchors	on	the	response	scale:	“0	=	strong	disliking”,	“25	=	major	disliking,	some	liking”,	“50	=	
mixed	 disliking	 and	 liking”,	 “75	 =	 major	 liking,	 some	 disliking”,	 “100	 =	 major	 liking”.	 For	
“resonance”,	 the	question	was	 formulated	as	 “To	what	extent	was	 the	music	 in	 resonance	
with	the	patient’s	subjective	experience?”,	with	the	following	anchors	on	the	response	scale:	
“0	=	strong	dissonance”,	“25	=	major	dissonance,	some	resonance”,	“50	=	mixed	resonance	
and	dissonance”,	“75	=	major	resonance,	some	dissonance”,	and	“100	=	strong	resonance”.	
And	 finally,	 for	 the	 third,	 the	question	was	 formulated	as	 “To	what	extent	was	 the	patient	
accepting	of	or	open	 to	 the	music-evoked	experience?”,	with	 the	 following	anchors	on	 the	
response	scale:	“0=	strong	resistance”,	“25	=	major	resistance,	some	openness”,	“50	=	mixed	
resistance	 and	 openness”,	 “75	 =	 major	 openness,	 some	 resistance”	 and	 “100	 =	 strong	
openness”.		
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6.2.12	Correlating	music-experience	with	psilocybin-experience	and	therapy	outcomes	
Pearson	correlation	tests	were	performed	between	the	three	music-experience	variables	and	
ratings	 from	 the	 11D-ASC.	 To	 reduce	 the	 number	 of	 comparisons,	 a	 principle	 component	
analysis	 (PCA)	 was	 performed	 on	 the	 11	 factors	 of	 the	 11D-ASC.	 Varimax	 rotation	 was	
performed	on	the	first	5	principal	components	(PCs)	that	explained	over	95%	of	the	variance	
(see	Figure	6.3	for	rotated	PCs	and	their	respective	loadings).	Subsequently,	the	three	music-
experience	variables	(liking,	resonance	and	openness)	were	correlated	with	these	5	PC’s.	To	
test	 whether	music-experience	 and	 drug-intensity	 are	 associated	with	 different	 aspects	 of	
subjective	experience	of	psilocybin,	drug-intensity	ratings	were	also	correlated	with	all	5	PC’s.	
False	discovery	 rate	 (FDR)	control	was	used	to	correct	 for	multiple	comparisons	 (Benjamini	
and	Hochberg,	1995).	
The	average	of	the	scores	from	all	researchers	was	calculated	for	each	patient,	and	a	Pearson	
correlation	 test	 was	 applied	 to	 test	 for	 a	 relationship	 between	 these	 variables	 and	 1)	
reductions	 in	depressive	 symptoms	1	week	and	6	months	after	 the	 last	 session	with	25mg	
psilocybin.	Reductions	in	depressive	symptoms	were	defined	as	the	percentage	reduction	in	
scoring	on	QIDS	relative	to	baseline	(i.e.	(score/baseline)	x	100).		To	test	for	the	discriminative	
value	 of	 music-experience	 variables	 in	 predicting	 therapy	 response,	 compared	 with	 mere	
drug-intensity,	ratings	for	drug	intensity	were	also	correlated	with	reductions	in	depression.	
	
6.2.13	Inter-rating	reliability	and	discriminative	validity	of	music-experience	variables	
Inter-rating	 reliability	 of	 researcher’s	 ratings	 was	 tested	 by	 correlating	 ratings	 of	 all	
researchers	 with	 each	 other.	 To	 test	 for	 differences	 between	music-experience	 and	 drug-
intensity	effects,	ratings	for	drug-intensity	were	correlated	with	each	music-experience	value.	
The	 three	 music-experience	 variables	 were	 correlated	 with	 each-other	 to	 test	 for	 their	
discriminative	value.		
	
6.3	Results	
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A	 total	of	 twenty	participants	were	enrolled	 in	 the	 trial,	 including	14	males	and	6	 females,	
with	an	average	age	of	44.1	±11	years.	Ethicities	 included	15	white,	3	black,	1	asian,	and	1	
hispanic.	 11	 were	 unemployed.	 Average	 years	 of	 depression	 was	 17.7	 ±8.5,	 and	 average	
severity	of	depressive	 symptoms	was	19	±2.7	on	QIDS-16,	35	±7.4,	23.9	±5.4.	 The	average	
number	of	different	medications	used	in	the	past	was	4.6	±2.6,	and	17	out	of	20	underwent	
psychotherapy	 in	 the	 past.	 18	 had	 higher	 education.	 	Weekly	 alcohol	 use	 in	 units	was	 3.7	
±6.5,	 and	 previous	 (life-time)	 use	 of	 psilocybin	 was	 0.7	 ±1.1.	 For	 more	 details	 on	
demographics	see	Carhart-Harris	et	al	(2016,	2017).	
Analayses	of	the	interview	resulted	in	the	identification	of	four	separate	groups,	that	include	
clusters	 of	 related	 themes.	 These	 groups	 were:	 1)	 “Welcomed	 influences”,	 including	 all	
influences	 of	 music	 on	 subjective	 experience	 that	 were	 described	 as	 welcomed,	 wanted,	
accepted	or	appreciated	(Figure	6.1)),	were	identified	in	18	out	of	19	patients	(95%	of	total);	
2)	 “Unwelcomed	 influences”,	 including	 all	 experienced	 influences	 of	 music	 that	 were	
described	 as	 unwelcomed,	 unwanted,	 unacceptable	 or	 unappreciated	 (Figure	 6.1)),	 were	
identified	 in	10	out	of	 19	patients	 (53%	of	 total);	 3)	 “Appreciated	music	 styles	 and	playlist	
features”,	including	all	aspects	related	to	music	genres,	styles,	and	playlist	design,	that	were	
appreciated	or	 liked,	 (Figure	6.2),	and	were	 identified	 in	all	19	patients	 (100%	of	 total)	 ;	4)	
“Unappreciated	music	styles	and	playlist	design”,	including	all	aspects	of	music	genres,	styles	
and	playlist	design	that	were	not	appreciated	or	were	disliked	(Figure	6.2),	were	identified	in	
11	 out	 of	 19	 patients	 (58%	 of	 total).	 Here,	 the	 term	 “music	 styles”	 refers	 broadly	 to	 the	
instrumentation,	 compositional-,	 genre-	 and	 acoustic-	 features	 of	 the	 music.	 The	 term	
“playlist	design”	refers	to	all	aspects	related	to	the	selection	and	structuring	of	the	music	into	
the	full	music	playlist.		
The	 figures	displaying	 the	 four	 groups	 (Figures	6.1	 and	6.2)	 include	 the	 clusters	present	 in	
more	 than	30%	of	 the	 respective	group,	and	 the	 themes	present	 in	more	 than	30%	of	 the	
respective	 cluster.	 All	 patient’s	 quotes	 of	 themes	 present	 in	 each	 of	 these	 groups	 and	
clusters,	are	displayed	in	separate	tables	(Table	1-11).	 It	 is	 important	to	emphasise	that	the	
identification	 of	 a	 theme	 in	 a	 patient’s	 experience,	 and	 subsequently	 the	 including	 of	 that	
theme	 in	 counting	 its	 presence	 in	 the	 total	 population,	 does	 not	 allow	 us	 to	 make	 any	
statements	on	the	duration	that	this	theme	was	present	in	the	patient’s	total	experience.	E.g.	
one	patient	may	have	experienced	a	 sense	of	 irritation	 in	 response	 to	one	particular	 song,	
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and	 therefore	 the	 theme	 “irritation”	 under	 the	 cluster	 “intensification”	 in	 the	 group	
“unwelcomed	 influences”	 is	 present.	 But	 this	 does	 not	 imply	 that	 the	 patient	 experienced	
persistent	feeling	of	irritation	during	his	or	her	experience.	In	addition,	the	measure	also	only	
allows	 the	 capturing	 of	 spontaneous	 mentioning	 and	 elaborations	 on	 the	 subjective	
experience	of	the	music,	as	opposed	to	the	questions	targeting	(and	biasing)	specific	facets	of	
the	patient’s	experience.	
	
	
	
	
	150	
	
	
Figure	6.1	|	Welcomed	and	unwelcomed	influences	of	the	music.	Welcomed	influences	are	displayed	on	the	left	
in	green,	and	unwelcomed	influences	are	displayed	on	the	right	in	red.	All	clusters	and	themes	that	are	defined	
as	an	accepted	or	welcomed	influence	of	the	music	on	subjective	experience.	The	figure	displays	cluster	present	
in	more	 than	30%	of	all	participants,	and	per	cluster	 the	 themes	 that	were	present	 in	more	 than	30%	of	 the	
cluster.	 The	 numbers	 below	 the	 group-,	 cluster-	 or	 theme-name,	 refers	 to	 the	 total	 number	 of	 patients	 that	
referred	to	this.	The	size	of	the	circle	is	proportional	to	the	percentage	of	patients	referring	to	the	group,	cluster	
or	theme.	
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6.3.1	Welcomed	influences:	Intensification	
The	 most	 prominent	 cluster	 in	 the	 group	 “welcomed	 influences”,	 including	 17	 out	 of	 19	
patients	(88%	of	total),	refers	to	themes	that	describe	an	“intensification”	of	the	subjective	
experience	 by	 the	 music.	 Within	 this	 cluster,	 themes	 that	 describe	 an	 “intensification	 of	
emotion”	were	 identified	 in	 15	 out	 of	 17	 (82%	 of	 cluster),	 including	 descriptions	 of	music	
enhancing	 or	 changing	 emotions.	 Importantly,	 the	 emotion-evoking	 effects	 that	 were	
welcomed,	 showed	 diverse	 emotional	 valence,	 and	 included	 descriptions	 of	 the	 music	
facilitating	 “happiness”	 or	 strong	 “ecstatic”	 experiences,	 as	 well	 experiences	 of	 the	music	
intensifying	“tearfulness”.		
Themes	describing	an	“intensification	of	imagination”	were	identified	in	9	out	of	17	(53%	of	
cluster).	 This	 included	 statements	of	 the	music	evoking	vivid	and	complex	mental	 imagery,	
and	of	the	concrete	imagery	related	to	specific	aspects	of	the	music.	Such	as	for	example	the	
ethnic	“Indian”	style	of	the	music	being	associated	with	“seeing	an	Indian	temple”.	8	out	of	
17	 patients	 (47%	 of	 cluster),	 mentioned	 a	 “general	 intensification”	 effect	 of	 the	 music,	
without	 specifically	 referring	 to	 this	 being	 an	 intensification	 of	 emotionality,	 imagery	 or	
others.	Other	themes,	present	below	30%	 in	the	cluster	“intensification”,	 include	effects	of	
music	on	“personal	thoughts	or	memories”	(2/17,	12%	of	cluster),	music	facilitating	a	“sense	
of	transcendence”	(2/17,	12%	of	cluster)	and	music	enhancing	“ego-dissolution”	(2/17,	12%	
of	 cluster)	 (Figure	 6.1).	 See	 Table	 6.1	 for	 a	 listing	 of	 all	 themes	 present	 in	 the	 cluster	
“intensification”.	
	
Table	6.1	|	Welcomed	influences:	Intensification.	A	list	of	all	the	themes	and	respective	quotes	by	patients,	that	
were	present	in	the	cluster	“intensification”	
#	 Quote	 Theme	
1	
“The	level	of	intensity	of	the	music	made	things	in	my	mind	seem	more	
intense.”	
General	
intensification	
3	
	
“[The	music]	can	amplify	the	emotions,	either	negatively	or	positively.”	 Emotionality	
“Make	you	feel	happy	when	there’s	a	good	song	on.”	
Emotionality	
(happiness)	
“it	was	all	good	[…]	all	in	the	same	area	where	it	can	get	people	meditating,	or	
releasing,	or	just	chilling	out	to	it.”	
Emotionality	
“Your	emotion	goes	with	that	[music]	and	the	happy	feeling,	and	its	like	all	 Emotionality	
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connected.”	 (happiness)	
4	
	
“[The	music]	made	me	even	more	emotional.”	 Emotionality	
“The	sad	songs	would	bring	painful	memories	on,	more	happy	songs	would	
make	me	think	of	a	really	good	period	in	my	life.”	
Personal	thoughts	
or	memories	
“I	didn’t	like	the	emotional	music	the	first	experience	cause	I	didn’t	want	to	cry,	
but	actually,	you	know,	the	second	time	I	sort	of	enjoyed	crying	to	this	music.”	
Emotionality	
(tearfulness)	
“[The	soothing	music]	brought	up	nice	images,	like	I	imagined	I	was	an	unborn	
child	and	I	felt	very	safe.	Every	new	song	could	bring	a	different	image,	and	I	
couldn’t	finish	the	previous	one	that	I	was	thinking	about.	It	was	interesting.”	
Imagination	
5	
	
“[The	music]	made	me	see	what	I	considered	ephemeral	things,	like	a	sense	of	
a	mother	and	a	sense	of	a	child.	And	their	behaviour	was	definitely	informed	by	
the	music.”	
Imagination	
“[The	music]	caused	different	feelings.”	 Emotionality	
“[The	music]	caused	the	different	imagery.”	 Imagination	
6(2)	
	
"There	were	moments	when	I	felt	just	this	burst	of	joy."	
Emotionality	
(happiness)	
"And	I	connected	[the	music]	very	strongly	thinking	about	Rembrandt	who	I	
love."	
Personal	thoughts	
or	memories	
"So	I	just	felt	overwhelmed	with	joy	and	gratitude	to	have	that	[music]	in	my	
life."	
Emotionality	
(gratitude)	
"There	was	one	piece	that	I	knew	very	well	and	it	reminded	me	of	somebody."	 Personal	thoughts	or	memories	
7	
	
“Some	bits	of	it	were	otherworldly.”	 Imagination	
“I	could	almost	picture	myself	there.”	 Imagination	
“[The	music]	seemed	to	heighten	the	experience.”	
General	
intensification	
“[The	music]	stirred	something.”	 Emotionality	
“[The	music]	seemed	to	fit	the	space	that	I	was	inhabiting.	I	felt	a	dissolution,	
where	you	sort	of	dissolve.	And	I	felt	the	music	after	the	quiet	ambient	music,	
in	the	beginning,	emphasized	that	beautifully.	And	it	definitely	enhanced	it.”	
General	
intensification,	Ego-
dissolution	
9	
	
“There's	one	track	[Greg	Haines	-	Azure]	that	gets	really	really	really	intense.”	 General	
intensification	
“[Greg	Haines	-	Azure]	I	felt	like	I	was	sort	of	the	highest	I	could	get,	it	was	like	
the	absolute,	the	top	of	everything.”	
Sense	of	
transcendence	
“[Greg	Haines	-	Azure]	really	really	beautiful,	overwhelming,	but	really	peaceful	
as	well.”		
Emotionality	
10	
“[The	music]	helped	me	to	emotionally	connect.”	 Emotionality	
“I	wouldn’t	say	that	I	felt	sad,	but,	I	obviously	cried,	but	I	don’t	know	why	I	did	 Emotionality	
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	 (half-laugh)-	but	I	wasn’t	sad.”	 (tearfulness)	
“if	I’d	listened	to	anything	else	then	I	probably	would	have	had	a	different	
experience	[emotionally].”	
Emotionality	
“At	the	beginning,	as	the	effects	starts	to,	you	know,	creep	up	on	me,	it	was	
quite	“Chinese-ey”?	And	(giggles)	the	bit	where	I	saw	the	psychedelic	Chinese	
dragon.”	
Imagination	
“I	was	tearful	at	some	points.”	 Emotionality	(tearfulness)	
11	
	
“In	terms	of	movement,	of	the	patterns	going	along	with	the	music.”		 Imagination	
“Indian	music,	where	I	was	seeing	an	Indian	temple.”	 Imagination	
“Setting	the	place,	an	Inca	princesses	singing	and	seeing	the	terraced	Inca-type	
setting.”	 Imagination	
“The	music	was	influencing	the	movements	and	influencing	the	setting.”	 Imagination	
“During	that	same	Indian	piece,	that’s	when	I	was	dancing	for	Shiva	and	then	I	
was	Shiva.”	 Imagination	
“[The	music]	influenced	this	sensory	perception.”	 Imagination	
	“Saying	that	it	made	me	sad	or	it	made	me	happy,	those	words	are	actually	not	
irrelevant,	a	little	too	mild	almost	to	explain	what	it	was.”	 Emotionality	
“I	felt	ecstasy,	“ek-stasis”.	It	was	hard	to	separate	out	what’s	happening	here,	
from	what’s	happening	here,	from	what’s	happening	here.”	
Emotionality	
(ecstasy)	
12	
	
“[The	music]	helped	with	the	visual	stuff	and	the	mood.”	
Imagination,	
Emotionality	
“the	visuals	…	[The	music]	kind	of	opens	up	your	imagination	in	a	way,	your	
imagination	is	much	easier	to	picture.	One	of	the	songs	created	imagery	of	a	
"wooden	bannister"	that	had	a	shape,	it	had	a	texture	and	a	material,	with	
some	water	and	marbles	with	rainbows	in	it.	I	could	picture	it	really	clearly.”	
Imagination		
“[the	music	and	the	experience]	was	a	symbiotic	kind	of	thing.”	 General	
intensification		
“That	piece	of	music	was	probably	the	peak	of	positivity,	it	was	almost	like	a	
subdued	kind	of	ecstasy,	you	know,	it	was	so	amazing.	It	was	such	a	beautiful	
feeling.”	
Emotionality	
(ecstasy)	
“[Experiencing	a	challenging	influence	of	the	music]	wasn’t	a	bad	thing	you	
know,	it	opened	you	up.”	
Openness	
“The	music	is	kind	of	changing	your	state	of	mind	almost,	or	putting	you	on	a	
different	resonance.”	
General	
intensification	
13	
“It	feels	like	your	mood,	or	the	the	intensity	of	the	drug,	it	feels	like	it	goes	with	
the	music.”	
Emotionality,	
General	
intensification	
14	 “Under	the	influence	of	psilocybin,[the	music]	absolutely	takes	over.”	 General	
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	 intensification	
“Normally	when	I	hear	a	piece	of	sad	music,	or	happy	music,	I	respond	through	
choice,	but	under	psilocybin	I	felt	almost	that	I	had	no	choice	but	to	go	with	the	
music.”	
Emotionality,	Ego-
dissolution	
“And	I	did	feel	like	[the	music]	opened	up	to	grief,	and	I	just	was	very	happy	for	
that	to	happen.”	
Emotionality	
(tearfulness)	
“Primitive	music	felt	like	it	was	taking	me	under,	I	had	no	choice.”	 Ego-dissolution	
“The	patterns	of	the	sound	were	doing	something	to	me	visually,	and	I	
responded	emotionally	to	the	visuals,	and	the	visuals	were	directly	related	to	
the	sound.”	
Emotionality,	
Imagination	
15	 “It’s	so	beautiful	it	just	made	me	cry.”	
Emotionality	
(tearfulness)	
16	
	
“It	changed	the	sort	of	imagery	in	my	head,	it	didn’t	make	it	any	better	or	
worse,	but	it	had	a	definite	impact”	
Imagination	
“It	felt	like	everything	added	towards	the	experience	rather	than	took	away”	
General	
intensification	
17	
	
“The	music	evoked	a	lot	of	emotions.”	 Emotionality	
“I	had	a	sort	of	ecstatic	experience.”	
Emotionality	
(ecstasy)	
“That	seemed	to	be	the	point	at	which	I	was	kind	of	carried	away,	in	this	
ecstatic	rapture.”	
Emotionality	
(ecstasy)	
“Clearly	the	music	enhanced	the	emotional	experience.”	 Emotionality	
“I	suppose	church-type	music,	I	think	was	responsible	for	enhancing	the	
religious	experience.”	
Emotionality	
(spirituality)	
18	
	
“My	experience	seemed	sometimes	to	coincide	with	the	lightness	of	the	music	
into	the	light	place	and	the	darkness	of	the	music	to	the	dark.”	 Emotionality	
“There	was	a	specific	moment	when	I	felt	as	though	I	was	being	given	birth	to	
the	universe,	and	I	semi-recall	there	was	this	sort	of	crescendo	of	music	at	that	
point,	that	was	a	very	strong	point	in	the	journey	for	me.”	
Imagination,	Sense	
of	transcendence	
“When	I	was	born	into	the	universe,	you	know,	everything	dropped	away	apart	
from	these	slight	tethers	that	were	holding	me	back,	and	I	was	into	the	
vastness	of	the	universe,	and	that	could	have	been	when	the	music	stopped,	
because	I	remember	at	that	particular	point	looking	at	this	immense	void	in	
front	of	me.”	
Sense	of	
transcendence	
19	
	
	“The	music	did	affect	[the	experience].”	
General	
intensification	
“The	music	just	made	it	more	emotional.”	 Emotionality	
“Yeah,	it	definitely	served	the	function	of	helping	emotions	flow.”	 Emotionality	
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6.3.2	Welcomed	influences:	Guidance	
The	second	most	prominent	cluster	of	welcomed	influences,	includes	themes	that	depict	the	
music	as	a	source	of	“guidance”.	This	cluster	was	mentioned	by	15	out	of	19	patients	(79%	of	
total).	Within	this	cluster,	statements	that	the	music	provided	a	“sense	of	being	on	a	journey”	
were	identified	in	11	out	of	15	(73%	of	cluster).	This	included	descriptions	of	the	music	being	
experienced	 as	 a	 “vehicle”	 that	 “transports”	 or	 “carries”	 the	 listener	 forward,	 providing	 a	
sensation	of	“traveling”	to	different	psychological	“places”.	
Themes	describing	 the	music	 as	 a	 source	 for	psychological	 “support”	were	 identified	 in	11	
out	of	15	(73%	of	cluster).	This	includes	various	statements	of	the	music	providing	a	sense	of	
“grounding”,	“help”	and	“reassurance”.	 	Descriptions	of	 the	music	being	 in	tune	with,	or	 in	
“resonance”	with	the	person’s	intrinsic	emotional	state	were	identified	in	6	out	of	15	(40%	of	
cluster).	 Rather	 than	 describing	 the	 music	 as	 evoking	 emotion,	 this	 theme	 is	 defined	 by	
statements	 of	 the	music	 being	 experienced	 as	 “fitting”,	 “following”	 or	 “matching”	 present	
emotional	states.	
Finally,	5	out	of	15	of	patients	(33%	of	cluster)	referred	to	the	music	as	providing	a	“sense	of	
continuity	and	direction”,	this	included	statements	of	music	providing	a	sense	of	connection	
between	different	parts	in	the	experience,	making	the	experience	feel	“driven”	by	the	music	
and	 “flowing”	 into	 a	 certain	direction	 (Figure	6.1).	 See	 Table	6.2	 for	 a	 listing	of	 all	 themes	
present	in	the	cluster	“guidance”.	
	
Table	 6.2	 |	Welcomed	 influences:	 Guidance.	A	 list	 of	 all	 the	 themes	 and	 respective	 quotes	 by	 patients,	 that	
were	present	in	the	cluster	“guidance”.	
#	 Quote	 Theme	
1	
	
“I	think	that	it	was	comforting,	knowing	that	the	music	was	there,	because	it	
was	there	the	whole	period,	the	music	was	always	in	the	background,	so	in	in	a	
way	it	grounded	me.”	
Sense	of	support	
“Having	the	music	in	the	background,	it	somehow	just	was	helpful.”	 Sense	of	support	
“[The	music]	gave	me	a	sense	of	safety	during	the	experience.”	 Sense	of	support	
“[The	music]	was	structured	in	line	with	the	way	the	effects	of	the	drug	were.”	 Resonance	
“It	was	there	throughout,	I	think	it	was	just	that	continuity.”	 Sense	of	continuity	
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and	direction	
2	
	
“The	music	was	spot	on	with	my	feeling.”	 Resonance	
“[The	music]	was	following	my	emotion	at	the	time.”	 Resonance	
“I	could	see	that	there	was	a	great	effort	to	put	the	music	together	in	a	way	that	
it	followed	the	experience	as	it	was	meant	to	be.”	
Resonance	
“[The	music	helped	with	the]	relaxation	I	went	through.”	 Sense	of	support	
4	
	
“When	I	had	this	difficult	moment	and	[I	was]	encouraged	to	focus	on	the	music	
and	I	put	the	headphones	on,	the	song	that	came	up	was	very	soothing	and	it	
made	me	calm	down	and	get	out	of	that.”	
Sense	of	support	
“[The	soothing	music]	brought	up	nice	images,	like	I	imagined	I	was	an	unborn	
child	and	I	felt	very	safe.	Every	new	song	could	bring	a	different	image,	and	I	
couldn’t	finish	the	previous	one	that	I	was	thinking	about.	It	was	interesting.”	
Sense	of	support	
6(2
)	
"It	all	just	flowed."	
Sense	of	continuity	
and	direction,	
Sense	of	support	
7	
	
“It	began	quite	ambient-like,	quite	relaxing,	which	I	felt	was	good.	It	calmed	you	
in	the	experience.”	
Sense	of	support	
“[The	music]	made	me	feel	that	I	was	in	different	locations.”	
Sense	of	being	on	a	
journey	
“I	could	almost	picture	myself	there.”	
Sense	of	being	on	a	
journey	
“I	felt	as	if	I	was	travelling.”	
Sense	of	being	on	a	
journey	
9	
	
“And	the	music	felt	really	open	itself.”	 Resonance	
“[Greg	Haines	-	Azure]	just	builds	and	builds.	You're	holding	on	to	an	extent,	you	
just	kind	of	go	up	and	you're	like	‘ok,	where	am	I?	Can	I	go	any	further?’”	
Sense	of	being	on	a	
journey	
“That	saying,	going	in	and	through	it,	really	helped	me	throughout	the	whole	
experience.”	
Sense	of	support	
10	
	
“it	was	all	kind	of	a	journey.”	
Sense	of	continuity	
and	direction,	
Sense	of	being	on	a	
journey	
“It	was	seamless-	apart	from	the	breaks.	But	after	breaks	they	would	put	the	
headphones	in	and	I	would	go	straight	back	into	that	world.”	
Sense	of	continuity	
and	direction	
“Without	it	I	would	have	gone	mad.”	 Sense	of	support	
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11	 “The	most	facilitative	to	the	trip	were	the	straight	on	classical	pieces.”	 Sense	of	support	
12	
	
“[The	music]	helped	with	the	visual	stuff	and	the	mood.”	 Sense	of	support	
It	was	like	a	rollercoaster,	you	move	with	the	music.”	
Sense	of	being	on	a	
journey	
“You	were	led	up	and	then	brought	down	and	led	up.”	
Sense	of	being	on	a	
journey	
“The	music	is	kind	of	changing	your	state	of	mind	almost,	or	putting	you	on	a	
different	resonance.”	
General	
intensification	
13	
	
“I	think	the	way	it	was	guiding	me.	It	was	good.”	 Sense	of	support	
“It’s	[the	music]	definitely	necessary.	It	kind	of	cuts	you	off	from	where	you	are	
at	that	time.”	
Sense	of	being	on	a	
journey	
14	
	
“I	feel	the	music	in	large	part	drove	a	lot	of	the	experience.”	
Sense	of	continuity	
and	direction	
“I	did	feel	as	if	I	was	being	held”	 Sense	of	support	
“[The	music]	took	my	thinking	and	my	experience	to	uncomfortable	places,	but	I	
was	kind	of	reassured	in	the	experience.”	
Sense	of	support	
“There	was	something	there	that	meant	that,	you	know,	‘I’m	going	to	take	you	
on	a	ride	here,	but	I	promise	I	won’t	abandon	you.	It’s	just	going	to	be	tough,	
and	you	know,	you’re	going	through	the	grinder	here,	but	you	won’t	be	left	in	
pieces.’	That	seemed	to	be	what	the	music	was	saying	to	me.”	
Sense	of	support,	
sense	of	being	on	a	
journey	
16	
	
“The	music	took	you	to	the	places	you	needed	to	be.”	
Sense	of	support,	
sense	of	being	on	a	
journey	
“It	felt	we	had	a	profound	relationship,	between	my	heartbeat	and	the	beat	of	
the	music.”	
Resonance	
“It	felt	like	the	music	picked	you	up	and	carried	you	to	the	next	part,	and	the	
next	piece,	and	it	was	the	vehicle	that	moved	you.”	
Sense	of	being	on	a	
journey,	Sense	of	
continuity	and	
direction	
“There	was	a		point	and	I	didn’t	want	music	anymore,	I	didn’t	want	anything	but	
I	definitely	think	the	music	sort	of	transported	there	to	where	you	should	be”	
Sense	of	being	
transported	
“It	felt	like	it	all	fitted	the	experience”	 Resonance	
17	
	
“That	seemed	to	be	the	point	at	which	I	was	kind	of	carried	away,	in	this	
ecstatic	rapture.”	
Sense	of	being	on	a	
journey	
“I	was	able	to	just	put	the	headphones	on	and	the	mask	on,	and	really	enjoy	it.”	 Sense	of	support	
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“The	music	definitely	assisted	me.”	 Sense	of	support	
18	
	
“The	music	both	took	me	to	very	beautiful	places	and	to	incredibly	dark	places.”	
Sense	of	being	on	a	
journey	
“My	experience	seemed	sometimes	to	coincide	with	the	lightness	of	the	music	
into	the	light	place	and	the	darkness	of	the	music	to	the	dark.”	
Resonance	
“I	went	to	a	very	dark	place.”		
Sense	of	being	on	a	
journey	
“It	was	a	woman’s	voice,	it	was	a	sort	of	operatic	voice,	and	first	it	was	beautiful	
because,	you	know,	I	was	following	it	and	it	took	me	to	a	beautiful	place.”	
Sense	of	being	on	a	
journey	
19	 “Yeah,	it	definitely	served	the	function	of	helping	emotions	flow.”	 Sense	of	support	
	
6.3.3	Welcomed	influences:	Calming	
10	out	of	19	patients	(53%	of	total)	described	calming	effects	of	the	music.	From	this	cluster,	
9	out	10	(90%	of	cluster)	described	“general	calming”	effects,	whereas	5	out	of	10	patients	
(50%	 of	 cluster)	 described	 the	 music	 as	 providing	 “mental	 calming”	 effects,	 including	
sensations	 of	 peacefulness	 and	 of	 the	music	 calming	 and	 “slowing	 the	mind”.	 1	 out	 of	 10	
(10%	of	cluster)	described	the	music	to	help	feel	more	physically	relaxed.	Calming	effects	of	
music	often	 referred	 to	ambient	music	by	Brian	Eno,	Harold	Budd	and	Stars	of	 the	 lid.	See	
table	2	for	a	listing	of	all	themes	present	in	more	than	30%	of	the	cluster	“guidance”	(Figure	
6.1).	See	Table	6.3	for	a	listing	of	all	themes	present	in	the	cluster	“calming”.	
	
Table	6.3	|	Welcomed	influences:	calming.	A	list	of	all	the	themes	and	respective	quotes	by	patients,	that	were	
present	in	the	cluster	“calming”.	
#	 Quote	 Theme	
1	
	
“The	music	helped	me	to	be	relaxed.”	 General	calming	
“My	body,	my	breathing,	was	better	when	the	medicine	was	wearing	off,	
because	the	music	was	very	mellow.”	
Physical	calming	
2	
	
“There	was	a	part	of	the	experience	where	I	felt	really	relaxed.	It	was	a	very	
relaxed	music	and	I	was	feeling	very	relaxed,	so	definitely	there	was	an	
influence	there.”	
General	calming	
“[The	music	helped	with	the]	relaxation	I	went	through.”	 General	calming	
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3	
“it	was	all	good	[…]	all	in	the	same	area	where	it	can	get	people	meditating,	or	
releasing,	or	just	chilling	out	to	it.”	
General	calming,	
Mental	calming	
4	
“When	I	had	this	difficult	moment	and	[I	was]	encouraged	to	focus	on	the	music	
and	I	put	the	headphones	on,	the	song	that	came	up	was	very	soothing	and	it	
made	me	calm	down	and	get	out	of	that.”	
General	calming,	
Mental	calming	
6(1
)	
	
"It	was	relief,	because	I	hadn't	liked	the	ones	before."	 General	calming	
"Just	relief	really	when	I	just	felt	oh,	its	ok,	its	ok."	 General	calming	
7	
	
“It	began	quite	ambient-like,	quite	relaxing,	which	I	felt	was	good.	It	calmed	you	
in	the	experience.”	
General	calming	
“It	did	help	to	calm	and	slow	the	mind.”	 Mental	calming	
9	
“[Greg	Haines	-	Azure]	really	really	beautiful,	overwhelming,	but	really	peaceful	
as	well.”		
Mental	calming	
10	
	
“More	often	than	not	I	was	sort	of	peaceful.”	 Mental	calming	
“I	was	really	calm	and	peaceful	and	relaxed.”	
General	calming,	
Mental	calming	
13	
“And	particularly	once	it	starts	to	mellow	out	towards	the	end,	you	do	feel	that	
more	relaxed.”	
General	calming	
15	 “There	was	a	piece	that	was	quite	calming,	so	that	was	very	positive.”	 General	calming	
	
6.3.4	Welcomed	influences:	Openness	to	music-evoked	experience	
7	out	of	19	patients	 (37%	of	 total)	made	statements	about	 their	own	attitude	of	openness	
towards	 the	 influences	 of	 the	music,	 and	 in	 addition,	 about	 the	 effects	 of	music	 on	 their	
attitude	 of	 openness.	 From	 this	 cluster,	 6	 out	 of	 7	 (86%	 of	 cluster),	 referred	 to	 the	
“importance”	 and	 the	 “purpose”	of	 being	open	 to	 “challenging	experience”	 evoked	by	 the	
music,	 and	 that	 this	 felt	 like	 an	 important	 part	 of	 the	 therapeutic	 process.	 This	 included	
statements	 of	 accepting	 being	 deeply	 emotionally	 moved	 by	 the	 music,	 and	 the	 music	
helping	to	“face”	or	“connect	with”	the	listener’s	“unresolved”	inner	conflicts.	4	out	of	7	(57%	
of	 cluster)	 described	 that	 some	 music	 specifically	 helped	 to	 enhance	 their	 attitude	 of	
openness,	such	as	statements	that	“the	music	opened	[him/her]	up”	or	that	because	of	the	
music	was	 “well-chosen”,	 the	 listener	 “felt	 open	 to	 it	 all”	 (Figure	 6.1).	 See	 Table	 6.4	 for	 a	
listing	of	all	themes	present	in	the	cluster	“openness	to	music-evoked	experience”.	
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Table	6.4	|	Welcomed	influences:	openness	to	music-evoked	experience.	A	list	of	all	the	themes	and	respective	
quotes	by	patients,	that	were	present	in	the	cluster	“intensification”.	
#	 Quote	 Theme	
3	
“That’s	not	what	it’s	about,	just	skipping	to	the	next	track	to	the	good	stuff.		It’s	
there,	that	you	don’t	like	it,	then	deal	with	it	(chuckles),	so	that’s	our	approach.”		
Openness	to	
challenging	
experience	feels	
therapeutic	
4	
	
“I	didn’t	like	the	emotional	music	the	first	experience	because	I	didn’t	want	to	
cry,	but	actually,	you	know,	the	second	time	I	sort	of	enjoyed	crying	to	this	
music.”	
Openness	to	
challenging	
experience	feels	
therapeutic	
“In	the	first	experience	I	was	a	bit	annoyed	that	this	music	is	too	emotional,	but	
I’m	sort	of	thinking	it	was	good	for	me,	so	I	wouldn’t	consider	it	as	bad	in	the	
end.”	
Openness	to	
challenging	
experience	feels	
therapeutic	
6(2
)	
"It	all	flowed,	I	opened	myself	to	it,	and	it	was	totally	positive."	
Music	facilitates	
Openness	
9	
	
“As	far	as	positivity	goes	it	was	amazing.	Yeah,	really,	really,	really	helped	to	
open	me	up...	[The	music]	really	opened	things	up.”	
Music	facilitates	
Openness	
“I	can	even	view	the	negative	moments	as	positive	in	a	way	because	they	
served	a	purpose.	The	purpose	was	to	sort	of	let	me	face	the	darkness,	and	my	
demons,	I	guess.	It	was	beautiful	at	times,	but	also…	yeah,	the	darker	moments	
really	helped	to	reflect	on	and	connect	with	your	demons,	your	unresolved	
shadows.”	
Openness	to	
challenging	
experience	feels	
therapeutic	
“[Henry	Gorecki	–	Symphony	of	sorrowful	songs]	was	uncomfortable,	but	not	
bad.		That	was	necessary	I	feel.”	
Openness	to	
challenging	
experience	feels	
therapeutic	
“There's	the	odd	chord	change	as	well	within	other	parts	of	the	music,	that	
affected	me	negatively,	but	that	all	served	a	purpose.”	
Openness	to	
challenging	
experience	feels	
therapeutic	
“It	wasn't	like	having	Justin	Bieber	for	6	hours,	‘everything's	jolly	and	light	and	
bright	and	saccharine!’”	
Openness	to	
challenging	
experience	feels	
therapeutic	
“It	was	such	a	well	chosen	playlist	I	felt	that	I	was	opened	to	all	of	it."	
Music	facilitates	
openness	
12	 “[Experiencing	a	challenging	influence	of	the	music]	wasn’t	a	bad	thing	you	
Openness	to	
challenging	
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know,	it	opened	you	up.”	 experience	feels	
therapeutic	
Music	facilitates	
Openness	
14	
	
“And	I	did	feel	like	[the	music]	opened	up	to	grief,	and	I	just	was	very	happy	for	
that	to	happen.”	
Openness	to	
challenging	
experience	feels	
therapeutic	
Music	facilitates	
Openness	
“It	wasn’t	particularly	pleasant	in	any	way,	but	extraordinarily	powerful.”	
Openness	to	
challenging	
experience	feels	
therapeutic	
16	
“There	was	a	point	and	I	didn’t	want	music	anymore,	I	didn’t	want	anything,	but	
I	definitely	think	the	music	sort	of	transported	there	to	where	you	should	be”	
Openness	to	
challenging	
experience	feels	
therapeutic	
	
	
6.3.5	Unwelcomed	influences:	Intensification	
The	most	prominent	cluster,	including	5	out	of	10	patients	(50%	of	cluster),	described	music	
to	“intensify”	emotions	they	did	not	want	to	feel,	such	as	increased	“fearfulness”,	“sadness”	
or	 “fear”.	 In	 addition,	 5	 out	 of	 10	 (50%	of	 cluster)	 said	made	 statements	 about	 the	music	
creating	 a	 sense	 of	 “discomfort”,	 including	 “unpleasant”	 or	 “uncomfortable”	 experiences,	
and	4	out	of	10	(40%	of	cluster)	described	“irritation”	as	a	consequence	of	the	music.	In	less	
than	30%	of	 the	 cluster,	 the	music	was	described	as	bringing	mental	 imagery,	 thoughts	or	
memories	 that	were	unwelcomed,	 a	 sense	of	 puzzlement,	 inner	 conflict,	 and	 tension,	 or	 a	
“dark	atmosphere”.	This	cluster	of	unwelcomed	“intensification”	influences,	forms	a	contrast	
with	the	cluster	of	themes	describing	intensification	as	a	welcomed	influence	(Figure	6.1	and	
Table	 6.1).	 See	 Table	 6.5	 for	 a	 listing	 of	 all	 themes	 present	 in	 the	 cluster	 unwelcomed	
“intensification”.		
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Table	6.5	|	Unwelcomed	influences:	 intensification.	A	list	of	all	the	themes	and	respective	quotes	by	patients,	
that	were	present	in	the	cluster	“intensification”.	
#	 Quote	 Theme	
3	
“It	was	crazy,	it	was	like:	change	the	song,	please	change	the	song!	[Interviewer:	
Like	a	discomfort?],	big	time.”	
Discomfort	
4	
	
“Very	trippy	music,	making	me	more	scared	when	I	had	this	difficult	phase,	that	I	
was	thinking	‘ah,	I’m	going	crazy!’”		
Emotionality	(fear)	
“In	the	first	experience	I	was	a	bit	annoyed	that	this	music	is	too	emotional”	 Irritation	
“I	didn’t	like	the	emotional	music	the	first	experience	because	I	didn’t	want	to	
cry.”	
Emotionality	
(tearfulness)	
5	
“My	response	to	the	music	was	one	of	fear,	I	guess,	in	part,	because	I	viewed	
part	of	the	music	as	this	really	sombre,	serious,	negative,	cynical	way	of	thinking,	
like	it	was	my	funeral,	or	like	something	really	profound	was	about	to	happen,	or	
death.	And	it	was	the	music	that	was	informing	that	feeling.”	
Emotionality	(fear,	
sadness),	
Imagination,	
personal	thoughts	
or	memories	
“In	the	period	where	it	wasn’t	so	intense,	when	I	cried	a	lot,	the	music	elicited	
that	sort	of	response.”	
Emotionality	
(tearfulness)	
“It	accentuated	any	sense	of	like…		emotional	music,	it	just	made	me	even	
sadder.”	
Emotionality	
(sadness)	
6(1)	
	
"A	sense	of	irritation,	frustration,	and	sense	of	lowering	mood."	
Irritation,	
Emotionality	
(sadness)	
"It's	music	that	I	can't	listen	to,	I	find	it	irritating	or	agitating."	 Irritation	
"I	felt	quite	torn."	 Inner	conflict	
7	
“Creating	puzzlement	rather	than	just	accepting	the	music.	[…]	‘Why	is	that	
person	singing	it	in	that	particular	way?’	and	I	felt	myself	spending	a	lot	of	time	
thinking	about	that.	Trying	to	work	out	why	she	was	singing	it	in	that	particular	
style.”	
Puzzlement	
9	
“[Some	of	the	music	influenced	the	experience	by]	making	things	seem	darker.”	 Dark	atmosphere	
“Uncomfortable	chord	changes.”	 Discomfort	
13	 “With	a	higher	tempo	everything	feels	a	bit	more	tense.”	 Tension	
15	
“I	wanted	to	explore	a	certain	experience	or	vision,	but	the	music	changed	that.	
I	was	experiencing	these	geometric	shapes	which	were	seeming	to	construct	
themselves	into	something	that	I	was	beginning	to	understand,	but	then	the	
music	interrupted	that	and	changed	it	and	I	was	slightly	annoyed	by	that.”	
Irritation	
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“The	piano	pieces,	irritated	me.	It	was	like	little	needles.”	
Irritation,	
Discomfort	
“The	piano	playing	was	irritating,	because	I	found	it	quite	amateurish.”	 Irritation	
17	
“There	was	some	sort	of	Indian-style	music,	I	think	I	found	it	a	bit	creepy	at	the	
time.”	
Emotionality	(fear)	
19	
“Made	me	a	bit	more	emotional,	more	vulnerable.”	 Emotionality	
“A	bit	annoying”	 irritation	
“What	I	was	experiencing	at	the	time,	it	was	you	know,	unpleasant”	 Discomfort	
“Made	me	feel	‘uurgh’”	 Irritation	
“Some	of	[the	music]	was	uncomfortable.”	 Discomfort	
	
6.3.6	Unwelcomed	influences:	Resistance	to	music-evoked	experience	
9	 out	 of	 19	 patients	 (47%	 of	 total)	 described	 feelings	 of	 “resistance	 to	 the	music-evoked	
experience”.	This	includes	statements	of	“not	liking”	or	“not	wanting”	the	subjective	effects	
of	 the	 music.	 This	 cluster	 of	 unwelcomed	 influences	 contrasts	 the	 cluster	 of	 themes	
describing	an	“openness	 to	music-evoked	experience”,	as	a	welcomed	 influence	 (see	Table	
6.4	and	Figure	6.1).	See	Table	6.6	for	a	full	list	of	all	themes	in	the	cluster	“intensification”.	
	
Table	 6.6	 |	 Unwelcomed	 influences:	 resistance	 to	 music-evoked	 experience.	 A	 list	 of	 all	 the	 themes	 and	
respective	quotes	by	patients,	that	were	present	in	the	cluster	“resistance	to	music-evoked	experience”.	
#	 Quote	 Theme	
3	
“It	was	crazy,	it	was	like:	change	the	song,	please	change	the	song!	
[Interviewer:	Like	a	discomfort?],	big	time.”	
Music	facilitates	
resistance	
4	
“I	didn’t	like	the	emotional	music	the	first	experience	because	I	didn’t	want	to	
cry.”	
Music	facilitates	
resistance	
5	
	“I	worried	that	I	let	[the	music]	shape	this	sort	of	melancholy.”	
Music	facilitates	
resistance	
“There	was	resistance,	massively,	to	everything,	every	sort	of	sensory	input	I	
had	a	fearful	response.	I	was	afraid	to	open	my	eyes,	I	was	afraid	to	do	
anything,	I	was	afraid	that	this	sort	of	music	was	the	last	thing	I’d	ever	hear.”	
Music	facilitates	
resistance	
“But	I	listen	to	a	lot	of	similar	kind	of	music	on	my	own,	so	obviously,	it	does	
move	me,	whether	or	not	I	admit	that,	it	does	shape	my	emotions	and	my	
Music	facilitates	
resistance	
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moods.”	
6(1)	 "I	was	trying	to	suppress	[the	anger]."	
Music	facilitates	
resistance	
7	
“Creating	puzzlement	rather	than	just	accepting	the	music.	[…]	‘Why	is	that	
person	singing	it	in	that	particular	way?’	and	I	felt	myself	spending	a	lot	of	time	
thinking	about	that.	Trying	to	work	out	why	she	was	singing	it	in	that	particular	
style.”	
Music	facilitates	
resistance	
9	 “There	were	times	when	I	thought	‘I	don't	like	the	effect	of	this,	on	me.’”	
Music	facilitates	
resistance	
14	
“I	noticed	I	didn’t	wanna	hang	around	for	the	last	hour,	that	version	of	Joe	
Cocker,	‘Love	Lift	Us	Up’.”	
Music	facilitates	
resistance	
“That	is	my	issue	sometimes,	not	being	willing	to	go	with	the	experience	[of	
disliked	music],	but	there’s	a	lesson	in	there	for	me.”	
Music	facilitates	
resistance	
15	
“It	was	very	difficult	to	totally	let	go	because	I	thought	that,	I	felt	that	if	I	totally	
let	go	I	might	not	be	able	to	bring	myself	back.”	
Music	facilitates	
resistance	
16	 “There	was	a	point,	and	I	didn’t	want	music	anymore,	I	didn’t	want	anything.”	
Music	facilitates	
resistance	
	
	
6.3.7	Unwelcomed	influences:	Misguidance	
6	 out	 of	 19	 (32%	 of	 total)	 made	 statements	 about	 the	 music	 providing	 a	 sense	 of	
“misguidance”,	this	cluster	primarily	includes	descriptions	of	the	music	being	a	“mismatch”	or	
being	 incongruent	 with	 the	 unfolding	 subjective	 experience.	 This	 cluster,	 named	
“dissonance”,	 was	 present	 in	 4	 out	 of	 6	 (67%	 of	 cluster),	 and	 forms	 a	 contrast	 with	 the	
welcome	influence	“resonance”,	when	the	music	was	experienced	as	harmonious,	or	a	good	
match,	with	 the	 subjective	 experience.	Other	 themes	 of	misguidance,	 present	 in	 less	 than	
30%,	 include	 descriptions	 of	 the	 “music	 feeling	 intrusive”,	 the	 music	 being	 “unable	 to	
positively	 influence	 a	 challenging	 experience”,	 the	 music	 giving	 a	 “sense	 of	 being	
manipulated”,	the	music	giving	a	“sense	of	unmet	potential”,	or	the	music	giving	a	sense	of	
“foreboding”,	 as	 if	 something	 “bad”	 was	 going	 to	 happen.	 This	 cluster	 of	 unwelcomed	
influence	 contrasts	 the	 cluster	 of	 themes	 describing	 a	 sense	 of	 “supportive”	 and	 “helpful”	
guidance,	as	a	welcomed	influence	(see	Table	6.2	and	Figure	6.1).	See	Table	6.7	for	a	full	list	
of	all	themes	in	the	cluster	“misguidance”.	
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Table	6.7	|	Unwelcomed	influences:	misguidance.	A	list	of	all	the	themes	and	respective	quotes	by	patients,	that	
were	present	in	the	cluster	“misguidance”.	
#	 Quote	 Theme	
5	
	
“My	response	to	the	music	was	one	of	fear,	I	guess,	in	part,	because	I	viewed	
part	of	the	music	as	this	really	sombre,	serious,	negative,	cynical	way	of	
thinking,	like	it	was	my	funeral,	or	like	something	really	profound	was	about	to	
happen,	or	death.	And	it	was	the	music	that	was	informing	that	feeling.”	
Sense	of	
foreboding	
“Everything	was	like	‘aaaaahh	you’re	about	to	die!’	(singing	in	dramatic	voice).”	
Sense	of	
foreboding	
6(1
)	
	
"To	me	[the	music]	didn't	feel	real."	 Dissonance	
"I	was	sort	of	feeling	bad,	because	I	wanted	to	work	with	it."	
Sense	of	unmet	
potential	
"I	sensed	the	potential	for	a	really	profound	experience,	but	I	couldn't	meet	
[that	potential]	with	music	that	I	felt	was	quite	mediocre."	
Sense	of	unmet	
potential	
14	
I’ve	heard	classical	music	perform	live	and	wonderfully,	but	I’m	kind	of	
suspicious	of	it	now.	There’s	something	malevolent	in	it,	maybe	not	totally,	but	
from	its	inspirations,	because	it	was	intended	to	be	nationalistic	and	patriotic.”	
Sense	of	being	
manipulated	
15	
	
“I	was	very	aware	of	the	influence	of	the	music,	which	I	found	at	times	
intrusive.”	
Music	feeling	
intrusive,	
Dissonance	
“The	music	was	discordant”	 Dissonance	
“I	just	found	it	[the	piano	music]	grating.	Intrusive	even.	Maybe	the	way	it	was	
being	played.”		
Music	feeling	
intrusive	
18	
“I	went	to	a	very	dark	place	with	that	beautiful	music	still	playing	for	a	while,	
and	then	it	got	darker.	The	music	didn’t	get	dark	and	then	I	went	to	the	dark	
place,	I	went	to	the	dark	place	with	the	light	mystical	music.”	
Dissonance,	Music	
unable	to	positively	
influence	
challenging	
experience	
“There	was	a	kind	of	out-of-place	piano,	that	was	almost	sort	of	‘hunky-tunky’,	
but	that	just	didn’t	sort	of	fit	really.”	
Dissonance	
“I	think	the	music	lured	me	to	this	beautiful	place,	and	then	things	started	to	
become	dark	even	with	this	beautiful	music	still	playing.”	
Music	unable	to	
positively	influence	
challenging	
experience	
“I	can	remember	thinking	‘this	is	beautiful	music,	why	am	I	going	to	this	dark	
place?’	It	didn’t	line	up	with	what	had	gone	on	before,	you	know,	that	pattern.	I	
just	felt	as	if	I	was	being	manipulated,	being	duped	almost.”	
Dissonance,	Sense	
of	being	
manipulated	
“A	little	conversely,	the	light	music	at	one	point	took	me	to	a	place	where	I	 Sense	of	being	
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thought	I	was	safe,	and	it	became	unsafe,	and	the	music	was	playing	a	trick	with	
me,	you	know,	sort	of	giving	me	a	false	sense	of	security.”	
manipulated	
I	think	really	only	that	that	luring	beautiful	woman’s	voice	that	took	me	initially	
to	a	beautiful	place,	and	then	it	took	me	to	a	really	bad	place.	A	really	bad	
place.”	
Transportation	to	
“bad	place”	
“That	was	profound,	because	it	was	as	though	there	was	somebody	
orchestrating	that,	somebody	manipulating	that,	you	know,	not	in	a	good	way.”	
Sense	of	being	
manipulated	
19	 “I	couldn’t	connect	with	the	music.”	 Dissonance	
	
	
	
	
	
Figure	 6.2	 |	 Appreciated	 an	 unappreciated	 music	 styles	 and	 playlist	 features.	 Appreciated	 music	 styles	 and	
features	are	displayed	on	the	left,	in	green,	and	un-appreciated	influences	are	displayed	on	the	right,	in	red.	The	
figure	only	displays	cluster	present	in	more	than	30%	of	all	participants,	and	per	cluster	the	themes	that	were	
present	in	more	than	30%	of	the	cluster.	The	numbers	below	the	group-,	cluster-	or	theme-name,	refers	to	the	
total	number	of	patients	that	referred	to	this.	The	size	of	the	circle	is	proportional	to	the	percentage	of	patients	
referring	to	the	group,	cluster	or	theme.	
	167	
6.3.8	Appreciated	music	styles	and	playlist	features:	Music	styles	
All	 19	 patients	 referred	 to	 some	music	 styles	within	 the	music	 playlist	 that	 they	 especially	
appreciated	 (Figure	6.2).	Most	 frequent	were	positive	 statements	about	“ethnic	or	cultural	
music”,	 present	 in	 8	 out	 of	 19	 patients	 (42%	 of	 cluster),	 such	 as	 “Indian”,	 “Spanish”	 or	
“African”	music	 styles	 (e.g.	 Jon	Hassel,	 Ry	 Cooder	&	 Ronu	majumdar).	 Positive	 statements	
about	music	 with	 human	 voice	were	mentioned	 by	 7	 out	 of	 19	 patients	 (37%	 of	 cluster).	
Importantly,	 this	 refers	 to	vocal	music	either	without	 lyrics	or	music	with	 lyrics	 in	a	 foreign	
language	 (e.g.	 The	 Journey	 by	 Ludivoco	 Enaudi,	 and	 Enya’s	 sumiregusa).	 One	 other	music	
style	that	was	frequently	appreciated	by	7	out	of	19	(37%	of	cluster),	was	neo-classical	music	
(e.g.	Max	 Richter	 or	 Olafur	 Arnalds)	 or	 classical	 music	 (e.g.	 Henryk	 Gorecki	 or	 Arvo	 Part).	
Apart	 from	these	styles,	 the	appreciated	music	styles	showed	a	noticeable	diversity.	 In	 less	
than	30%,	positive	statements	were	directed	to	“music	with	crescendo”	(5	out	of	19,	26%	of	
total),	“powerful	music”	(4	out	of	19,	21%	of	total),	and	only	1	to	2	out	of	19	made	explicit	
statements	about	their	appreciation	for	specific	instruments,	such	as	violin,	guitar,	piano,	or	
“music	with	 a	 solid	 drone”.	 See	 table	 6.8	 for	 a	 full	 listing	 of	 all	 themes	 referring	 to	music	
styles	that	were	explicitly	appreciated.	
	
Table	6.8	|	Appreciated	music	styles	and	playlist	features:	music	styles.	A	list	of	all	the	themes	and	respective	
quotes	by	patients,	that	were	present	in	the	cluster	“music	styles”.	
#	 Quote	 Theme	
1	
“I	liked	the	piano	pieces.”	 Piano	music	
“A	Spanish	piece	with	a	guitar	and	the	singing,	that	was	quite	beautiful,	I	still	
remember	that	one.”	
Ethnic	or	cultural	
music	(Spanish),	
Guitar	music,	Vocal	
music	
“Like	I	said	there	was	a	Spanish	piece	and	there	was	a	piece	that	sounded	more	
African.”	
Ethnic	or	cultural	
music	(Spanish,	
African)	
2	
“It	was	a	song	that	is	quite	special	to	me,	there	was	the	one	in	Spanish,	I	knew	
what	it	was	saying.	It’s	a	very	popular	song,	especially	for	people	of	my	age.”	
Ethnic	or	cultural	
music	(Spanish),	
Familiar	music	
“I	think	the	one	that	I	liked	the	most	was	the	one	in	the	beginning,	sort	of	film-
like	music?”	
Cinematic	music	
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“There	was	some	sort	of	activity	going	on	and	a	suspense,	and	I	did	like	that	
one.”	
Cinematic	music	
“There	was	activity	going	on	and	at	the	same	time	some	feeling	of	expected,	
which	you	would	see	in	film,	a	soundtrack.”	
Cinematic	music	
3	
“At	the	end	where	there	were	more	words,	which	was	pretty	good.	I	respect	
that	maybe	in	the	beginning	I	wouldn’t	have	appreciated	that	as	much,	when	
the	drug	was	at	its	most	intense.”	
Vocal	music	
“There	was	an	“African”	song,	where,	I	think	they’re	singing	about	“our	father”	
or	something?	And	it	was	just	a	whole	bunch	of	voices	most	of	the	time	in	the	
song,	which	was	pretty	good.”	
Ethnic	or	cultural	
music	(African)	
“There	was	one	that	just	built	up,	[Greg	Haines	–	Azure]	was	one	example	
where	in	the	beginning	it	just	sounds	like	someone	is	just	hitting	sh*t	randomly	
in	his	music	room	and	then	it	all	comes	together	in	the	end	and	blows	your	
mind.”	
Music	with	
crescendo,	
powerful	music	
“Those	aspects	of	it	where	it’s	like,	slightly…	surprising.	It	just	builds	up,	and	
with	it	your	emotion	goes	with	that	and	the	happy	feeling,	and	its	like	all	
connected.”	
Music	with	surprise	
4	
“[The	soothing	music]	brought	up	nice	images.”	 Soothing	music	
“The	second	time	I	sort	of	enjoyed	crying	to	this	music.”	 Emotional	music	
5	 “African-like	music	tapped	into	some	deeper,	more	ancient	part.”		
Ethnic	or	cultural	
music	(African)	
6(2)	
"I	knew	lots	of	the	music."	 Familiar	music	
"I	felt	joy	of	the	existence	of	Bach."	
Classical	or	neo-
classical	music	
7	
“It	began	quite	ambient-like,	quite	relaxing,	which	I	felt	was	good.	It	calmed	you	
in	the	experience.”	
Ambient	music	
“Arabian	music	was	quite	strong.”	
Ethnic	or	cultural	
music	(Arabic),	
Powerful	music	
“With	instrumental	music	[the	story]	is	left	to	you.”	 Instrumental	music	
“I	preferred	ambient	music,	and	more	broadly	I	preferred	the	music	without	
lyrics.”	
Music	selection	
8	
"Quite	liked	the	sort	of	more	operatic	one,	with	the	lady	that	sang	in	Italian."	
Vocal	music	
(female),	Choral	or	
opera-like	music	
"Guitar	playing,	like	a	solo,	I	really	liked	that	one."	 Guitar	music	
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"Some	parts	being	more	energetic,	and	more	sort	of	driven."	 Energetic	music	
"Other	things	being	more	quiet	and	subtle,	and	maybe	encouraging	reflection."	 Calming	music	
9	
“[Henry	Gorecki	–	Symphony	of	sorrowful	songs]	starts	off	very	nice	chorally	
and	then	it	goes	off	into	a	more	kind	of	uncertain	dark	place	and	then	comes	
back	to	the	choral	part	again.”	
Dynamic	music,	
Choral	or	opera-
like	music	
“[Greg	Haines	-	Azure]	I	felt	like	I	was	sort	of	the	highest	I	could	get,	it	was	like	
the	absolute,	the	top	of	everything.”	
Powerful	music	
“I	thought	ambient	music	would've	resonated	more	with	me	than	the	rest”	 Ambient	music	
“I'm	not	a	massive	classical	music	fan,	but	the	classical	pieces	that	were	there	
worked	really	well.”	
Classical	or	
neoclassical	music	
“[Greg	Haines	-	Azure]	just	builds	and	builds.	You're	holding	on	to	an	extent,	
you	just	kind	of	go	up	and	you're	like	‘ok,	where	am	I?	Can	I	go	any	further?’”	
Music	with	
crescendo	
10	
“It	was	more	upbeat,	so	it	was	almost	like	it	was	arousing	me	from	my	
slumber.”	
Energetic	music	
11	
“Indian	music,	where	I	was	seeing	an	Indian	temple.”	
Ethnic	or	cultural	
music	(Indian)	
“For	me	what	worked	best	in	the	sense	of	being	the	most	facilitative	to	the	trip,	
were	the	straight	on	classical	pieces.”		
Classical	or	neo-
classical	music	
“I	recognized	a	couple	of	pieces,	those	were	very	strong	for	me.”	 Familiar	music	
“During	that	same	Indian	piece,	that’s	when	I	was	dancing	for	Shiva	and	then	I	
was	Shiva.”	
Ethnic	or	cultural	
music	(Indian)	
“Some	Celtic	music.”	
Ethnic	or	cultural	
music	(Celtic)	
“That’s	just	what	I	normally	respond	to.”	 Familiar	music	
“Pieces	that	had	a	solid	drone	to	them	drew	me	right	in”	 Drone	music	
“The	drone,	it	was	the	chanted	repetition	of	that,	it	was	the	layering	of	the	
other	voices	and	the	other	instruments	and	the	other	syncopation	and	the	
rhythm	as	they	would	all	come	in	and	just	build.”	
Drone	music,	Vocal	
music	(chanting),	
Music	with	
regularity,	Music	
with	rhythm,	Music	
with	crescendo	
12	
“The	violin	music,	it	was	stunningly	beautiful.”	
Violin	music,	
Classical	or	neo-
classical	music	
“[The	violin	music	was]	very	beautiful.	It’s	one	of	my	favourite	kind	of	
instruments.”	
Violin	music	
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13	
“As	the	energy	[in	the	music]	kind	of	builds	upward,	it	reaches	a	tension	point.”	
Music	with	
crescendo	
“But	at	the	same	time	I	kind	of	think	that	the	other	higher	intensity	stuff	is	
probably	necessary,	I	think,	to	get	you	along.”	
Powerful	music	
14	
"Primitive	and	deep	“African”	music,	it	wasn’t	particularly	pleasant	in	any	way,	
but	extraordinarily	powerful”	
Ethnic	and	cultural	
music	(African)	
“The	Composer	has	stayed	true	to	his	or	her	own	intuition	or	inspiration.	
Almost	the	antithesis	to	the	Bach	and	the	Brahms,	which	I	felt	were	terribly	
contrived.”	
Authentic	music	
“There	was	something	in	the	regularity,	but	also	the	pattern,	the	pattern	of	it.	I	
seem	to	be	responding	to	the	patterns	of	the	sound.””	
Music	with	
regularity		
15	
“One	of	the	vocal	tracks	reminded	me	of	one	of	Nusrat	Fateh	Ali	Khan’s	tracks,	
Yeni	Yeniden,	it’s	so	beautiful	it	just	made	me	cry.”		
Familiar	music	
[interviewer:	were	there	any	ones	that	you	had	a	particular	preference	for?]	
“Yeah,	the	classical	pieces.”	
Classical	or	neo-
classical	music	
16	
“There	were	some	[that	I	preferred],	a	man’s	voice.	The	experience	changed	
when	there	was	a	voice,	from	when	it	was	just	music.”	
Vocal	music	(male)	
17	
“I	heard	the	beginning	of	one	of	my	favourite	pieces	of	music.	Beethoven’s	
Emperor	Piano	Concerto,	the	second	movement.”	
Familiar	music,	
Classical	or	neo-
classical	music	
“I	preferred	I	suppose	(chuckles)	the	sort	of	Classic	FM	stuff	on	the	whole.”	
Classical	or	neo-
classical	music	
“I	suppose	church-type	music,	I	think	was	responsible	for	enhancing	the	
religious	experience.”	
Choral	or	opera-
like	music	
“I	think	it	was	probably	the	great	works	of	classical	music	that	I	preferred.”		
Classical	or	neo-
classical	music	
“Great	works	of	music	by	great	composers,	it’s	normally	expected	to	sort	of	
move	you	more.”	
Classical	or	neo-
classical	music	
“I	think	[classical	music]	was	more	moving.”	
Classical	or	neo-
classical	music	
18	
“There	was	a	woman’s	beautiful	voice.”	
Vocal	music	
(female)	
“There	was	a	specific	moment	when	I	felt	as	though	I	was	being	given	birth	to	
the	universe,	and	I	semi-recall	there	was	this	sort	of	crescendo	of	music	at	that	
point,	that	was	a	very	strong	point	in	the	journey	for	me.”	
Music	with	
crescendo	
19	 “The	Mexican	song	I	thought	was	quite	good.”	 Ethnic	or	cultural	
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6.3.9	Appreciated	music	styles	and	playlist	features:	Playlist	design	
17	out	of	19	patients	(89%	of	total)	made	statements	reflecting	appreciation	for	the	design	of	
the	playlist	(Figure	6.2).	Most	prominent	were	positive	descriptions	of	the	“music	selection”,	
described	 by	 12	 out	 of	 17	 patients	 (71%	 of	 cluster),	 including	 descriptions	 of	 the	 music	
“working	 well”	 or	 being	 “well-selected”.	 Secondly,	 9	 out	 of	 17	 patients	 (53%	 of	 cluster),	
provided	positive	descriptions	on	the	way	the	music	was	structured	into	the	full	playlist.	This	
theme,	named	“music	order”,	is	defined	by	statements	of	the	“structure”	and	the	“ordering”	
of	the	music	playlist,	“aligned”	well	with	the	drug-effects.	The	third	most	prominent	theme,	
present	 in	 6	 out	 of	 17	 (35%),	 corresponds	 to	 the	 “music	 presence”,	 meaning	 the	 mere	
presence	 of	 the	 music	 itself.	 This	 includes	 descriptions	 from	 the	 music	 being	 present	 as	
“helpful”,	to	statements	that	it	couldn’t	be	imaginable	doing	the	sessions	without	it	and	that	
the	music	presence	felt	“necessary”.	Finally,	other	themes	include	appreciation	for	“calming	
music”	 to	 be	 played	 mainly	 during	 “onset”,	 “ascent”	 and	 “return”	 phases,	 whereas	 more	
emotive	music	(i.e.	“sentimental”	or	“cinematic”	music)	to	be	better	reserved	for	late	in	the	
“ascent”	 phase	 and	 during	 “peak”	 phase.	 See	 Table	 6.9	 for	 a	 full	 listing	 of	 all	 themes	
describing	playlist	design	features	that	were	appreciated.	
	
	
music	(Mexican)	
“The	Spanish	guitar	song	was	probably	my	favourite	track	out	of	all	of	them,	
with	a	man	singing.”	
Ethnic	or	cultural	
music	(Spanish),	
Guitar	music,	Vocal	
music	(male)	
“It’s	a	classical	track	that	was	on	both	[playlists].	Probably	a	bit	overused	in	the	
media,	but	an	emotive	piece	of	music.”	
Classical	or	neo-
classical	music	
“Because	I	play	guitar,	and	I	can’t	play	piano,	I	find	guitar	music	more	
accessible.”		
Guitar	music,	music	
with	personal	
connection	
“Like	the	kind	of	world	music	as	well,	it’s	more	interesting.”	
Ethnic	or	cultural	
music	
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Table	6.9	|	Appreciated	music	styles	and	playlist	features:	playlist	design.	A	list	of	all	the	themes	and	respective	
quotes	by	patients,	that	were	present	in	the	cluster	“playlist	features”.	
#	 Quote	 Theme	
1	
“I	liked	that	there	was	a	lot	of	variety.”	 Variety	
“Gentle	at	the	beginning,	I	think	that	that	did	help.”	
Calming	music	in	
pre-onset	
“Having	the	music	in	the	background,	it	somehow	just	was	helpful.”	 Music	presence	
“I	think	that	that	it	was	comforting,	knowing	that	the	music	was	there.”	 Music	presence	
“Variations	in	the	degree	of	the	music	and	the	intensity	of	it.	Some	of	it	was	
more	mellow,	some	of	it	more	forceful.”	
Variety	
“[The	music]	was	structured	in	line	with	the	way	the	effects	of	the	drug	were.”	 Music	order	
“I	think	that	the	music,	because	it	was	so	varied	I	think	it	did	kind	of	make	you	
think	a	bit.”	
Variety	
2	
“I	think	the	one	that	I	liked	the	most	was	the	one	in	the	beginning,	sort	of	film-
like	music?”	
Cinematic	music	in	
ascent-phase	
“I	could	see	that	there	was	a	great	effort	to	put	the	music	together	in	a	way	that	
it	followed	the	experience	as	it	was	meant	to	be.”	
Music	order	
“The	fact	that	it	was	put	together	in	that	sequence	made	sense.”	 Music	order	
“[The	playlist	was]	made	in	a	sort	of	logical	order.	It	had	some	sort	of	beginning,	
halfway	through,	and	then	the	end,	it	was	logical,	it	was	good.”	
Music	order	
3	
“There	was	quite	a	variance.”	 Variety	
“And	most	of	it	was	good,	because	it	was	flipping	good	music.”	 Music	selection	
“It	was	all	good.”	 Music	selection	
“I	don’t	know	which	one	I’d	say	I	prefer.	I	liked	them.”	 Music	selection	
“[The	music]	had	their	moments	for	each	time	of	the	dosage.”	 Music	order	
“At	the	end	where	there	were	more	words,	which	was	pretty	good.	I	respect	
that	maybe	in	the	beginning	I	wouldn’t	have	appreciated	that	as	much,	when	
the	drug	was	at	its	most	intense.”	
Vocal	music	during	
return	phase	
“In	the	beginning	part,	the	uh,	the	Greg	Haines	stuff	was,	pffff..	f*%#ing,	in	
another	planet!”	
Music	with	
crescendo	during	
peak	phase	
5	 “[I	preferred]	the	changes	in	style.”	 Variety	
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	 “I	don’t	know	if	I	preferred	any	one	above	the	other.”	 Variety	
6	
"[The	music]	all	worked	really,	really	well."	 Music	selection	
"Even	bits	that	I	didn't	necessarily	love,	it	all	flowed."	 Music	selection	
7	
“Certainly	the	first	time	[the	music	had	a	greater	influence],	cause	I	think	the	
second	time	you’re	sort	of	familiar	with	the	music.”	
Unfamiliar	music	
“It	began	quite	ambient-like,	quite	relaxing,	which	I	felt	was	good.	It	calmed	you	
in	the	experience.”	
Calming	music	in	
pre-onset	phase	
“There	was	no	uncertainty	because	of	it,	it	didn’t	create	any	anxiety	or	'woah,	
what	is	this?!’”	
Music	selection	
“[The	songs]	Superb	they	were	without	doubt	you	know.”	 Music	selection	
“In	terms	of	the	musical	choice	I	think	it	was	absolutely	superb.”	 Music	selection	
8	
"Well-composed	sort	of	selection."	 Music	selection	
"Well	done,	really	well	put	together."	 Music	order	
"I	think	I	could	kind	of	understand	what	each	part	was	meant	to	evoke."	
Understanding	
thoughts	behind	
playlist	design	
9	
“[Buffy	Saint	Marry	-	Up	Where	We	Belong]	You	could	tell	that	was	quite	
cheesy,	a	bit	of	an	anomaly	in	there,	but	no,	it	just	worked.”	
Music	selection	
“It	all	worked	together	really	well.”	 Music	order	
“The	music	worked	really	well,	within	the	context	of	the	rest	of	the	music	and	
that	setting.”	
Music	order	
10	
“Whoever	thought	of	putting	that	playlist	together	in	the	order	that	they	did	is	
a	genius.”	
Music	order	
“It	was	seamless-	apart	from	the	breaks.	But	after	breaks	they	would	put	the	
headphones	in	and	I	would	go	straight	back	into	that	world.”	
Music	order,	music	
presence	
“Without	it	I	would	have	gone	mad.”	 Music	presence	
“Certainly	the	experience	would	not	have	been	a	positive	one	were	it	not	for	
that	music.”	
Music	presence	
11	 “[Some	songs]	I	connected	immediately	with.”	 Music	selection	
12	
“When	there	was	a	pause	in	the	music	it	was	really	noticeable.	It	just	felt	that	all	
the	energy	kind	of	drained	out	of	the	room,	I	really	wanted	the	music	back.”	
Music	presence	
“There	was	one	point,	that	was	very	beautiful.”	 Music	selection	
“Wouldn’t	have	been	as	positive	without	the	music,	absolutely,	you	know.	No,	a	 Music	presence	
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hundred	percent.”	
“I	think	it	was	designed	that	way.”	 Music	order	
13	
“And	particularly	once	it	starts	to	mellow	out	towards	the	end,	you	do	feel	that	
more	relaxed.”	
Calming	music	
during	return	
phase		
“[I	preferred]	more	towards	the	end	of	the	session,	I	think,	whenever	it’s	a	bit	
more	mellowed	out.	I	kind	of	felt	like	a	nicer	place	to	be.”	
Calming	music	
during	return	
phase		
“The	music	is]	definitely	necessary.”	 Music	presence	
“I	wouldn’t	see	any	major	changes	with	the	music.”	 Music	selection	
“I	think	it	was	a	good,	a	good	layout.”	 Music	order	
14	 “I	preferred	Mendel’s	playlist.”	 Music	selection	
15	
“An	hour	and	a	half	before	the	end,	when	the	music	began	to	wind	down,	and	it	
was	at	that	point	that	I	thought	“oh	yes,	this	is,	this	is	much	better.	This	is	
helping.	Yeah,	because	I	was	slowly	coming	out.	So	yes,	that	was	positive.”	
Calming	music	
during	return	
phase	
“One	of	the	vocal	tracks	reminded	me	of	one	of	Nusrat	Fateh	Ali	Khan’s	tracks,	
Yeni	Yeniden,	it’s	so	beautiful	it	just	made	me	cry.”		
Familiar	music	
[interviewer:	were	there	any	ones	that	you	had	a	particular	preference	for?]	
“Yeah,	the	classical	pieces.”	
Classical	or	neo-
classical	music	
16	
“I	get	the	impression	that	if	the	music	wasn’t	there	it’d	been	a	very	different	
experience.”	
Music	presence	
“There	wasn’t	any	that	I	didn’t	like.	It	felt	like	it	all	fitted	the	experience,	and	
that	everything	was	in	the	right	order.”	
Music	selection,	
music	order	
17	
“I	was	able	to	just	put	the	headphones	on	and	the	mask	on,	and	really	enjoy	it.”	 Music	selection	
“When	the	music	stopped	it	was	a	very	spooky	atmosphere.”	 Music	presence	
“I	think	it	was	the	beauty	of	the	music,	and	the	sort	of	uplifting	nature.”	 Music	selection	
18	
“On	the	whole	really	lovely	music,	with	obviously	the	dark	music	sometimes	
taking	me	to	dark	places,	but	I	wasn’t	really	aware	of	that	at	the	time,	it	just	sort	
of	happened.”	
Music	selection	
	
6.3.10	Unappreciated	music	styles	and	playlist	features:	Music	styles	
11	 out	 of	 19	 patients	 (58%	 of	 total)	 referred	 to	musical	 styles	 that	were	 not	 appreciated.	
These	 responses	 reflected	 different	 degrees	 of	 the	 individual’s	 disliking	 of	 the	music,	 and	
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were	highly	diverse,	making	no	theme	present	in	more	than	30%	of	this	cluster	(Figure	6.2).	
Some	examples	of	 themes	 in	 this	cluster	 refer	 to	“music	with	 lyrics”,	“vocal	music”,	“piano	
music”	 “classical	 or	 neo-classical	 music”	 and	 “cheesy	 music”.	 	 Often,	 “vocal	 music”	 and	
“cheesy	music”	 referred	 to	 one	 particular	 song	 played	 during	 the	 final	 “return”	 phase	 by	
Buffy	Saint	Mary,	up	where	we	belong.	See	Table	6.10	for	a	list	of	all	themes	present	in	the	
cluster	of	un-appreciated	music	styles.	
	
Table	 6.10	 |	 Unappreciated	 music	 styles	 and	 playlist	 features:	 music	 styles.	 A	 list	 of	 all	 the	 themes	 and	
respective	quotes	by	patients,	that	were	present	in	the	cluster	“music	styles”.	
Un-appreciated	music	styles	and	playlist	features:	music	styles	
#	 Quote	 Theme	
4	
“Very	trippy	music	[…]	making	me	more	scared	when	I	had	this	difficult	phase,	
that	I	was	thinking	‘ah,	I’m	going	crazy!’”	
Trippy	music	
5	
“It	was	all	sad	music.”	 Sad	music	
“It’s	all	very	serious	music,	there	was	no	light.	It	was	all	really,	serious,	
profound.”	
Serious	music	
7	
“I	found	lyrics	confusing.”	 Lyrics	
“No	interpretation,	the	story	is	being	told	to	you…	with	lyrics,	whereas	with	
instrumental	music	it’s	left	to	you.”	
Lyrics	
11	
“I	remember	at	some	point	saying	“this	music	is	really	corny”,	and	there	was	
one	particular	part	where	there	was	music	going	on	that	just	reminded	me	of	
the	‘Sound	of	Music’,	which	our	theatre	in	my	little	college	town	played	for	
months,	because	that’s	what	the	old	folks	in	the	town	wanted	to	see,	and	it	just	
had	that	sense	of	being	that	kind	of	kitsch	almost.”	
Cheesy	music	
13	 “With	a	higher	tempo	everything	feels	a	bit	more	tense.”	
Music	with	high	
tempo	
14	
“I	did	struggle	with	the	Brahms	and	the	Bach.”	
Classical	or	neo-
classical	music	
“Almost	the	antithesis	to	the	Bach	and	the	the	Brahms,	which	I	felt	were	terribly	
contrived.”	
Classical	or	neo-
classical	music	
“I	noticed	I	didn’t	wanna	hang	around	for	the	last	hour,	that	version	of	Joe	
Cocker,	‘Love	Lift	Us	Up’.	I	would	consider	that	there	was	other	music	which	is	
subtly	more	powerfully	sort	of	joyous,	rather	than	stating,	claiming,	‘love	will	lift	
us	up	where	we	belong’.”	
Music	with	lyrics,	
Cheesy	music	
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15	
“The	piano	pieces,	irritated	me.	It	was	like	little	needles.”		 Piano	music	
“I	don’t	know	why,	I	found	the	vocal	pieces	so	amusing.”		 Vocal	music	
16	
“I	could	remember	hearing	tracks	that	I’d	heard	before.	I	wasn’t	unaware,	you	
know,	because	I	could	remember	music	from	the	last	time.	And	I	could	
remember	how	I	felt	when	I’d	heard	that	track	the	first	time,	which	was	another	
thing	that	I	found	for	the	second	one,	which	was	‘why	is	it	not	feeling	the	
same?’”	
Familiar	music	
17	
“I	didn’t	really	like	the	sort	of	world	music	stuff.”	
Ethnic	and	cultural	
music	
“There	was	some	sort	of	Indian-style	music,	I	think	I	found	it	a	bit	creepy	at	the	
time.”	
Ethnic	and	cultural	
music	(Indian)	
“There	was	a	sort	of	ambient	musical	sound	which	I	found	too	non-specific.”	 Ambient	music	
“I	complained	a	bit	about	the	ambient	music	because	I	thought	it	was	it	was	too	
downbeat.	It	wasn’t	sufficiently	uplifting.”	
Ambient	music	
18	
“There	was	a	kind	of	out-of-place	piano,	that	was	almost	sort	of	‘hunky-tunky’,	
but	that	just	didn’t	sort	of	fit	really.”	
Piano	music	
“[Henryk	Gorecki	–	Symphony	of	sorrowful	songs]	It	was	a	woman’s	voice,	it	
was	a	sort	of	operatic	voice,	and	first	it	was	beautiful	because,	you	know,	I	was	
following	it	and	it	took	me	to	a	beautiful	place.	And	then	there	was	almost	a	
shriek	that	started,	and	that	that	perhaps	that	shrieking,	that	really	high	
pitched,	almost	reaching	the	end	of	that	particular	song,	that	was	when	things	
started	to	turn	for	me.”	
Vocal	music	
(female)	
19	
“I	found	the	first	[playlist]	a	bit	of	synthetic.”		 “Synthetic”	music	
“Didn't	like	George	Harrison	or	the	Louis	Armstrong.	And	there	was	that	weird	
kind	of	cover	[Buffy	Saint	Mary	-	Love	Lifts	Us	Up].	It	didn’t	feel	bad,	it	just	felt	a	
bit	cheesy,	a	bit	annoying.	It	was	a	bit	like	forcing	a	point.”	
Cheesy	music	
“Even	though	there	was	the	opera	stuff,	I	can’t	speak	Latin,	I	couldn’t	
understand	it”	
Music	with	lyrics	in	
foreign	language	
“I	don't	really	understand	opera.”		
Music	without	a	
personal	
connection	
“I	think	if	you	appreciate	opera,	Classic	FM,	you	would	have	got	something	else	
out	of	it.”	
Choral	or	opera-
like	music,	Classical	
or	neo-classical	
music	
“Classical	to	me	can	be	a	bit	inaccessible,	a	bit	highbrow.”	
Classical	or	neo-
classical	music	
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“Opera	as	well,	because	I	don't	understand	the	stories	behind	it.”	
Choral	or	opera-
like	music,	Music	
with	lyrics	in	
foreign	language	
	
6.3.11	Unappreciated	music	styles	and	playlist	features:	Playlist	design	
6	out	of	19	patients	 (32%	of	 total)	 referred	 to	aspects	of	 the	playlist	design	 that	were	not	
appreciated.	 In	 2	 out	 of	 6	 (33%	 of	 cluster),	 a	 clear	 disliking	 of	 the	 “music	 selection”	 was	
present,	and	a	preference	 for	“own	music	 selection”	was	expressed	 (Figure	6.2).	See	Table	
6.11	for	a	complete	list	of	all	themes	present	in	the	cluster	of	un-appreciated	playlist	design	
features.	
	
Table	 6.11	 |	 Unappreciated	 music	 styles	 and	 playlist	 features:	 playlist	 design.	 A	 list	 of	 all	 the	 themes	 and	
respective	quotes	by	patients,	that	were	present	in	the	cluster	“playlist	features”.	
#	 Quote	 Theme	
6	
"The	majority	of	them	are	not	my	kind	of	music,	I	can't	sit	with	that	music,	I	
have	to	leave	the	room."	
Music	selection	
"It's	music	that	I	can't	listen	to,	I	find	it	irritating	or	agitating."	 Music	selection	
7	
“Second	time,	not	as	much	[influence	of	the	music].”	 Familiar	music	
	“I	would	finish	with	more	sort	of	ambient	music	rather	than		to	try	and	bring	
the	lyrics	in.”	
Lyrics	during	return	
phase	
13	 “Some	of	the	earlier	stuff	did	get	a	bit	tense	at	times.”	
Intense	music	
during	ascent	
15	
“I	did	ask	if	I	could	have	my	own	music,	I	would	probably	have	chosen	my	own	
pieces.”	
Preference	for	own	
music	selection	
“Less	of	the	piano	music.”	 Piano	music	
“Maybe	the	pieces	could	be	slightly	shorter.”	
Preference	for	
shorter	pieces	
17	 “When	the	music	stopped	and	it	was	a	very	spooky	atmosphere.”	 Silences	in	playlist	
19	
“There	was	stuff	in	the	second	playlist	I	didn't	like	as	well.”		 Music	selection	
“Nothing	I	would	have	chosen	if	I	wanted	to	relax.”	
Preference	for	own	
music	selection	
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6.3.12	Predictors	in	music-experience	for	psilocybin-experience	and	therapy	outcomes	
PCA	reduced	the	dimensions	of	 the	11-ASC	to	5	 factors,	explaining	more	than	95%	of	 total	
variance.	 These	 PC’s	 are	 1)	 “Peak	 experience”	 (loadings	 from	 “experiences	 of	 unity”,	
“spiritual	 experience”	 and	 “blissful	 state”),	 2)	 “Impaired	 cognition	 (loadings	 from	
“disembodiment”,	 “impaired	 cognition”	 and	 “new	meanings”),	 3)	 “Audiovisual	 perception”	
(loadings	 from	 “audio/visual	 synaesthesia”	 and	 “elementary	 imagery”),	 4)”	 Anxiety”	
(primarily	 loaded	 by	 “anxiety”),	 and	 5)	 “Insightfulness”	 (loadings	 from	 “insightfulness”	 and	
“complex	imagery”)	(see	Figure	6.3).	Subsequently,	music-experience	(liking,	resonance,	and	
openness)	 and	 drug-intensity	 scores,	 were	 correlated	 with	 these	 5	 factors	 and	 ratings	 for	
reductions	in	depression	(1	week	after	psilocybin,	and	6	months	after	psilocybin,	defined	by	
%	reduction	in	QIDS	score).	
Reductions	in	depression	one	week	after	psilocybin	were	significantly	predicted	by	the	music-
experience	 variables	 “liking”	 (r	 =	 0.60,	 p	 =	 .006),	 “resonance”	 (r	 =	 0.59,	 p	 =	 .008),	 and	
openness	 (r	=	0.57,	p	=	 .001),	but	not	by	drug-intensity	 (r	=	0.004,	p	=	0.98)	or	depression	
severity	at	baseline(measured	by	QIDS,	r	=	0.27,	p=0.27,	df=18).		
Peak	experience	during	the	psilocybin	sessions	was	significantly	predicted	by	music-variables	
liking	(r	=	0.61,	p	=	.006),	resonance	(r	=	0.67,	p	=	.002),	openness	(r	=	0.70,	p	=	.0008),	and	by	
drug-intensity	(r	=	0.58,	p	=	0.009).	Insightfulness	was	predicted	by	music	variables	resonance	
(r	=	0.53,	p	=	.016)	and	openness	(r	=	0.59,	p	=	.007),	as	well	as	by	drug-intensity	(r	=	0.65,	p	=	
0.002),	but	not	by	music	liking	(r	=	0.44,	p	=	.06).	Impaired	cognition	(r	=	0.55	p	=	0.01),	and	
audiovisual	perception	changes	(r	=	0.71,	p	=	0.0006)	were	only	predicted	by	drug-intensity,	
and	not	by	any	of	the	music	variables.	Anxiety	was	not	predicted	by	any	of	the	variables.	All	
reported	 significant	 p-values	 refer	 to	 FDR-adjusted	 threshold	 for	 significance	 of	 0.016.	
Baseline	depression	severity	(QIDS)	did	not	show	a	significant	correlation	for	any	of	the	ASC-
factors	 (peak	 experience,	 r=0.11,	 p=0.66,	 df=18;	 impaired	 cognition,	 r=0.21,	 p=0.4,	 df=18;	
audiovisual	 perception,	 r-0.05,	 p=0.84,	 df=18;	 anxiety,	 r=0.3,	 p=0.2,	 df=18;	 insightfulness,	
r=0.08,	 p=0.74,	 df=18).	 Finally,	 no	 significant	 correlation	 was	 found	 between	 severity	 of	
“Like	the	kind	of	world	music	as	well,	it’s	more	interesting.”	
Preference	for	
more	ethnic	or	
cultural	music	
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depression	at	baseline	(QIDS)	and	music-variables	liking	(r=0.013,	p=0.96,	df=18),	resonance	
(r=0.07,	p=0.78,	df=18)	and	openness	(r=0.14,	p=0.55,	df-18)		
	
	
	
Figure	6.3	|	Principle	component	analysis	(PCA)	of	variables	from	the	11D-ASC.	Loadings	of	the	11	dimensions	of	
the	ASC,	on	 the	 first	5	PCs	obtained	 from	PCA	 followed	by	varimax	 rotation	explained	more	 than	95%	of	 the	
variance.	The	x-axis	 shows	 the	ordering	of	principal	 components,	with	 the	components	ordered	by	explained	
variance	(from	left	to	right).	The	colour	bar	corresponds	to	the	strength	of	the	loading	for	each	acoustic	feature	
for	that	components:	warm	colours	indicates	a	positive	loading,	and	cold	colours	a	negative	loading.		
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Figure	 6.4	 |	 Correlations	 between	 music-experience,	 and	 therapy-experience	 and	 outcomes.	 Outcomes	 of	
Pearson	 correlation	 tests	 between	 drug-intensity	 ratings,	 baseline	 depression	 scores	 and	 music-experience	
variables	(on	y-axis),	with	reductions	in	depression	1	week	after	psilocybin	and	the	acute	psilocybin-experience	
(5	PC’s	from	ASC	principle	components)	(on	x-axis).	*	=	p	<	0.05,	after	FDR	correction	for	multiple	comparisons	
(FDR	djusted	P	=	0.02).	
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6.3.13	Inter-rating	reliability	and	discriminative	validity	of	music-experience	variables	
Pearson	correlation	tests	between	the	scores	of	all	researchers	(n=4)	who	rated	the	three	
music-experience	variables	(liking,	resonance	and	openness),	demonstrated	good	inter-rater	
reliability	(average	r	=	0.6	±0.1,	from	total	of	18	correlations).	Pearson	correlation	tests	
between	the	three	music-experience	variables	showed	significant	correlations	(r	=	0.9,	
r=0.96,	and	r=0.91).	Drug	intensity	did	not	correlate	with	any	of	the	music-experience	
variables.	
	
6.4	Discussion	
This	study	reported	marked	effects	of	music	on	the	subjective	experiences	of	patients	with	
major	 depression	 who	 underwent	 psychedelic	 therapy	 with	 psilocybin.	 Phenomenological	
analysis	 revealed	several	prominent	 influences	of	 the	music	 that	were	welcomed,	 including	
an	 intensification	 of	 emotions	 and	 of	 mental	 imagery,	 calming	 effects,	 and	 the	 music	
providing	 a	 sense	 of	 guidance.	 The	 music-experience	 was	 selectively	 associated	 with	 the	
occurrence	 of	 peak	 experience	 and	 insightfulness.	 The	 music-experience	 also	 predicted	
reductions	 in	 depression	 after	 psilocybin,	 whereas	 drug-intensity	 did	 not.	 Together,	 these	
findings	 suggest	 that	 music	 has	 a	major	 influence	 on	 patient’s	 experiences	 in	 psychedelic	
therapy,	 and	 that	 music	 may	 play	 an	 important	 function	 in	 facilitating	 positive	 therapy	
outcomes.	
6.4.1	Music-experience	
From	all	the	themes	identified,	patients	most	frequently	reported	that	emotions	and	mental	
imagery	were	intensified	by	music	under	psilocybin,	and	the	study	thereby	complements	the	
previous	studies	included	in	this	thesis	that	demonstrated	a	modulatory	influence	of	LSD	on	
music-evoked	emotion	(study	1	and	study	2)	and	music-induced	imagery	(study	3)	in	healthy	
volunteers.	 By	 focussing	 on	 detailing	 the	 phenomenology,	 the	 present	 study	 also	 provides	
new	insights	 into	other	aspects	of	the	music-experience.	 In	addition	to	 influencing	emotion	
and	mental	 imagery,	 the	music	was	 also	 often	 described	 as	 providing	 a	 sense	 of	 guidance	
within	 the	experience,	 including	 feeling	personally	 supported	by	 the	music	 (with	 the	music	
serving	to	“ground”	and	“help”	the	listener),	the	music	being	“resonant”	with	the	individual’s	
intrinsic	emotional	state	(the	music	being	in	tune	or	a	good	match	with	inner	feelings),	and	
	182	
the	music	bringing	the	sensation	of	being	guided	on	a	journey.	In	these	scenarios,	the	music	
was	 frequently	 referred	 to	 as	 a	 “vehicle”	 that	 “carried”	 and	 “transported”	 the	 listener	 to	
different	parts	in	their	mind,	rich	with	personally	meaningful	emotionality	and	imagery.	“The	
sad	 songs	would	bring	painful	memories	on,	more	happy	 songs	would	make	me	 think	of	a	
really	good	period	in	my	life.	Every	new	song	could	bring	a	different	image”,	one	patient	(#4)	
remarked.	 One	 other	 patient	 (#14),	 provided	 a	 particularly	 good	 example	 of	 experiencing	
such	welcomed	intensification	and	guidance	sensations	from	the	music:	
“I	 feel	 the	music	 in	 large	part	drove	a	 lot	of	 the	experience.	Under	 the	 influence	of	
psilocybin,	 the	 music	 absolutely	 takes	 over.	 Normally	 when	 I	 hear	 a	 piece	 of	 sad	
music,	or	happy	music	 I	 respond	through	choice…	but	under	psilocybin	 I	 felt	almost	
that	I	had	no	choice	but	to	go	with	the	music.	[…]	I	did	feel	I	was	being	held.	And	it	did	
feel	 like	 the	music	 opened	 [me]	 up	 to	 grief,	 and	 I	 just	 was	 very	 happy	 for	 that	 to	
happen.	 It	 wasn’t	 particularly	 pleasant	 in	 any	 way,	 but	 extraordinarily	 powerful.	 It	
took	 my	 thinking	 and	 my	 experience	 to	 uncomfortable	 places,	 but	 I	 was	 kind	 of	
reassured	 in	 the	 experience.	 There	was	 something	 there	 that	meant	 “I’m	 going	 to	
take	you	on	a	ride	here,	but	I	promise	I	won’t	abandon	you.	It’s	just	going	to	be	tough,	
and	you	know,	you’re	going	through	the	grinder	here,	but	you	won’t	be	left	in	pieces.”	
That	seemed	to	be…	what	the	music	was	saying	to	me”.	
	
In	contrast	to	the	sense	of	(welcomed)	guidance	by	the	music,	were	descriptions	of	the	music	
providing	a	sense	of	(unwelcomed)	misguidance.	In	these	situations,	the	music	was	typically	
described	 as	 being	 “dissonant”	with	 the	 patient’s	 intrinsic	 emotional	 state:	 The	music	was	
perceived	as	being	“out	of	tune”,	“misplaced”,	or	as	a	“mismatch”	with	their	inner	emotions	
and	thoughts.	One	example	of	the	experience	of	misguidance	by	the	music	can	be	found	in	
the	response	by	patient	#16:	
“The	 light	music	at	one	point	 took	me	to	a	place	where	 I	 thought	 I	was	safe,	and	 it	
became	unsafe,	and	the	music	was	playing	a	trick	with	me,	you	know,	sort	of	giving	
me	a	false	sense	of	security.	I	can	remember	thinking	“this	is	beautiful	music,	why	am	
I	going	to	this	dark	place?”	It	didn’t	line	up	with	what	had	gone	on	before.	I	just	felt	as	
I	was	being	manipulated,	being	duped	almost.	The	music	 lured	me	 to	 this	beautiful	
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place,	 and	 then	 things	 started	 to	 become	 dark	 even	 with	 this	 beautiful	 music	 still	
playing.”	
	
An	 important	 observation	 is	 that	 effects	 of	 the	 music	 that	 were	 welcomed,	 sometimes	
included	 emotions	 such	 as	 increased	 grieving	 or	 tearfulness.	 This	 attitude	 of	 openness	
towards	 “negative”	 music-evoked	 emotions,	 was	 frequently	 described	 as	 an	 important	
therapeutic	aspect,	to	bring	to	expression	and	to	find	resolution	in	unresolved	inner	conflicts.	
These	experiences	were	grouped	under	the	theme	“openness	to	challenging	experience	feels	
therapeutic”,	and	one	example	of	this	attitude	of	openness	towards	the	music	can	be	found	
in	the	responses	from	patient	#9:	
“I	 can	even	view	 the	negative	moments	as	positive	 in	a	way	because	 they	 served	a	
purpose.	 The	 purpose	 was	 to	 sort	 of	 let	me	 face	 the	 darkness,	 and	my	 demons,	 I	
guess.	It	was	beautiful	at	times,	but	also…	yeah,	the	darker	moments	really	helped	to	
reflect	on	and	connect	with	your	unresolved	shadows.”	
	
Contrasting	 such	 an	 attitude	 of	 openness,	 is	 an	 attitude	 of	 resistance	 to	 the	 intensifying	
effects	 of	 the	 music.	 This	 experience	 was	 characterised	 by	 not	 wanting	 the	 music	 or	 its	
effects,	 and	was	 named	 “resistance	 to	 intensification”.	 An	 example	 of	 this	 is	 described	 by	
patient	#5,	who	stated:	
“I	worried	that	I	 let	[the	music]	shape	this	sort	of	melancholy.	There	was	resistance,	
massively,	 to	everything,	every	sort	of	sensory	 input,	 I	had	a	 fearful	 response.	 I	was	
afraid	to	open	my	eyes,	I	was	afraid	to	do	anything,	I	was	afraid	that	this	sort	of	music	
was	the	last	thing	I’d	ever	hear.”	
	
When	taking	these	findings	together,	a	diverse	and	mixed	picture	emerges	of	welcomed	and	
unwelcomed	 influences	 of	 the	 music	 on	 patient’s	 subjective	 experiences.	 Welcomed	
influences	were	characterised	by	often	 intense	and	personally	meaningful	emotionality	and	
imagery,	a	sense	of	guidance	by	the	music,	calming	effects,	and	an	attitude	of	openness	to	
the	music-experience.	On	the	other	hand,	unwelcomed	effects	of	music	were	characterised	
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by	 unwanted	 emotionality	 and	 imagery,	 feelings	 of	 discomfort	 and	 irritation,	 a	 sense	 of	
misguidance	 by	 the	 music,	 and	 an	 attitude	 of	 resistance	 to	 the	 music-experience.	 These	
findings	suggest	that	in	order	for	the	music	to	act	therapeutically,	it	may	require	a	sufficient	
degree	 of	 resonance	with	 the	 individual’s	 intrinsic	 feeling	 state,	 and	 a	 sufficient	 degree	 of	
openness	or	receptivity	to	the	resulting	intensification	effects.	This	hypothesis	will	be	further	
discussed	in	paragraphs	6.4.4	and	6.4.5.	
	
6.4.2	Music	styles	and	playlist	design	
The	present	study	did	also	shed	 light	on	 the	experience	of	different	musical	 styles	and	 the	
design	of	the	music	playlist.	The	choice	of	the	music	and	the	design	of	the	music	playlist	was	
overall	well-appreciated,	with	the	most	frequently	appreciated	musical	genres	being	ethnic-,	
vocal-	 and	 (neo-)	 classical	 music.	 Appreciation	 was	 also	 expressed	 for	 the	 design	 of	 the	
playlist,	in	particular	for	the	calming	music	to	be	primarily	present	during	the	early	(pre-onset	
and	 early	 ascent)	 and	 the	 final	 (return)	 phases,	 and	 of	 the	 more	 emotive	 music	 to	 be	
reserved	 for	 the	 peak	 phase.	 This	 provides	 indirect	 support	 for	 previous	 frameworks,	 to	
structure	 the	 music	 according	 to	 its	 emotional	 intensity	 into	 different	 phases	 of	 drug-
experience	 (Bonny	 and	 Pahnke	 1972;	 Grof,	 1980;	 Richards	 2015).	 Strong	 disliking	 of	 the	
music-selection	was	 rare	 (patient	#6),	but	when	 this	did	occur	 it	 proved	 insightful	 into	 the	
role	of	music-selection:	Typically,	disliking	of	the	music	seemed	to	be	associated	with	either	a	
“diminishment”	 of	 the	 drug-experience,	 with	 unpleasant	 feelings	 (such	 as	 discomfort	 and	
irritation),	 and	 with	 an	 attitude	 of	 resistance,	 characterised	 by	 an	 attempting	 to	 distance	
oneself	from	the	music,	such	as	detailed	in	the	following	excerpt:	
“The	music	blocked	my	experience	and	feelings.	A	sense	of	irritation,	frustration,	and	
sense	of	lowering	mood.	The	majority	of	the	songs	were	not	my	kind	of	music,	I	can't	
sit	with	 that	music	…	 I	have	 to	 leave	 the	 room.	 I	was	 sort	of	 feeling	bad,	because	 I	
wanted	 to	 work	 with	 it.	 I	 sensed	 the	 potential	 for	 a	 really	 profound	 experience.	 I	
couldn't	meet	that	potential	with	music	that	I	felt	was	quite	mediocre.	To	me	it	didn't	
feel	real,	so	I	felt	quite	torn.	(#6)	
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In	study1,	a	positive	relationship	between	the	liking	of	the	music	and	the	emotional	response	
to	music	was	shown,	and	such	an	association	has	been	reported	by	other	studies	too	(North	
and	 Hargreaves	 1997).	 The	 present	 data	 does	 therefore	 suggest	 that	 the	music	 style	may	
require	a	sufficient	degree	of	appreciation	in	order	for	meaningful	emotionality	to	be	evoked	
by	 the	music,	 and	 thereby	 for	 the	 therapeutic	 process	 to	be	 supported	by	 the	music.	 This	
hypothesis	will	be	discussed	further	in	the	subsequent	paragraph.	
	
6.4.3	Music-experience	predicts	experience	and	therapy	outcomes	
As	outlined	above,	this	study	found	noticeable	polarities	in	the	music-experience,	such	as	the	
music	being	either	 liked	or	disliked,	 the	music	being	either	 resonant	or	dissonant	with	 the	
patient’s	experience,	and	the	patient	being	either	open	or	 resistant	 to	 the	 influence	of	 the	
music.	These	three	variables	(liking,	resonance	and	openness)	positively	predicted	the	extent	
to	 which	 patients	 reported	 having	 peak	 experiences	 (defined	 as	 the	 experience	 of	 unity,	
blissful	 emotionality	 and	 spirituality).	 In	 addition,	 resonance	 and	 openness,	 but	 not	 liking,	
predicted	the	extent	to	which	people	reported	experiencing	insightfulness	(defined	by	having	
inventive	 ideas,	 feelings	 of	 profoundness,	 insights	 and	 the	 experience	 of	 vivid	 personal	
memories	or	mental	 images).	Drug-intensity,	on	 the	other	hand,	also	correlated	with	other	
aspects	of	the	psilocybin-experience,	such	as	impaired	cognition	and	audio-visual	perception	
changes.		
The	 finding	 that	 the	 music-experience	 variables	 were	 selectively	 associated	 with	 peak	
experience	 and	 insightfulness,	 but	 not	with	 other	 subjective	 experiences	 under	 psilocybin,	
supports	the	original	motivations	to	include	music	in	psychedelic-therapy,	i.e.	to	promote	the	
occurrence	 of	 personally	 meaningful	 experiences	 (such	 as	 peak	 experiences	 or	
autobiographical	experiences)	 (Hoffer	1965;	Bonny	and	Pahnke	1972;	Grof,	1980).	Modern	
studies	have	confirmed	that	psilocybin	can	reliably	facilitate	peak	experiences	(Griffiths	et	al.,	
2006;	 RolandGriffiths	 et	 al.,	 2011),	 and	 these	 experiences	 have	 been	 associated	 with	
sustained	 positive	 changes	 in	 behaviour	 and	 personality	 (MacLean	 et	 al.,	 2011),	 and	 with	
positive	 therapeutic	 outcomes	 (Garcia-Romeu,	 Griffiths,	 and	 Johnson	 2014;	 Griffiths	 et	 al.,	
2016;	 Ross	 et	 al.,	 2016).	 Although	 all	 these	 studies	 incorporated	 music-listening	 in	
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combination	 with	 psilocybin,	 this	 is	 the	 first	 study	 to	 demonstrate	 that	 the	 experience	 of	
music	is	related	to	the	occurrence	of	peak	experiences.		
A	 positive	 relationship	 was	 found	 between	 the	 music-experience	 and	 reductions	 in	
depression	one	week	after	the	psilocybin-experience.	 Importantly,	reductions	 in	depression	
were	 not	 related	 to	 the	 intensity	 of	 the	 drug-effects,	 and	 only	 to	 the	 music-experience	
variables	 liking,	 resonance	 and	 openness.	 This	 finding	 provides	 tentative	 support	 for	 the	
hypothesis	that	it	is	not	merely	the	drug	effects	in	isolation,	but	an	interaction	between	the	
drug	 and	 the	 music	 that	 promotes	 therapeutic	 experiences	 and	 positive	 therapeutic	
outcomes.	Due	the	prominence	of	music-listening	in	psychedelic	therapy,	understanding	the	
therapeutic	 function	 of	 music	 in	 psychedelic	 therapy	 may	 be	 fundamental	 in	 maximising	
therapeutic	efficacy.		
	
6.4.4	Possible	therapeutic	mechanisms	of	music	in	psychedelic	therapy	
A	 principal	 effect	 of	 psychedelics	 is	 that	 they	 temporarily	 impair	 brain	 mechanisms	 that	
usually	 regulate	 emotion	 (Carhart-Harris	 et	 al.,	 2016,	 2012;	 Muthukumaraswamy	 et	 al.,	
2013),	 and	 this	 could	 underlie	 the	 enhanced	emotional	 responsiveness	 to	 stimuli	 reported	
here	and	elsewhere	(Vollenweider	et	al.,	2007;	Quednow	et	al.,	2012;	Griffiths	et	al.,	2006).	
Importantly,	 the	 emotional	 experiences	 to	music	 in	 this	 study	were	 not	 only	 described	 as	
more	 intense	 than	 usual,	 but	 as	 a	 “release”	 of	 meaningful	 psychological	 content	 (ex:	
autobiographical	 memories	 and	 deep	 tearfulness).	 The	 belief	 that	 accepting	 and	 moving	
through	challenging	emotions	is	 important	for	psychotherapeutic	change	is	central	to	many	
psychotherapeutic	models	(Greenberg,	2008),	and	has	empirical	support	(Whelton	2004).		
In	 psychedelic	 therapy,	 the	 function	 of	 psychedelics	 may	 be	 to	 bring	 about	 a	 quick	
relinquishment	 of	 psychological	 control	 (i.e.	 ego-dissolution),	 thereby	 allowing	 a	 fuller	 (i.e.	
less	 inhibited)	 expression	 of	 emotionality.	 The	 music,	 in	 turn,	 may	 play	 the	 important	
function	 of	 activating	 emotionality,	 thoughts	 and	 memories	 that	 are	 most	 personally	
significant,	 thereby	 guiding	 the	 patient’s	 experience	 into	 directions	 that	 are	 most	
therapeutically	 salient.	 The	 key	 difference	 between	 psychedelic	 therapy	 and	 other	
psychotherapies,	may	be	the	capacity	of	psychedelics	and	music	to	facilitate	such	emotional	
“breakthrough”	 experiences	more	 quickly	 and	 with	 deeper	 emotional	 intensity.	 It	 may	 be	
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specifically	 the	 interaction	 between	 the	 psychological	 state	 induced	 by	 psychedelics	 and	
music,	that	facilitated	the	acute	and	sustained	changes	in	mood	and	behaviour	reported	in	in	
this	trial	 (Carhart-Harris	et	al.,	2016)	and	several	other	studies	(Gasser	et	al.,	2014;	Grob	et	
al.,	2011;	Griffiths	et	al.,	2016;	Johnson	et	al.,	2014;	Johnson	et	al.,	2016;	Ross	et	al.,	2016)		
	
6.4.5	Implications	for	psychedelic	therapy	
The	findings	in	this	study	show	similarities	with	the	therapeutic	guidelines	for	music	as	it	was	
developed	by	Helen	Bonny	and	colleagues	working	with	LSD	 in	 the	1960s,	who	referred	 to	
the	 therapeutic	 influence	 of	 music	 as	 being	 of	 “profound	 significance”.	 Bonny	 also	
emphasised	the	care	needed	 in	selecting	the	right	music	and	playing	the	music	at	the	right	
moments	 (Bonny	 and	 Pahnke	 1972).	 The	 present	 study	 showed	 that	 when	 the	 music	 is	
dissonant	(out	of	tune)	with	the	experience,	this	was	related	to	reduced	therapy	outcomes,	
whereas	when	 the	music	was	more	 resonant	 (in	 tune)	with	 the	patient’s	 intrinsic	 feelings,	
this	was	predictive	of	 better	 therapy	outcomes.	 This	 finding	provides	 support	 for	 the	 view	
that	 adapting	 the	 music	 to	 patient’s	 individual	 and	 highly	 dynamic	 experiences	 under	
psychedelics	 may	 be	 critical	 to	 provide	 adequate	 therapeutic	 support.	 It	 also	 suggests	 a	
considerable	 responsibility	 on	behalf	 of	 the	 therapists	 to	 use	music	 appropriately,	 and	 the	
present	 study	 has	 provided	 some	 insight	 into	 how	 therapists	may	 best	 do	 so	 to	 optimise	
psychedelic	therapy	sessions.		
First,	 the	musical	 style	 may	 require	 a	 sufficient	 degree	 of	 appreciation.	 Liking	 of	 music	 is	
usually	defined	as	a	mixture	of	genre-appreciation	and	aesthetic	 judgements	 (Juslin,	2013),	
and	 this	 factor	 may	 be	 an	 important	 pre-requisite	 for	 music	 to	 evoke	 meaningful	
emotionality.	In	addition,	some	musical	styles	and	acoustic	properties	may	be	more	suitable	
for	 the	 state	 of	 consciousness	 induced	by	 psychedelics,	 than	others,	 although	 this	 has	 not	
been	 studied	 yet.	 Secondly,	 when	 the	 music	 is	 liked,	 the	 music	 may	 still	 require	 an	
appropriate	attunement	 to	 the	 inner	emotional	state	of	 the	patient.	By	being	 in	 resonance	
with	the	present	emotional	state	of	the	patient,	 the	music	can	enable	him	or	her	to	better	
explore	and	express	personal	narratives	more	easily	and	deeply.	 In	contrast,	when	music	 is	
dissonant,	this	may	“block”	such	progress	or	may	even	become	counter-therapeutic.	Thirdly,	
the	 patient’s	 attitude	 requires	 a	 sufficient	 degree	 of	 openness	 to	 the	 music-evoked	
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experience.	This	openness	may	 include	not	only	a	 state	of	 surrender,	but	also	a	pro-active	
focus	and	engagement	together	with	the	minimization	of	intellectualisation.			
This	 hypothetical	 framework	 holds	 that	 if	 these	 three	 requirements	 are	 met	 (style	 liking,	
music’s	resonance	and	openness	to	music),	an	expression	of	meaningful	therapeutic	content	
could	 occur,	 often	 characterized	 by	 the	 sense	 of	 being	 on	 a	 personal	 journey,	 with	 a	
spontaneous	and	often	 intense	emergence	of	personally	meaningful	 imagery,	thoughts	and	
emotionality.	 If	 any	 of	 these	 pre-requisites	 is	 not	 met	 adequately,	 the	 patient	 is	 likely	 to	
distance	 him	or	 herself	 from	 the	music	 and	 the	 experience,	 and	 a	 rejection	 of	meaningful	
therapeutic	 content	 could	 occur,	 characterised	 by	 feelings	 of	 discomfort,	 or	 the	 absence	
personally	meaningful	 imagery,	 thoughts	and	emotionality	 (i.e.	 the	absence	of	 the	sense	of	
being	on	a	journey).		
Resolving	any	such	resistance	 in	 these	scenarios	may	be	 the	responsibility	of	 the	 therapist,	
such	 as	 ensuring	 music	 styles	 are	 sufficiently	 liked,	 via	 thoughtful	 music-selection,	 and	
ensuring	the	appropriate	attunement	of	the	music	to	the	patient’s	unfolding	experience,	via	
thoughtful	playlist-design	and	adaptation	of	the	music	when	needed.	In	other	scenario’s,	the	
music-evoked	 experience	 may	 be	 rich	 with	 therapeutically	 meaningful	 content,	 yet	 the	
experience	 may	 be	 highly	 unpleasant	 or	 in	 other	 ways	 emotionally	 challenging.	 In	 these	
scenarios,	 feelings	 of	 resistance	 may	 be	 due	 the	 patient	 wanting	 the	 experience	 to	 be	
different,	 and	 this	 may	 be	 resolved	 by	 the	 therapist’s	 reassurance	 of	 their	 safety,	 and	
providing	therapeutic	support	to	explore	these	challenging	feeling	states.	In	this	framework,	
resistance	can	be	regarded	as	an	important	indicator	of	music’s	failure	to	act	therapeutically,	
and	 the	 type	 of	 intervention	 needed	 to	 restore	 music’s	 therapeutic	 function	 may	 be	
determined	by	one	central	question	the	therapist	may	need	to	clarify,	i.e.	what	is	the	source	
of	resistance?	 Is	 it	due	a	disliking	of	music	style,	or	due	a	dissonance	of	the	music	with	the	
individual’s	experience,	or	due	a	resistance	to	therapeutically	meaningful	content?	
	
6.4.6	Limitations	and	future	directions	
This	study	has	a	number	of	limitations.	First	of	all,	the	data	was	acquired	without	a	placebo-
condition,	 making	 inferences	 about	 the	 effects	 of	 psilocybin	 on	 the	 experience	 of	 music	
problematic.	Secondly,	 the	main	body	of	data	used	for	 this	study	was	qualitative	 in	nature.	
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Therefore,	the	experiment	did	not	allow	studying	the	magnitude	of	the	observed	effects	of	
music.	 It	 should	 therefore	 be	 emphasised	 that	 the	 primary	 objective	 of	 this	 study	 was	 to	
provide	 a	 patient-perspective	 on	 the	 influence	 of	 music.	 We	 hope	 that	 the	 theoretical	
framework	this	provided,	 inspires	 testable	hypotheses	 for	 future	studies,	and	that	 it	assists	
therapists	 and	 researchers	 in	 their	 use	 of	 music	 in	 psychedelic	 therapy.	 Example	 of	 such	
hypotheses	 are	 whether	 an	 optimisation	 of	 resonance/attunement,	 and	 the	 attitude	 of	
openness	could	improve	therapy	outcomes,	and	to	what	extend	these	variables	are	part	of	a	
similar	construct	or	represent	separate	factors	in	larger	sample	sizes.		
Furthermore,	to	advance	the	therapeutic	use	of	music,	a	significant	body	of	work	is	required	
to	 establish	 baseline	 measures	 that	 predict	 music-experiences	 during	 psychedelic	 therapy	
sessions.	 Such	 predictive	 measures	 can	 range	 from	 personality	 traits	 (e.g.	 openness	 to	
experience,	 absorption	 or	 suggestibility),	 to	 measures	 for	 music	 preferences	 at	 baseline.	
Furthermore,	 research	 that	 focusses	 on	 identifying	 reliably	 indicators	 for	 positive	
(welcomed/supportive)	and	negative	(unwelcomed/unsupportive)	influences	of	music	on	the	
therapeutic	processes	during	psychedelic	therapy	sessions,	may	be	highly	significant	for	the	
development	of	psychedelic	 therapy,	and	 the	 tools	used	during	psychedelic	 therapy.	These	
could	 range	 from	 simple	 physiological	measures,	 such	 as	 heart-rate,	 body	movement,	 and	
breathing	 patterns,	 or	 more	 complex	 measures	 such	 as	 facial	 affect-coding,	 vocal-affect	
coding,	 and	EEG-signatures,	 that	 could	 inform	 therapists	 in	on-the-fly	 adaptation	of	music-
selection,	or	inform	playlist	generation	algorithms.	
	
6.4.7	Conclusions	
Music	was	 described	 as	 having	 a	 substantial	 influence	 on	 the	 therapeutic	 experience	with	
psilocybin.	 The	 music-experience	 was	 predictive	 for	 peak	 experiences	 and	 insightfulness	
during	the	sessions,	and	reductions	in	depression	after	the	sessions.	This	suggests	that	music	
may	play	 a	 fundamental	 role	 in	 facilitating	 therapeutic	 change	 in	 psychedelic	 therapy.	 The	
findings	 support	 the	 usefulness	 of	 music	 in	 psychedelic	 therapy,	 but	 more	 research	 is	
warranted	 to	better	understand	 the	 therapeutic	 effects	of	music,	 including	how	music-use	
can	 be	 optimised	 for	 different	 types	 of	 psychotherapeutic	 experiences,	 as	 well	 as	 to	
investigate	the	specific	therapeutic	mechanisms.	
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“We	should	long	ago	have	become	angels	had	we	been	capable	of	paying	
attention	to	the	experience	of	art,	and	allowing	ourselves	to	be	changed	in	
accordance	with	the	ideals	it	expresses”	
Andrey	Tarkovsky	
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7	 Summary	and	discussion
The	 research	 presented	 in	 this	 thesis	 investigated	 how	 psychedelic	 drugs	 and	music	 work	
together	in	the	brain	to	change	subjective	experience,	and	how	music	is	experienced	during	
psychedelic	therapy	sessions	by	patients.	Changes	in	brain	function	under	LSD,	as	measured	
with	 fMRI,	 were	 associated	 with	 enhanced	 music-evoked	 emotion	 and	 music-induced	
imagery	 in	 healthy	 volunteers.	 In	 a	 separate	 study,	 the	 phenomenology	 of	 the	 music-
experience	 was	 assessed	 in	 patients	 diagnosed	 with	 depression	 undergoing	 psychedelic	
therapy	with	psilocybin.	This	chapter	will	summarize	and	discuss	the	primary	findings	of	these	
studies,	and	discuss	possible	brain	mechanisms	and	therapeutic	mechanisms	of	psychedelics	
and	music.	The	primary	research	findings	were:	
• Enhanced	music-evoked	emotion	under	psychedelics.	
• Altered	processing	of	acoustic	features	by	the	brain	under	LSD,	and	in	particular	of	“timbral	
complexity”,	 which	 was	 associated	 with	 increased	 activity	 in	 brain	 networks	 previously	
implicated	in	music	perception	and	emotion.	
• Increased	activation	of	 the	 right	 inferior	 frontal	gyrus	 (IFG)	and	 right	precuneus	 to	 “timbral	
complexity”	under	LSD	was	associated	with	increased	music-evoked	feelings	of	wonder.	
• Enhanced	 information	 flow	 from	 the	parahippocampus	 to	 the	 visual	 cortex	was	 found	with	
music	 in	combination	with	LSD,	and	this	effect	correlated	with	 increased	ratings	of	complex	
mental	imagery	and	ratings	for	autobiographical	memories.	
• Music	 has	 different	 influences	 on	 the	 subjective	 experience	 of	 patients	 undergoing	
psychedelic	 therapy	 with	 psilocybin,	 including	 an	 intensification	 of	 subjective	 experience,	
calming	effects,	and	providing	a	sense	of	guidance.	
• Music-experience	 (resonance	 of	 music	 with	 intrinsic	 emotion,	 and	 openness	 to	 music-
experience)	predicted	 insightfulness,	and	music-experience	 (liking	of	music	 style,	 resonance	
of	 music	 with	 intrinsic	 emotion,	 and	 openness	 to	 music-experience)	 predicted	 peak	
experience	and	reductions	in	depression.	
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7.1	Summary	of	qualitative	findings	
7.1.1	Effects	of	psychedelics	on	music-evoked	emotion	
Study	1	(Chapter	3)	reported	that	healthy	participants	were	significantly	more	“emotionally	
affected”	by	music	under	LSD	than	under	placebo.	In	addition,	both	study	1	(Chapter	3)	and	
study	2	 (Chapter	4)	 reported	on	 the	 implementation	of	 the	Geneva	Emotional	Music	 Scale	
(GEMS)	to	assess	the	effects	of	LSD	on	different	types	of	music-evoked	emotions.	In	both	of	
these	 studies,	 the	GEMS	showed	significant	higher	 ratings	under	LSD	 for	 the	music-evoked	
emotions	 “wonder”	 (filled	 with	 wonder,	 dazzled,	 moved),	 “transcendence”	 (fascinated,	
overwhelmed,	feelings	of	transcendence	and	spirituality),	“tenderness”	(tender,	affectionate,	
in	love)	and	“power”	(strong,	triumphant,	energetic).	In	addition	to	these	types	of	emotions,	
chapter	 3	 also	 showed	 a	 significant	 increase	 under	 LSD	 for	 the	 emotions	 “nostalgia”	
(nostalgic,	 dreamy,	 melancholic),	 “peacefulness”	 (serene,	 calm,	 soothed),	 and	 “joyful	
activation”	(joyful,	amused,	bouncy).	Both	studies	reported	no	significant	increases	in	music-
evoked	 emotions	 of	 negative	 valence	 (“sadness”	 (sad,	 sorrowful)	 or	 “tension”	 (tense,	
agitated,	nervous)).	The	findings	reported	in	study	4	(Chapter	6)	supplemented	these	findings	
by	showing	that	the	most	frequently	mentioned	influence	of	music	on	subjective	experience	
during	psychedelic	therapy	sessions	with	psilocybin,	was	an	“intensification	of	emotion”,	and	
that	in	the	therapeutic	context	this	applied	to	both	positive	emotions	and	negative	emotions	
(e.g.	tearfulness).		
	
7.1.2	Effects	of	psychedelics	on	music-evoked	mental	imagery	
In	 study	 3	 (Chapter	 5),	 the	 neurophysiological	 correlates	 underlying	 LSD	 and	 music’s	
combined	effects	on	mental	 imagery	were	examined	 via	 rating	 scales	during	 and	after	 the	
neuroimaging	 procedures.	 During	 scanning,	 changes	 in	 eyes-closed	 mental	 imagery	 were	
assessed	via	ratings	for	simple	visual	 imagery	(i.e.	colours	and	patterns)	and	complex	visual	
imagery	 (i.e.	 concrete	 objects,	 landscapes	 or	 beings).	 Subsequently,	 the	 effect	 of	 LSD,	 of	
music,	 and	 of	 their	 interaction	 between	 the	 two,	were	 assessed	 separately	 via	 a	 repeated	
measures	ANOVA.	Ratings	 for	simple	hallucinations	were	 found	to	be	 increased	under	LSD,	
but	no	 increase	was	found	as	an	effect	of	music	or	as	an	effect	of	the	 interaction	between	
music	 and	 LSD.	Ratings	 for	 complex	 visual	 imagery	were	 also	 found	 to	be	 increased	under	
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LSD,	and	a	trend	level	significant	increase	in	complex	visual	imagery	was	found	as	an	effect	of	
music,	but	no	 significant	 interaction	effect	was	 found	between	LSD	and	music.	 In	addition,	
after	 fMRI	 scanning	 the	 participants	 completed	 a	 survey	 about	 their	 subjective	 experience	
inside	the	scanner,	and	a	significant	increase	was	found	under	LSD	for	the	item	that	rated	the	
spontaneous	recollection	of	autobiographical	memories:	“I	saw	scenes	from	my	past”.	These	
findings	 suggest	 that	 psychedelics	 do	 increase	 mental	 imagery,	 and	 that	 music	 may	
selectively	 modulate	 “complex”	 mental	 imagery,	 and	 not	 “simple”	 mental	 imagery.	 The	
qualitative	 analysis	 reported	 in	 study	 4	 (Chapter	 6)	 showed	 that	 “intensification	 of	 the	
imagination”	 was	 one	 of	 the	 most	 prominently	 mentioned	 influences	 of	 music	 during	
psychedelic	therapy	with	psilocybin	for	depression,	which	included	descriptions	of	the	music	
influencing	the	content	of	 the	mental	 imagery,	as	well	as	descriptions	of	 the	music	making	
mental	imagery	more	vivid.	Study	4	(Chapter	6)	also	reported	that	the	music-experience	was	
associated	with	a	 factor	called	 insightfulness,	which	was	defined	by	having	 inventive	 ideas,	
feelings	of	profoundness,	 insights,	 as	well	 as	 the	experience	of	 vivid	personal	memories	or	
mental	images.	
	
7.1.3	Phenomenology	of	the	music-experience	during	psychedelic	therapy	
Study	4	 (Chapter	6)	 reported	 in	detail	on	phenomenological	 themes	presented	 in	patient’s	
descriptions	 of	 their	 subjective	 experience	 of	 the	 music	 while	 under	 the	 influence	 of	
psilocybin.	 The	 study	 showed	 that	 patients	 experienced	 “welcomed”	 and	 “unwelcomed”	
influences	 of	 the	 music,	 each	 including	 several	 prominent	 clusters	 of	 themes.	 The	 most	
frequently	 described	 welcomed	 influences	 of	 the	 music	 included	 an	 “intensification”	 of	
emotion	and	imagination,	calming	effects	of	the	music,	and	of	the	music	providing	a	sense	of	
guidance.	 This	 sense	 of	 guidance	 included	 a	 sense	 of	 personal	 support,	 a	 sense	 of	 being	
“carried	away”	or	“being	transported	on	a	journey”,	and	a	sense	that	the	music	was	resonant	
or	in	tune	with	the	patient’s	intrinsic	emotional	state.	In	addition,	a	recurrent	theme	included	
descriptions	 that	 an	 attitude	 of	 openness	 to	 the	 music-evoked	 experience	 felt	 like	 an	
important	therapeutic	element,	and	also	that	music	itself	can	help	facilitate	such	an	attitude	
of	openness	to	the	music-experience.		
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In	 contrast,	 the	 most	 frequently	 described	 unwelcomed	 influences	 of	 the	 music	 were	 an	
intensification	of	(undesirable)	or	a	diminishing	of	(desirable)	emotions	and	imagery,	and	the	
music	 facilitating	 feelings	 of	 resistance	 (i.e.	 the	 opposite	 of	 openness)	 or	 a	 “sense	 of	
misguidance”	 (i.e.	 the	 opposite	 of	 “sense	 of	 guidance”).	 This	 sense	 of	 misguidance	 most	
often	 included	 the	 sense	 that	 the	 music	 was	 dissonant	 or	 not	 in	 tune	 with	 the	 present	
internal	emotional	state	of	the	patient	(i.e.	the	opposite	of	resonance).		
Study	4	(Chapter	6)	also	reported	on	appreciated	and	un-appreciated	music	styles,	showing	
that	 the	most	 appreciated	musical	 styles	 included	ethnic	music,	 neo-classical-	 and	 classical	
music,	 vocal	music	 (non-lyrical),	 followed	by	 ambient	music.	 The	 liking	 and	 disliking	 of	 the	
music	styles	showed	a	remarkable	diversity,	but	one	compositional	feature	in	the	music	that	
was	 found	 to	 be	 in	 particular	 appreciated	 was	 music	 with	 a	 build-up	 or	 “crescendo”	 or,	
contrastingly,	 music	 that	 helped	 to	 feel	 calm	 and	 secure.	 Music	 that	 was	 most	 disliked	
included	music	with	lyrics,	and	music	with	high	pitched	sounds.	
The	music-evoked	experiences	were	often	described	as	personally	meaningful.	The	degree	to	
which	patients	described	a	resonance	of	the	music	with	their	underlying	emotional	state,	as	
well	 as	 the	 degree	 to	 which	 patients	 described	 an	 attitude	 of	 openness	 to	 music-evoked	
experience,	 and	 a	 liking	 of	 the	 musical	 styles	 -	 these	 three	 variables	 were	 found	 to	
significantly	predict	the	occurrence	of	‘peak	experiences’.	Resonance	and	openness,	but	not	
liking,	were	associated	with	experiences	of	insightfulness.	All	three	variables	predicted	clinical	
improvements	 one	 week	 after	 psilocybin,	 whereas	 drug-intensity	 did	 not.	 These	 findings	
suggest	 important	 therapeutic	 functions	 of	 music	 during	 psychedelic	 therapy,	 which	 are	
discussed	in	more	detail	in	section	7.4.	
	
7.2	Summary	of	neuroimaging	findings	
7.2.1	The	effects	of	LSD	on	the	brain’s	processing	of	musical	features	
The	fMRI	study	reported	in	study	2	(Chapter	4)	investigated	the	effects	of	LSD	on	the	brain’s	
processing	 of	 distinct	 acoustic	 features	 of	 music	 under	 naturalistic	 listening	 condition	 in	
healthy	 volunteers.	 	 The	 study	 revealed	 widespread	 BOLD	 activity	 changes	 under	 LSD	 in	
cortical	 and	 subcortical	 areas	 to	 different	 acoustic	 features	 in	 the	music,	 including	music’s	
fullness,	brightness,	timbral	complexity,	and	others.	Considered	the	most	meaningful	of	these	
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findings	were	 the	BOLD	signal	 increases	 that	were	observed	under	 LSD	 for	 the	component	
timbral	 complexity.	 Not	 only	 because	 these	 changes	 were	 particularly	 marked,	 but	 also	
because	 these	 changes	 were	 localised	 to	 brain	 networks	 commonly	 identified	 for	 music-
perception	 and	 music-evoked	 emotion.	 These	 include	 the	 bilateral	 auditory	 cortices,	
including	the	superior	temporal	gyrus	(STG)	and	the	planum	temporale,	right	inferior	frontal	
gyrus	 (IFG,	 also	 known	 as	 broca’s	 area),	 right	 insula,	 precuneus,	 bilateral	 striatum	 and	
supplementary	motor	area	 (SMA).	The	significant	BOLD	 increases	under	LSD	 in	 the	planum	
temporale	 and	 in	 the	 IFG	 to	 timbral	 complexity	 were	 suggested	 to	 be	 of	 particular	
significance	 for	 understanding	 how	 LSD	 affects	 the	 brain’s	 processing	 of	 acoustic	 features.	
Timbral	complexity	refers	to	the	spread	and	the	spikiness	(hence,	complexity)	of	the	power-
spectrum	of	auditory	 information	(Toiviainen	et	al.,	2014).	The	planum	temporale	 is	argued	
to	 be	 specialised	 in	 analysing	 these	 spectral	 properties	 in	 sound	 by	 segregating	 them	 into	
distinct	 spectrotemporal	 patterns	 (Griffiths	 and	Warren	 2002a).	 Subsequently,	 the	 planum	
temporale	(together	with	other	auditory	cortices	such	as	the	superior	temporal	gyrus	(STG))	
forms	a	circuit	of	information	exchange	with	the	IFG	(Kumar	et	al.,	2007,	2016).	This	circuitry	
is	 found	 to	 be	 important	 for	 auditory	 perception	 and	 music	 perception	 (Zatorre	 and	
Salimpoor,	 2013b).	 In	 addition,	 the	 psychophysiological	 interaction	 (PPI)	 analysis	
demonstrated	 a	 significant	 decoupling	 of	 the	 precuneus	 from	 this	 circuitry	 (i.e.	 the	 right	
auditory	 and	 IFG)	 to	 the	 timbral	 complexity.	 Together,	 these	 findings	 suggest	 that	 a	major	
effect	 of	 LSD	 is	 to	 change	 the	 brain’s	 processing	 of	 music’s	 timbral	 or	 spectrotemporal	
content	 via	modulating	 a	 neural	 circuit	 encompassing	 the	planum	 temporale,	 the	 STG	 and	
the	IFG,	and	by	functionally	decoupling	this	circuit	from	the	precuneus.	
	
7.2.2	Neural	correlates	of	LSD	and	music-evoked	emotion	
Following	 the	 neurophysiological	 measures	 in	 study	 2	 (Chapter	 4),	 the	 changes	 in	 music-
evoked	BOLD	activation	were	related	to	changes	in	music-evoked	emotion	measured	by	the	
GEMS	via	correlation	analyses.	These	analyses	were	performed	between	increases	in	music-
evoked	 emotions	 “wonder”	 and	 “transcendence”	 (LSD	 >	 Placebo)	 and	 increases	 in	 music-
evoked	 BOLD	 activation	 to	 timbral	 complexity	 (LSD	 >	 Placebo)	 for	 nine	 regions	 of	 interest	
(ROIs).	 Only	 changes	 in	 music-evoked	 feelings	 of	 “wonder”	 and	 “transcendence”	 were	
included	 in	 this	 analysis,	 because	 these	 are	 typically	 associated	 with	 peak	 experiences	
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(Maslow	1971,	1964;	Richards	2015).	Psychedelic	peak	experiences	occurring	under	music-
listening	conditions	have	been	related	to	enduring	positive	behaviour	change	(MacLean	et	al.,	
2011;	Griffiths	et	al.,	2011)	and	therapeutic	outcomes	(Johnson	et	al.,	2014;	Griffiths	et	al.,	
2016;	Ross	et	al.,	2016).	The	nine	ROI’s	were	pre-defined	based	on	their	implication	in	music-
perception,	music-evoked	emotion	and	the	effects	of	psychedelics,	by	previous	literature	and	
by	 their	 increased	 activation	 to	 timbral	 complexity	 under	 LSD	 in	 the	 present	 study.	 These	
included	 right	 and	 left	 planum	 temporale	 (Griffiths	 and	 Warren,	 2002a),	 precuneus	
(Muthukumaraswamy	et	al.,	2013;	Carhart-Harris	et	al.,	2016;	Trost	et	al.,	2012),	the	striatum	
(right	and	 left	putamen,	 right	and	 left	 caudate)	 (Salimpoor	et	al.,	2011;	Blood	and	Zatorre,	
2001),	right	IFG	(Zatorre	and	Salimpoor,	2013b;	Koelsch	and	Friederici,	2003;	Koelsch	et	al.,	
2002),	and	right	anterior	insula	(Trost	et	al.,	2012;	Koelsch	2014).		
Significant	 positive	 correlations	 were	 found	 between	 increased	 music-evoked	 feelings	 of	
wonder	and	music-evoked	BOLD	activation	to	timbral	complexity	within	the	precuneus	and	
within	 the	 right	 IFG.	 A	 trend-level	 positive	 correlation	 was	 detected	 between	 increased	
music-evoked	 feelings	 of	 transcendence	 and	 the	 right	 IFG.	Despite	 previous	 literature	 that	
associates	the	striatal	system	with	music-evoked	emotion	(Salimpoor	et	al.,	2011;	Blood	and	
Zatorre,	 2001),	 and	 the	 significant	 bilateral	 increases	 in	 BOLD	 activation	 observed	 in	 the	
striatum	to	timbral	complexity	under	LSD,	none	of	these	striatal	regions	were	associated	with	
increased	 music-evoked	 emotions	 of	 wonder	 and	 transcendence.	 Instead,	 the	 findings	
suggest	that	music-evoked	emotions	of	wonder	and	transcendence	are	enhanced	to	music’s	
timbre	 properties	 under	 LSD	 via	 functional	 changes	 occurring	 in	 high-level	 association	
cortices	(IFG	and	precuneus).	
A	body	of	previous	research	has	implicated	the	IFG	in	evaluating	emotional	valence	in	music	
and	 speech	 (Frühholz	 and	 Grandjean,	 2013;	 McGettigan	 et	 al.,	 2013),	 and	 the	 syntactical	
analysis	of	auditory	 information	 (Koelsch	2006;	Maess	et	al.,	2001;	Patel	2003;	Tyler	et	al.,	
2011).	Timbre	is	an	important	acoustic	feature	for	conveying	emotionality	in	voice	and	music	
(Hailstone	et	al.,	2009;	Eerola	et	al.,	2012),	and	the	present	study	suggests	that	LSD	increases	
the	emotional	response	to	music	via	modulating	the	way	brain	networks	process	the	timbre	
of	music.	
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7.2.3	Neural	correlates	of	LSD	and	music-evoked	mental	imagery	
In	 study	 3	 (Chapter	 5),	 a	 seed-based	 functional	 connectivity	 analysis	 with	 the	 bilateral	
parahippocampus	(PHC)	was	reported,	showing	increased	functional	connectivity	of	the	PHC	
with	the	left	IFG,	the	left	insula	and	the	visual	cortex	(VC)	during	music	listening	under	LSD.	
Subsequently,	 a	 dynamic	 causal	 modelling	 (DCM)	 was	 implemented	 to	 assess	 changes	 in	
effective	 connectivity	 (i.e.	 the	 direction	 of	 information	 flow),	 and	 this	 analysis	 revealed	 a	
positive	modulation	(i.e.	an	increase)	of	effective	connectivity	from	the	PHC	to	the	VC	by	an	
interaction-effect	 between	 LSD	 and	 music.	 The	 magnitude	 of	 this	 modulation	 positively	
correlated	with	 increased	ratings	for	eyes-closed	“complex”	mental	 imagery	and	ratings	for	
the	 item	 “I	 saw	 scenes	 from	 my	 past”.	 These	 findings	 are	 consistent	 with	 evidence	 that	
implicate	the	PHC-VC	network	 in	the	construction	of	mental	visual	 images	(Chadwick	et	al.,	
2013;	Zeidman	et	al.,	2014;	Barbeau	et	al.,	2005;	Bartolomei	et	al.,	2004),	and	suggest	that	
psychedelics	 and	 music	 interact	 to	 enhance	 autobiographically	 relevant	 complex	 mental	
imagery	via	increasing	information	flow	from	the	PHC	to	the	VC.	
	
7.3	Possible	brain	mechanisms	of	psychedelics	and	music	
This	paragraph	will	outline	hypothetical	brain	mechanisms	via	which	psychedelics	and	music	
possibly	work	together	to	change	subjective	experience.	This	model	will	be	formulated	within	
the	framework	of	predictive	coding	-	a	mechanistic	account	that	describes	perception	as	the	
creative	process	of	 the	brain	 to	 statistically	match	 (i.e.,	 predict)	 incoming	 information	with	
prior	learned	representation	(i.e.	predictions).	These	predictions	are	derived	via	experience,	
and	 represent	 learned	 representations,	 beliefs	 and	 expectations.	 These	 are	 matched	 with	
incoming	information	in	a	top-down	fashion,	and	this	process	is	believed	to	occur	at	all	stages	
of	the	processing	hierarchy	(e.g.	in	the	context	of	auditory	perception:	all	the	way	from	the	
cochlea,	to	auditory	cortices,	to	multimodal	cortices).	Perception	in	the	context	of	predictive	
coding	 comprises	 a	 continuous	 updating	 of	 the	 brain’s	 internal	 predictive	 models	 of	 the	
world	based	on	 the	accuracy	of	 its	predictions	 (i.e.	 via	a	bottom-up	signalling	of	prediction	
errors)	(Bastos	et	al.,	2012;	Apps	and	Tsakiris,	2014).		
LSD	 activates	 serotonin	 2A	 receptors	 (Halberstadt	 and	 Geyer,	 2010),	 which	 are	
predominantly	expressed	on	deep-layer	V	pyramidal	neurons	(Béïque	et	al.,	2004;	Aghajanian	
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and	 Marek,	 1999;	 Celada	 et	 al.,	 2013).	 These	 deep-layer	 V	 pyramidal	 neurons	 provide	
predictions	 via	 backward	 projections	 to	 subordinate	 (hierarchically	 lower)	 brain	 regions	
(Bastos	et	al.,	2012).	Serotonin	2A	receptor	activation	by	LSD	increases	the	firing-likelihood	of	
the	 deep	 pyramidal	 neurons	 (Aghajanian	 and	 Marek,	 1999),	 arguably	 leads	 to	 an	 un-
coordinated	or	an	“entropic”	activation	of	the	predictions	encoded	by	these	neurons.		
A	 state	 of	 “hyper-activation”	 of	 prior	 predictions	 has	 previously	 been	 argued	 to	 lead	 to	 a	
“perceptual	inference	in	the	absence	of	sensory	evidence”	(Adams	et	al.,	2013).	Studies	have	
linked	deficient	predictive	coding	in	the	auditory	cortex	with	auditory	hallucinations	(Horga	et	
al.,	 2014)	 and	 musical	 hallucinations	 (Kumar	 et	 al.,	 2014).	 The	 planum	 temporale	 is	
considered	 an	 important	 computational	 hub	 to	 segregate	 complex	 spectrotemporal	
information	(Kumar	et	al.,	2007;	Griffiths	and	Warren	2002a),	and	altered	functioning	of	the	
planum	temporale	has	been	related	changes	in	auditory	perception	(Looijestijn	et	al.,	2013;	
Leveque	 et	 al.,	 2016).	 The	 marked	 BOLD	 increases	 under	 LSD	 observed	 in	 the	 planum	
temporale	to	music’s	timbral	complexity	may	therefore	indicate	increased	activation	of	deep-
pyramidal	 neurons	 that	 encode	 predictions	 for	 the	 music’s	 spectrotemporal	 (timbral)	
information.	Although	the	present	study	did	not	formally	address	effects	of	LSD	on	acoustic	
perception,	 increased	 activation	 of	 deep	 pyramidal	 neurons	 in	 the	 planum	 temporale	 to	
timbral	 complexity	under	LSD	may	yield	 significant	changes	 in	auditory	perception	and	 this	
may	 be	 one	 route	 via	 which	 psychedelics	 alter	 the	 subjective	 experience	 of	 music	 (from	
altered	perception	to	altered	emotionality).		
Serotonin	2A	receptors	are	densely	expressed	within	the	 insula	and	the	 IFG	(Erritzoe	et	al.,	
2010;	Ettrup	et	al.,	2014;	Beliveau	et	al.,	2017),	and	overstimulation	of	 the	deep-pyramidal	
neurons	 expressing	 serotonin	 2A	 receptors	 in	 these	 regions	 could	 result	 in	 the	 auditory	
cortex	 (planum	 temporale	 and	 STG)	 to	 receive	 increased	 top-down	predictions	 from	 these	
higher	 regions.	There	 is	evidence	 for	a	selective	 role	of	 timbre	 features	 to	convey	emotion	
(Hailstone	et	al.,	2009;	Eerola	et	al.,	2012),	and	 for	 the	 insula	and	 IFG	playing	a	key	role	 in	
detecting	 emotional	 valence	 in	 sound	 (Frühholz	 and	 Grandjean,	 2013;	 McGettigan	 et	 al.,	
2013),	 and	 more	 generally	 in	 processing	 and	 regulating	 emotions	 (Craig	 2009;	 Gu	 et	 al.,	
2013).	 The	marked	 BOLD	 activation	 to	 timbral	 complexity	 in	 a	 network	 encompassing	 the	
auditory	cortex,	the	IFG	and	the	insula,	may	therefore	reflect	a	“hyper-associative”	matching	
of	the	brain’s	emotional	interpretations	(predictions)	with	activated	acoustic	representations.	
	199	
Mechanistically,	 this	may	be	 instantiated	 via	 increased	 input	 into	 the	 auditory	 cortex	 from	
projections	 originating	 in	 the	 IFG	 and	 insula	 that	 encode	 learned	 representations	 for	
emotional	meaning	in	sound.	
Study	2	(Chapter	4)	also	reported	a	functional	decoupling	of	the	auditory/IFG	circuitry	from	
the	precuneus,	and	 this	was	 interpreted	as	 reduced	 top-down	 regulation	of	 the	precuneus	
over	activity	in	the	auditory/IFG	circuit.	The	precuneus	is	significantly	functionally	affected	by	
psychedelics	 alone	 (Carhart-Harris	 et	 al.,	 2014;	Muthukumaraswamy	 et	 al.,	 2013;	 Carhart-
Harris	 et	 al.,	 2016),	 and	 given	 the	 significant	 role	 of	 the	 precuneus	 in	 regulating	 and	
coordinating	global	brain	function	(Fransson	and	Marrelec	2008;	Cavanna	and	Trimble	2006),	
disrupting	 it’s	capacities	to	do	so	may	 lead	to	an	unconstrained	or	“entropic”	processing	of	
information	in	subordinate	brain	regions.	In	the	present	context,	this	may	be	the	case	for	the	
processing	of	timbre	features	in	music	in	the	auditory/IFG	circuitry.	Activation	of	this	circuit,	
with	simultaneous	de-coupling	from	the	precuneus,	may	subsequently	lead	to	a	disinhibited	
processing	of	musical	 information,	 and	hence	a	more	 intense	 subjective	experience	of	 this	
musical	information.		
The	precuneus	 is	also	densely	 connected	with	 the	visual	 cortex	and	medial	 temporal	 lobes	
(including	the	PHC)	(Zhang	and	Li	2012;	Cavanna	and	Trimble	2006;	Ward	et	al.,	2014).	In	a	
similar	 fashion	 as	 for	 the	 auditory-IFG	 circuit,	 the	 reported	 enhanced	 top-down	 PHC->VC	
information	flow	under	LSD	and	music	may	be	consequential	of	a	temporary	“lifting”	of	the	
usual	top-down	control	from	the	precuneus,	yielding	an	unregulated	spread	of	activation	of	
learned	representations.	The	VC	and	(to	a	lesser	extend)	the	PHC	(entorhinal	cortex)	express	
significant	 levels	of	serotonin	2A	receptors	(Beliveau	et	al.,	2017;	Erritzoe	et	al.,	2010),	and	
research	 implicates	 the	 PHC->VC	 pathway	 in	 the	 construction	 of	 complex	 mental	 images	
(Zeidman	et	al.,	2014;	Chadwick	et	al.,	2013;	Barbeau	et	al.,	2005).	This	finding	may	indicate	
an	increased	activation	of	top-down	projecting	deep-pyramidal	neurons	within	the	PHC	that	
encode	 (complex)	 visual	 mental	 representations	 (i.e.	 “concrete”	 images)	 and	
autobiographical	scenes,	to	the	visual	cortex.		
The	notion	that	psychedelics	facilitate	a	temporary	“collapse”	of	the	usual	hierarchy	of	brain	
function	 is	 receiving	 increasing	 empirical	 support	 from	 studies	 that	 report	 effects	 of	
psychedelics	 under	 resting	 state	 (stimulus-free)	 conditions	 (Carhart-Harris	 et	 al.,	 2014;	
Tagliazucchi	et	al.,	2014,	2016).	The	studies	presented	in	this	thesis	are	the	first	to	illustrate	
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that	 such	 an	 effect	 may	 have	 dramatic	 consequences	 when	 the	 brain	 is	 subsequently	
exposed	to	emotionally	salient	stimuli,	such	as	music.	The	model	outlined	in	this	paragraph,	
aimed	to	provide	a	mechanistic	explanation	for	the	intensified	subjective	experience	of	music	
under	 psychedelics,	 but	more	 research	 is	 warranted	 to	 test	 these	 hypotheses	 empirically.	
How	 these	 findings	 and	 these	 hypotheses	 can	 inform	 an	 empirical	 framework	 for	 their	
therapeutic	use	will	be	the	focus	of	the	subsequent	paragraph.	
	
7.4	Implications	for	psychedelic	therapy	
As	was	reviewed	in	the	introduction	chapter	of	this	thesis	(Chapter	1),	one	major	motivation	
for	 introducing	 music	 in	 psychedelic	 therapy	 in	 the	 1950s	 and	 1960s	 was	 its	 purposed	
capacity	 to	modulate	emotionality	and	mental	 imagery,	as	well	 as	 its	 capacity	 to	provide	a	
sense	of	calm,	direction	and	continuity	within	the	experience	((Chandler	and	Hartman,	1960;	
Hoffer,	1965;	Bonny	and	Pahnke	1972;	Grof,	1980).	The	findings	presented	 in	this	research	
are	to	author’s	knowledge	the	first	to	provide	empirical	support	for	these	motivations	within	
a	modern	scientific	framework,	and	to	ground	the	therapeutic	work	within	a	neurobiological	
understanding.	 This	 section	 will	 summarise	 some	 of	 the	 central	 implications	 that	 these	
findings	have	for	psychedelic	therapy:	The	possible	therapeutic	functions	and	mechanisms	of	
psychedelics	and	music	in	combination,	and	how	music	may	best	be	used	during	psychedelic	
therapy	sessions.	Its	aim	is	to	provide	a	theoretical	framework	of	which	it	is	hoped	it	will	help	
to	better	understand	and	employ	the	therapeutic	actions	of	music	in	psychedelic	therapy.	
	
7.4.1	Possible	therapeutic	functions	of	music	
There	are	several	important	observations	with	regard	to	the	possible	therapeutic	functions	of	
music	in	psychedelic	therapy.	First,	a	growing	body	of	evidence	associates	peak	experiences	
during	 psychedelic	 therapy	 with	 positive	 therapy	 outcomes	 (Garcia-Romeu,	 Griffiths,	 and	
Johnson	2014;	Griffiths	et	al.,	2016;	Ross	et	al.,	2016).	One	motivation	to	introduce	music	in	
psychedelic	therapy	was	its	capacity	to	facilitate	peak	experiences	(Bonny	and	Pahnke	1972;	
Kurland	et	al.,	1971;	Hoffer	1965;	Richards	2015),	and	the	present	findings	support	this.	The	
findings	reported	 in	chapter	3	and	4	suggest	music	may	help	facilitate	peak	experiences	by	
evoking	 emotions	 that	 are	 typically	 associated	 with	 peak	 experiences,	 such	 as	 feelings	 of	
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wonder	and	transcendence.	Furthermore,	chapter	6	showed	that	from	the	diverse	subjective	
experiences	 patients	 can	 report	 under	 psilocybin	 (ranging	 from	 increased	 emotionality,	
audio-visual	 effects,	 to	 anxiety	 and	 cognitive	 impairments),	 the	 music-experience	 was	
selectively	 predictive	 for	 peak	 experiences	 (feelings	 of	 union,	 bliss,	 and	 spirituality)	 and	
insightfulness	 (having	 innovative	 ideas,	 a	 sense	 of	 profoundness,	 and	 experiencing	 vivid	
personal	 memories).	 This	 is	 important,	 as	 it	 indicates	 that	 music	 can	 be	 effective	 in	
engendering	 specific	 emotionally	 charged	 experiences	 that	 hold	 particular	 therapeutic	
meaning	and	potential	value,	and	that	music	may	thereby	play	an	 important	role	 in	driving	
positive	therapeutic	outcomes	in	psychedelic	therapy.	The	finding	in	chapter	6	that	it	 is	not	
the	 mere	 intensity	 of	 the	 drug-effects,	 but	 the	 quality	 of	 the	 music-experience	 that	 is	
predictive	for	positive	therapy	outcomes,	provides	further	support	for	this	view.		
Secondly,	 early	 researchers	 reported	 that	 LSD	 has	 “the	 astonishing	 quality”	 to	 re-activate	
patient's	 “repressed	 emotional	 attitudes"	 (Feld,	 Goodman,	 and	 Guido	 1958),	 and	 that	
“frequently	whole	sequences	unroll	before	the	patient's	eyes	as	though	they	had	been	stored	
on	 microfilm”	 (Eisner	 and	 Cohen	 1958).	 One	 important	 motivation	 to	 introduce	 music	 in	
psychedelic	 therapy	 was	 to	 promote	 a	 “deeper	 involvement”	 with	 these	 autobiographical	
processes	 (Grof,	 1980),	 and	 the	 findings	 of	 this	 thesis	 support	 this	 motivation	 too.	 The	
findings	 presented	 in	 chapter	 4	 indicated	 that	 psychedelics	 and	 music	 modulate	 mental	
imagery,	by	revealing	a	relationship	between	enhanced	PHCàVC	information	flow	in	healthy	
volunteers,	 and	 enhanced	 complex	 mental	 imagery	 (i.e.	 concrete	 objects,	 beings	 or	
landscapes)	and	autobiographical.	Interestingly,	this	association	was	only	found	for	complex	
visual	 imagery,	 and	 not	 for	 simple	 visual	 imagery.	 Accordingly,	 in	 chapter	 6,	 the	 music-
experience	during	psychedelic	therapy	sessions	was	predictive	for	insightfulness,	a	factor	that	
included	 loadings	 from	 items	capturing	 the	experience	of	vivid	personal	memories,	but	not	
simple	mental	 imagery	 (audio-visual	 synaesthesia	 or	 elementary	 imagery).	 Together	 these	
findings	 suggest	 that	one	other	 function	could	be	 to	 shift	 the	 focus	within	 the	eyes-closed	
visual	 experience,	 towards	 imagery	 that	 is	 particularly	 autobiographically	 “insightful”,	 and	
hence	particularly	therapeutically	meaningful.		
Finally,	for	many	patients,	music	was	found	to	be	helpful	in	providing	states	of	calm,	comfort,	
and	 security.	 Related	 to	 this	 are	 the	 feelings	 of	 guidance	 attributed	 to	 the	music,	 such	 as	
feeling	personal	helped	by	the	music,	and	the	music	being	grounding	and	reassuring.	These	
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securing/calming	 effects	 were	 found	 to	 be	 particularly	 appreciated	 in	 situations	 where	
apprehensions	were	present,	such	as	prior	to	the	onset	of	drug-effects,	or	when	mental	calm	
and	“clarity”	was	required,	such	as	after	emotionally	intense	periods.	These	findings	suggest	
that	one	other	function	of	music	may	be	to	provide	a	sense	of	calm,	security	&	guidance	-		a	
function	 that	may	 form	an	 important	 contrast	with	 the	previously	described	evocative	 (i.e.	
intensifying)	influences	of	music.	
The	findings	in	these	studies	show	a	remarkable	congruency	with	theoretical	frameworks	and	
patient-experiences	of	“introspective”	forms	of	music	therapy,	where	music	is	utilised	as	the	
means	 to	 provide	 an	 experience	 -emotionally	 and	 mentally-	 that	 is	 thought	 to	 help	 the	
listener	 to	 examine	 and	 change	 the	 relationships	 with	 themselves	 (Abbott	 2005;	 Summer	
1992;	 Albornoz	 2013).	 This	 includes	 using	 music	 to	 evoke	 intense	 emotional	 experiences	
(Albornoz	2013),	as	well	as	a	way	 to	provide	a	“holding	environment”,	 that	 feels	“safe	and	
secure”	 to	 express	 and	 experience	 new	 aspects	 of	 oneself	 (Carroll	 2011;	 Schulberg	 1999).	
Anxiety-	and	tension-reducing	effects	of	music	are	widely	reported	in	 literature	and	utilised	
across	 different	 health	 care	 disciplines	 (Finch	 and	 Moscovitch	 2016;	 Pavlov	 et	 al.,	 2017;	
Mondanaro	et	al.,	2017).		
Taking	 these	 findings	 together,	 it	 can	 be	 concluded	 that	 music	 can	 modulate	 subjective	
experience	in	psychedelic	therapy	in	profound	and	functional	ways,	and	that	the	therapeutic	
functions	of	music	in	this	context	may	be	generally	classified	into	two	distinct	categories:	
1) A	directive/suggestive	function,	characterised	by	the	music	being	arousing/activating	
(emotionally,	bodily	and	mentally),	and	the	listener	becoming	fully	immersed	into	the	
music-experience	(E.g.	the	music	furthering	ego-dissolution).	Directive	music	may	be	
seen	as	to	provide	non-verbal	“suggestions”	that	the	 listener	can	personally	 identify	
with	 and	 follow.	 Once	 surrendered	 to	 the	 perceived	 suggestions	 of	 the	music	 (i.e.	
open	 to	 the	music-evoked	 experience),	 the	 experience	 unfolds	 as	 a	 “journey”,	 rich	
with	personally	meaningful	thoughts,	emotionality	and	imagery.	This	function	may	be	
especially	important	to	facilitate	an	expression	or	“release”	of	(previously)	previously	
suppressed	 psychological	 content	 and	 emotionality.	 Music	 styles	 that	 may	 be	
particularly	 suitable	 for	 this	 function	are	emotive	or	cinematic	music	 styles,	 such	as	
for	example	(neo)classical	music	and	ethnic	music	styles.	
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2) 	A	 non-directive/non-suggestive	 function,	 characterised	 by	 the	music	 being	 calming	
(emotionally,	 bodily	 and	 mentally),	 and	 the	 listener	 becoming	 more	 relaxed	 and	
present	in	the	here	and	now.		This	function	may	be	especially	important	to	facilitate	a	
sense	 of	 security,	 that	 subsequently	 facilitates	 an	 attitude	 of	 openness	 to	 the	
experience,	 as	 well	 as	 to	 create	 an	 environment	 that	 allows	 contemplation	 and	
interaction,	 with	 oneself	 or	 with	 the	 therapist	 (i.e.	 the	 music	 furthering	 ego-
(re)integration).	Music	 styles	 that	may	 be	 particularly	 suitable	 for	 this	 function	 are	
ambient	or	other	“non-musical”	styles	that	focus	on	creating	an	acoustic	ambience,	a	
climate,	rather	than	to	a	dynamic	musical	experience	that	demands	attention.	In	the	
words	of	the	ambient	music	pioneer	Brian	Eno:	
“Ambient	 music	 is	 intended	 to	 induce	 calm	 and	 a	 space	 to	 think.	 Ambient	
music	 must	 be	 able	 to	 accommodate	 many	 levels	 of	 listening	 attention	
without	enforcing	one	in	particular;	it	must	be	as	ignorable	as	it	is	interesting.”	
–	Brian	Eno	(1978)	
	
Technically	 speaking,	 one	 may	 argue	 that	 here	 is	 not	 such	 a	 phenomenon	 as	 non-
directive/non-suggestive	music,	since	any	stimulus	will	have	a	capacity	to	trigger	emotional-
mental	 associations,	 and	 hence	 induce	 psycho-behavioural	 changes	 in	 the	 listener.	 Non-
suggestive	music	may	indeed,	in	reality,	be	suggestive	of	for	example	calmness	and	security.	
Yet,	 how	 the	 two	 functions	 differ,	 is	 in	 the	 “coerciveness”	 of	 the	 suggestion.	Where	 non-
directive/non-suggestive	music	can	be	“as	ignorable	as	it	is	interesting”,	directive/suggestive	
music	 can	 be	 seen	 as	more	 or	 less	 un-ignorable,	 and	 does	 not	 give	 “space	 to	 think”,	 but	
instead	requires	a	full	surrender	to	the	direction	or	suggestion	that	the	listener	perceives	in	
the	music.	
	
7.4.2	Possible	therapeutic	mechanisms	of	psychedelics	and	music		
The	presented	research	did	not	directly	 study	 therapeutic	mechanisms	of	psychedelics	and	
music,	 but	 provided	 important	 clues	 as	 to	 how	 and	why	 psychedelics	 and	music	 may	 act	
therapeutically	 in	 combination.	 Indeed,	 the	 two-fold	 functions	 of	 music	 as	 defined	 above	
raise	 the	question	why	such	musical	 experiences	would	be	 therapeutic.	One	key	 finding	of	
this	 research,	 is	 that	 the	 music-experience	 seems	 to	 be	 substantially	 intensified	 under	
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psychedelics,	and	that	this	can	evoke	meaningful,	but	also	sometimes	challenging	emotional	
experiences.	An	open	and	interactive	attitude	towards	these	music-evoked	experiences	was	
frequently	described	as	being	important	in	finding	therapeutic	resolution,	and	“openness”	to	
the	music-evoked	experience	correlated	with	reductions	 in	depression.	This	section	aims	to	
consolidate	 these	 findings	 into	 a	 theoretical	 framework,	 based	 on	 neuroscience	 and	
psychotherapeutic	 thinking,	 that	 proposes	 the	 therapeutic	 mechanisms	 via	 which	
psychedelics	and	music	possibly	work	together.	
An	important	function	of	the	brain	 is	to	maintain	homeostasis	(i.e.	balance),	and	to	acquire	
learned	representations	(i.e.	predictions)	that	guide	this	process	effectively	(Seth	and	Friston	
2016).	 Throughout	 life,	 the	 many	 learned	 representations	 are	 assembled	 into	 a	 complex	
inner	 working	 model,	 that	 functions	 (to	 introduce	 a	 simplifying	 analogy)	 like	 an	 inner-
roadmap:	 it	determines	how	information	is	processed,	what	it	means,	 it	 informs	behaviour,	
and	produces	a	coherent	sense	of	self	or	identity	(Apps	and	Tsakiris	2014;	Carhart-Harris	and	
Friston	2010).	The	main	purpose	of	this	inner	roadmap,	is	to	help	the	self	survive	and	thrive	
in	a	highly	complex	and	always-changing	world.	Yet,	it	can	also	be	this	inner	roadmap,	or	the	
use	of	 it,	that	 is	the	source	of	psychological	suffering,	and	which	individuals	seek	to	change	
when	 seeking	 help	 in	 psychotherapy	 (Young,	 Klosko,	 and	 Weishaar	 2006;	 Beck	 and	 Beck	
2011).	Subsequently,	 it	 is	goal	of	all	psychotherapies	“to	influence	the	client	 in	such	a	way”	
(Yapko	 2001)	 so	 that	 new	 aspects	 of	 oneself	 and	 new	 ways	 of	 experiencing	 oneself	 are	
discovered	and	re-assembled	 into	a	new	self-concept,	an	updated	roadmap	(Joyce	and	Sills	
2014;	 Young,	 Klosko,	 and	 Weishaar	 2006;	 Beck	 and	 Beck	 2011;	 Rogers	 1996;	 Black	 and	
Mitchell	1996).	
Deeply	 feeling	 and	 expressing	 challenging	 emotions	 is	 argued	 to	 be	 important	 for	
psychotherapeutic	 change	 (Whelton	 2004),	 and	 this	 aim	 is	 central	 to	 many	
psychotherapeutic	 models	 (Greenberg	 and	 Pascual-Leone	 2006).	 Some	 research	 has	
indicated	 that	 the	patient’s	 level	of	experiencing	emotions	 (i.e.	 its	 “depth”)	during	 therapy	
sessions,	 is	predictive	 for	positive	 therapy	outcomes	 (Hendricks,	2002;	Orlinsky	et	al,	2004;	
Greenberg	et	al.,	2002).	Psychedelics	temporarily	disorganise	the	brain’s	functional	hierarchy	
(Carhart-Harris	 et	 al.,	 2016,	 2012;	Muthukumaraswamy	et	 al.,	 2013),	 and	 this	dissolving	of	
the	 usual	 roadmap	 (i.e.	 ego-dissolution)	 has	 been	 argued	 to	 underlie	 the	 intensified	
subjective	 response	 to	 music	 under	 psychedelics	 (summarized	 in	 paragraph	 7.7.2).	 In	 line	
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with	 many	 earlier	 researchers	 (Eisner	 and	 Cohen	 1958;	 Busch	 and	 Johnson,	 1950;	 Hoffer	
1965;	 Butterworth	 1962;	 Feld,	 Goodman,	 and	 Guido	 1958;	 Kurland	 et	 al.,	 1971),	 these	
findings	 suggest	 that	 a	 central	 therapeutic	 function	 of	 psychedelics	 is	 to	 provide	 a	 rapid	
relinquishment	of	 emotional	 control,	 so	 that	 emotions	 can	be	 aroused	and	expressed	 to	 a	
fuller	extent.		
This	effect	of	psychedelics,	however,	is	considered	unspecific,	leading	to	a	wide	spectrum	of	
possible	subjective	experiences	(Grof,	1980).	In	the	absence	of	the	usual	roadmap,	music	in	
this	context	may	play	the	important	role	of	a	“road-navigator”,	guiding	the	experience	(either	
in	 directive	 or	 non-directive	 ways	 (see	 paragraph	 7.4.1))	 into	 territories	 beyond	 the	 usual	
road-map	(beyond	the	usual	boundaries	of	the	self),	to	remember	or	experience	new	aspects	
of	 oneself	 that	 are	 most	 therapeutically	 significant	 (characterised	 by	 the	 qualities	 of	
autobiographical-	 and/or	 peak	 experience	 (see	 paragraph	 1.4.1	 and	 paragraph	 7.4.1)).	
Subsequently,	 newly	 acquired	 self-representations	 (new	 routes	 or	 guidelines)	 can	 be	
assembled	 into	 an	 updated	 working	 model	 (an	 updated	 inner-roadmap)-	 or,	 as	 the	
pioneering	humanistic	psychologist	Carl	Rogers	formulated,	an	altered	self-concept:	
“To	perceive	a	new	aspect	of	oneself	is	the	first	step	toward	changing	the	concept	of	
oneself.	The	new	element	is,	in	an	understanding	atmosphere,	owned	and	assimilated	
into	a	now	altered	self-concept.	This	is	the	basis,	 in	my	estimation,	of	the	behaviour	
changes	 that	 come	 about	 as	 a	 result	 of	 psychotherapy,	 Once	 the	 self-concept	
changes,	the	behaviour	changes	to	match	the	freshly	perceived	self”(Rogers	1996)	
	
7.4.3	The	unique	therapeutic	value	of	music	
Compared	with	other	psychotherapy	modalities,	psychedelic	therapy	is	unique	in	its	capacity	
to	facilitate	rapid	and	sustained	therapeutic	changes	(Ross	et	al.,	2016;	Griffiths	et	al.,	2016;	
Carhart-Harris	 et	 al.,	 2016;	 Gasser,	 Kirchner,	 and	 Passie	 2014,	 2015;	 Grob	 et	 al.,	 2011;	
Bogenschutz	 et	 al.,	 2015;	 Johnson	 et	 al.,	 2014;	 Johnson	 et	 al.,	 2016).	 The	 promising	
effectiveness	 of	 psychedelic	 therapy	may	 be	 due	 its	 focus	 on	 providing	 a	 deeply	 felt	 and	
personally	meaningful	experience,	 rather	 than	 conventional	mental	health	 treatments,	 that	
tend	 to	 focus	 on	 changing	 cognition,	 behaviour,	 or	 neurochemistry	 (see	 Chapter	 1.6).	
Experiences	are	the	basis	for	implicit	learning,	and	implicit	learning	is		the	foundation	for	any	
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behavioural	 change.	 The	 studies	 in	 this	 thesis	 indicated	 that	 music	 can	 help	 engender	
implicit-learning	experiences	that	may	be	particularly	therapeutic	significant.	
There	may	indeed	be	other	means	than	music	to	facilitate	meaningful	experiences,	and	more	
generally,	to	fulfil	the	therapeutic	objections	discussed	above;	but	the	unique	value	of	music	
in	 this	 context	 may	 be	 1)	 its	 capacity	 to	 convey	 emotional	 experiences	 that	 are	 dynamic	
(time-based),	 and	 2)	 do	 so	 without	 the	 use	 of	 words.	 The	 significance	 of	 this	 can	 be	
conceptualised	 through	 the	 process	 of	 “affect	 attunement”	 -	 a	 term	 formalised	 by	 the	
developmental	 psychologist	 Daniel	 N.	 Stern.	 Stern	 argued	 that	 the	 very	 first	 interpersonal	
world	 of	 human	 experience,	 that	 of	 the	 infant	 interacting	 with	 his	 or	 her	 mother,	 is	 in	
essence	 a	musical	 relationship.	 Affect	 attunement	 refers	 to	 the	matching	 of	 the	mother’s	
non-verbal	expressions	(the	changes	in	intensity	and	tonality	of	her	voice),	with	the	infant’s	
behaviour.	 Affect	 attunement	 does	 not	 imply	 the	 providing	 of	 perfect	mirror-image	of	 the	
infant’s	experience,	but	 the	providing	of	a	 reflection	 in	a	different	modality	 (i.e.	 sound),	of	
the	dynamic	contours	of	the	infant’s	internal	feeling-states	(Stern	1995,	1998).		
According	to	Stern	“for	the	infant,	the	music	comes	before	the	lyrics”,	and	“the	entire	flow	of	
maternal	social	behaviors	can	be	likened	to	a	symphony,	in	which	the	musical	elements	are	
her	changing	facial	expressions,	vocalizations,	movements,	and	touches”	(Stern	2010).	Affect	
attunement	 is	 believed	 to	 guide	 the	 awareness	 of	 the	 infant	 to	 the	 subjective	 basis	
underlying	his	or	her	own	behaviour,	while	maintaining	a	 sense	of	being	securely	held	and	
“contained”	by	the	caregiver.	Mother-infant	interactions	are	present	cross-culturally	(Trehub	
and	Trainor	1998),	and	are	argued	to	promote	emotional	learning	(Licata,	Kristen,	and	Sodian	
2016;	Schore	and	Schore	2007;	Thompson	1991).		
In	 psychedelic	 therapy,	 the	 therapeutic	 actions	 of	 music	 may	 resemble	 the	 process	 of	
mother-infant	 affect	 attunement.	 Here,	 music	 can	 be	 seen	 as	 a	 non-verbal	 (or	 even	 pre-
verbal)	 language,	 that	 provides	 an	 attunement	 to	 dynamic	 internal	 feeling	 states	 of	 the	
listener,	thereby	facilitating	emotional	learning	experiences,	while	simultaneously	providing	a	
sense	of	being	securely	held	and	supported.	By	dramatically	enhancing	the	usual	subjective	
response	to	music,	psychedelics	may	create	a	unique	therapeutic	opportunity	for	the	music-
experience	 to	 become	 deeply	 experiential	 (i.e.	 the	 listener	 becomes	 fully	 immersed	 in	 the	
music).	Importantly,	the	musical	(non-verbal)	language	is	entirely	process-based,	as	opposed	
to	 content-based	 (example:	 movies).	 This	 may	 be	 particularly	 important,	 as	 music	 can	
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thereby	 can	 reflect	 and	activate	 intrinsic	 feeling	 states	 (i.e.	 the	processes	 conveyed	by	 the	
music),	while	allowing	the	specific	autobiographical	content	to	be	spontaneously	associated	
with	 the	 music	 by	 the	 mind	 of	 the	 listener.	 As	 the	 classical	 composer	 Richard	 Wagner	
eloquently	formulated:	
“What	music	expresses,	 is	eternal,	 infinite	and	 ideal:	 it	does	not	express	 the	
passion,	 love,	or	 longing	of	such-and-such	an	 individual	on	such-and-such	an	
occasion,	 but	 passion,	 love	 or	 longing	 in	 itself,	 and	 this	 it	 presents	 in	 that	
unlimited	 variety	 of	 motivations,	 which	 is	 the	 exclusive	 and	 particular	
characteristic	 of	music,	 foreign	 and	 inexpressible	 to	 any	 other	 language”.	 –	
Richard	Wagner,	quoted	by	Anthony	Storr	in	Music	and	the	Mind	(Storr	1997)	
	
7.4.4	Implications	for	using	music	in	psychedelic	therapy		
The	findings	suggest	several	implications	for	therapists	working	with	music	in	the	context	of	
psychedelic	 therapy.	The	ability	of	music	 to	evoke	meaningful	 therapeutic	experiences	was	
discussed	 as	 a	mixed	 function	 of	 (1)	 the	 patients’	 liking	 of	 the	music	 styles,	 (2)	 the	music	
being	in	resonance	or	in	tune	with	the	patient’s	dynamic	feeling	states,	and	(3)	an	attitude	of	
openness	on	behalf	of	the	patient	to	the	resulting	music-evoked	experience.	Resistance	was	
suggested	 to	 be	 an	 important	 indicator	 of	 the	 patient	 rejecting	 the	 music,	 and	 thereby	
hindering	therapeutic	progress.	Here,	resistance	was	defined	as	a	distancing	of	the	music	and	
its	 influences,	 and	 was	 often	 characterised	 by	 an	 intellectualisation	 of	 the	 experience,	 by	
feelings	 of	 discomfort,	 irritation,	 fear,	 and	 a	 by	 general	 sense	 of	 the	 experience	 being	
diminished	 or	 blocked	 by	 the	 music.	 This	 experience	 can	 be	 seen	 as	 the	 opposite	 of	 the	
often-reported	music-evoked	sense	of	being	on	a	journey	(characterised	by	the	dispensing	of	
intellectualisation),	which	was	associated	with	a	welcomed	music-experience.	
The	findings	do	suggest	that	resistance	should	not	be	merely	understood	as	an	inability	of	the	
patient	to	open	up,	but	that	it	could	occur	for	different	reasons,	and	hence	require	different	
interventions:		
1) 	The	 music	 may	 be	 rejected	 because	 the	 experience	 it	 evokes	 is	 challenging,	 yet	 the	
experience	may	hold	therapeutic	significance	(e.g.	the	music	may	remind	the	listener	of	
a	deceased	loved-one,	and	the	resulting	emotions	may	feel	too	overpowering).		
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2) The	 music	 may	 be	 rejected	 because	 of	 a	 disliking	 of	 the	 music	 style	 (e.g.	 a	 lack	 of	
personal	connection	with	the	music	style,	or	finding	the	music	aesthetically	abrasive).		
3) The	music	may	be	dissonant	(out	of	tune	/	a	mismatch)	with	the	patient’s	internal	feeling	
states	 (e.g.	 the	 individual	 undergoing	 a	 deep	 sensation	 of	 grief,	 and	 the	music	 being	
joyful).	
An	 attitude	of	 openness	 to	 the	music-evoked	 experience	 could	 be	 optimised	 via	 adequate	
preparation	 prior	 to	 the	 therapy	 session.	 This	 would	 include	 an	 encouragement	 of	 full	
immersion	 into	 the	 experience,	 and	 a	 curious	 and	 interactive	 engagement	 with	 the	
experience	 even	 in	 situations	 when	 it	 becomes	 challenging.	 The	 aid	 of	 music-listening	
exercises	prior	 to	 therapy	sessions	have	as	yet	not	been	explored,	yet	may	be	an	effective	
way	 to	prepare	a	mind-set	 conducive	 to	 immersion.	 Such	exercises	might	 also	provide	 the	
therapist	with	some	idea	of	music	styles	that	may	work	best	for	the	individual	patient.			
Dialogue	may	determine	the	right	response	to	resistance	as	it	arises	during	a	session.	When	it	
occurs	 in	 relation	 to	 therapeutically	 meaningful	 psychological	 material,	 a	 constructive	
relationship	with	the	experience	can	be	increased	via	a	reassurance	and	reminder	of	safety	
and	personal	support,	an	encouragement	to	explore	the	experience	interactively.		
In	 contrast,	when	 the	music	 is	 rejected	due	disliking	 of	 the	music	 styles,	 and	or	when	 the	
music	 is	dissonant	with	 the	patients	underlying	emotional	state,	 the	therapist	may	need	to	
take	 action.	 Analogous	 to	 usual	 client-centred	 dialogues	 in	 psychotherapy,	 where	 the	
therapist	 listens	 attentively	 and	 reflects	 back	 to	 the	 patient	 his	 or	 her	 observations	 in	 a	
dynamic	and	interactive	fashion,	so	it	may	be	necessary	for	the	therapists	to	ensure	that	the	
music	 is	 adequately	 “attuned”	 to	 the	 patient’s	 dynamically	 unfolding	 experience	 and	
psychotherapeutic	needs.	Liking	of	the	music	may	be	an	important	primary	pre-requisite	for	
the	individual	to	be	able	to	relate	personally	and	respond	emotionally	to	the	music.	This	liking	
may	 not	 only	 reflect	 the	 individual’s	 aesthetic	 judgements,	 but	 could	 also	 refer	 to	 the	
suitability	of	the	music	styles	to	the	conscious	state	induced	by	psychedelics.	Needless	to	say,	
this	area	requires	significant	more	research.		
When	the	music	is	dissonant	with	the	patient’s	emotional	state,	a	change	in	the	music	may	
be	 required.	 This	 would	 include	 a	 better	matching	 of	 the	music’s	 emotional	 and	 dynamic	
characteristics	to	the	patient’s	present	internal	emotional	state,	on	the	assumption	that	this	
would	help	him	or	her	experience	these	feelings	more	deeply,	and	that	this	experience	would	
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lead	 to	meaningful	 therapeutic	 processing.	 For	 example,	 feelings	 of	 grief,	 can	 be	matched	
with	music	that	symbolises	this	process	of	grief.	The	capacity	of	music	to	not	merely	convey	
tonic	 emotional	 states,	 but	 also	 emotional	 dynamics	 (e.g.	 with	 nadirs,	 crescendo	 and	
breakthrough)	may	help	develop	a	constructive	and	meaningful	experience.	To	continue	this	
example,	the	subsequent	development	of	the	resonant	music	is	not	merely	reflecting	a	state	
of	 grief,	 but	 a	 dynamic	 process	 that	 can	 carry	 the	 engaged	 listener	 through	 a	 deeply	 felt	
emotional	release,	towards	subsequent	constructive	resolution.	
	
7.4.5	Implications	for	psychedelic	therapy:	Summary	
The	 findings	 of	 this	 research	 suggest	 that	 psychedelics	 and	 music	 interact	 on	 subjective	
experience	 to	 provide	 a	 unique	 opportunity	 for	 experiential	 learning.	 A	 hypothetical	
framework	was	described	in	which	psychedelics	function	to	dissolve	the	usual	psychological	
control	 mechanisms,	 thereby	 facilitating	 a	 substantial	 intensification	 of	 the	 subjective	
experience	of	 the	music.	Music	here	has	been	 suggested	 to	have	 a	 two-fold	 function,	 one	
being	 directive/suggestive	 (activating),	 and	 the	 other	 being	 non-direct/non-suggestive	
(calming).	The	musical	experience,	in	turn,	has	been	argued	to	act	therapeutically	when	the	
music	 is	 sufficiently	 attuned	 to	 (in	 resonance	 with)	 the	 patient’s	 intrinsic	 dynamic	 feeling	
states,	in	order	to	facilitate	a	fuller	emotional	expression	of	these	feeling	states.	When	fully	
experientially	 immersed	 in	 the	music,	and	when	openly	and	 interactively	engaged	with	 this	
experience,	 music	 can	 facilitate	 personally	 meaningful	 experiences	 (autobiographical	
experience	 and	 peak	 experiences),	 via	 which	 new	 self-concepts	 can	 be	 acquired	 that	 can	
form	the	basis	for	sustained	positive	therapeutic	changes.	
	
7.5	Study	limitations	and	future	directions	
The	research	findings	present	several	 limitations	and	opportunities	 for	 future	research	(see	
paragraphs	 3.4.2,	 4.4.5,	 5.4.3	 and	 6.4.6)	 First,	 despite	 the	 GEMS	 being	 designed	 and	
formulated	 to	 specifically	 assess	 music-evoked	 emotions,	 the	 experimental	 design	 of	 the	
studies	reported	in	study	1	(Chapter	3)	and	study	2	(Chapter	4)	did	not	allow	us	to	separate	
drug-effects	from	music-effects	on	emotion.	For	example,	LSD	may	have	produced	sensations	
of	 “transcendence”	 alone,	 without	 the	 music,	 and	 increased	 ratings	 of	 music-evoked	
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transcendence	 under	 LSD	 and	music-listening	may	 therefore	 be	 influenced	 by	 this.	 Future	
studies	are	warranted	that	better	enable	a	separation	between	music-	and	drug-conditions	
to	deepen	our	understanding	of	their	interactive	effects	on	emotion.	Secondly,	although	such	
design	was	 implemented	 for	 the	 study	 assessment	 of	 LSD’s	 and	music’s	 effects	 on	mental	
imagery,	reported	in	study	3	(Chapter	5),	only	a	trend-level	effect	of	music	was	observed	for	
enhanced	“complex”	visual	imagery.	Mental	imagery	was	however	significantly	enhanced	by	
LSD	alone.	 It	may	be	that	music	 influences	a	certain	component	of	mental	 imagery,	and	as	
such,	more	specific	measures	may	be	needed	to	detect	those	changes,	such	as	for	example	
measures	 that	 not	 only	 assess	 vividness	 of	 the	 visual	 imagery,	 but	 also	 the	 content	 or	 the	
visual	 imagery.	The	absence	of	 finding	a	significant	music	effect	or	a	significant	 interaction-
effect	 of	music	 and	 LSD	 on	 visual	mental	 imagery,	may	 also	 be	 due	 a	 significant	 variance	
within	 the	 study	 population	 and	 the	 study	 population	 being	 small.	 This	 explanation	 is	
supported	 by	 the	 correlation-analyses	 in	 study	 3	 (Chapter	 5),	 showing	 individuals	 with	
increased	 PHCàVC	 information	 flow	 reporting	 increased	 mental	 imagery,	 while	 other	
individuals	 reported	decreased	PHCàVC	 information	and	decreased	mental	 imagery	under	
LSD	in	response	to	music.		
Using	a	similar	line	of	reasoning,	the	study	reported	in	study	2	(Chapter	4)	showed	a	positive	
correlation	between	music-specific	changes	 in	brain-activity	 (i.e.	 to	 timbral	complexity)	and	
music-evoked	 emotion	 (wonder	 and	 transcendence).	 One	 may	 argue	 that	 if	 an	 effect	 on	
emotion	 was	 primarily	 due	 to	 LSD	 alone,	 a	 neurobiological	 measure	 highly	 specific	 to	 a	
feature	within	 the	music	 (i.e	 timbral	 complexity)	would	 not	 be	 expected	 to	 correlate	with	
changes	in	music-evoked	emotion.	
Finally,	the	qualitative	findings	discussed	in	study	4	(Chapter	6)	provided	insight	into	patient-
experiences,	but	the	lack	of	placebo	condition	emphasises	the	care	needed	in	drawing	strong	
inferences.	The	study	should	be	valued	for	its	exploratory	nature,	and	its	discussion,	including	
the	 suggested	possible	 therapeutic	 functions	of	music,	must	be	viewed	as	 speculative.	The	
study	provides	directions	for	 future	studies	where	these	hypotheses	can	be	tested	directly,	
and	 under	 placebo-controlled	 conditions.	 Examples	 of	 future	 studies	 that	 can	 test	 these	
hypotheses	via	better	controlled	experiments,	are	studies	that	assess	the	predictive	value	of	
liking	 of	 the	 music,	 resonance	 of	 the	 music,	 and	 openness	 to	 the	 music	 for	 subjective	
experience	 and	 therapy	 outcomes.	 Self-rating-scales	 can	 be	 implemented	 for	 the	 general	
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experience	of	 the	playlist,	or	better,	 for	 specific	genres	of	music.	 Such	a	 study	would	have	
capacity	 to	 identify	 separate	 factors	 within	 the	 music-experience,	 and	 could	 help	 identify	
aspects	 of	 the	 music-experience	 (e.g.	 optimisation	 of	 music’s	 resonance	 via	 an	 adaptive	
approach)	 may	 yield	 better	 therapy	 outcomes.	 Other	 important	 facets	 invite	 further	
investigation	 are	 the	 role	of	 an	 individuals’	music-listening	history	 (individuals’	 usual	music	
taste)	in	determining	the	music-experience	under	a	psychedelic,	and	the	relative	contribution	
to	music	 to	 the	therapeutic	experience	and	outcome	compared	to	other	 factors	 in	 therapy	
sessions,	such	as	for	example	interpersonal	factors	or	the	design	of	the	physical	environment	
in	which	the	experience	takes	place.	Furthermore,	studies	can	aim	to	better	understand	the	
interactions	 between	 mind-set	 (mood	 and	 attitudes)	 and	 personality-traits	 (ex:	 trait	
absorption,	openness,	suggestively)	with	the	subjective	experience	of	music	under	psilocybin.		
Research	 that	 focusses	on	 identifying	 reliably	 indicators	 for	positive	 (welcomed/supportive)	
and	negative	(unwelcomed/unsupportive)	 influences	of	music	on	the	therapeutic	processes	
during	 psychedelic	 therapy	 sessions,	 may	 be	 highly	 significant	 for	 the	 development	 of	
psychedelic	therapy,	and	the	tools	used	during	psychedelic	therapy.	These	could	range	from	
physiological	measures,	such	as	heart-rate,	body	movement,	and	breathing	patterns,	or	more	
complex	measures	 such	 as	 facial	 affect-coding,	 vocal-affect	 coding,	 and	 brain	mechanisms	
(EEG-signatures),	 that	 could	 yield	 technologist	 that	 can	 assist	 therapists	 in	 on-the-fly	
adaptation	of	music-selection	to	maximise	music’s	attunement	to	the	individual’s	therapeutic	
needs,	or	inform	playlist	generation	algorithms.	
It	must	 be	 emphasised	 that	 these	 studies	were	 amongst	 the	 first	 to	 assess	 the	 combined	
effects	 of	 music	 and	 psychedelics	 on	 subjective	 experience	 and	 on	 brain	 function.	 The	
findings	 therefore	naturally	 necessitate	 their	 replication	 in	 future	 independent	 studies.	 For	
example,	 the	 choice	 of	 music	 may	 have	 significantly	 influenced	 the	 present	 findings,	 and	
future	studies	that	use	different	or	a	multitude	of	musical	genres,	may	be	utilised	to	control	
for	this.	Additionally,	although	the	majority	of	individuals	in	the	neuroimaging	study	and	the	
clinical	 study	 reported	 a	 “liking”	 of	 the	 music,	 no	 measures	 were	 implemented	 to	 assess	
music	 taste	 or	 attitudes	 to	 music-listening	 beforehand,	 and	 these	 variables	 could	 have	
influenced	the	presented	the	results	too.		
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7.6	Concluding	remarks	
The	 findings	 reported	 in	 this	 thesis	 support	 the	 hypothesis	 that	 the	 music-experience	 is	
intensified	under	psychedelics,	and	provide	support	for	the	widely-held	view	that	this	effect	
can	be	therapeutically	utilised.	Further	research	is	warranted	to	better	understand	the	brain	
mechanisms	 of	 psychedelics	 and	 music,	 and	 the	 therapeutic	 mechanisms	 of	 music	 in	
psychedelic	therapy.	
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Appendix:		
Study-details	for	behavioural	and	clinical	
studies	referenced	in	chapter	1.6.1	-1.6.6	
	
Abbreviations:	LSD;	Lysergic	Acid	Diethylamide;	DMT;	Dimethyltryptamine,	VLD;	Very	low	dose,	LD;	
Low	dose,	MD;	Medium	dose;	HD;	High	dose,	CBT;	Cognitive-behavioural	therapy,	FTCD;	Fagerström	
Test	 for	 Cigarette	 Dependence,	 TQD;	 Target	 Quit	 Date,	 5D-ASC;	 5-Dimensional	 Altered	 States	 of	
Consciousness	 Scale,	 11D-ASC;	 11-Dimensional	 Altered	 States	 of	 Consciousness,	 MEQ;	 Mystical	
Experience	 Questionnaire,	 ARCI;	 Addiction	 Research	 Center	 Inventory,	 SIP;	 Short	 Inventory	 of	
Problems,	BAC;	Breath	Alcohol	Concentration,	SOCRATES	8A;	The	Stages	of	Change	Readiness	and	
Treatment	 Eagerness	 Scale,	 AASE;	 The	 Alcohol	 Abstinence	 Self-Efficacy	 Scale,	 PACS;	 The	 Penn	
Alcohol	Craving	Scale,	POMS;	The	Profile	of	Mood	States,	NEO-PI-3;	the	NEO	Personality	Inventory	3,	
TLFB;	Timeline	Follow-back,	QSU;	Questionnaire	on	Smoking	Urges,	SASE;	Smoking	Abstinence	Self-
Efficacy	Scale,	HRS;	Hallucinogen	Rating	Scale,	SOCQ;	States	of	Consciousness	Questionnaire,	SCID-
IV;	Structured	Clinical	Interview	for	DSM-IV,	BPRS;	Brief	Psychiatric	Rating	Scale,	YMRS;	Young	Mania	
Rating	 Scale,	 HAM-D;	 Hamilton	 Rating	 Scale	 for	 Depression,	 MADRS;	 Montgomery-Asberg	
Depression	Rating	Scale,	GAF;	Global	Assessment	of	Functioning,	QIDS;	16-item	Quick	 Inventory	of	
Depressive	 Symptoms,	 BDI;	 Beck	 Depression	 Inventory,	 STAI-T;	 Spielberger’s	 State-Trait	 Anxiety	
Inventory	 [trait	 version],	 SHAPS;	 Snaith-Hamilton	 Pleasure	 Scale,	 fMRI;	 functional	 Magnetic	
Resonance	Imaging,	WSWS;	Wisconsin	Smoking	Withdrawal	Scale,	EORTC-QLQ-30;	European	Cancer	
Quality	 of	 Life	 Questionnaire	 30-item	 version	 1.0,	 HADS;	 Hospital	 Anxiety	 and	 Depression	 Scale,	
GRID-HAMD;	 GRID-Hamilton	 Depression	 Rating	 Scale,	 HAM-A;	 Hamilton	 Anxiety	 Rating	 Scale,	 BSI;	
Brief	Symptom	Inventory,	MQOL;	McGill	Quality	of	Life	Questionnaire,	LOT-R;	Life	Orientation	Test-
Revised,	 LAP-R;	 Life	 Attitude	 Profile-Revised,	 DEM;	 Demoralization	 Scale,	 HAI;	 Hopelessness	
Assessment	 and	 Illness,	 DAS;	 Death	 Anxiety	 Scale,	 DTS;	 Death	 Transcendence	 Scale,	 WHO-Bref;	
World	Health	Organization	Quality	of	Life	scale,	brief	version,	FACIT-SWB;	Functional	Assessment	of	
Chronic	 Illness	 Therapy-Spiritual	Well-Being,	 YBOCS;	 The	 Yale-Brown	 Obsessive	 Compulsive	 Scale,	
VAS;	 Visual	 Analogue	 Scale,	 FERT;	 Facial	 Emotion	 Recognition	 Task,	MET1;	Multifaceted	 Empathy	
Test,	PLMT;	Pattern/Line	Meanings	Task,	ZKPQ;	Zuckerman-Kuhlman	Personality	Questionnaire,	FPI;	
Freiburg	 Personality	 Inventory,	 TAS;	 Tellegen	 Absorption	 Scale,	 PASI;	 Passive-Spontaneous	
Imagination,	 SCL-90-R;	 The	 Symptom	 Check-List-90-Revised,	 SVO;	 Social	 Value	 Orientation,	MET2;	
Motivational	Enhancement	Therapy		
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Behavioural	/	questionnaire	studies	
Study	 Drug	 Dose	
Route	of	
admini-
stration	
Tasks/Questionnai
res	
Timing	of	
task/questionnaire	
relative	to	drug-
administration	(prior,	
baseline	or	post)	
Vollenweider	
et	al.,	1998	 Psilocybin	 250	µg	/kg	 Oral	
APZ-OAV		
DRT	(Delayed	
Response	Task)	
Prior:	unspecified	
Post:	80	min	
Hasler	et	al.,	
2003	 Psilocybin	
VLD	=	45	µg/kg	
LD	=	115	µg/kg	
MD	=	215	µg/kg	
HD	=	315	µg/kg	
Oral	
5D-ASC	
AMRS	
Frankfurt	Attention	
Inventory	
	
unspecified	
Carter	et	al.,	
2005	 Psilocybin	 215	µg/kg	 Oral	
Multiple	Object	
Tracking	
CANTAB	(spatial	
working	memory)	
	
Prior:	unspecified	
Post:	120	min	
	
	
	
5D-ASC	 180	min	
Griffiths	et	
al.,	2006	 Psilocybin	 30mg/70kg	 Oral	
Monitor	Rating	
Questionnaire	
	
	
	
Prior:	10	min		
Post:	30	min,	60	min,	90	
min,	120	min,	180	min,	
240	min,	300	min	and	360	
min		
Hallucinogen	
Rating	Scale	
APZ	
ARCI	
States	of	
Consciousness	
Questionnaire	
Mysticism	
Questionnaire	
Post:	7h	
	
PEQ	
Mysticism	Scale		
Post:	2	months	
	240	
Spiritual	
Transcendence	
Scale	
NEO	PI-R	
PANAS-X	
Wittmann	et	
al.,	2007	 Psilocybin	
MD	=	115	µg/kg	
HD	=	250	µg/kg	
Oral	
Sensorimotor	tasks	
	
Prior:	unspecified	
Post:	90	min	
	
AMRS	
	
Baseline		
Post:	80	min	and	280	min	
5D-ASC	
	
Post:	110	min	
	
SSP	(CANTAB)	
Baseline	
Post:	100	min	and	360	min	
Wackermann	
et	al.,	2008	 Psilocybin	
VL=	12	µg/kg	
MD	=	115	µg/kg	
HD	=	250	µg/kg	
Oral	
Duration	
Reproduction	Task	
AMRS	
	
Prior:	unspecified	
Post:	90	min	and	240	min	
	
	
ASC	 Not	specified	
Griffiths	et	
al.,	2008	 Psilocybin	 30mg/70kg	 Oral	
VAS	 Post:	0.5	–	6	h	
HRS	
APZ	
Mysticism	Scale	
Pahnke-Richards	
Mystical	
Experience	
Questionnaire	
Post:	7	h	
NEO	PI-R	
PANAS-X	
Quality	of	Life	
Inventory	
Measure	of	
Actualisation	
Potential	
Post:	2	months	14	months	
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Mysticism	Scale	
Spiritual	
Transcendence	
Scale	
Faith	Maturity	
Scale	
FACIT-Sp-NI-12	
PEQ	
	
Post:	2	months	
	
Retrospective	
Questionnaire	 Post:	14	months		
Griffiths	et	
al.,	2011	 Psilocybin	
0,	5,	10,	20	and	
30	mg/70	kg	
	
Ascending	
order	in	1	
month	intervals	
Oral	
Hallucinogen	
Rating	Scale	
APZ	
ARCI	
State	of	
Consciousness	
Questionnaire	
Mysticism	Scale	
(Experience-
Specific)	
	
	
Post:	7h	
	
	
	
	
	
Retrospective	
Questionnaire	
PEQ	
Mysticism	Scale	
(Lifetime)	
DTS	
Post:	1	month	and	14	
months	
	
	
Carhart-
Harris	et	al.,	
2011	
Psilocybin	 1.5	mg	and	2	mg	 IV	
Post-drug	ratings	
questionnaire	
	
Post:	25	min	
	
5D-ASC	
	
Post:	60-90	min	
Maclean	et	
al.,	2011	 Psilocybin	
30mg/70kg	
0,	5,	10,	20	and	
	 NEO	Personality	Inventory	
Baseline	
Post:	1	and	2	months	
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30	mg/70	kg	
	
Ascending	
order	in	1	
month	intervals	
States	of	
Consciousness	
Questionnaire	 Post:	7	h	
Mysticism	Scale	
APZ	 Unspecified	
Quednow	et	
al.,	2012	 Psilocybin	 260	µg/kg	 Oral	
PPI	(prepulse	
inhibition)	
	
Post:	60	min	
	
	
Stroop	Task	
	
Post:	85	min	
	
5D-ASC	 Post:	125	min	
Kometer	et	
al.,	2012	
Psilocybin	
	
215	µg/kg	 Oral		
Facial	Emotional	
Recognition	
	
Emotional	
Go/Nogo	task	
	
EEG	
5D-ASC	
PANAS	
STAI-S	
Post:	130	min	
	
	
	
	
	
Self-report	 Post:	360	min	
Schmid	et	al.,	
2015	 LSD	
200	µg,		
2.84	±	6.13	
µg/kg		
(mean	and	
SEM;	range,	
2.04–3.85	μg)	
Oral	
5D-ASC	
VAS	
Prior:	24	h		
Baseline	
Post:	0.5	h,	1	h,	1.5	h	and	
24	h	
AMRS	
ARCI	
Prior:	Unspecified	
Post:	3	h,	10	h	and	24	h	
Kuypers	et	
al.,	2016	
Ayahuasc
a	
Group	1	(mean	
and	SD):	75.5	±	
11.1	mg	DMT,		
98.4	±	14.4	mg	
harmine,	
	88.6	±	13.0	mg	
Oral	
PLMT	
Picture	Concept	
Task	
Prior:	3	h		
Post:	1.5-2	h	
	
VAS	 Post:	After	acute	effects	subsided	(not	specified)	
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tetrahydroharm
ine,		
and	11.3	±	1.7	
mg	harmaline	
	
Group	2	(mean	
and	SD):	42.8	±	
14.9	mg	DMT,		
21.4	±	7.5	mg	
harmine,		
30.8	±	10.8	mg	
tetrahydroharm
ine,	and	4.6	±	
1.6	mg	
harmaline	
Dolder	et	al.,	
2016	 LSD	 100	and	200	µg	 Oral	
FERT	
MET1	
	
Post:	5	h	(for	100	µg)	and	7	
h	(for	200	µg)	
SVO		
	
Post:	6	h	(for	100	µg)	and	8	
h	(for	200	µg)	
VAS	
AMRS	
Repeatedly	(not	specified)	
Family	et	al.,	
2016	 LSD	 40	and	80	mcg	 IV	
Picture-naming	
task	 Post:	180–300	min		
Preller	et	al.,	
2016	 Psilocybin	 215	µg	/kg	 oral	 Cyberball	Task	
Post:	during	fMRI	(not	
specified)	
Clinical	studies	
Study	 Drug	 Dose		(all	oral)	 Procedures	
Duration	
of	
procedur
es		
Tasks/Quest
ionnaires	
Timing	of	
task/questionnaire	
relative	to	drug-
administration	
(prior,	baseline	or	
post)	
Moreno	et	
al.,	2006	 Psilocybin	
VLD:	25µg/kg	
	
LD:	100	µg/kg	
	
MD:	
200	µg/kg	
	
HD:	300µg/kg	
PAT	for	
obsessive	
compulsive	
disorder	
8h	
YBOCS	
VAS	
	
	
	
	
	
Baseline	
Post:	4h,	8h	and	24h	
	
	
Grob	et	al.,	
2011	 Psilocybin	 0.2mg/kg	
PAT	for	end-
of-life	anxiety	 8h	
HRS	 Post:	8h	
POMS	 Prior:	Day	
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STAI	
5D-ASC	
Brief	
Psychiatric	
Rating	Scale	
Post:	ending	of	each	
session	
	
BDI	
POMS	
STAI	
Post:	One	day,	2	
weeks,	and	at	
monthly	intervals	
for	6	months	
Bogenschut
z	et	al.,	
2012	
Psilocybin	 0.3	mg/kg	0.4	mg/kg	
PAT	for	
alcoholism	
	
Psychosocial	
intervention	
(MET2)	
	
	
4	
sessions	
before	
1st	
psilocybi
n	
session,		
4	
sessions	
between	
1st	and	
2nd	
psilocybi
n	
session,	
and	4	
sessions	
after	2nd	
psilocybi
n	session	
HRS	
5D-ASC	
SOCQ	
MEQ	
SOCRATES	
8A	
AASE	
PACS	
POMS	
Hood	
Mysticism	
Scale	
PEQ	
ASPIRES	
Spiritual	
Transcende
nce	Scale	
Brief	
Multidimens
ional	
Measure	of	
Religiousnes
s/Spirituality	
NEO-PI-3	
Schwartz	
Value	
Survey	
ARCI		
SIP	
	
	
Post:	7h	
TLFB	
	
Baseline:	covering	
12	week	prior	to	
enrollment	
BAC	 Every	session	
Gasser	et	
al.,	2014	 LSD	
200	µg	
(experimental	
dose)	and	20	
µg	(active	
placebo)	
PAT	for	end-
of-life	anxiety	
	
	
	
8h	
	
	
	
	
	
	
SCID	
STAI-T	
EORTC-QLQ-
30	
SCL-90-R	
HADS	
	
	
Baseline	
Post:	1	week,	2-
month,	12-month		
Drug-free	
psychotherapy		
60-90	
min	
	
SOCQ	
After	each	
experimental	
session	
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Follow-up	
evaluation	
2	months	
after	
second	
experime
ntal	
session	
Johnson	et	
al.,	2014	 Psilocybin	
20mg/70kg	
	
30mg/70kg	
Preparation	
meetings:	
CBT	based	on	
“Quit	For	life”	
programme	
	
90	min	-
Weekly	
for	4	
weeks	
prior	to	
TQD	
TLFB	
FTCD	
	
	
Baseline	
Post:	Every	week	2-
15	and	6-month	
Integration	
meetings	
	
1h	-	Day	
after	
psilocybi
n	session	
QSU	
SASE	
WSWS	
	
Baseline	
Post:	6	weeks,,	
Week	8-15	and	6-
months	
Support	
meetings	
	
45	min	-	
Weekly	
after	
TQD	for	
10	weeks	
Visual	
Effects	
Questionnai
re	
	
Baseline	
Post:	6-months	
	
Support	
meetings	
PAT	for	
smoking	
cessation		
45	min	-	
Weekly	
after	
TQD	for	
10	weeks	
8h	
	
Post-session	
Headache	
Interview		
	
Post:	One	day	
	
Support	
meetings	
PAT	for	
smoking	
cessation		
TQD	
45	min	-	
Weekly	
after	
TQD	for	
10	weeks	
8h	
At	5th	
week	
Mysticism	
Scale	
	
Baseline	
Post:	1-week,	2	
weeks	and	3	weeks	
	
SOCQ	
	
Post:	7h	
	
PEQ	 Post:	1	week	after	every	session	
TQD	
	
Baseline	
	
TQD	
QSU	
SASE	
	
Baseline	
Post:	weekly	and	6-
months	
Garcia-
Romeu	et	
al.,	2014	
Psilocybin	 20mg/kg	30mg/kg	
TQD	
Medical	
interview	
Laboratory	
tests	
Assessment	of	
tolerability	
At	5th	
week	
Not	
specified	
TQD	
QSU	
SASE	
HRS	
	
Baseline		
Post:	7h,	weekly,	6-
months,		
	
TQD	
Medical	
interview	
Laboratory	
tests	
Assessment	of	
tolerability	
At	5th	
week	
Not	
specified	
Check-in	
and	
physiolo
Mysticism	
Scale	
SOCQ	
Post:	At	end	of	each	
session	
Ratings	of	
Personal	
Meaning,	
Post:	15	weeks	
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Non-directive	
approach	
gical	
recordin
gs	at	30,	
60,	120,	
180,	240,	
300,	and	
360	min	
post	
dose	
Spiritual	
Significance,	
and	Well-
being	
BPRS	
YMRS	
HAM-D	
MADRS	
	
Prior:	10	minutes	
Post:	40min,	80	min,	
140	min,	180	min;	1	
day,	7	days,	14	days,	
21	days	
QIDS	
BDI	
STAI-T	
SHAPS	
	
	
	
	
	
	
	
Baseline	
Post:	1	day	and	3	
days	after	high	dose	
	
	
	
	
	
Osorio	et	
al.,	2015	 Ayauasca	
120-200	ml	
(2.2	ml/kg)	
Ayahuasca	
	
0.8	mg/ml	
DMT	
0.21	mg/mL	
harmine	
Non-directive	
approach	
Experimental	
sessions	
	
	
	
Check-in	
and	
physiolo
gical	
recordin
gs	at	30,	
60,	120,	
180,	240,	
300,	and	
360	min	
post	
dose	
8h	
	
	
	
	
	
	
11D-ASC	
	
Post:	6-7h	
	
Carhart-
Harris	et	al.,	
2016	
Psilocybin	
Low:	10	mg	(2	
x	5	mg)	
	
High:	25	mg	
(5	x	5	mg)	
Non-directive	
approach	
Experimental	
sessions	
	
	
Drug-free	
psychotherapy	
sessions	
Check-in	
and	
physiolo
gical	
recordin
gs	at	30,	
60,	120,	
180,	240,	
300,	and	
360	min	
post	
dose	
8h	
	
	
	
	
HAM-D	
MADRS	
GAF	
	
Post:	1	day	(after	
high	dose)	
	
QIDS	
	
Post:	2,	3,	and	5	
weeks	
SCID	
STAI-T	
EORTC-QLQ-
30	
SCL-90-R	
HADS	
	
	
Baseline	
Post:	1	week,	2-
months,	and	12-
months	(after	high	
dose)	
SOCQ	
After	each	
experimental	
session	
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60-90	
min	
	
Gasser	et	
al.,	2014	 LSD	
200	µg	
(experimental	
dose)	and	20	
µg	(active	
placebo)	
Follow-up	
evaluation	
2	months	
after	
second	
experime
ntal	
session	
SOCQ	
GRID-HAM-
D-17		
HAM-A	with	
SIGH-A	
BDI	
HADS	
STAI	
POMS	
Total	Mood	
Disturbance	
Subscale	
BSI	
MQOL	
LOT-R	
LAP-R	Death	
Acceptance	
DTS	
Purpose	in	
Life	Test	
LAP-R	
Baseline	
Post:	After	each	
experimental	
session,	5	weeks,	
and	6-months	
Meetings	with	
session	
monitors	
(non-directive	
and	
supportive)	
Day	after	
each	
session	
(mean	
1.2	h),	on	
two	or	
more	
occasion
s	
between	
first	and	
second	
session	
(mean	
2.7	
occasion
s	for	a	
mean	
total	of	
3.4h),	
and	on	
two	or	
more	
occasion
s	
between	
second	
session	
and	6-
month	
follow-
up	
SOCQ	
GRID-HAM-
D-17		
HAM-A	with	
SIGH-A	
BDI	
HADS	
STAI	
POMS	
Total	Mood	
Disturbance	
Subscale	
BSI	
MQOL	
LOT-R	
LAP-R	Death	
Acceptance	
DTS	
Purpose	in	
Life	Test	
LAP-R	
HADS	
BDI	
STAI	
	
	
	
	
	
	
Baseline		
Post:	After	each	
experimental	
session,	5	weeks,	6-
months	
	
Prior:	1	day		
Post:	1	day	after,	1-
2	weeks	after,	6	
weeks	after,	7	
weeks	after	dose	1	
(corresponding	to	1	
day	prior	to	dose	2)	
1	day	after,	6	weeks	
after,	and	26	weeks	
after	dose	2	
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Assessments	
6	weeks	
post	
dose	1,	6	
weeks	
post	
dose	2	
	
6-month	
follow-
up	
Griffiths	et	
al.,	2016	 Psilocybin	
Low:	
1mg/70kg	
	
High:	
22mg/70kg	
Assessments	
6	weeks	
post	
dose	1,	6	
weeks	
post	
dose	2	
	
6-month	
follow-
up	
DEM	
HAI	
DAS	
DTS	
WHO-Bref	
FACIT-SWB	
PEQ	
2	weeks	post	dose	
1,	26	weeks	post	
dose	2	
	
	
	
	
Ross	et	al.,	
2016	 Psilocybin	 0.3mg/kg	 Oral	
Assessm
ents	
6	weeks	
post	dose	1,	
6	weeks	
post	dose	2	
	
6-month	
follow-up	
HADS	
BDI	
STAI	
	
	
	
	
	
	
	
DEM	
HAI	
DAS	
DTS	
WHO-Bref	
FACIT-SWB	
PEQ	
	 MEQ		
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Appendix:	The	music	playlist	
The	 music	 playlist	 used	 in	 the	 depression	 trial	 is	 displayed	 below.	 Please	 note	 that	 following	 this	
playlist,	an	updated	version	of	 this	playlist	has	been	developed.	Also	note	 that	 the	playlist	used	did	
not	merely	list	the	songs	in	the	structure	suggested	below,	but	included	a	mixing	of	volume,	fade-ins,	
fade-outs,	etc.	Other	playlists	are	developed	that	employ	different	music	styles	and	target	different	
therapy	 objectives.	 For	 access	 to	 the	 latest	 version	 of	 this	 playlist	 and	 other	 works,	 visit	
www.mendelkaelen.com	
	
Music	playlist	(v1.2.)	for	psychedelic	therapy	sessions	for	depression	with	psilocybin	
	Time		 	 Track		
00:00:00		 Stars	of	the	Lid	-	Dungtitles	(In	A	Major)		
00:05:57		 Stars	of	the	Lid	-	Articulate	Silences	Part	1		
00:11:20		 Stars	of	the	Lid	-	Articulate	Silences	Part	2		
00:16:58		 Stars	of	the	Lid	-	Evil	that	never	arrived		
00:22:03		 Harold	Budd	&	John	Fox	-	Sunlit	Silhouettes		
00:25:05		 Harold	Budd	&	John	Fox	-	A	Delicate	Romance		
00:32:36		 Brain	Eno	&	Harold	Budd	-	Against	the	Sky		
00:37:29		 Brain	Eno	&	Harold	Budd	-	Lost	in	the	Humming	Air		
00:41:43		 Robert	Rich	&	Lisa	Moskow	-	Bija		
00:52:24		 Robert	Rich	–	Sagrada	Familia		
00:56:15		 Robert	Rich	–	The	spiral	steps		
Silence	(3	minutes)		
01:08:34		 Henry	Gorecki	-	Lento	-	Sostenuto	Tranquillo	Ma	Cantabile		
01:33:44		 Maria	Bayo	&	Sinfonica	De	Tenerife	-	Bailero		
01:39:25		 David	Darling	–	Prayer	for	compassion		
01:43:36		 David	Darling	–	Stones	start	spinning		
01:47:53		 Carlos	Cipa	–	The	Whole	Truth		
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01:53:25		 Greg	Haines	–	183	Times		
02:02:36		 Harold	Budd	&	John	Fox	–	Coming	into	focus		
Silence	(30	seconds)		
02:08:06		 Ludovico	Einaudi	-	The	Journey		
02:10:43		 Arvo	Part	–	Da	Pacem	Domine		
02:16:28		 Max	Richter	–	The	Young	Mariner		
02:20:39		 Max	Richter	–	Diner	and	the	ship	of	dreams		
02:26:07		 Henryk	Gorecki	-	Lento	e	Largo	Tranquillissimo		
02:35:41		 Greg	Haines	–	Azure		
Silence	(20	seconds)		
02:50:12		 Otto	A.	Totland	-	Open		
02:52:42		 Otto	A.	Totland	-	Steps		
02:54:34		 Federico	Albanese	-	Disclosed		
Silence	(50	seconds)		
03:01:21		 Dead	Can	Dance	-	Devorzhum		
03:07:30		 Robert	Rich	-	Amrita	(Water	of	Life)		
03:13:56		 Ólafur	Arnalds	&	Alice	Sara	Ott	-	Verses		
03:17:54		 Ólafur	Arnalds	&	Alice	Sara	Ott	-	Piano	Sonata	No.3	Largo		
03:26:58		 Ólafur	Arnalds	&	Alice	Sara	Ott	-	Nocturne	in	C	Sharp	Minor		
03:31:23		 David	Darling	–	Beautiful	Life		
03:33:30		 David	Darling	–	When	we	Forgive		
03:37:35		 Enya	-	sumiregusa		
03:42:20		 Jon	Hassel,	Ry	Cooder	&	Ronu	majumdar	-	Bay	of	Bengal		
03:47:08		 Jon	Hassel,	Ry	Cooder	&	Ronu	majumdar	-	River	song		
Silence	(25	seconds)		
04:12:55		 Anugama	-	Shamanic	dream		
Silence	(20	seconds)		
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04:24:26		 Arvo	part	-	Spiegel	Im	Spiegel		
04:35:12		 Nest	-	Stilness		
04:40:49		 Arve	Henriksen	-	Glacier	descent		
04:48:17		 Arve	Henriksen	-	Opening	Image		
04:52:33		 Arve	Henriksen	-	Hambopolskavalsen		
04:57:54		 Daniel	Namkhay	-	Um	Bolero	Galíctico		
Silence	(15	seconds)		
05:04:05		 Dead	Can	Dance	-	Nierika		
Silence	(15	seconds)		
05:09:49		 Brian	McBride	–	Toil	Theme	Part	1,2&	3		
05:17:31		 Nils	Frahm	-	Ambre		
05:21:19		 Nils	Frahm	-	Tristana		
Silence	(2.5	minutes)		
05:42:44		 Mozart	-	Ave	Verum	Corpus		
05:46:46		 Mercedes	Sosa	-	Gracias	a	la	Vida		
05:51:17		 Ladysmith	Black	Mambazo	-	King	of	Kings		
05:55:33		 Buffy	saint	Mary	-	Up	where	we	belong		
06:00:10		 Olafur	Arnalds	&	Alice	Sara	Ott	-	Letters	of	a	traveler		
06:04:22		 Stars	of	the	Lid	-	Don't	Bother	They're	Here		
	
	
	
	
	
	
	
